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Psychotropic medication Any agent prescribed for the purpose of bringing about
behavioural, cognitive or emotional changes.
Psychoactive medication Any agent that has psychotropic effects regardless of
the intent when prescribing the drug.
Mental retardation
Learning disability
Normalization
Deinstltutionalisatlon
Front line staff
Difl8ren~ald~gnos~
Challenging behaviour
Mental retardation refers to substantial limitations in
present functioning. It is manifested as significantly
sub-average intellectual functioning, existing
concurrently with related disabilities in two or more of
the following applicable adaptive skill areas:
communication, self-care, home living, social skills,
community use, self-direction, health and safety,
functional academics and work. Mental retardation
begins before age 18.
The preferred term for mental retardation used in the
republic of Ireland. Definition as above.
The process of bringing or restoring to the normal
standard. In the case of persons with learning
disability, normalisation refers to the process of
integrating them into the community so as to lead as
normal a life as possible.
The practice of caring for individuals in the community,
rather than in an institutional environment with resultant
effects on the individual, the individual's family, the
community, and the health care system.
Staff working directly with persons with learning
disability. Such staff include nursing staff, childcare
staff, teachers, workshop supervisors and unqualified
staff.
The determination of which two or more diseases (or
disorders) with similar symptoms is the one from which
a patient is suffering from based on an analysis of the
clinical data.
Culturally abnormal behaviour of such an intensity,
frequency or duration that the physical safety of the
person or others is likely to be placed in serious
jeopardy, or behaviour which is likely to seriously limit
use of, or result in the person being denied access to,
ordinary community facilities.
xvii
Stereotypy
Tardive Dyskinesia
Anticholinergic
medication
Stimulant medication
Anxiolytlc medication
Hypnotic medication
Polypharmacy
Motor behaviour that is repetitive, often seemingly
driven, and non-functional. This behaviour markedly
interferes with normal activities or results in severe
bodily self -injury. The behaviour is not due to the direct
physiological effects of a substance or a general
medical condition.
A syndrome of potentially irreversible, involuntary,
dyskinetic movements that may develop in patients
who have been treated with antipsychotic medications
(for example phenothiazines) longer-term. Other drugs
known to cause tardive dyskinesia include: tricyclic
antidepressants, selegiline, clozapine, levamisole and
metoclopramide.
An agent that blocks the parasympathetic nerves. An
agent commonly prescribed to counter the
extrapyramidal side effects (shaking, orofacial
movements etc) of many of the antipsychotic
medications
A class of medication which includes amphetamine and
dexamphetamine. Amphetamines act by releasing
noradrenaline stored in nerve endings in both the eNS
and the periphery. Typically stimulant medication or
psychostimulants are used in the treatment of attention
deficit disorder (with and without hyperactivity) and in
some cases for appetite control.
Agents that alleviate anxiety, tension, and neurotic
symptoms, promote sedation, and have a calming
effect without affecting clarity of consciousness or
neurological conditions. Some are also effective as
anticonvulsants, muscle relaxants, or anaesthesia
adjuvants. Adrenergic beta-antagonists are commonly
used in the symptomatic treatment of anxiety but are
not included here.
Substances with a benzodiazepine ring structure widely
used to treat anxiety and neuroses. Drugs in this class
also generally have sedative or weak hypnotic
properties and may be effective as muscle relaxants,
anticonvulsants, and anaesthesia adjuvants.
A class of medications used to induce sleep.
Hypnotics in full doses can disrupt the normal sleep
pattern. Hypnotics do not induce natural sleep.
The administration of two or more medications from
one class of medication.
xviii
Co-pharmacy
Monopharmacy
Diagnostic over-
shadowing
PRN medication
Antidepressant
medication
Antipsychotic medication
The administration of two or more medications from
different classes of medications.
The administration of one medication only from one
class of medication.
Where diagnosticians tend to attribute abnormal
behaviour to the presence of a learning disability and
overlook coexisting psychopathology.
Medication prescribed on an "as required" basis.
An agent that stimulates the mood of a depressed
patient, including tricyclic antidepressants and
monoamine oxidase inhibitors.
Antipsychotic drugs (also called neuroleptic drugs and
major tranquillisers) are a chemically diverse (including
phenothiazines, thioxanthenes, butyrophenones,
dibenzoxazepines, dibenzodiazepines and
diphenylbutylpiperidines) but pharmacologically similar
class of drugs used to treat schizophrenic, paranoid,
schizoaffective and other psychotic disorders, acute
delirium and dementia and manic episodes (during
induction of lithium therapy), to control the movement
disorders associated with Huntington disease, Gilles de
la Tourette's syndrome and ballismus and to treat
intractable hiccups and severe nausea and vomiting.
Antipsychotic agents bind to dopamine, histamine,
muscarinic cholinergic, a adrenergic and seratonin
receptors. Blockade of dopaminergic transmission in
various areas is thought to be responsible for their
major effects: antipsychotic action by blockade in the
mesolimbic and mesocortical areas, extrapyramidal
side effects (dystonia, akathisia, parkinsonism and
tardive Dyskinesia) by blockade in the basal ganglia
and antiemetic effects by blockade in the
chemoreceptor trigger zone of the medulla.
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ABSTRACT
The administration of psychotropic and psychoactive medication for persons
with learning disability and accompanying mental illness and/or challenging
behaviour has undergone much critical review over the past two decades.
Assessment and diagnosis of mental illness in this population continues to be
extremely problematic. Some of the common problems of
psychopharmacological treatment include polypharmacy, irrational
prescription procedures and frequent over-prescription. It is clear that all
forms of treatment including non-pharmacological interventions need to be
driven by accurate and appropriate diagnoses. Where a psychiatric diagnosis
has been identified, it greatly aides the selection of appropriate medication,
although a specific medication for each diagnosis, as was once hoped, is
simply no longer a reality in practice. Part one of the present thesis seeks to
address many of the current issues in mental health problems and
pharmacological treatment to date. The author undertook a drug prevalence
study within both residential and community facilities for persons with learning
disability within the Mid-West region of Ireland in order to ascertain the current
level of prescribing of psychotropic and psychoactive medications for this
population.
While many attempts have been made to account for the variation in
prescribing, little systematic and empirical research has been undertaken to
investigate the factors thought to influence such prescribing. While studies
investigating the prescribing behaviours of General Practitioners (GP's) have
illustrated the complex nature of the decision making process in the context of
general practice, no similar efforts have yet been directed at examining the
prescribing behaviours of Consultant Psychiatrists. Using The Critical
Incident Technique, the author interviewed Consultant Psychiatrists in the
Republic of Ireland to gather information relating not only to their patterns of
prescribing for learning disabled populations, but also to examine reasons
influencing their prescribing in addition to several related factors. Part two of
this thesis presents the findings from this study and a number of issues are
raised, not only in relation to attempting to account for the findings from part
one of the thesis, but also with respect to implications for improved
management and clinical practice.
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CHAPTER ONE
INTRODUCTION TO LEARNING
DISABILITY
1.1 Chapter Introduction
In recent years significant advances have been made in the field of
Learning disability/mental handicap. There is now a greater
understanding of the condition of learning disability per se in addition to
the many complex secondary handicaps associated with it (epilepsy,
challenging behaviour etc.). In few other professions can the concept of
the inter-disciplinary process be seen to be as effective as it has been
and continues to be within learning disability. Perhaps the most
significant of these changes has been the shift from Ninstitutional" or
hospital settings to community integration and living. This has been
particularly evident in Great Britain (and also in Ireland) where the
number of hospital beds for people with learning disability has been
greatly reduced and many of these hospitals have been closed down.
This has invariably led to an increase in the number of community
facilities required. Such changes have been very beneficial in many
respects, especially for the individuals in question, but such policy
changes do create anxiety amongst the families and carers of these
clients. Much of this anxiety rests with the fact that many families feel
their family member will not be able to cope and integrate into community
living and on this basis, a service will not be available. If anything, this
emphasises the need for continuing residential care for many clients and
the importance of the support that is required for client and family alike.
1.2 Aims of the Chapter
The aims of this chapter are several-fold. Firstly one will examine some
of the historical perspectives in terms of the study of learning disability.
Terminology and labelling will be examined in some detail before moving
on to a definition of learning disability and the many problems associated
with the varying definitions and classification systems used.
Epidemiology, prevalence and causes of learning disability will be
discussed before moving on to look at the social aspects of learning .
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disability and their relevance. Many other associated topics will be
discussed in conjunction with the main sections throughout the course of
the chapter. .
1.3 Terminology and Labelling
For the last number of years there has been a growing debate as to the
terminology used within the field of what is presently termed learning
disability. For years, especially in Ireland, the term mental handicap was
used and to date some centres still adhere to this term. If one looks to
the general public, there is still a great deal of confusion regarding the
differences between mental handicap and mental illness. The majority of
this confusion tends to stem from the historical perspectives of mental
handicap where these individuals were segregated from society and
placed in psychiatric institutions alongside patients with mental illness. In
this respect there is still a sense of stigmatisation associated specifically
with the term "mental handicap", perhaps far more than any other term
used to date. From the perspective of the individual, one has to search
for a term, which will both describe and place an emphasis on their real
difficulties, while also and perhaps more importantly have no negative
connotations for the individual, which may deter community integration.
Those who bear the term "mental handicap" find it stigmatising and
offensive while the parents of these individuals are often hurt and
shocked when such terminology is used.
Fraser and Green (1991) note that definitions and classification systems
will always be a problem area and the field of learning disability is by no
means an exception. No matter what terms and definitions one uses,
there will always be connotations involved - be they positive or negative.
To date there is still no one globally accepted term for or definition of
learning disability/mental handicap, and there is far more involved than
just using a term or understanding a definition. "Mental handicap is in
some respects a confusing and unsatisfactory term used to describe a
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condition of lifelong intellectual impairment and accompanying disabilities
in social functioning. It is not simply a clinical diagnosis: it is a social
process of changing expectations, labelling and families coming to some
understanding of what handicap means" (Fraser and Green, 1991, p.1;
Booth, 1978).
Although several varying terms have been used over the past century (in
every twenty five years, there has been a new term used and adapted),
the question must be asked as to whether there is the need to constantly
develop new definitions and incorporate new terminology. On the one
hand there is clearly the need to constantly develop new ideas and
terminology as a stigma will always be attached to terms over the years
(negative or otherwise). In addition and on the other hand, simply
changing a label will not change public perception, nor will it decrease
the many problems that these individuals have. As the report of the
second PSI Mental Handicap Group (working party on client terminology)
has stated "it will be meaningful and important to find anew, more
appropriate terminology that would create in the public mind, a truer
picture of people's difficulties and remove the unnecessary additional
hurt caused them by the current terms" (1992, p.2).
No matter what terminology is to be used, the issue of labelling will
always be a pertinent one. Whether or not to label has been an issue for '
workers in the field for some years, and if one were to label, which labels
should be used (Hastings, 1994). Specific to the field of learning
disability, research has been undertaken ,which has supported both the
positive and the negative effects of labelling. On the basis of the
research to date on labelling in the field of learning disability, there are
still no clear answers available and this has "led to a 'not proven' verdict
on the damaging effects of labelling" (Hastings, 1994, p.363; Franco,
1982; MacMillan et al., 1974). As has been mentioned above, a change
in terminology will not necessarily mean a change in labelling but it may
necessitate more positive connotations toward the individual. As Baroft
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(1991) has stated "labels cannot erase biologically determined
differences, but the connotations that they evoke can affect the means
through which those differences can be diminished" (p.1 00).
More recent research by Hastings and colleagues (Hastings and
Remington, 1993; Hastings et aI., 1993) on the effects of labelling,
indicated that although the newer terms such as "Learning disability" and
"Learning Difficulty" have more positive connotations than do the older
terms such as "mental sub normality" or "mental handicap", all labels
used were negatively evaluated by subjects. The only term to receive a
positive rating was the use of the term "exceptional", although whether
after a period of time of usage, this term would still be used in a positive
sense, remains to be seen.
In Ireland and Britain up until recently, the term mental handicap was
most in favour - at least in terms of those who were undertaking research
and working in the field. With the development of concepts such as
normalisation and advocacy in particular, the field of learning disability
continued its work in trying to find de-stigmatising terminology.
Individuals (with learning disability) who were involved in self-advocacy
groups who were verbal and could express their views reacted strongly
to the use of terminology such as "mental handicap". Although at the
time this term fitted in well with the notion of physical disability, clients
themselves felt the term was highly stigmatising and incorporated the
notion that "mental" referred to mental illness - terminology that the field
was striving to get away from for many years and the notion that
"handicap" referred to a from of physical disability. These clients were
more in favour of terms such as learning disability or learning difficulty.
One is now into a situation similar to the States where learning disability
or difficulty refers more to problems of education. In the United Kingdom
in 1991, the then Minister for Health stated that the term learning
disability was to be the official term used. Although service provision
. ..
was quite similar in Ireland, there was no official stance on the matter,
and the term learning disability gradually became used more frequently.
Interestingly parents of children with learning disability have reacted
negatively to the use of this term as many of them feel that there is too
much emphasis placed on the notion of learning, thus education and
thus intellectual level and it does little for those who have sensory and
physical handicaps or disabilities. The term developmental disability was
a term that was introduced in order to cover the entire range of
handicapping conditions in the mid 1970's and in a sense it was a
definition that placed an emphasis on the fact that individuals who had
handicapping conditions outside of learning disability also required .
service provision. The term developmental disability was defined as "a
severe, chronic disability, which is attributable to a mental or physical
impairment or combination of mental and physical impairments; is
manifested before age 22; is likely to continue indefinitely; and results in
substantial functional limitations in three or more areas of major life
activity" (Grossman, 1983, p.168). No matter what terminology one
wishes to use, there will always be the effect of labelling although this
can sometimes have a positive outcome as has been emphasised by
Zigler and Burack (1989) when they stated "labels can often have
positive consequences, particularly since they are often a necessary
precondition to the receipt of services" (cited in Reid, 1997,p.1).
More recently the term intellectual disability is being used with increased
frequency, although it begs the question are we now going back to our
system of classification on an intellectual basis and placing less
emphasis on adaptive behaviour and social factors - factors which
should have a greater emphasis placed on them in any future definition
of learning disability. As is stated by Reid (1997) "terminology in this field
has a short shelf life, however, and intellectual disability will probably go
downhill before long also" (p.1).
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1.4 Historical Perspectives
In terms of a history of the study of learning disability, this particular field
has had a very difficult start. It has by no means been straightforward
with the development of accurate and reflective definitions, terminology
and classification systems - on the other hand it has progressed very
slowly and gradually with new definitions and terminology being
introduced every number of years. Previous to the twentieth century, the
concept of learning disability (which will be used throughout this chapter
to denote mental handicap/mental retardation/intellectual impairment
etc.) was defined largely in terms of social and vocation competence. In
many communities this was an accepted value and the majority of
communities cared and looked after those who needed providing for.
1.5 "De-institutionalisation" and Community Integration.
Throughout the 1980's in Ireland we have seen a marked shift away
from this residential care system towards care in the community
(McConkey and Conliffe, 1989) - a term commonly known as de-
institutionalisation. The philosophy of de-institutionalisation represents a
return to community orientation, especially for those with severe and
profound levels of learning disability, which was in evidence prior to the
setting-up of residential facilities (institutions) in the late 1800's.
Government Policy in both the Republic of Ireland and Northern Ireland
have reflected the above aims and although the two services both North
and South have very different styles, their objectives are very similar in
nature. The Minster for Health and Social Welfare in 1985 in their green
paper on services for clients with a disability stated:
"there is no disagreement about the philosophy which should
underpin the development ofpolicies and programmes for
disabled people. The ultimate objective is to equip disabled
people to realise their full potential and to participate to the
greatest degree possible in the life of the community. The
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Government fully accepts that this should be the aim ofpublic
policy':
In a similar fashion, in Northern Ireland, the Dept. of Health in their
Regional Strategy for Health and Social Services stated:
"the core of the Department's policy for the mentally handicapped
is to help them to lead their lives as normally as possible and to
keep to an absolute minimum the need for long-term hospital care,
especially for children ... Concerted action to improve community
services will also form an essential component of the policy':
Apart from major advances such as de-institutionalisation, psychological
activities have had a specific impact in the field of learning disability.
Whereas psychology started out in the field purely in terms of intellectual
assessment, it soon branched into areas such as treatment, research,
and evaluation and was involved in the principles of normalisation and
advocacy. With the move to community living, there is now an even
greater need for psychological input and specialist services to be
delivered. The concept of normalisation is certainly one of the new
buzzwords in the field of learning disability in recent years. Although the
term has been around for some years now (Wolfensberger, 1972), and in
a sense tackles the issue of labelling, it is only relatively recently that it
has come of age. Normalisation refers to "provision of services and
supports to people with disabilities in the ways that they are most
normally provided in society for people without disabilities. It has
provided a touchstone for the context and structure of service delivery
and doctrines of least restrictiveness in treatment" (Jacobson and Mulick,
1996, p.3).
1.6 Establishment and Development of The American
Association on Mental Deficiency (AAMR).
One of the most fundamental points in terms of a history of the study of
learning disability was the establishment of a manual for classification
and it was not until the late 1950's that this manual was published by the
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AAMD (American Association on Mental Deficiency). This manual drew
heavily on the side of those in favour of intelligence as a system of
classification and thus the IQ definition of learning disability was
incorporated. Although level of learning disability was defined in terms of
deviation in measured intelligence, there was note taken of adaptive
behaviour - especially in a later edition published two years later. Still at
this time the only scientific measure of social adequacy was the Vineland
Social Maturity Scales, which were developed by Doll (1936). On this
basis alone, there was not enough evidence or instruments available in
order to change the classification system of the time. Nihira (1969) in the
United States in the late sixties was the first to develop a truly scientific
approach to the assessment of adaptive behaviour and in 1969 the first
edition of the Adaptive Behaviour Scale was published.
1.7 Definitions of Learning disability - AAMR and WHO
Definitions
Defining learning disability is by no means an easy task and there is still
much debate in the field as to how intelligence should be defined. Some
theorists such as Guilford (1979) define intelligence in terms of a
theoretical cognitive capacity. Others such as Sternberg (Sternberg and
Salter, 1982) define intelligence as "goal directed adaptive behaviour"
while Kimble et al. (1984) see intelligence in terms of the ability to solve
real life tasks. Either ways, both approaches (intelligence V's adaptation)
can have a contribution to the definition of learning disability - each with
their advantages and disadvantages. Perhaps the greatest advantage in
terms of intellectual capacity as the criterion is that intelligence quotient
measures have been developed methodically over the years on large
samples of individuals, they have explicit strengths and weaknesses and
they do not prejudge adaptability. If one used social adaptation as the
criterion, this generally fails to distinguish individuals of normal
. intelligence - -who have a psychiatric disorder, a specific learning
disability, or who are socially impaired for some other reason. It harks
back to the days when many such people were placed in institutions for
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the retarded" (Scott, 1994, p.617). Both the WHO (World Health
Organisation -ICD-10) and the APA (American Psychiatric Association-
DSM-IV) use both these criterion in their definitions of learning disability.
The American Association on Mental Retardation's (AAMR) latest
definition of Learning disability places further emphasis on the notion of
adaptive behaviour. Their definition of mental retardation (learning
disability) published in 1992 is as follows:
"Mental retardation refers to substantial limitations in present
functioning. It is manifested as significantly sub-average
intellectual functioning, existing concurrently with related
disabilities in two or more of the following applicable adaptive skill
areas: communication, self-care, home living, social skills,
community use, self-direction, health and safety, functional
academics and work. Mental retardation begins before age 18".
(AAMR, 1992).
In a similar fashion the World Health Organisation (WHO) in its ICD-10
classification system takes into account both intellectual functioning and
adaptive behaviours when it states:
"Mental retardation is a condition of arrested or incomplete
development of the mind, which is especially characterised by
impairment of skills manifested during the developmental period,
which contribute to the overall level of intelligence, i.e. cognitive,
language, motor, and social abilities ... Adaptive behaviour is
always impaired ... the assessment of intellectual level should be
based on whatever information is available, including clinical
findings, adaptive behaviour and psychometric performance".
(WHO, 1992).
No matter what definition one wishes to choose when referring to those
with learning disability, in a sense all definitions only tell one so much
and as can be seen from the above, the major influence is still in terms
of intellectual capacity with only slight reference to adaptive functioning.
However, over the decades, substantial changes have taken place in
terms of the terminology that is used to describe individuals with learning
disability. At the start of this decade, terms such as idiots, momns and
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feeble-minded were very much in vogue and in part it was due to the use
of such terminology that the distinctions between learning disability and
mental illness were so unclear.
1.8 Degrees/Levels of Learning disability.
The degree or level of learning disability is again within the framework of
a classification system based largely on intellectual assessment and
performance. Learning disability is divided into four distinct levels or
strata - mild, moderate, severe and profound. Severity of learning
disability is based or determined by concurrent presence of IQ scores in
addition to adaptive limitations within the above four ranges. Table 1.1
below indicates the four levels of learning disability, as determined by
intellectual level and adaptive limitations.
Table 1.1: A table depicting the four levels of learning disability,
their IQ range and extent of adaptive limitations.
Level/degree of IQ range Extent of concurrent
learning disability adaptive limitations
Mi/d 55-70 2 or more domains
Moderate 35-54 2 or more domains
Severe 20-34 all domains
Profound Below 20 all domains
As the level or degree of learning disability becomes more severe, the
prognosis and outcome of the individual becomes more restrictive.
Mild level of learning disability can be viewed largely in terms of
academic achievement and cognitive performance. Very often mild
learning disability is not picked up on straight away in terms of schooling
and it may not be until a problem arises (Le. academic failure or problem
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behaviour) that the possibility of learning disability is looked into. This
again emphasises the society is which we live in - which places so much
emphasis on academic performance and achievement purely in terms of
schooling and one's ability to perform in this respect. Language
development is generally quite good in those within the mild range and
they have a good ability to put together a complex sentence. Schooling
will generally follow the normal routine and movement in the adult role
will also develop normally. However in terms of "fitting in" to this adult
role, many complications may arise especially in terms of involvement in
adult services and participation.
Those with a moderate level of learning disability will generally be
recognised earlier as having some form of learning disability because of
the evident delays in their developmental milestones. Language in
particular is affect~ and on entry to school, these children will generally
communicate in one to two word utterances and gestures. Academic
performance as predicted is delayed when one compares them to those
with mild levels of learning disability. Supervision is required in respect
to vocational activities and very often self-care supervision may also be
needed.
Similar to individuals with a moderate degree of learning disability, those
within the severe range are identified quite early in life. Not only are
there substantial deficits in developmental milestones but milestones
such as standing, walking and toilet training may also be delayed
significantly. As noted by Jacobson and Mulick (1996), these children
are also at greater risk of developing conditions such as epilepsy and
cerebral palsy. These children need much supervision in the areas of
self-care, toileting and feeding. Generally language development is poor
with only some children using two or three word utterances later in years.
Close supervision and assistance is needed with vocational skills and
attention span on tasks can be quite poor. In the past, residential care
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•was perhaps the only option for many but this process is gradually
beginning to change over time and especially in the last two decades.
Clients with a profound level of learning disability are identified very early
in infancy, largely due to severe limitations in development. Mortality
rates are generally far higher in these clients than in those with severe or
other levels of learning disability. Mobility can very often be quite poor
due to physical handicaps, motor or sensory difficulties and by the age of
ten only some of these children will have developed the skills to walk
unaided. Self-care skills are quite poor and require much supervision, as
do their skills in general. The communication process is developed by
means of gesture rather than language although one-word utterances or
vocalisations are quite common. Basic skills that these individuals have
can be worked with by means of individual input, structured stimulation
and interaction with others. Full time care is generally required, and this
has been provided by residential care settings up until now - the process
of de-institutionalisation is far more difficult with these clients compared
to others due to many of them being in a fragile medical condition or the
lack of adaptive skills or the basic coping strategies required for a move
to the community.
1.9 .Differential Diagnosis and Classification.
Differential diagnosis of learning disability should always be undertaken
before a prognosis is established, as there can be discrepancies
between functioning in terms of intelligence and adaptation. For
example if one scores quite low on an intelligence test and ones adaptive
functioning is above the norms for that particular level, then by taking a
less severe degree than is depicted solely on the basis of the individuals
intellectual score alone. In this sense one can see that a classification
system based purely on intellectual criterion can be fundamentally flawed
and if one classifies an individual purely on the basis of scores on an
intelligence test, then one may be doing the individual a great injustice in
terms of over-representing the problem - classifying the individual as
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more severe than they actually are, or on the other hand under-
representing the problem and classifying the individual at a level higher
than they are actually functioning.
As has been mentioned in the opening pages of this chapter, there are
specific problems with regard to the classification system used in
determining level or degree of learning disability. Apart from the
intellectual versus social criterion approaches to classification of learning
disability, additional problems have emerged with regard to assessment
of intelligence, and some of these problems are specific to individuals
with mild learning disability. Concern has been expressed with regard to
identification of those with a mild learning disability in early childhood as
the identification process can be culturally biased or even linguistically
biased and this has been strongly supported by research to date
(Mercer, 1973). In this sense many feel that the classification system
and means of identification of learning disability is inappropriate for many
individuals. Again this problem has arisen largely due to a strong
reliance on the use of intellectual assessment as the fundamental means
of determining ones functional level.
As is noted by Zucker and Polloway (1987) "many students who are
reasonably successful in relatively unstructured social or recreational
activities have significant difficulty in the school setting in academic
achievement, social skill development, and coping abilities" (p. 75). One
can bring in the idea here of conceptual intelligence (10) and social
intelligence (practical ability and the process of being able to adapt to
ones environment). Research, which has focused on intellectual versus
adaptive functioning, has shown significant differences in terms of
assessment by means of intelligence and assessment by means of
adaptive behaviour. The study of Popoff-Walker (1982) has shown that
40% of EMR individuals (educable individuals) did not show evidence of
adaptive behaviour performance, which fell within the category of
educable "mental retardation".
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Another major problem with classification has been the notion of socio-
economic status. As is well known in the literature there are strong links
between intelligence and status (Reschly, 1981) and from research to
date the links between poorer children being at greater risk of having
some form of learning disability are well established. What is not so well
established is how socio-economic status interacts with the many cultural
factors in the classification of learning disability. Although while research
is saying that those individuals who are of lower socio-economic status
are at increased risk of having a learning disability especially mild
learning disability, there is at the same time a significant number within
these circumstances who are not classified as being within the mild
range. This particular problem raises several questions with regard to
research to date in addition to cultural and status factors.
On the basis of these many criticisms regarding classification, the
question then arises, how does one overcome these problems and what
strategies should be developed in trying to alleviate them. The answer to
this question still falls within the realm of compensating for problems in
intellectual assessment. For example in order to compensate for cultural
or linguistic bias (apart from the obvious), it has been suggested that a
scheme should be developed in order to get over the problem of such
biases - initial results of this development process have essentially led to
the universal "declassification" of children in many services such as EMR
(education able mentally retarded individuals). A second strategy which
has been discussed is to develop more stringent cut-off scores on
intelligence tests - although it would alleviate the process somewhat, it
would really only lead to more consistency in clinical practice. A third
suggestion which has been made is to rely less on intellectual
performance and to develop criteria which are sensitive to both
intelligence and adaptive behaviours - 8 suggestion which is gaining
momentum at present._
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1.10 Service Provision for clients with Learning disability in
Ireland.
Clients with a learning disability have long being classified as a unique
population. Such classification has had both its positive and negative
connotations, perhaps the majority being negative in terms of labelling
individuals with learning disability. Part of this uniqueness has been an
inability to cope with the society in which they are living in and a difficulty
to adapt to an ever-changing society. In the early 1800's, in a time when
the industrial revolution took over society, there was little room for those
who were not productive and who were not capable of working. It was
due to the industrial revolution that the process of segregation was
introduced and has stayed with us in various forms (i.e.
institutionalisation) since this time. The negative implications of the
process of segregation still exist and the field of learning disability has
being trying to break the links which existed between it and the field of
mental illness for some years now. In 1992 for example, the figure
quoted for individuals with learning disability whose service consisted of,
and was based in psychiatric hospitals in Ireland was one thousand
despite the fact that these clients did not have any form of mental illness
(McGinley, 1992). It is surprising in this day and age that such a system
still operates in this country despite the many specialist services which
exist solely for those with learning disability.
Although there are extensive specialist services for clients with learning
disability throughout Ireland at the present time it is only relatively
recently that this group were identified as needing such a service. Up
until the Irish state was founded in 1922, Ireland was under the rule of
Britain and any law passed in Britain was incorporated into Irish society.
Workhouses were the usual places that those with a learning disability
were placed in Ireland and they were also admitted and cared for in
asytums which were based throughout the country under the Lunacy
Laws of the 19th century (McLoone, 1988). It was not until 1869, that the
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first service provision was developed specifically for those with learning
disability in Ireland and this was based in the Stewart Institute for
Education, Training and Maintenance of Idiotic and Imbecile children in
Dublin. As can be seen from its title, the terminology used was identical
to that used in the United Kingdom at the time - largely due to it being
initially established in Britain. However it was a starting point and it was
not until this point that the distinctions between learning disability and
mental illness were being made - it would take some time longer for the
distinctions to be clarified however.
1.11 Service Provision: Planning for the Future.
Still despite the many developments over the years, the fact still remains
that service provision is still not capable of dealing with the entire
learning disabled population in Ireland. Those who have lost out in
particular are families who have kept their children at home, especially
when regional services were just being developed. Residential services
are particularly difficult to obtain as although the move is from residential
to community living, no new residential services are being developed and
the existing services have long waiting lists and such waiting lists have
continued to develop over the years. In 1987, it was estimated that
approximately three hundred clients were in need of urgent residential
placement (McConkey, 1987), whereas by the year 2000, this figure will
have risen to one thousand. Since the early 1980's, due to many
cutbacks, funding is quite scarce and this continues to be the picture at
present, unlike Britain where an estimated £29 million pounds is given
each year to learning disability services and mental health work.
McConkey and Conliffe (1989) note in relation to planning for future
services "effective planning involves more than counting heads or beds.
Peoples needs, wishes and aspirations have to be taken into account.
There are three major stakeholders involved. First the people with a
mental handicap; secondly their families and third the professional staff
involved in service delivery""(p.4)..
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Throughout the 1990's, a good deal of work has been undertaken by the
Government in terms of the planning of services for those with learning
disability. Two publications, which have been published in the 1990's
have gone to some lengths to set about planning for the future are:
1] Needs and Abilities: A Policy for the Intellectually Disabled (July 1991)
and
2] Shaping a Healthier Future: A Strategy for Effective Healthcare in the
1990's (1994).
The first of these publications is the report from the review group on
mental handicap services which was initially developed and set-up in
1986 after discussions with the Dept. of Health and major Organisations
catering for those with learning disabilities. In all there were
approximately sixty-one major recommendations from the findings of the
review committee and these recommendations ranged from a changing
of the term mental handicap (a formal debate to be initiated into the
terminology to be accepted) to the detailed cost analysis of alternative
levels of care (1990).
1.12 Chapter Conclusions.
To conclude, the present chapter has focused on some of the points
central to an understanding of learning disability. Despite the many
achievements and developments to date, there is still much work to be
undertaken in this highly specialised field, not only in terms of theory but
also in terms of practice. In a sense the field of learning disability has
had quite a unstable foundation as there is much disagreement on the
definitions and terminology used to describe this most unique and
individualistic population. There is no doubt but the debate regarding
which terminology is most appropriate will continue for some time and
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whether a consensus will be formed remains to be seen. What will be of
interest in Irish terms is whether formal debate will commence regarding
terminology to be used - a recommendation from the review group on
mental handicap services (1990). Assessment and treatment
procedures will continue to be refined as new and more effective
techniques are implemented. The role of research in determining their
effectiveness cannot be over-emphasised and many services are
gradually beginning to commence research projects - many of which
were long overdue. In addition with the development of concepts such
as advocacy, normalisation and empowerment, individual clients are
having their say as to how the future of services should be developed
and what they would like to be incorporated in these services. The multi-
disciplinary team will continue to be of the utmost importance in service
delivery of any kind and the results of this can speak for themselves. To
conclude, Scott (1994) states, "the skills of many disciplines are required,
so over emphasis on one approach is detrimental. Traditionally this area
has often been characterised by a lack of services, reflecting a feeling
that little can be done ... there are now many opportunities to develop
services and apply our knowledge, offering the prospect for the children
and their carers to lead more rewarding lives" (p.640).
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CHAPTER TWO
PSYCHOPATHOLOGY AND LEARNING
DISABILITY
2.1 Chapter Introduction.
The provision of mental health services for persons with learning
disability has received increased interest in recent years. One of the
main reasons for such increased interest has been the move from older
institutional-type settings to community-based services - a process
known as de-institutionalisation or community integration
(Wolfensberger, 1972). With the advent of de-institutionalisation, there
has been a greater need for recognition that those with varying forms of
learning disability are subject to the full range of mental health problems,
and thus should be in receipt of the full range of mental health services
(Simpson, 1997). A second reason for such interest in the mental health
needs of those with learning disability is related to the first point outlined
above. Now that these Service Users are moving from large
institutions/residential settings to the community, there is a far greater
emphasis on the principles of normalisation (Wolfensberger, 1972) for
those in community care.
Before moving on, central to this discussion is the issue of mental health
and more importantly mental health problems. As with the general
population, mental health problems (of whatever form or level of severity)
in persons with learning disability, can have serious implications for the
individual themselves, their families, those caring for them and for public
policy (Fletcher, 1988; Szymanski, 1994 and Caine &Hatton, 1998). As
is noted by Simpson (1997) it is far easier to recognise health problems
than it is to recognise health itself and there is a huge "subjective
element" to this process (Moss, 1999) which will be discussed later in the
chapter. If one turns for a moment to look for a definition of "mental
health", it is by no means an easy process for anyone, and when such a
definition is applied to the learning disabled population, more questions
are asked than answers forthcoming. Simpson (1997) suggests a
possible definition of mental health, bearing in mind the difficulties-
surrounding this area. He suggests a possible definition as follows:
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"persons who have good mental health are able to respond to their social
situation and environment in a way that is expected for their level of
development, and have no significant alteration of mental functioning
associated with distress or disability. It is easier to recognise health
problems than to recognise health" (p.35). As will be seen later on, the
above definition is largely based around the current DSM definition of
Mental Disorder (DSM-IV, APA, 1994) which is the most current
definition utilised at present.
2.2 Diagnosis of Mental Disorders.
Diagnosis of any form of mental disorder is based around the issue of
abnormal behaviour and how this "abnormal" behaviour can be
examined and identified (Davison & Neale, 1994). Essentially there are
six components or methods for examining abnormal behaviour:
Statistical infrequency, Deviation from social norms, Maladaptiveness of
behaviour, Personal Distress, Disability or dysfunction and finally
Unexpectedness (Davidson & Neale, 1994).
If one examines the diagnosis of mental disorders from a historical
perspective, much of the earlier work (5th century B.C. onwards) was
based around the writings of philosophers, theologians and physicians,
which examined mental disorders in terms of "demonology",
·somatogenesis" and "psychogenesis" (Davidson and Neale, 1994,
pp.1 0-11). The basic premise of much of this work was that an evil spirit
was said to have taken over the body of the person and this was the
reason for their mental illness. On the basis of such ideas, persons who
were said to be "possessed" (mentally ill) were either treated with ridicule
and scorn (and put to death - witches being burned at the stake for
example) or with compassion, depending on the era (Nezu, 1994). As a
result of such beliefs and practices, segregation of those who were in
any way "different" or "deviant" became common practice regardless of
whether the person in question was deemed to have a mental illness or
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have a learning disability. This had the overall effect of drawing little
distinction between those with a mental disorder/illness and those with a
learning disability (Nezu, 1994), a belief still held by many to the present
day.
If one looks to the term "diagnosis", Szymanski et at (1998) state that
the term diagnosis "is an application of a standardised name to a certain
problem, and in general medicine, a recognition and naming of a
disease" (p.3). If a clinician wishes to make a diagnosis of a mental
disorder either in the general population or in the learning disabled
population, they refer to DSM (Diagnostic and Statistical Manual of
Mental Disorders) which is now in its fourth edition, DSM-IV (APA, 1994).
According to DSM-IV, a mental disorder may defined as "a clinically
significant behavioural or psychological syndrome or pattern that occurs
in an individual and that is associated with present distress (e.g. a painful
symptom) or disability (i.e. impairment in one or more important areas of
functioning) or with a significantly increased risk of suffering death, pain,
disability, or an important loss of freedom" (APA, 1994, P.xxi).
Diagnosis of a disorder (of whatever type) may take many levels
according to Szymanski et at (1998). Diagnoses may be either 1}
"pathoetiologic" (describing the specific cause of the disorder - this type
of diagnosis is most accurate), or 2} "syndromic" (the clustering of
symptoms and signs - not as accurate because of multiple agents
causing a syndrome). Single symptom ("monosymptomatic") diagnosis
is far less accurate in comparison to the other levels of diagnosis above.
Most mental disorders are diagnosed using a "syndromic" diagnosis
(meeting at least 6 of the 12 criteria for example) or "monosymptomatic"
diagnosis (stereotypic disorder with self-injurious behaviour (Szymanski
et at, 1998, p.3).
Since the introduction of DSM by the American Psychiatric Association in
1952 (DSM-I), there have been numerous changes. The most notable of
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these changes has been that DSM has transformed from being a largely
psychodynamic and psychobiological model to being an objective
research-based neuroscientific model. Resulting from these changes,
and especially with the introduction of DSM-III (APA, 1980) DSM now
incorporates a "multi-axial" model, with five main axes incorporating
several categories of mental disorders.
Despite the many changes to DSM criteria over the years, it still remains
a classification system for the general population for the diagnosis of
mental disorders. This issue in itself poses significant problems for the
field of learning disability as one fundamental question arises concerning
the extent to which a classification system derived for the general
population can be valid, and used effectively and accurately with a
population as diverse and complex as learning disability.
Before moving on however, it is necessary to review the historical
perspectives on the issue of psychopathology and learning disability and
how they have had impacted on the field, to the present day.
2.3 Psychopathology and Learning Disability: Historical
Perspectives.
The notion that learning disability was a deficit of intellectual functioning
only became truly established in the earlier part of the nineteenth
century. Prior to this little distinction was made between the concepts of
learning disability and mental illness. Nezu (1994) notes that "dUring the
past 2 centuries, clinical observations and systematic research
addressing these two constructs have developed along separate lines"
(p.4). Early theorists tended to view the two constructs as being similar
and such beliefs had major implications for both fields in terms of their
theoretical understanding, research and experimentation, treatment and
public policy concerns (Reiss, 1994, p.67). With the advent of a more
objective approach to the study of both learning disability and mental
illness, conceptual lines were drawn between the two, with intellectual
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deficits been viewed as the primary deficit of learning disability, and
emotional impairment been viewed as the primary deficit of mental
illness. Although the drawing of "conceptual lines" between the two
proved to be useful, it also served as a disadvantage which will be
outlined below.
Because of the distinction now drawn between the two, many
professionals in both fields felt that that those with a learning disability
were in some way "immune" to psychiatric disorders (Nezu, 1994).
Fletcher (1988) outlines one of the commonly held attitudes and beliefs
of many professionals at the time. He notes "the mildly retarded have
been characterised as worry-free and thus mentally healthy. The
severely retarded have been considered to express no feelings and
therefore do not experience emotional stress" (p.255). Borthwick-Duffy
(1994) elaborates on this point, stating that "historically, one perspective
held by many professionals has been that individuals with mental
retardation were incapable of developing emotional disorders that could
be characterised as mental illness (Le. they were thought to be incapable
of acquiring the same disorders as people without mental retardation).
Behaviour disturbances were attributed to the impaired development that
characterised mental retardation" (p.17; also Schroeder et al., 1979).
Another commonly held view at the time was that if those with learning
disabil.ity did develop some form of psychiatric disorder, it was
qualitatively different to that of the general population. "People with
mental retardation were indeed vulnerable to mental disorders but their
emotional problems were of a different quality and were usually of
biologic origin (Borthwick-Duffy, 1994, p.17; Szymanski & Grossman,
1984).
It was largely due to the above beliefs that the concept of "diagnostic
overshadowing" was developed by Reiss, Levitan and Szyszko (1982).
Diagnostic overshadowing refers to when the learning disability itself
"overshadows" any additional impairments, specifically mental illness
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(Reiss et at, 1982). This concept has had important implications,
especially in terms of initial diagnosis and later treatment. This has been
supported by the research of (Reiss et at, 1982) during which case
studies were presented to two groups of psychologists. The groups
differed in that one was told the client had an 10 of 60 and the other
group was told the clients had an 10 of 102. Both groups were asked to
diagnose the fear and plan out a treatment strategy. Findings from the
study indicated that in the person with an 10 of 60, the fear was
diagnosed to a far lesser degree and less likely to be referred for
appropriate treatment in comparison to the other person of 10 102
(Reiss, 1982a, 1982b). Such findings attest to the powerful nature of
diagnostic overshadowing. In the above examples, Reiss (1994) states
"the presence of mental retardation overshadowed the accompanying
presence of abnormal behaviour usually considered indicative of
psychopathology" (p.69).
Menolascino and McCann (1983) characterised the period of the early
20th century as being a "tragic interlude", in that the gap between the
fields of learning disability and mental illness continued to diversify
independent of each other (Nezu et at, 1992). Pollock (1944) at a joint
meeting of the APA (American Psychiatric Association) and AAMD
(American Association on Mental Deficiency) stated "ordinarily we regard
the mentally ill and the mentally defective as separate and distinct
groups ... comparatively little thought is given to the mental hygiene
needs of mental defectives" (pp.261-363). Over thirty years later,
Gualtieri (1979) notes that very little has changed: "Psychiatry needs to
reconsider its stance towards retarded people, because a terrible barrier
has grown up between the fields of mental health and mental retardation-
(p.26).
Distinguishing between "primary" and "secondary" handicaps has proven
useful, to a point. This debate has continued for some time - does the
person primarily have a learning disability or a mental illness ? (Reiss,
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1994). Asking such a question may be useful in terms of administration,
planning for the future and very importantly funding, but it has immense
implications for treatment. If the person is deemed to have primarily
learning disability, then the mental illness is "diagnostically
overshadowed". Essentially this has lead to inadequate mental health
services being developed for persons with learning disability (Reiss,
Levitan and McNally, 1982). "A practical consequence of labelling
psychiatric disorders as 'secondary' in importance is that the needed
mental health services are less likely to be funded" (Reiss, 1994, p.67).
Another factor which has led to inadequate mental health services for
persons with learning disability is the shortage of qualified professionals
trained specifically in the mental health needs of those with learning
disability (Nezu et aI., 1992). From a purely historical perspective,
Gualtieri (1979) reviewed the four main Psychiatric Journals of the time.
Of the 612 articles published by these journals in 1977, only 20 were
devoted to "mental retardation". From the perspective of training, Phelps
and Hammer (1989) surveyed Clinical and Counselling Psychology
trainees, in terms of their training in learning disability. Findings
indicated that 750/0 of clinical psychology and 67% of counselling
psychology trainees did not receive training in learning disability. Finally
on this point, Nezu (1994) reviewed articles from the Journal of
Consulting and Clinical Psychology from 1972 to 1992 and found that of
the 3,431 published articles, only 11 articles were published on the topic
of learning disability (mental retardation) (p.4).
By undertaking an examination of the historical perspectives that
surround the fields of learning disability and mental illness, one may now
begin to understand the many difficulties that the field of learning
disability is facing in the present day. With little or no real interest in the
two concepts emerging until quite recently, the "gap" between the two
fields is still quite distant. In addition many professionals are still of the
opinion that those with learning disability are still "immune" to mental
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illness, and in those persons who are dually diagnosed, their disorders
are in some way "different" than others - without the presence of learning
disability.
2.4 Issues In the Assessment and Diagnosis of Mental Illness in
Persons with Learning Disability.
"The accurate assessment and effective treatment of mental health
problems in people with intellectual disabilities is an essential component
of any service aiming to improve the quality of life of its users" (Caine &
Hatton, 1998, p.210). In beginning any discussion on assessment and
diagnosis of mental illness in the learning disabled population, one is
immediately struck by the vast amount of problems that the field is faced
with. From the historical perspectives outlined above, one can see how
the two fields diverged in their own ways and how this has had such a
huge impact, to the present day.
As we are aware, up until recently the mental health needs of those with
learning disability have been greatly neglected and this has had the
effect of an under-diagnosis of mental health problems in this population
(Caine & Hatton, 1998; Charlot et at, 1993; Patel et at, 1993). In tum,
the "knock-on" effect of under-diagnosis, has been the inadequacy of
specialist mental health services for these people (Day, 1994; Patel et
at, 1993). The reasons for inadequate mental health services may be
classified as follows:
=> Separation of mental health and learning disability services (based on
historical perspectives - divergence of the two fields). This has led to
the two fields operating independently of each other, and to date an
integrated approach has not been developed and utilised (Campbell &
Malone, 1991; Day, 1994, Caine &Hatton, 1998).
=> Difficulty in regard to the assessment protocol used for those with
learning disability. Many assessment tools are available, specifically
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for those with learning disability but many clients are non-verbal and/or
unable to talk about how they feel and about their mental health
status. Assessment of those within the severe and profound ranges
of learning disability is frought with difficulties (Moss, 1999).
=> The classification systems used presently are either DSM-IV (APA,
1994) or ICD-10 (WHO, 1992). These classification systems have
been developed from the general population and there is currently
much disagreement about how such classification systems can be
used and adapted with the learning disabled population (Moss, 1999,
Szymanski et al., 1998).
=> Diagnostic-overshadowing (Reiss et at, 1982; Spengler et at, 1990):
this occurs when the learning disability ·overshadows" the presence of
a psychiatric illness. As a result of this, many of the common mental
illnesses have not been diagnosed in persons with learning disability
which has had an impact of prevalence and epidemiology.
=> Differential diagnosis. This has been a particular issue with regard to
diagnosis of mental illness. Is the person suffering from a mental
illness, or do they have challenging behaviour 11 Many of the
common mental disorders display themselves by means of aggressive
episodes and challenging behaviour. How to distinguish between the
two is particularly difficult, especially those who have poor verbal skills
or are non-verbal, and in those who are low functioning (below 10 50)
(Moss, 1995).
=>Absence of adequate referral systems (Caine &Hatton, 1998). As
was mentioned in the opening paragraph of this chapter, now that
there is a greater emphasis on community integration and the rights of
those with learning disability to mental health services, a greater
emphasis must be placed on mental health service provision. This is
being achieved to a certain degree with those living in the community •
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as when they have problems fulfilling their "social roles", attention may
be drawn to their mental health (Caine & Hatton, 1998, p.211). For
those in residential care, provision of mental health services needs to
be addressed, due to there not being the same emphasis on "social
roles" as there is in the community, by virtue of their placement in a
residential setting.
However, despite these problems being encountered, there is now a far
greater understanding amongst professionals in the field of learning
disability that there is a necessity for quality mental health services
(Bouras, 1994, Bouras et at, 1995) and much work is being undertaken
in order to resolve many of the issues at hand.
2.5 Further Issues in the assessment and diagnosis of mental
illness in persons with learning disability.
Just as learning disability is a social construct, so too is mental illness
(Caine & Hatton, 1998, p.211), and both are subject to much variation
across time and across cultures (Littlewood & Lipsedge, 1989; Porter,
1990; Scull, 1993). If one takes the construct of learning disability, it has
been subject to much change over the past number of decades. The
latest definition of "mental retardation" as outlined by the AAMR
(Luckasson et al., 1992) is radically different from any definition of MR in
the past, as it places much emphasis on the concept of adaptive
functioning, in addition to intellectual functioning, as part of its definition.
This is just one example to hand, of the importance of time, a shift in
thinking, importance of new knowledge, and cultural influences on one
such construct. In a similar fashion with the advent of DSM (whose first
edition was published in 1952 - DSM-I, APA, 1952), there have been
many changes witnessed throughout the history of The Diagnostic and
Statistical Manual of Mental Disorders, leading up to the recent version
published in 1994 - DSM-IV (APA, 1994). As new knowledge has been
gained and gathered since first published in 1952, significant changes
have occurred in its Axes, categories and sub-categories. Perhaps the
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most notable change (& a change which affected all versions of DSM
from 1980 onwards) between DSM II (APA, 1968) and DSM-III (APA,
1980) was the change from psychobiological and psychodynamic
underpinnings to a more descriptive model of reference (Szymanski et
at, 1998). This again shows us the importance of the gathering of new
knowledge and a change in thinking over time.
Although the DSM is a means of classification and an aid to diagnosis.
historically and to a large degree, diagnosis of psychiatric disorders has
been made by a psychiatrist. However as the research of Ash (1949),
Sandifer et at (1970) and Termelin (1968) has shown, very often the
"clinical judgement" of a psychiatrist may be called into question and may
be unreliable. As is noted by Moss (1995) when the psychiatrist
undertaking or attempting a diagnosis is untrained or inexperienced itt,
the field of learning disability, this has further repercussions for the
validity of the clinical judgement.
However, as will be seen below, although the introduction of DSM (and
the categorisation of psychiatric disorders) has greatly improved the
reliability and validity of diagnoses, there are many problems inherent in
the diagnosis of mental disorders in persons with learning disability using
"standardised" criteria (DSM-IV or ICD-10).
2.6 The "Pathway" to Mental Health Services for Persons with
learning Disability.
In discussing diagnosis and assessment of mental health in any
population, one must make reference to how a person goes about any
diagnosis or any assessment. In the general population, if a person feels
ill (in any way), they may tell a friend, phone a doctor or pay a visit to the
doctor themselves. The person's ability to recognise that they may feel
unwell is paramount - once the person recognises that they are feeling
unwell, they may be referred or they may then visit the doctor themselves
and report the symptoms they are feeling (stomach ache, back pain etc.).
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It is this "ability to report" the symptoms of their illness which is so very
important.
Essentially, "case recognition" is the first part of any assessment process
(Moss, 1999). "Cases which are not detected and referred cannot be
assessed and treated" (Moss, 1999, p 2). It is in this very first phase of
assessment that those with a learning disability are at a significant
disadvantage. Because of the nature of the person's learning disability,
they may have difficulty in verbalising how they are feeling or on the
other hand, they may be non-verbal and have no means of
communicating their feelings or their needs. As a result of poor
communication skills, cases may not be referred and thus cannot be
treated by mental health services.
The persons' ability to recognise that they are not "feeling weIr is an
essential part in the referral and assessment process. As the research
of Patel et at (1993) has shown, many persons with learning disability
may have an accompanying mental illness, but many of these are simply
not detected. Due to the hugely "subjective" element to this process,
those with a learning disability, are again at a disadvantage due to the ,.
verbal skills necessary to identify how they are feeling. An issue which
was mentioned in the earlier pages of this chapter is of relevance to the
present discussion on case detection. This is the issue of staff training
and the importance of staff identifying a possible problem. When the
person is non-verbal or has poor communication skills, the importance of
staff training in mental health cannot be over-emphasised. A number of
important factors are outlined below:
=> Obviously when a client is non-verbal, information obtained about the
person must be sought from a third-party (i.e. a person familiar with
the client and interacting with them for a considerable length of time).
It is necessary for that person to be in a position to provide useful and
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relevant information about the client's behaviour over a period of
time.
=> Observed and recorded changes in behaviour are the most useful
pieces of information in addition to patterns of behaviour displayed by
the client (Caine & Hatton, 1998). Invariably, most mental illnesses
have a predictable time course and are recognised by a combination
of behaviour patterns. If a mental illness has gone unrecognised for
some time however, this makes the assessment process even more
difficult as it is harder to ascertain what the pattern of behaviour has
been prior to onset. Particular difficulties occur in the diagnosis of
dementia in persons with learning disability as levels of cognitive
functioning before and after onset may be difficult to assess (Aylward
et aI., 1995).
=> One must make allowances for individual differences in the way that
disorders or the symptoms of disorders may be displayed. "The level
of intellectual disability is likely to have a substantial impact on how
symptoms of distress are expressed, with people with more severe
disabilities expressing distress in more behavioural rather than verbal
ways" (Caine & Hatton, 1998, p.215). This raises many issues in
relation to challenging behaviour and its relationship to mental illness.
This issue will be discussed later in the chapter.
=> Staff should reflect and consider alternatives for unusual behaviour
displayed by the person. The particular behaviour or patterns of
behaviour may not be indicative of a mental illness. For a person
who is non-verbal, aggressive behaviour may be a result of physical
pain or illness which has gone unnoticed. In a similar fashion,
differential diagnosis may show that the behaviours displayed may be
a result of the side effects of neuroleptic (or other) medication (Aman
et al., 1988; Caine &Hatton, 1998).
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~ Finally, some mental illnesses are notoriously difficult to diagnose
and it may take some time to accurately diagnose a particular
condition. For those persons in the severe and profound ranges of
learning disability, it may be virtually impossible to assess their
mental health needs due to insufficient evidence.
Whether the person in question is verbal or non-verbal, the assessment
process will always involve the staff who interacts with the client, as a
means of providing information. Staff perceptions of what constitutes a
mental illness is another factor to be considered. How do we actually
define and identify a mental iIIness?1 Although we broadly define
"mental disorders" - see above definition - through the use of DSM-IV
(APA, 1994), there are still many issues around terminology and
definitions used to the present day.
As far back as 1980, Szymanski noted the problems of terminology and
how they had an impact on epidemiology and prevalence. Szymanski
notes "professionals in the fields of retardation and mental health often
use a variety of terms such as mental illness, mental disorders,
psychiatric disorder (problem, condition), emotional disorder, behavioural
disorder. These 'labels' often reflect the psychological theoretical
background of the person rather than a specific category, and in fact
these terms are usually used interchangeably" (1980, p.63).
Even when the key informant gives information on the presenting
symptoms, they may not necessarily be an accurate reflection on the
behaviours, and may differ from what the client themselves feels and
reports (Moss, 1999). By the very nature of third-party or key-informant
reports, validity may be called into question and the information received
may be influenced by a variety of factors, the most notable of these
being:
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=> The nature of the relationship between the client and the key
informant. This can have a major bearing on the information received
as obviously familiarity with the client is essential. Familiarity over
time is also essential as otherwise it may not be possible to gain an
accurate picture of the persons behaviour before and after onset of
the symptoms.
=> The existence ofa prior labe/- such as "challenging behaviour". The
relationship between mental illness and challenging behaviour is as
yet poorly understood. When a person with learning disability
displays challenging behaviour, the presence of this label can have
profound effects on assessment and diagnosis of mental illness.
Very often, when the person presents with challenging behaviour, the
possibility of an accompanying mental illness may be overlooked. It
may be felt that the problem at hand is challenging behaviour-related,
rather than being due to the presence of a mental illness.
=> Diagnostic overshadowing. When the presence of the person's
learning disability "overshadows" the person's mental illness and thus
the accompanying mental illness is not detected.
The above three factors contribute significantly to the information
received from third-party or key-informant responses (Levitan &Reiss,
1983; Moss, 1999, p.12) and should be taken into consideration when
examining the validity of information obtained.
All of the above points combined are of relevance to the next section on
epidemiology and prevalence. Although there are a number of problems
inherent in any discussion on epidemiology and prevalence, it is
necessary to examine the overall findings in relation to the research
undertaken to date. Such a discussion offers us a unique profile of the
type of prevalence research undertaken, the methodological problems
encountered, while also offering us some possible explanations and
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alternatives to examining psychopathology in the learning disabled
population.
2.7 Epidemiology and Prevalence of Psychopathology in the
Learning Disabled Population.
Upon discussing some of the issues surrounding assessment and
diagnosis of mental illness in the learning disabled population, it is not
surprising a wide range of rates have been reported in the literature to
date (Borthwick-Duffy, 1994; Caine &Hatton, 1998; Campbell &Malone,
1991; Reiss, 1990; Simpson, 1997; Iverson & Fox, 1989; Bernal &
Hollins, 1995; Collacott et aI., 1992; Crews et at, 1994; Borthwick-Duffy
&Eyman, 1990; Gilberg et aI., 1986; Jacobson, 1990; Linaker &Nitter,
1990 and Szymanski, 1994).
Although to a large extent, much of the problem has rested with the fact
that few studies can be compared, as they used very different
methodologies and modes of assessment (Caine &Hatton, 1998), there
are a host of contributing factors.
Borthwick-Duffy (1994) examines these factors and notes that: "several
factors have been identified as being responsible for the wide range of
reported prevalence rates of psychiatric disorders among people with
mental retardation and have been discussed in the recent literature ...
these factors fall into two general categories including (a) definitional and
identification issues and (b) sampling issues. Prevalence rates should
be interpreted in the context of these factors, which may explain
discrepancies and limit generalisation of findings" (p.17).
Resulting from the above statement, and as further stated by Szymanski
(1994) "there are few reliable data" (p.26; also Szymanski, 1980;
Szymanski & Crocker, 1989 and Russell, 1988).
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2.7.1 Definitional and Identification Issues.
By means of "definitional and identification issues", Borthwick-Duffy
(1994) refers to the difficulty in defining and classifying both learning
disability (mental retardation) and mental illness. As was discussed
earlier, the concept of learning disability has undergone radical changes
over the past number of decades (Luckasson et al., 1992). Depending
on the research undertaken, various researchers have used a variety of
definitions and classification systems for classifying learning disability
(Lowitzer et al., 1987). In terms of mental illness and how it is defined
and classified, a variety of terms have been used from "mental disorder"
to "behaviour disorder" (Szymanski, 1980, p.63). Depending on what
definitions, terminology and classification system is used, research has
varied considerably and has led to considerable differences in empirical
findings.
In terms of disorders chosen to be studied from a research perspective,
Costello (1982) notes that "one problem is that personality disorder, or
what might more loosely be termed difficult behaviour associated with a
severe functional handicap, is not always easy to distinguish from classic
psychiatric disorder, and it is a moot point whether this distinction should
be made" (p.39).
2.7.2 Sampling Issues.
Many of the studies to date have focussed on "selected" populations -
that is populations either referred to clinics or clients in institutional
settings (Szymanski, 1994). Selection of the "target" population is vital in
any piece of research and it can have serious implications in terms of
empirical findings (Borthwick-Duffy, 1994; Borthwick-Duffy & Eyman,
1990; Reiss et at, 1982; Schroder et al., 1979).
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From the prevalence studies undertaken to date, figures obtained have
ranged from 100/0 to 80% (Jacobson, 1990) depending on the target
population selected, the definitions used and the mode of assessment
incorporated (Campbell &Malone, 1991; Borthwick-Duffy, 1994; Caine &
Hatton, 1998).
If one looks to figures obtained from studies in the general population,
the rates reported are approximately 200/0 (Caine &Hatton, 1998). The
research of Meltzer, Gill and Petticrew (1995) found that approximately
14% of adults between the ages of 16 and 64 years had some form of
mental health problem, with 10% of the population studies having a
diagnosable disorder (Simpson, 1997). Jacobson (1990) notes that
conditions such as affective and anxiety disorders occur more frequently
than schizophrenic disorders in the general population, as do personality
disorders (Mezzich et aI., 1984). Antisocial and substance abuse
disorders are more frequent for males than females, while major
depressive disorders, simple phobias and agrophobia are more common
in females (Jacobson, 1990; Myers et aI., 1984; Robins et at, 1984).
In contrast studies undertaken in the learning disabled population have
given us a very different picture. The findings of Benson (1985), Forness
&Polloway (1987), Fraser et al. (1986), Menolascino et al. (1986), Myers
(1987), Philips & Williams (1975) and Reiss (1982) have shown that
anxiety disorders, affective disorders and personality disorders occur at
lower rates in comparison to schizophrenic disorders.
Studies specific to the learning disabled population have shown us that
when the target population is from a "referred" sample (i.e. referred for
psychiatric evaluation) figures are generally elevated (Bouras &
Drummond, 1992; Pary, 1993) and if behaviour disturbance is included
as a psychiatric disorder, then prevalence figures tend to be over 40%.
The lower prevalence rates - i.e. those below 15% tend to be based on
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research which examined case files as a means of identifying psychiatric
disorders.
2.8 Studies on Selected/Referred Populations.
On those studies undertaken on selected populations, some of which are
now quite dated, the main findings are as follows. Menolascino (1965) in
a study examining the prevalence of psychopathology in children with
learning disability, found an overall prevalence rate of 24.5% in this
population. Webster (1970) evaluated 159 children and found in all
cases there was some form of emotional disorder, and in 18%, psychosis
(not specified) was diagnosed. The study of Philips & Williams (1975)
examined a population of 100 children referred to a psychiatric clinic for
evaluation. Of these 100 children, 87% were given a diagnosis, with the
most common disorders being - psychosis (380/0), behaviour disorders
(260/0), personality disorders (16%) and neurosis (5%). In terms of
symptomatology, the author's notes that the symptoms observed in .
these children were similar to symptoms observed in children without
learning disability (Philips & Williams, 1975).
In a survey of 132 children referred to a learning disability clinic,
Szymanski (1977) found a rate of mental disorder in conjunction with
learning disability in 54% of this population. In a large-scale study of
1507 residential service users, Wright (1982) found a rate of "serious
mental disorders" in just 7.3% of the population studied. When these
figures are broken down into the various disorders, findings show that
schizophrenia occurred in 1.8%, affective disorder was diagnosed in
2.8% and early childhood psychosis in 2.70/0.
In an unpublished piece of work (Szymanski - cited in Szymanski, 1994)
utilised diagnostic criteria from DSM III (APA, 1980) examining a total of
123 adults and 277 children with mild and moderate levels of learning
disability. According to the DSM III criteria, a diagnosis of Axis I mental
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disorders occurred in 74% of the adults studied and 700/0 of children.
The breakdown of adult diagnoses were as follows: adjustment disorder
(15%), affective disorder (15%), psychotic disorder (13°k), and pervasive
developmental disorder (11 %). In the children studied, the most
frequently occurring disorders were: pervasive developmental disorder
(22%), affective disorder (12%) and adjustment disorder (10%). What
was interesting to note from this study was that results obtained were
from children and adults with mild and moderate levels of learning
disability. As was noted earlier, this begs the question as to how
applicable diagnoses are when clients are below the moderate level of
learning disability?
The study of Linaker &Nitter (1990) examined rates of psychopathology
in an "institutionalised" population of 168 clients. In terms of the
assessment method incorporated, the authors used both the PIMRA
(Psychopathology Instrument for Mentally Retarded Adults) - a third party
rating scale completed by staff, and case note review. Results from the
study found that in terms of DSM III Axis I disorders, 146 of the 168
adults studied satisfied the criteria for same, while 153 satisfied the
criteria for at least one disorder on either Axis I or Axis II. The authors
also found that multiple diagnoses were common and that "level of
functioning was not found to predispose to any particular diagnosis"
(Linaker & Nitter, 1990, p.522). In terms of individual disorders,
schizophrenia was diagnosed in 48 cases, anxiety disorder in 94 and
personality disorder in 85 cases. Interestingly no diagnosis of affective
disorder was identified, despite the PIMRA being significantly correlated
with the Hamilton Rating Scale for Depression and the Beck Depression
Inventory (Kazdin et at, 1983).
More recently the study of Crews at at (1994) examined rates of dual
diagnosis in a large state residential facility in Virginia. Although the
study examined prevalence in a sample of referred service users, it
utilised DSM-III-R (APA, 1987) criteria in terms of diagnoses. The
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population studied were 1,273 children and adults between the ages of
10 and 80 years with levels of learning disability ranging from mild to
profound. Findings showed that the overall prevalence rate for dual
diagnosis was 15.55%. Although the rate achieved is quite low in
comparison to other studies, the authors note that "the relatively low rate
of dual diagnoses may also indicate a diagnostic overshadowing
phenomenon ... abnormal behaviour in some individuals with mental
retardation may be solely attributed to their mental retardation as
opposed to the actual psychopathology that it reflects. Because
psychopathology is overlooked, the true prevalence is underestimated"
(p.729).
2.9 Studies on Unselected/Random Populations.
In one of the most widely documented studies in the literature, Rutter,
Graham and Yule (1976) examined the prevalence of psychopathology
in the entire population of children between the ages of 9 and 11 years
on the Isle of Wight. The methodology incorporated was multi-modal as
it incorporated parent and teacher questionnaires and direct interviews.
Level of learning disability was ascertained by means of 10 score only.
On the basis of this methodology, psychiatric disorder was diagnosed in
70/0 of the population studied. However, in children with an 10 of under
70, psychiatric diagnosis was deemed to be in the range of between 30
and 420/0 (Rutter et at, 1970).
A longitudinal study undertaken by Koller et at (1983) followed-up on a
cohort of persons with learning disability over the period of 5 years.
Retrospectively in terms of those disorders diagnosed in childhood, 61 %
of those studied were deemed to have a behavioural disorder. The study
of Lund (1985) used a random sample of 302 adults with learning
disability and found that in using modified DSM III criteria, the rate of
psychiatric disorders was 28%. Although "behaviour disorder" is not a
formal DSM III diagnostic criteria, it was the most frequent diagnosis at
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110/0. The next most frequently diagnosed condition was psychosis
(uncertain type) at 50/0, dementia and autism (3.60/0 respectively),
neurosis (2%), affective disorder (1.70/0) and finally schizophrenia (1.30/0).
Gostasson (1985) studied a random sample of adults with learning
disability and found that in those with severe learning disability, mental
illness was diagnosed in 550/0 of cases, while for those in the mild range
of learning disability, the corresponding figure was 17%. For control
subjects (with no learning disability) the rate of mental illness was 8%.
The study of Gillberg et al. (1986) although it did not incorporate DSM III
criteria, reported on the results of 149 adolescents between the ages of
13 and 17 years of age. These children were assessed by child
psychiatrists and findings indicated that 64% of those with severe
learning disability and 570/0 of those with mild learning disability were
deemed to have a diagnosis of some form of "handicapping psychiatric
condition" (Szymanski, 1994, p.29). Fourteen per cent of mild and 50%
of those with severe learning disability had psychotic behaviour
(including schizophrenia, autism and social impairment).
Iverson and Fox (1989) used a similar methodology to Linaker and Nitter
(1990) (PIMRA rating scale), but their findings were based on a random,
stratified sample of 165 adults with learning disability. Results from their
study showed that 35.90/0 of the sample had "at least one significant
psychopathological disorder" (p.77). In addition, those with mild learning
disability were found to have higher rates of psychopathology than those
in the moderate to profound ranges. Although methodological
considerations may be a factor for such a finding in the present study (an
under-representation of those with mild learning disability in comparison
to other levels of LD), an alternative explanation may lie in terms of the
assessment method used. The PIMRA (Matson, 1989) although based
on DSM III criteria, it has limitations in its use for those with learning
disability who are unable to verbalise (for a discussion on assessment
40
tools, see next chapter). Such a factor could account for the findings
achieved in the study of Iverson & Fox (1989).
In a large-scale study of 78,603 clients with learning disability, Borthwick-
Duffy & Eyman (1990) conducted a study examining prevalence of dual
diagnosis. The sample under study were selected from those receiving
services from the Californian Department of Developmental Services and
were included in the State Database. Ages ranged from 0 years to 86
years and included those service users living in state-run residential
facilities, community homes, health care facilities, with parents or family
members or in alternative accommodation such as psychiatric clinics or
living independently. The instrument used to obtain data on dual
diagnosis was the Client Development Evaluation Report (COER,
California Department, 1978; Borthwick-Duffy &Eyman, 1990). Findings
indicated that approximately 10% of the clients under study were likely to
be given a psychiatric diagnosis, with those in the mild range of learning
disability more likely to receive a diagnosis than those in the severe
range. Specific psychiatric disorders were not discussed in this paper as
a specific assessment protocol was not administered and results were
based on recorded information (COER - computerised system).
The study of Reiss (1990) was unique in that he selected a population
attending a community-based day programme. The methodology
incorporated was a "two-step" methodology, which was stringent in terms
of operationalisation. It firstly involved a random sample of 205 clients
with learning disability in which a dual diagnosis-screening test was
administered. Step two involved 59 clients being assessed blindly (i.e.
unaware of the results of stage 1) by a clinical psychologist. The
instruments used were the Reiss Screen for Maladaptive Behaviour
(Reiss, 1988), case note information regarding diagnosis and finally
psychological evaluations. Overall results indicated that when diagnosis
was undertaken by means of a screening instrument approximately 39%
of the population studied were deemed as having a dual diagnosis.
When the diagnosis was based on case note information and case files,
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the figure obtained was 11.7%. Thus the two contrasting figures which
emerged in this study show that "these findings support the view that
surveys of case files obtain relatively low rates because the mental
health problems of mentally retarded people have been under-
diagnosed" (Reiss, 1990, p.584).
2.10 More Recent Findings on Prevalence.
With the development of a novel assessment tool in the UK, the PAS-
ADD - Psychiatric Assessment Schedule for Adults with a Developmental
Disability (Moss et aI., 1993), new impetus has been placed on the
effectiveness of this assessment for persons with learning disability. An
increasing volume of data is being published outlining its effectiveness
as an assessment tool, be it in its checklist form, expanded rating scale
form or semi-structured interview format (Moss & Patel, 1995; Moss,
Prosser & Goldberg, 1996; Moss et aI., 1993). It has been used
frequently in the UK over the past five years, particularly on surveys of
psychiatric disorders in older people with learning disability examining
dementia.
As those with learning disability increasingly survive into old age (Caine
& Hatton, 1998) and with a substantial volume of literature being
published on ageing and learning disability, so too has there been
increased interest into psychiatric disorders of old age, namely dementia
(Patel et al., 1993; Zigman et aI., 1995). From the research to date, the
rates of dementia in persons with learning disability far outweighs those
found in the general population (Patel et al., 1993; Turner and Moss,
1996).
Moss and Patel (1995) examined psychiatric symptoms associated with
dementia in older persons with learning disability. They found that in
those over 50 years of age who had definite dementia, they also has
higher levels of sleep difficulty, hypersomnia, irritability, loss of interest
and inefficient thought. Similar to studies from the general population,
Moss and Patel (1995) found that cognitive and non-cognitive features
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are "weakly related" and "psychiatric symptom information may be useful
in screening for dementia in people with learning disability" (p.663).
Research on dementia and its association with Down's syndrome is
another area growing interest for the field of learning disability. Findings
to date have shown that those with Down's syndrome are "at particular
risk of developing dementia" (Caine & Hatton, 1998 p.213; Zigman et al.,
1995) and many over 40 years of age can develop the neuropathological
signs of Alzheimer's disease (Wisniewski, Rabe & Wisniewski, 1987).
2.11 Conclusions and Recommendations.
Over the past two decades there has been a significant increase in the
research undertaken in the study of persons with learning disability and
accompanying psychopathology. Although many issues have been
addressed, there still remain many questions to be answered. Research
on identification, epidemiology and prevalence has proved useful in that
it has provided us with evidence that: a} the full range of mental
disorders that occur in the general population also exist in those with
learning disability and b} generally, there has been an under-reporting of
psychiatric conditions in this population, largely due to diagnostic
overshadowing.
Researchers and clinicians alike, call for continuing epidemiological type
research, as it forms the basis for definitions, causes, the planning of
treatment strategies and public policy concerns. As Scott (1988) states
"valid epidemiological research requires that sound, unbiased,
descriptive data be collected as the cornerstone of research on the
definition, causes, treatment, and basic understanding of mental
retardation" (p.25).
Issues surrounding DSM criteria and classification systems still remain
quite problematic. Although not discussed in any great detail in the
present chapter (see chapter three on assessment issues), the question
still arises regarding the applicability of any classification system based
around the general population and how it may be used for persons with
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learning disability (Moss, 1999; Szymanski et at, 1998). From the
studies on prevalence outlined in the present chapter, it can be seen that
very different figures emerge when DSM criteria are used and when the
DSM criteria are adapted to suit better the needs of those being
assessed. There is no doubt but future research will have to address
this issue further, placing the emphasis on either adapting DSM (or leO)
to the requirement of persons with learning disability or developing a
novel classification system based on the learning disabled rather than
the general population.
In relation to the above point on classification systems and diagnostic
criteria, how can one develop adequate and accurate assessment tools if
many of the underlying theoretical issues still have to be resolved. Great
advances have been made over the past fifteen to twenty years on
assessment tools, but there are still major limitations. The development
of the Reiss Screen for Maladaptive Behaviour (Reiss et al., 1988), The
PIMRA (Psychopathology Instrument for Mentally Retarded Adults) as
developed by Matson (1989) and more recently the PAS-ADD
(Psychiatric Assessment Schedule for Adults with a Developmental
Disability) (Moss et ai., 1993) have yielded interesting results in terms of
overall prevalence, and also in terms of what type of disorders are
occurring most frequently in this population. Much work has yet to be
done on assessment and the key to future research on this area lies in
developing or adapting existing classification systems.
Developing a framework around assessment issues in those who have
either poor verbal skills are or non-verbal requires careful consideration.
Invariably what the findings to date have shown us are that it is
particularly difficult to assess and diagnose those with an 10 of under 50
and frequently it is an impossible task. Even if the client is verbal to
some degree, they may not be able to verbalise how they are feeling -
thus the subjective element which is so important in assessment (and
referral) is absent. One is then reliant on basing one's assessment on a
third party report, which has implications in terms of reliability and
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validity. This issue is where current assessment instruments very often
meet their downfall and fail to assess objectively, reliably and with
questionable reliability.
In conclusion, it is hoped that over the course of the next decade, similar
advances will be made to those of the past ten years. There is no
doubting that the next decade will offer substantial opportunities for
research which will enhance our understanding and practice of
assessment, caring for, and treating those with learning disability and
psychopathology. However, not only is quality research necessary, but
the research undertaken must be effectively translated into practice.
Finally, as Kiernan (1994) has pointed out "there appears to be a growing
antiintellectualism in services and in political thinking which may, in part,
be a result of the failure to translate enlightenment research, e.g. on
cognitive disabilities, into 'tangible deliverables'. Antiintellectualism is a
dangerous trend which needs to be countered by more effective
demonstrations of the value of academic research" (p. 63).
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CHAPTER THREE
ISSUES IN THE ASSESSMENT,
CLASSIFICATION AND DIAGNOSIS OF
MENTAL HEALTH PROBLEMS IN
PERSONS WITH LEARNING DISABILITY
3.1 Chapter Introduction.
In the previous chapter the author discussed some of the principle issues
arising in the field of learning disability and psychopathology. These
issues included the increased demand for appropriate mental health
services for persons with learning disability, historical perspectives and
how these have impinged on present day services for those with a dual
diagnosis, the importance of accurate and detailed assessment and
diagnosis and the significance of case detection and how this proves
. difficult, especially in those who have poor communication skills, or those
who are non-verbal. An underlying theme in all of the above issues is
the issue of classification, and the classification systems used to assess
and diagnose psychiatric problems. At the outset, there are many
problems evident with the current classification systems used in the
present day - DSM-IV (APA, 1994) and ICD-10 (WHO, 1992). One view
that many professionals hold is that "psychiatric diagnosis are the
creations of committees" (Sturmey, 1999, p.3), while others see
psychiatric classification systems as an unnecessary "medicalisation" of
many everyday problems.
The present chapter seeks to address some of the existing and current
arguments surrounding psychiatric classification systems in general, and
also issues pertaining to these systems when they are applied to a
population such as those with learning disability. Several arguments
surround applying a classification system such as DSM-IV (APA, 1994)
to the learning disabled population, and how accurate and reliable
assessment and diagnosis can occur on the basis of the application of
such systems. This chapter will examine in detail some of the relevant
issues in classification systems in the general population, and in tum see
how these apply to the learning disabled population.
In addition, the present chapter will address some of the conceptual
issues in terms of the interaction of different diagnostic categories and
how linguistic competency is so vital for diagnosis if one uses these
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standard diagnostic categories. Sturmey (1995) discusses the "potential
mismatch between psychopathology in people with mental retardation
and the DSM-III-R nosology" (p.357) - such issues will be paramount to
the present chapter.
3.2 Common Problems In the Classification and Identification of
Psychopathology in Persons with Learning Disability.
Historical perspectives have indicated to us that there has always been
interest in the presence of psychiatric disorders in persons with learning
disability (Nezu, 1994; Borthwick-Duffy, 1994; Sturmey, 1995). Recently
however (over the past two to three decades), there has been increased
interest in t~e concept of dual diagnosis and diagnostic overshadowing
(Reiss et at, 1982) in persons with learning disability (Rutter, 1971;
Matson &Barrett, 1982; Reid, 1982, Stark et at, 1988, Bouras, 1994 and
Moss, 1999). Perhaps one of the major "breakthroughs" in the field of
dual diagnosis is that there is now the realisation that persons with
learning disability do exhibit the full range of psychiatric disorders that
are present in the general population (Sturmey et at, 1991). From the
reviews of Rutter et at (1976), Reid, (1982) and Iverson & Fox (1989), it
is reported that the presence of psychiatric disorders are more frequently
reported in the learning disabled population when compared to the
general population. Despite this fact however, Sturmey et at (1991)
state, "the precise magnitude of this effect is not clear" (p.143).
Although the previous chapter (Chapter six) examined some of the
current issues in the field of psychopathology and learning disability, the
author did not examine in detail issues pertaining to classification and its
impact on assessment and diagnosis. To review the problematic areas
in the study of psychiatric disorders in persons with learning disability,
one can see seven major problems arising (some of these being
discussed in the previous chapter). The first of these problems relates to
the under-reporting of the reliability of classification and diagnosis.
Second, major problems exist in transferring a classification system
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(developed with the general population) to the learning disabled
population, without any form of modification or empirical validation.
Third, persons with learning disability who have poor communication
skills or linguistic abilities find it difficult to report what they are feeling
(internal states, emotions and experiences) (Sturmey et al., 1991;
Marcell &Jett, 1985; Moss, 1999) - standard classification systems rely
heavily on verbal reports. Fourth, third-part reports are frequently used
in the assessment and diagnosis of psychiatric disorders in this
population. Fifth, many clients are unable to maintain records of their
behaviours and/or emotions. Sixth, differential diagnosis: - major
difficulties exist in differentiating psychiatric symptoms from symptoms of
inappropriate or challenging behaviour. Challenging behaviour may be
related to the presence of a psychiatric disorder, but it may not
necessarily be a symptom of it. Lastly, there is a poor relationship
between diagnosis of a psychiatric disorder and treatment of it. It was
once thought that specific drugs would be used in the treatment of
specific disorders, but this is no longer a reality in practice.
3.3 General Issues in Diagnosis and Classification Systems.
Any diagnostic system or classification framework provides a set of
"templates" in which the clinician can classify conditions and "compare
information relating to the condition of a particular client" (Frude, 1998,
p.9). As is noted by Sturmey (1999) classification has been the source
of much controversy over the years. The issue of labelling has been
seen in a very negative light, especially in the field of learning disability
due to it being "dehumanising" (Sturmey, 1999).
3.4 Rational and Empirical Classification Systems.
Essentially there have been two approaches employed in the
development of any classification system: rational and empirical.
According to Frances et at (1990) the rational approach is typified in the
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transition from DSM-III-R to DSM-IV. DSM-III-R evolved into DSM-IV by
means of a three-stage process. It incorporated extensive literature
reviews (Widiger et al. (1990), analysis of unpublished data sets and field
trials (Kline et at, 1993). Hence, committees were set-up to co-ordinate
each of the various activities, for each of the above areas. Perhaps the
main criticism of the development of such committees was that the
process was open to "non-scientific influences such as socia-political
pressure to make DSM compatible with ICD" (Sturmey, 1999, p.7; Malt,
1987; Frances et aI., 1989 and Thompson &Pincus, 1989), along with
dominant committee members and poor empirical decision making
process (Zimmermann, 1988).
The second approach to classification of psychiatric disorders has been
the empirical one. Empirical approaches to classification assess
conditions in terms of the presenting symptoms and subject them to
statistical analysis to determine if groupings of behaviours exist. The
research of Farmer et al. (1994) typifies the empirical based approach to
. classification in which the author assessed 862 people on variables such
as physical and sensory disabilities, adaptive and maladaptive
behaviours. Upon statistical analysis, three factors emerged "physical"
(physical abilities), "lack of skills" (general adaptive behaviours) and
-behaviour" (behaviour disorders). Cluster analysis then took place,
which was validated with staffing levels and residential placement.
Results from statistical analysis showed the clusters where behaviour
problems were prevalent and high staffing ratios were needed and where
skills were in abundance and lower staffing ratios were required.
If anything, empirical based approaches to classification try to avoid
·presupposed" ideas of classification based around DSM and ICD. In
addition, by its very nature, empirical classification is -data driven" and
uses the data formulated as a method of problem solving, which is
effective in comparison to committee consensus. In terms of
disadvantages, there are a number clearly evident. Firstly, due to
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empirical classification being data and hypothesis driven, it is quite time-
consuming and does require large sets of data, in addition to
independent replications. Due to the empirical approach being based
around statistical analysis, it may be limited by the pool of items placed
in the data set to be analysed. A final criticism as outlined by Sturmey
(1999) is that empirical classification does not always rely on theory. The
development of many instruments tends to rely on theoretical
assumptions, which are also an important part of clinical practice.
3.4.1 DSM and ICD Classification Systems.
The Diagnostic and Statistic Manual of Mental Disorders (DSM) was first
published by the American Psychiatric Association (APA) in 1952.
Revised and updated versions have been published in 1968 (DSM-II),
1980 (DSM-III), 1987 (DSM-III-R) and in 1994, the most recent version-
DSM-IV was published. The World Health Organisation has followed a
similar pattern over the years, and its classification system termed The
International Classification of Disease (ICD) is now in its tenth edition
(ICD-10). ICD-10 (WHO, 1992) is European based, while DSM-IV
originated and is developed in America. Despite differences in origin, the
two classification systems in their latest versions are quite similar and
their categories may be used in conjunction with each other (Frude,
1998).
According to Parker et at. (1995), one of the main failings of classification
systems such as DSM and ICD is "adequately to represent the diversity
of human experiences of distress and the role of these category systems
in practices which intensify the distress of certain groups in society"
(p.37). These classification systems tend to individualise the presenting
conditions, rather than considering the wider social factors, which include
gender and race. Other general criticisms of DSM and ICD are that they
are the creations of committees (Sturmey, 1999), categorisation and
labelling are dehumanising (Frude, 1998) and fitting people into these
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categories is inappropriate "medicalisation" of life's problems. In
addition, Wilson (1993) has noted that power disputes are a common
feature of DSM categories as many diagnostic categories serve a wide
variety of interests including research, treatment, administrative and legal
(Parker et aI., 1995, p.38). Kirk and Kutchins (1992) note in their critique
of classification systems that much of the time classification systems are
driven by commercial interests, Tomm (1990) notes that classification
systems are very individualistic; Gaines (1992) view is that they are
"dominant conceptions of the Western self" (cited in Parker et aI., 1995,
p.38), while McNamee & Gergen (1992) feel they are social
constructions, and are empirically invalid (Boyle, 1990).
Further criticisms relate to both the inclusion and exclusion of particular
disorders. From observing both DSM and ICD one can see the number
and variety of categories included in both manuals. Those clinicians who
may agree and accept the value of classification and categorisation,
disagree on the types of some of the categories included. Conditions
such as "nicotine dependence" and "partner relational problems" may be
only part of, or contribute to a wider psychiatric disorder. In relation to
the exclusion of various conditions - DSM-III no longer used such
terminology, as "hysteria and neurosis" which many clinicians felt were
useful terms.
As Sturmey (1999) states "when DSM-IV expanded its codes to
include 'other conditions that may be a focus of clinical attention',
it encompassed a broad array ofproblems including relationship
problems, abuse and neglect, non-compliance with treatment,
academic achievement, occupational, identity, religious,
acculturation and phase of life problems. Some view expansion of
the scope of DSM-IV as a legitimate reflection ofpsychiatry, whilst
others view it as the expansion of billable experiences to include
almost all of life's problems" (p.3).
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•Problems of categorisation are another criticism of both the DSM and
ICD classification system. Psychiatric disorders are classified according
to "categories". Cases are assigned to categories (depending on the
number and variation of presenting conditions or behaviours) and there
is very little emphasis placed on the severity or degree of the condition
(Frude, 1998).
3.5 Specific Difficulties in Applying Standard Taxonomies to the
Learning Disabled Population.
As mentioned in the opening pages of this chapter, there is now the
realisation that persons with learning disability are subject to the full
range of psychiatric disorders that are present in the general population.
Although this can be viewed in a positive light, as previously those with
learning disability within the mild or moderate range were seen as "worry-
free", while those within the more severe ranges were seen as not being
capable of a range of emotions such as depression and anxiety
(Szymanski, 1980), it also brought with it the implication that a standard
classification would be suitable for both the general population and the
learning disabled population. As Einfeld &Aman (1995) have stated "the
notion that the psychiatric problems of mentally retarded persons are
similar to the rest of the population implies that the standard
classifications of psychopathology are applicable to mentally retarded
persons" (p.147). Two other authors who are in support of such a view
are Russell (1988) and Matson (1988) and they believe that DSM-III-R
criteria can be used in an essentially unmodified state to assess the
psychiatric problems of persons with learning disability. The PIMRA
(Psychopathology Instrument for Mentally Retarded Adults) assessment
developed by Matson (1988) follows closely DSM-III-R criteria.
An opposing view held by authors such as Sovner (1986), Corbett
(1979), Szymanski (1988), Aman (1991) and Moss (1995) is that the
psychiatric status of persons with learning disability are fundamentally
different to those seen in the general population. Moss (1995) notes that
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Jl "research on the psychiatric status of people with learning disability
suggest that there are important differences from the general population
in terms of the prevalence of various mental disorders" (p.9).
The research of Sovner (1986) suggests that problems such as
·concrete thinking", "bizarre behaviour" and "impaired communication"
limit the use of DSM-III-R criteria in assessing people with learning
disability for psychopathology. The earlier study of Corbett (1979), which
attempted to utilise ICD-9 criteria in an epidemiological study, also found
many problems. These included a difficulty in diagnosing autism in
persons with severe learning disability (in the absence of language
deviance), and a difficulty in assessing the severity of stereotypic
behaviours (without severity criteria). The study of Reid (1983) found
that with such an emphasis placed on linguistic competency in the
assessment process, it was not possible to diagnose schizophrenia in
persons with learning disability with an IQ of under 40.
Aman (1991) urges caution in terms of the applicability of DSM criteria in
persons with learning disability. Aman notes that the application of DSM
criteria becomes more susped as the persons level of learning disability
increases. Such caution is emphasised in conjundion with the DSM-III-
R's caution of "mechanical use" of criteria in persons from different
cultures without assurance of cultural validity.
APA (1987, p. xxvi) state "when the DSM-III-R classification and
diagnostic criteria are used to evaluate a person from an ethnic or
cultural group different from that of the clinicians, ... caution
should be exercised in the application of DSM-III-R diagnostic
criteria to assure that their use is culturally valid. It is important
that the clinician not employ DSM-III-R in a mechanical fashion,
insensitive to differences in language, values, behavioural norms,
and idiomatic expression of distress".
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,This said however, Aman (1991) states, "the presence of a substantial
intellectual handicap may be functionally equivalent to and probably even
more profound than the cultural barriers alluded to in the DSM-III-R
caveat" (p.13).
On reporting the conclusions of the Presidents Committee on Mental
Retardation, Maclean (1991) states, "psychiatric diagnoses based on
existing nosological schemes such as DSM-III ... may be appropriate for
persons with mild mental retardation, but such schemes are inadequate
for describing the disturbances of severely retarded persons". Although
many researchers have used standard classification systems such as
DSM and ICD to classify disorders in the learning disabled population,
these classification systems do nothing to "validate" the use of such a
classification system. As Einfeld & Aman (1995) emphasise "validity is
conferred by a more extensive process such as examination of long-term
outcome, response to treatment, etiology and relation of different
diagnoses within the system to outside variables" (p.148).
Finally on this issue, there does seem to be some agreement in relation
to when the level of 10 increases, the presence of psychiatric disorders
seem to resemble more closely those seen in the general population
(Bruinninks et at, 1988, Russell, 1985, Stark et at, 1988). The problem
with this lies with the uncertainty of where this "cut-off' 10 occurs. Many
researchers feel that the psychopathology of moderate learning disability
should be grouped with those of the mild range, whereas others feel that
those with moderate lD should be grouped with the more severe levels
of lD (Russell, 1988).
3.6 Requirements of an "ideal" Assessment Instrument.
1. Ask patients about presenting symptoms, their duration and historical
development.
2. Examine mental state.
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3. Use informant data to corroborate history and additional information.
4. Use historical information from case notes and other relevant medical
records.
5. Be standardised and repeatable.
6. Allow standardised research diagnoses using ICD-10 and/or DSM IV.
7. Be of the simplest possible linguistic structure commensurate with an
appropriate degree of sensitivity to, and discrimination between
symptoms.
(Taken from Moss, 1995, p.13).
Traditionally, two principle areas of information which are used for
making a diagnosis are firstly a history of the particular complaint and
secondly, information gained from assessment of current mental state
(Moss, 1995). One may ask the question - why such disagreement
among clinicians regarding diagnosis. The answer to this question lies in
the fact that clinicians do not collect information in a standardised way -
collection of information is based on the clinician being:
"armed with a variable amount of background information like the
patients age and occupation and source of referral, holds a free-
ranging discussion interview with the patient, lasting anything from
twenty minutes to an hour or more. In this interview he seeks to
establish a diagnosis by asking the patient first about his current
symptoms and difficulties and then about an ever-widening circle
of other experiences and events, past and present·
(Kendell, 1975, cited in Moss, 1995, p.11).
Diagnosis in persons with learning disability has traditionally been based
on clinical judgement rather than on standardised collection of
information per see In this respect the criteria for making a diagnosis was
not specified and hence was difficult to determine the reliability and
validity of a diagnosis. Certainly in the case of the client whose verbal
skills were poor (or non-verbal), the interviewing technique as a means of
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collecting information was not longer of use and this called the validity of
the diagnosis into question even further. Two issues of relevance here
are the issue of the small number of expert professionals in the field
capable of making an accurate diagnosis when the client is unable to be
interviewed and secondly, major discrepancies exist between
professionals regarding the conditions or symptoms necessary for a
specific diagnosis to be made.
As with the general population, applying a more structured methodology
to assessment and diagnosis will invariably lead to a more reliable
diagnosis. The question here for professionals working in the field of
learning disability is whether applying a classification system such as
DSM-IV or ICD-10 will produce diagnoses of sufficient validity and
reliability and whether using these classification systems will produce a
valid diagnosis from a third party report, where the client in question is
unable to be interviewed due to poor linguistic abilities.
Determining whether ICD-10 and DSM-IV are valid for the learning
disabled population will largely depend on studies conducted which will
examine the manifestations of symptoms across all levels of learning
disability, and which will include the clusters of symptoms which occur in
individuals. On the basis of the results achieved from such studies,
novel classification systems may be constructed which may be more
"adaptable" so as to take into account the variety of mental illness found
in all levels of learning disability. Verhoeven & Tuinier (1999) have made
great strides towards describing specific psychiatric illnesses occurring in
individuals with specific syndromes - such as Praeder-Willi syndrome.
These authors believe that existing classification systems do not take
into account specific psychiatric illness which occurs only in specific
syndromal conditions, and which are presently "unclassifiable" with
existing classification systems. Such avenues of research seem to yield
exciting and novel results which point to the existence of a novel means
of classifying "difficult to diagnose" disorders.
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3.7 Empirical Studies reviewing the use of ICD and DSM
Diagnostic Criteria.
Empirical studies to date which have examined the use of ICD and DSM
in the learning disabled population have progressed along three major
avenues: 1] the use of clinical interviews, 2] the use of case note reviews
and 3] behavioural checklists. Each of these three areas has developed
somewhat independently from each other, but are still used
interchangeably and in conjunction with one another. Essentially the use
of clinical interviews and case note diagnosis and used jointly, whereas
psychometric measures such as checklists are used independently,
although as Sturmey (1993) notes "both address essentially similar
issues" (p.38).
3.7.1 Clinical Interviews & Case Note Reviews: StUdies
incorporating ICD.
In terms of ICD based research, a number of studies have been
undertaken using ICD-9. Wing (1977) and Corbett (1977, 1979 & 1985)
undertook a study using the Camberwell register, reported on the
prevalence of disorders as assessed by ICD in both children and adults.
Corbett (1977) reports on a community sample of 140 children in which
470/0 met the ICD criteria for diagnosis. The three principle diagnoses
were: childhood type psychosis (170/0), severe stereotypes and pica
(10%). In a later study Corbett (1985), both affective illness and
behaviour/personality disorders began to emerge when the population
was aged between 9-24 years.
In a study reported by Lund (1985) using a Dutch national register, a
sample of 324 adults were chosen from the register. Of those sampled
280/0 were deemed to have a diagnosis according to the ICD-8
framework. In adults with severe and profound learning disability, this
figure rose to 40% with the most common diagnoses being behaviour
disorders, psychosis of uncertain-type and early childhood autism. 10/0-
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3% of the sample were said to have a diagnosis of schizophrenia,
affective disorder, dementia and neurosis.
From the above studies, very similar results were found - especially in
adults with severe and profound learning disability. In a more recent
study Ballinger et al. (1991) randomly selected one hundred
residential/institutional clients and reported diagnoses using ICD-9.
From their sample Ballinger et al. found a diagnosis in 80% of cases with
the most frequently occurring diagnoses being personality disorder
(17%), conduct disturbance (15%) and childhood psychosis (12%).
3.7.2 Studies Incorporating DSM. '
The study of Gostason (1985) incorporated DSM-1I1 criteria with a mild to
profound learning disability sample, which also included a non-learning
disabled control group. Findings from the study showed that those
within the mild to moderate range showed symptoms and diagnoses
similar to the non-learning disabled group. Those within the severe and
profound group showed differences from the other groups in that they
had a higher frequency of multiple diagnoses with the common
diagnoses being stuttering and atypical stereotyped movement disorder
(Gostason, 1985).
Eaton and Menolascino (1982) reported on diagnoses made in a series
of 168 referrals for psychiatric evaluation. Of these 168 referrals, 124
diagnoses were made, the most common being - schizophrenia (34),
personality disorder (31), anxiety disorder (1), adjustment reaction (24)
and organic brain syndrome (34).
The study of Sovner & DeNoyes-Hurley (1983) was interesting in that it
examined DSM-III criteria in relation to diagnosis and applicability of
diagnosis. A case was deemed "definite" if the client met DSM-III
criteria, "probable" if a diagnosis was likely but not strictly with DSM-III
criteria, an~ "doubtful" if there was a question of differential diagnosis.
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Their conclusions were that the use of DSM criteria was suitable for
persons in the mild to severe range, but other criteria such as behaviour
pattern and family history should also be taken into consideration.
What is interesting to note from the above studies based on interviews
and case note review is the similar pattern of results achieved from these
studies in addition to the ability to replicate them. However Sturmey
(1993) makes the point that "not one study reported the reliability of
psychiatric diagnosis, although a few studies have reported the reliability
of eliciting and recognising individual symptoms" (p.39; Ballinger et at,
1975; Bouras & Drummond, 1989 and Bouras et at, 1988).
A second point to note is that many of the studies reported used
modified diagnostic criteria and did not adhere rigidly to ICD and DSM
criteria. As Corbett (1977) has stated specifically in relation to ICD
diagnoses: 'he difficulty of applying the glossary definitions was so great
that a fourth digit of .8 (other) or .9 (unspecified) could only be applied-
(p.315). In this respect it is particularly difficult to draw specific
conclusions about the research conducted on applying both DSM and
ICD diagnostic criteria to persons with learning disability as any minor
change in the diagnostic criteria used can lead to a significant change in
diagnosis itself (Zimmerman et at, 1986).
Finally, problems of methodology are another area to be resolved. Many
of the earlier published studies fail to give details about how a diagnosis
was reached. The studies of Meadows et al. (1991) and Hucker at al.
(1979) are exceptions to this as they state their methodology explicitly,
whereas others have failed to do so.
3.8 Psychometric Measures/Behavioural Checklists.
As an alternative to clinical interviews and case note review, a number of
psychometric measures have been developed in order to aid in the
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diagnostic process. These psychometric measures have developed in
the form of brief questionnaires and behavioural checklists in order to try
and circumvent some of the many problems of assessment - the most
difficult of these being that many persons with learning disability are
unable to give reliable information about their mental state (Caine &
Hatton, 1998). These questionnaires and checklists may be
administered to the client themselves (provided they are verbal), but they
are primarily used to facilitate assessment and gain information from a
third party (i.e. a direct-care worker). One of the principle advantages of
these scales is that they are brief to administer and score, and invariably
do not require any form of training in administration. Most of the
checklists available are explicitly related to either DSM or ICD criteria and
"yield subscales that correspond to DSM-III disorders" (Sturmey, 1993,
p.40).
Psychometric measures developed to date have taken two avenues:
firstly those scales developed as "broad measures of psychiatric
disorders" and secondly "measures of mental state"/assessments of
specific disorders (Sturmey et at, 1991). For the purposes of the
present review, the author will review briefly some of the most common
broad measures of psychopathology. The interested reader is referred
to the excellent review of measures as undertaken by Sturmey et at
(1991) and by Aman (1991), both of which examine in detail
assessments of specific psychiatric disorders.
3.8.1 The Psychopathology Instrument for Mentally Retarded
Adults - PIMRA
(Matson et at, 1984; Senatore et at, 1985). The PIMRA was initially
developed by Matson and colleagues in 1984 and is based on the DSM-
III classification system. It consists of 56 items organised into seven
subscales which include: Schizophrenic Disorder, Affective Disorders,
Psychosexual Disorder, Adjustment Disorder, Anxiety Disorders,
Somatoform Disorders, Personality Disorders and finally Inappropriate
60
Mental Adjustment Disorder. Two forms of the PIMRA are available -
the Self-report version (which can be administered to clients who are
verbal and have the ability to describe how they are feeling) and the
Informant version (for use with a third-party). Obviously as the name of
the scale states, it is used primarily for adults with a learning disability.
The psychometric properties of the PIMRA are average as reported
internal consistencies were deemed modest by the study of Aman et al.
(1986) and Watson et al. (1988). In the study of Iverson and Fox (1989),
inter-rater reliabilities ranged from 70% to 950/0, while the reliability of the
presence or absence of a disorder was 89%. Finally from the studies of
Senatore et at (1985) and Sturmey & Ley, (1990), Sturmey et at (1991)
states, "this suggests that the PIMRA may be less robust than desirable"
(p.144).
3.8.2 The Reiss Screen for Maladaptive Behaviour (Reiss, 1988a,
1988b).
The Reiss Screen is a measure of the likelihood that an adolescent or
adult has a significant mental health problem. It is specifically designed
for persons with learning disability within the mild to profound ranges,
and is not deemed suitable for children under the age of twelve years
(Reiss, 1988a). Appropriate uses of the Reiss Screen include:
=> Screening for dual diagnosis in all service areas. It provides an cost-
effective means of identifying those individuals likely to need a mental
health service.
=> Assessment of adolescents in high school who may be in need if
psychiatric intervention.
=> To assist in "intake evaluations" at community mental health centres,
outpatient mental health clinics and all forms of psychiatric facilities.
=> To be used as a research tool in dual diagnosis research.
(Taken from Reiss, 1988a, b).
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The Reiss Screen is made up of 36 items, providing both a total score
and a score on eight individual subscales. These subscales include:
Aggressive behaviour, Psychosis, Paranoia, Depression (behavioural
signs), Depression (physical signs), Dependent Personality Disorder,
Avoidant Disorder and Autism. Psychometric properties of the Reiss
Screen are adequate, but as Caine & Hatton (1998) note "data
concerning the validity of the individual scales is questionable" (p.217;
Sturmey & Bertman, 1995 and Sturmey et at, 1996).
3.8.3 The Diagnostic Assessment for the Severely Handicapped -
DASH
(Matson et at, 1991). The DASH was developed in order to gain
information on persons with severe and profound levels of learning
disability. It contains a total of 83 items with 13 subscales which include:
Anxiety, Depression, Mania, Pervasive Developmental Disability/Autism,
Schizophrenia, Stereotypesrrics, Self-injurious behaviour, Elimination
disorders, Eating disorders, Sleep disorders, Sexual disorders, Organic
syndromes and Impulse control/miscellaneous. Similar to the other
scales mentioned, the DASH is to be completed by appropriate
informants such as relatives or direct-care staff. It is made up of two
main sections, the first of these being concerned with relevant
background information (12 items), with the second being a behaviour
rating component (96 items). Very little psychometric data are present
for the DASH and what data are available are based on institutional
service users and no test-retest reliability data is currently available.
Aman (1991) upon reviewing the DASH states "the DASH is at a very
eariy stage of development and it may be premature to subject it to
review so soon ... this is an instrument which holds a great deal of
promise, provided that the appropriate psychometric studies are carried
out" (p.79).
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3.8.4 The Psychiatric Assessment Schedule for Adults with a
Developmental Disability: PAS-ADD, PAS-ADD Checklist &
Mini PAS-ADD. Moss et at (1996), Prosser et at (1996).
The PAS-ADD schedules have been developed to aid diagnosis and
detection of psychiatric disorders in persons with learning disability.
Unlike the PIMRA (Matson et at, 1984), the Reiss Screen (Reiss, 1988,
a, b) and the DASH (Matson et al., 1991) which are based on DSM
criteria, the PAS-ADD schedules are based upon the ICD-10 (WHO,
1992) European classification system. The PAS-ADD schedules consist
of:
1] The PAS-ADD - a semi-structured clinical interview for use with
respondents who are verbal and with key informants. The PAS-ADD
produces research diagnoses, and it involves a present state interview
with the service user in question, followed by a similar interview with a
key informant or direct-care staff. Completed interviews (service user or
otherwise) can produce a diagnosis and in this respect, it is useful for
clients whose linguistic ability does not permit an interview (Patel et al.,
1993)
2] The PAS-ADD Checklist - a psychiatric symptom checklist which is
used as a means of screening populations for mental health problems or
to monitor symptoms of "at-risk" individuals. It is a relatively short
checklist to be completed by relatives, family members or staff, placing
emphasis on changes in behaviour and whether further assessment of
mental health is required. It may be used as a screening tool or for
regular monitoring of an individual focussing on the full range of mental
health problems. The checklist produces a total of three scores which
relate to: 1] Affective or neurotic disorder; 2] Possible organic condition
and 3] Psychotic disorder. If completion of the PAS-ADD checklist yields
a high score, further assessment can take place utilising the Mini PAS-
ADD. This is now described.
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3] The Mini-PAS-ADD - This is a more detailed assessment in
comparison to the PAS-ADD checklist. Its purpose is to discriminate
between those clients who do not have a mental health problem and
those who may be presenting with the symptoms of a potential mental
health problem. The Mini PAS-ADD therefore gives a much more
detailed description of the persons presenting mental status and uses a
glossary of definitions to aid diagnosis in the preliminary stages of
psychiatric assessment. The Mini-PAS-ADD may be used by staff or
professionals, once some training has been undertaken. It consists of
11 sections, each corresponding to the following psychiatric disorders: 1]
Depression, 2] Anxiety, 3] Expansive mood, 4] Obsessive Compulsive
Disorder, 5] Psychosis, 6] Unspecified Disorder and finally 7] Autism.
Any individual who scores on or above the threshold scores should be
referred for further psychiatric assessment. As all three schedules are
very recently developed and are as yet in their infancy, information and
published studies are currently being collected.
3.8.5 Other Psychometric Scales of Interest.
The above instruments are the most widely documented as they are
designed specifically for use with the learning disabled population and
their psychometric properties are reported in the literature. In addition to
these, a number of other instruments exist which both examine global
features of psychiatric disorders or which focus solely on specific
disorders. Two global scales of psychopathology not mentioned in the
present review but which may be of interest are the Emotional Disorders
Rating Scale for Developmental Disabilities (EDRS-DD) developed by
Feinstein et at (1988) and the Clinical Psychopathology Mental
Handicap Scale (CPMHS) developed by Bouras et al. (1987,1988).
Although these scales are as yet only in the preliminary stages of
development and little if no data are available on them, they have proved
useful tools in the assessment of disorders such as affective and mood
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disorders (Sturmey et aI., 1991), while also being of use in clinical
practice (Bouras & Drummond, 1989).
Other measures specific to the assessment of mental state include The
Mini-Mental State - (MMS) (Folstein et al., 1975), The Clifton
Assessment Schedule (CAPE) and The Shortened Stockton Rating
Scale (SSRS) as developed by Smith et al. (1981).
In terms of assessments utilised to assess specific disorders, a number
of instruments designed and developed for the general population have
been adapted for use with the learning disabled. As an assessment of
depression scales adapted include The Beck Depression Inventory (BDI)
(Beck et al., 1961), The Hamilton Rating Scale for Depression (Hamilton,
1960), The Zung Self-Rating Depression Inventory (Zung, 1965), the
MMPI-D Scale (Hathaway & McKinley, 1967) and the Reynolds
Adolescent Depression Scale (RADS) (Reynolds et aI., 1987).
For anxiety disorders, specific scales adapted include The Children's
Manifest Anxiety Scale (CMAS) (Castaneda et al., 1956), The Fear
Survey Schedule (FSS) (Duff et aI., 1981) and the Zung Self-Rating
Anxiety Scale (Zung, 1971), while for the assessment of Personality
disorders, scales which have been used include The Standardised
Assessment of Personality (SAP) (Mann at aI., 1981) and the Special
Hospital Assessment of Personality and Socialisation (SHAPS)
developed by Blackburn (1982).
Interestingly reviews of schizophrenia in learning disability have
generated much interest but in terms of assessment, little if any specific
information on assessment instruments is available. However scales
such as the PIMRA (Matson et at, 1984) and the DASH (Matson et at,
1991) do have specific subscales, which relate to schizophrenia. As
Reid (1989) cited in Sturmey et at (1991) states •... in general there is
nothing unique or esoteric in the symptomatology of schizophrenia in
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mentally retarded people" (p.151). For a more in-depth analysis on the
issue of schizophrenia in learning disability, the reader is referred to the
review article by Turner (1989).
To conclude this section on assessment of psychopathology, one can
see that of the available methodologies (i.e. clinical interviews; case note
assessment and psychometric checklists), considerably more research
has been conducted into the development of psychometric measures
than any other form of assessment. However despite the number of
psychometric tools available specifically for the assessment of
psychiatric disorders in persons with learning disability, as yet the vast
majority of these tools are in their infancy and require much work before
their true benefits are recognised. There is no doubt but the number and
diversity of tools available is quite large, but on reviewing the literature on
these instruments, the majority have only been developed since 1984.
This said however, many of these tools are adaptations of assessments
used in the general population or are parts of existing assessment tools.
In this respect Aman (1991) makes the point "most of them simply have
not been evaluated for their utility as diagnostic instruments" (p.174).
Common problems with these existing tools include: problems of
sensitivity and specificity (Kleinbaum et at, 1982), problems pertaining
to the precision of many of these tools «Aman, 1991) or the lack of an
available "Gold Standard" (Moss, personal communication) - thus the
diagnostic accuracy of many instruments is untested. Finally the issue of
inadequate standardisation of assessments still remains largely due to
many of these instruments being developed on small-scale budgets and
therefore large-scale standardisation studies prove exceptionally difficult.
3.9 Summary, Conclusions and Recommendations.
The present chapter had several foci of interest, which expanded upon
issues discussed in the previous chapter on psychopathology. Any
discussion on issues pertaining to psychopathology in persons with
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learning disability warrants a discussion on the classification systems
used and incorporated in the assessment and diagnostic phases. From
this chapter, one can see that many problems are evident in
incorporating a classification system (such as ICD or DSM) developed for
the general population to the learning disabled. Although the learning
disabled population do exhibit the full range of psychiatric disorders,
these disorders are often presented in ways not usually seen in the
general population. Existing classification systems like ICD and DSM
simply do not cater for such "atypical" presentations and attempting to fit
existing models of psychopathology (developed for the general
population) in a learning disabled population does seem questionable at
times.
The author presented empirical studies conducted in the learning
disabled population which utilised both the DSM and ICD modes of
classification. Despite many of these studies being methodologically
sound and replicable, many important issues were left unanswered.
Very often in such studies, no figures were available on the reliability of
psychiatric diagnoses made - either through clinical interview, case note
review or psychometric testing. Where clinical interviews and case note
reviews were the methodology of choice, elevated figures have been
reported frequently. A major flaw in many of the studies reported is that
ICD and DSM criteria were modified in some way, thus having an impact
on the diagnoses formed (Zimmerman et aI., 1986).
Upon reviewing the current psychometric tests available to assess
psychopathology in this population, numerous tests are available, but
many of these are still only in the developmental phase and require
much refinement (Aman, 1991). The author reviewed the four most
common instruments available to date and gave a brief overview of each.
The four instruments reviewed were: 1] The DASH - Diagnostic
Assessment for the Severely Handicapped (Matson et aI., 1991), 2] The
Reiss Screen for Maladaptive Behaviour (Reiss, 1988a, b), 3] The
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PIMRA - Psychopathology Instrument for Mentally Retarded Adults
(Matson et aI., 1984) and finally The PAS-ADD - Psychiatric Assessment
Schedule for Adults with Developmental Disabilities (Moss et aI., 1996,
Prosser et al., 1996). Some of the principle points of each assessment
were discussed in addition to the subscales included in each instrument.
The present chapter on assessment, classification and diagnostic issues
should not be viewed in isolation from the other theoretical chapters.
Rather it should be viewed as a continuation of the issues discussed in
the previous chapter on psychopathology. Although issues of
appropriate classification are of paramount importance in the
development of any framework (and especially so in terms of
psychopathology), as it has wide ranging implications for assessment
and diagnosis, but these issues need to be addressed in terms of the
"broader picture" witnessed in the field of learning disability. From
reading the previous chapter one can see that even if existing
classification systems were deemed appropriate and accurate, it does
not necessarily mean that the case identification will take place. If case
identification does take place, assessment and diagnosis should not be
based solely in terms of completion of a psychometric checklist, a clinical
interview or case note review. Psychometric checklists for example offer
the clinician the ability to assess current behaviour over a specific time
period. These checklists do not assess in detail issues around
developmental appropriateness of the behaviours in question, nor do
they place emphasis on the client's history, which is often very valuable
in formulating a diagnosis. Moss (1999) emphasises this point when he
makes reference to the inclusion of "the wider aspects of individuals
lives, such as their ability to cope with life transitions, and the adequacy .
of their support networks" (p.33). Frequently these issues are forgotten
about or their significance is underestimated. In addition and specifically
in relation to classification and diagnosis, Falloon & Fadden (1993 - in
Moss, 1999) note that "diagnostic classification is likely to provide only
partial guidance on the morbidity and quality of life experienced by
individuals suffering from mental disorders" (p.34).
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Finally, development of a more structured approach to the assessment
and diagnosis of psychiatric disorders in the learning disabled population
has facilitated a better means of communication between all those
involved with this population. As was discussed in this chapter,
traditional approaches to assessment and diagnosis have tended to
place emphasis on clinical interviews and case note reviews - whose
reliability has been questionable. With the development of semi-' -,
structured clinical interviews and psychometric instruments, reliability of
diagnoses has improved considerably (Moss, 1995), through employing
the same diagnostic criteria in all samples. Although many of these
instruments need to be refined and further developed, they are greatly
aiding the process of assessment and yielding far more accurate
diagnoses than in previous times.
In an attempt to further develop and adapt the ICD-10 classification
system for persons with learning disability the World Health Organisation
(WHO 1996) has published the ICD-10 Guide for Mental Retardation.
Einfeld &Tonge (1999) note that this guide was developed Min
acknowledgement of the challenges posed by the diagnosis of mental
disorders in people with intellectual disability" (p.408). Although
publication of the Guide is both valuable and warranted, it does suffer
from a number of inconsistencies and has its limitations, but as yet it is
only in its first edition. Einfeld and Tonge (1999) report on its use in
conjunction with ICD-10 in a sample of 106 persons with learning
disability and behavioural and emotional problems. Although they found
it a useful tool to be used in conjunction with ICD-10, many problems
were evident in utilising each Axis, the most notable of these being Axis I
and Axis II (severity of retardation and problem behaviours and
associated medical conditions respectively).
However as Einfeld and Tonge (1999) summarise "The ICD-10 Guide for
Mental Retardation provides a valuable first attempt to develop an official
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descriptive system and taxonomy of associated health problems in
people with ID. An examination of The Guide reveals a number of areas,
particularly with regard to behavioural and psychiatric disturbances,
which will benefit from further consideration in future editions ...•.
There is no doubt but publication of the ICD-10 Guide for Mental
Retardation is a major advancement for the field of learning disability.
Up to this point, clinicians and researchers alike were formulating their
diagnoses upon existing systems (ICD-10 and DSM-IV) - classification
systems that were designed for use with the general population. What
lies ahead for the field of learning disability now, is to further develop the
ideas proposed in the ICD-10 Guide and engage in research
investigating their reliability in order to develop an appropriate and
reliable measure of psychopathology in this population.
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CHAPTER FOUR
PRESCRIBING AND LEARNING
DISABILITY: RESEARCH FINDINGS
4.1 Chapter Introduction
/ ,
The issue of prescribing for clients with learning disability has had an
e,motive history over the past number of decades. Gualtieri (1991) cited
in Crabbe (1994) notes "the epidemic of neuroleptic overuse among
people with mental retardation is one of those tragic experiments that
nature, or history, will sometimes play" (p.187). In terms of an historical
overview, several problems are evident. There are two beliefs in terms of
prescribing for clients with learning disability: firstly there are those who
are firmly rooted in the medical model and believe that pharmacological
intervention should be the technique of choice, and secondly, there are
those who believe that the risks greatly outweigh the benefits in terms of
prescribing of medication. This is especially true of psychotropic
medication in clients with learning disability as the risk-benefit ratio can
be difficult to determine at times. In the United States in recent years,
there has been much litigation about psychotropic medication and many
cases have been taken against organisations and institutions which cater
for clients with learning disability, largely due to the many negative side
effects of particular medications which were prescribed. In general,
there is a much greater awareness and interest by professionals who
work with clients with learning disability in relation to the prescribing
practices for these clients. The implementation of the multi-disciplinary
team in many organisations to review medication use is evidence of this
heightened interest.
4.2 Aims of The Chapter
The present chapter has several foci of interest. It Firstly examines the
relationship between the field of learning disability and the field of
pharmacology and why medication is prescribed and administered to
clients with various levels of learning disability. Although clients with
learning disability have been prescribed medication for several decades,
there are a number of significant factors which have occurred in the field
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in the last decade which have had quite an influence, and will shape the
field of prescribing in this population for some time to come. Such
factors are discussed. As in most texts dealing with this area, a detailed
history of the prevalence of prescribing for the learning disabled
population will be discussed, making particular reference to some of the
more pertinent drug prevalence studies which are frequently cited.
Although a substantial volume of research has not been undertaken on
the factors affecting prescribing in the learning disabled population, the
present chapter will examine research undertaken on the general
population and how this research may be applied to clients with learning
disability. The issue of psychopathology, learning disability and
prescribing of medication has received some attention over the years but
it has not been examined in any great detail - research to date will be
presented on this topic. Although the many positive aspects of
prescribing will be dealt with throughout the chapter, there will also be
reference to the many negative aspects of prescribing such as irrational
practice and polypharmacy for example. Arising from the litigation
surrounding psychotropic medication, the notion of the inter or multi-
disciplinary team is very much in use, especially in the United States and
it is slowly coming of age in Ireland and the United Kingdom. Such
teams are being set-up in order to review medication use and to
determine the effectiveness of such medications. Resulting from the
development of the inter-disciplinary team, rigorous medication
monitoring and the implementation of guidelines for medication use are
being written into policy and becoming law in many states in America and
elsewhere. Each is discussed in tum.
4.3 Definitions and Terminology
Before commencing any discussion on medication and prescribing, two
important definitions must be outlined - the use of the term psychotropic
drug and psychoactive drug will be used throughout the chapter and a
definition of each is as follows:
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Psychotropic drug: "any agent prescribed for the purpose of bringing
about behavioural, cognitive or emotional changes". (the typical example
given of this category of drug would be the antidepressants, anxiolytics
etc.).
Psychoactive drug: "any agent that has these effects, regardless of the
intent when prescribing the drug". (the typical example here would be the
anticonvulsants or anti-epileptic drugs).
(Taken from Aman and Singh, 1991, p.348).
4.4 Issues in Psychopharmacological Research to Date
The use of psychopharmacological interventions in clients with learning
disability has been hindered by a host of various factors (Lewis et at,
1996) including a marked lack of objectivity and reliability in terms of
early research of the effects of medication in this population - thus the
necessary empirical research base was lacking in this field up until quite
recently. The field of learning disability in general has been a field which
has been lacking from quality input from the field of psychiatry, although
the medical model is still the dominant model. In terms of psychiatry and
medication use in the field, there is still quite an air of subjectivity in
relation to prescribing for clients with learning disability. Although the
majority of drugs have specific uses and guidelines regarding their use,
drugs such as the antipsychotics are still widely prescribed for both
suppression of the symptoms of psychosis and mental illness, while also
being administered for the purposes of behaviour control. Such
widespread use of the antipsychotics in particular has brought about a
very negative attitude by many professionals as prescribing in this
respect is often unwarranted in many cases. In relation to the notion of
subjectivity, the problem of accurate psychiatric diagnosis still remains in
the field of learning disability. A major problem in relation to the
diagnosis of psychiatric problems in clients is that many clients are non-
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verbal and diagnoses are based on the reports of their carers, and
secondly, a significant majority of individuals with a learning disability are
within the severe to profound ranges of learning disability and
assessment of these clients is extremely difficult due to the majority of
these clients not being able to express how they are feeling even if they
are verbal and have a means of communicating.
4.4.1 "Anti-Drug Sentiment" in the Field.
Since the early 1980's, there has been considerable emphasis placed on
administration of medication in the learning disabled population. The
main impetus of this heightened interest arose out of genuine concern by
professionals in the field as firstly clients were being grossly
overmedicated (over prescription), secondly the practice of
polypharmacy was very much in vogue and used in many clients, thirdly
there were frequent irrational prescription practices in operation and
finally inadequate reviews of medication use inevitably lead to prolonged
and unnecessary drug treatment (Fan, 1991).
Aman and Singh (1986) in a highly influential article wrote Min the last few
years we have been struck by an apparent crystallisation of what we
would characterise as 'anti-drug' attitudes in this field. Most often, this is
conveyed more by the general tone of articles on the topic, rather than
by bald statements of opposition to pharmacotherapy per see
Nevertheless, we believe that, in recent years, there has been a strong
undercurrent of feeling that the net effect of most pharmacotherapy is
adverse to the individuals being treated" (p.203). As mentioned above,
perhaps one of the most significant factors which lead to an increased
interest in the use of medication in the field of learning disability was the
inappropriate use of psychotropic drugs for these clients. In previous
times, psychotropic drugs were administered purely for the convenience
of staff caring for these clients and such drugs were used as a method of
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punishment due to their ease of use. Clearty such uses were both highly
inappropriate and extremely unethical.
4.4.2 Negative Side Effects of Medication In the Leamlng Disabled
Population
Another factor, which has lead to this "apparent negative attitude" toward
medication use, has been the many negative side effects, which are
evident in clients, which have been treated with certain classes of drugs.
Neurological side effects such as tardive dyskinesia (which in many
cases is irreversible) are evident in many clients who have been on long-
term antipsychotic medication. Although clinical descriptions of tardive
dyskinesia were reported as earty as 1956, it was not until the 1970's
that it had been documented in some detail (Campbell et al., 1983).
Since this time various prevalence rates have been put forward from
approximately 200/0 (Paulson et at, 1957) to 33% (Gualtieri et at, 1982)
to an alarmingly high rate of over 80%, as was documented by
(Kalachnik et at, 1984). If anything these figures pointed out to
professionals in the field that there were substantial risks in relation to
the use of medication, many of which were not envisaged before this
time.
4.4.3 The Research of Stephen Breunlng
The work of Stephen Breuning (Breuning, 1982; Breuning et al., 1982)
also contributed greatly to the heightened interest in this area, as from
his research, serious questions were asked as to the efficacy of drug
usage in this field. However as will be mentioned in the paragraph
below, the work of Breuning has itself being called into question and
hence raises serious questions about the findings and implications of his
research.
Many developments have taken place in the field of pharmacotherapy
and learning disability in recent years, the majority being to the
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advantage of the client with learning disability. Firstly, due to the
heightened interest in this particular area, there has been a rapid
increase in the number of publications on the topic of drug usage in the
learning disabled population. From the mid-1970's to approximately
1987, there were about 30 published articles on the topic of drug
prescribing for clients with learning disability (Aman, 1987). From 1987
to 1995, there have been at least another twenty publications on this
topic in such a short space of time. The majority of the latter publications
have been in respect to clients living in the community, rather than in
institutional or residential facilities, as was the case with the majority of
the older studies published (Aman, et aI., 1995). The second major
development was very much on the negative side and it pertained to the
research of Stephen Breuning - which at the time of its publication was
widely accepted and generated much interest. Breuning, in the early
1980's published a series of well-researched, methodologically "sound"
studies (Breuning, 1982; Breuning et aI., 1982) which examined the
effects of neuroleptic drugs on individuals with learning disability.
Findings from the research of Breuning showed clear-cut evidence in
terms of the detrimental effects that such medication use was having on
these clients - in terms of adaptive functioning and scope for learning etc.
The research of Breuning "had a marked effect on the field, to the extent
that at least one state modified its guidelines regarding the use of
psychotropic drugs to be consistent with Breuning's findings" (Aman and
Singh, 1988, p.vii; Holden, 1987)..
4.4.4 Legislation and Litigation Regarding the Use of Medication
Due to the points above, especially in the United States, there have been
major social and legal changes in terms of medication use in both
residential and community facilities. Litigation surrounding the misuse of
drugs in the field of learning disability has been widely documented and
due to the many court cases use of medication in many States is now
strictly controlled and subject to an annual audit by the mUlti-disciplinary
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team. Another point of interest, especially with regard to the field of
pharmacotherapy is that in recent times, the focus of attention and
interest has been in relation to the negative side effects of drug therapy
rather than the therapeutic effects of these drugs as was the case
previously (Sovner &Hurley, 1984). The final point of interest (again
very much related to the United States) is that there is increased interest
at federal level in terms of drug prescribing and its effects. This interest
has been developed in the setting up of special working parties and
committees which examine a number of drug related issues in the
learning disabled population.
4.5 Kalachnik's Theoretical Perspective on Psychotropic
Prescribing
Kalachnik (1988) states in relation to the prescribing of drugs for the
learning disabled that "psychotropic medication is prescribed for mentally
retarded people primarily to suppress behaviour disorders (e.g.
aggression, self-injury) or to alleviate the symptoms of mental illness
(conditions such as psychosis or depression)" (p.231). He also notes a
number of fundamental points with regard to the prescribing of such
drugs to clients with LD in the fact that in the first case psychotropic
drugs are frequently prescribed to this population, both within residential
facilities and community facilities, secondly there has been much
concern over prescribing to these clients over the past two decades and
finally as a result of litigation and stringent regulations, in many States
strict guidelines have been implemented and enforced which guard
against the misuse of drugs in these clients. Kalachnik notes that
implementation of such guidelines may require the following:
• Delineation of specific target behaviours.
• Written informed consent.
• Use of a minimum effective dose.
• Periodic attempts at dosage reduction.
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• Integration of behavioural, educational and medical
interventions.
• Monitoring for side-effects (tardive dyskinesia etc.)
• Interdisciplinary assessment of the need for medication
• Periodic data based evaluations of drug efficacy.
(taken from Kalachnik, 1988, p.231).
4.6 Prevalence rates of Prescribing in the Learning Disabled
Population.
In one of the most widely documented drug prevalence studies cited in
the literature, Lipman (1970) conducted a drug prevalence study
involving 109 residential facilities in the United States. The results of this
study were quite startling as 51 % of clients were administered
psychotropic medication. Resulting from the findings of this study,
extreme concern was expressed by many professionals in the field that
such a percentage of clients administered psychotropic medication was
far too high a figure. In addition Lipman's study acted as a catalyst for
further research on the topic of prevalence of prescribing for this
population. Due to the increased volume of studies published since
Lipman's study in 1970, there has since been far more accurate and well
documented studies of this nature, which has inevitably lead to the
heightened interest in this field.
Since the 1970's a considerable amount of interest has been drawn to
the rates of prescribing for clients with various forms of learning disability,
namely in residential facilities (Spencer, 1974; Hughes, 1977; Jonas,
1980; Aman et ai, 1985a). It is only relatively recently in the UK that any
studies pertaining to the prescribing practices for clients in community
facilities have been published - one of the first of these to be published
by Hemming (1984) and subsequently by Clarke et at (1990).
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As is noted by Aman and Singh (1991) clients with learning disability "are
among the most medicated populations in our society" (p.348). In terms
of the figures quoted for clients living in residential or institutional
facilities, the figures have ranged from 30 to 50% for psychotropic drugs
and in terms of anticonvulsant or antiepileptic medication, the figures
have ranged from 25% to 35%. If one combines these totals, one is
looking at an overall prevalence rate of between 50 and 700/0 (Aman and
Singh, 1988).
When one looks to clients living in the community, the typical
prevalence rates of prescribing are within the range of 20 to 360/0. For
anticonvulsant medication, the figures have ranged from 20 to 25%. For
a total combined prevalence rate, the figures published for community
clients are 36 to 48%. The figures quoted above are for adults with
various forms of learning disability ranging from mild to profound.
When it comes to children with learning disability, considerably less
research has been undertaken and the rates to date are quite low with
school-age children in the community being prescribed psychotropic .
medication within the range of 3 to 7%, the figures for anticonvulsants
being 12 to 170/0, with the combined rates falling within the 18 to 21 %
range (Aman et aI., 1985a; Gadowand Kalachnik, 1981).
4.7 Variables Studied In Relation to Prescribing Rates.
In terms of prescribing rates, many variables have been examined in
order to ascertain which are of importance in relation to prescribing rates.
Demographic variables such as gender, age and level of learning
disability have been some of the more common demographic variables
studied, while more recently Aman at al., (1995) undertaken in the USA,
examined variables such as seizure condition, visual status, hearing
status, level of mobility and race. Results to date which have examined
the main variables such as gender, age and functional level have had
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non-conclusive results, largely due to the small number of studies
reported. The study of Aman et ai., (1995) found that seizure disorder
was associated with lower levels of prescribing of the neuroleptics,
anticonvulsants (primarily for behaviour control rather than seizure
control) and lithium. The more severe the level of learning disability, the
less drugs these clients were administered which is quite a surprising
result in light of previous research as was noted by Aman and Singh
(1991). Unimpaired ambulation was positively linked with greater use of
medication, while those with visual impairments were less likely to be
administered medication. It is quite clear that further research is required
to ascertain which variables are of significance in terms of prescribing for
clients with learning disability.
Professionals and workers in the field of learning disability cannot ignore
such figures and although many drug reduction programmes are in
operation in many facilities, there is still the need to emphasise that
much of the drug use in this population is unwarranted and must be
called into question. The main evidence for this statement lies in the fact
that discrepancies still exist between issues such as - is psychoactive
medication prescribed primarily for the suppression of the symptoms of
mental illness or purely for the purposes of behaviour control. If the latter
is the case then stringent guidelines need to be enforced so as to
oversee the effectiveness of medication in such cases. Not only does
effectiveness need to be stringently measured, one also has to take note
of the many negative side effects that such drugs may present mainly in
terms of impairment of cognitive function and learning ability. As Aman
and Singh (1991) have stated "the figures on prevalence indicate that
pharmacotherapy is one of the most prevalent forms of treatment in the
developmental disabilities... not only do these agents have important
effects in their own right, but they have the potential to interact with other
forms of treatment, such as special education and behaviour
modification" (p.349).
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Table 4.1 below gives some of the most frequently cited drug prevalence
studies published since 1970, while Table 4.2 takes into account the
setting and type of facility studied in terms of more recent studies
published in the UK and the USA.
Table 4.1: A table depicting the prevalence of prescribing for
residential and community clients with learning disability
(psychotropic and anticonvulsant medication) from 1970 to 1987.
Authors No. of o~ receiving o~ receiving Total
persons psychotropic anticonvulsant percentage
surveyed medication medication
Residential
Lipman, 1970 109 51 NR NR
institutions
Spencer,
1974 585 22 24 51
DiMascio, 1232 26 21 NR
1975 785 53 90 NR
Pulman et al., 435 47 34 60
1979
Craig and 161 83 NR 83
Behar, 1980
White, 1983 415 19 36 51
Radinsky,
1984 1687 27 48 51
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Intagliata and
Rinck, 1985 171 54 42 76
Aman et alo, 531 37 41 58
1987 937 39 28 60
Community
Hansen and 229 31 NR NR
Keogh, 1971
Radinsky, 575 36 33 36
1984
Martin and 178 32 24 48
Agran, 1985
Hill et alo, 962 26 22 40
1985
Gowdeyet 1389 20 23 40
aI., 1987
Table 40 1 adapted from Aman and Singh, (1988), pp03-4. (NR =not
reported)
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Table 4.2: A table depicting the prevalence of psychotropic
medication prescribed to clients with learning disability according
to setting, type of facility and country.
Authors Setting Facility Country Prevalence
Gowdeyet Community Residential Canada 26%
aI., 1987
Clarke et at, Community Residential UK 19°k
1990 Community Family home UK 100/0
Wressel at Hospital Hospital UK 240/0
at, 1990
Zaharia and
Struxness, Community Residential USA 19%
1991
Harvey and Hospital Hospital UK 37%
Cooray, 1993
Lepler et at, Community Residential USA 18%
1993
Branford, Hospital Hospital UK 440/0
1994 Community Residential UK 190/0
Community Family Home UK 9%
Table 4.2 taken from Fleming et al., (1996) p.195.
4.8 Psychotropic drugs used in therapy.
4.8.1 The Antipsychotics
Antipsychotic drugs are the most frequently prescribed drugs to clients
with learning disability living in residential facilities. Approximately half of
clients in residential facilities and approximately 200k of clients in the
community are administered these drugs (Hill et at, 1985; Intagliata and
Rinck, 1985). Antipsychotic medications are prescribed for a range of
different symptoms such as hyperactivity, aggression, antisocial
behaviours and self-injurious behaviour. Although there are many well-
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controlled studies which have reported the positive effects of such drugs,
there is also quite a volume of literature which has examined the
negative effects of such drugs (Aman et at., 1991).
4.8.2 The Antidepressants
Antidepressant medication is used in the learning disabled, although not
to the extent of the antipsychotics. Antidepressant drugs include the
tricyclic antidepressants, monoamine oxidase inhibitors, selective
serotonin uptake inhibitors and 5-HT 1A agonists. Antidepressants have
been used in children and adults for a range of different problems, the
most common of these being phobias, encopresis, sleepwalking and
enuresis. Antidepressants are used more frequently in clients living in
the community (with mild and moderate levels of LD) and the trend
seems to be that a greater proportion of females compared to males are
administered this class of drug. In recent years, antidepressants are
being used for more varied purposes, the typical example being
Flouxetine (ProZ8C) which is now prescribed for depression, Bulimia
nervosa and more recently Obsessive-Compulsive Disorder (1993).
4.8.3 The Anticonvulsants
Anticonvulsant drugs: although the primary reason for prescribing
anticonvulsant drugs is for the control of seizures, there is now a growing
body of literature which is recognising the psychotropic effects of many
of these drugs. Even when anticonvulsant drugs are administered solely
for the purposes of controlling seizures, their psychotropic properties are
often clearly evident. In this way they have the ability to control
behaviour as do the more common antipsychotics. Anticonvulsants also
appear to have an effect on cognition in addition to behaviour. On the
negative side, some clients when administered certain anticonvulsant
drugs, after a period of time show reactions similar to clients on long-
term antipsychotic treatment. The toxic effects of the anticonwlsants
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build up and produce similar reactions to tardive dyskinesia. Prescribing
rates for anticonvulsants have ranged form 25 to 350/0 for residential
clients, while in community clients the figure is 20 to 250/0 - which is
approximately the prevalence of epilepsy/seizure pattern in this
population.
4.8.4 Carbamazapine for Behaviour Control
Within clinical practice, a small proportion of clients are administered
anticonvulsant medication for the purposes of behaviour control, or as a
mood stabiliser. The typical example here would be the administration of
Carbamazepine (Tegretol) to clients who display aggression as this drug
has strong psychotropic properties and has the effect of reducing
aggression in a proportion of clients. Caution must be urged in such
cases as there is a lack of research investigating the effects of this class
of drug on behaviour. In addition there is a large range of antipsychotics
available for the purposes of suppression of behaviour disorders with
relevant research on their effectiveness. Many practitioners however still
firmly believe that in many patients' aggressive episodes are a result of
epileptic features and epileptic activity and in prescribing an
anticonvulsant, one is reducing brain activity and thus reducing
aggressive episodes. This said however, Evans et al., (1986) have
stated that "carbamazepine has not yet been properly investigated with
children having specific disorders and with attention to a number of
relevant drug parameters to allow conclusions to be drawn" (cited in
Aman and Singh, 1991, p.254). ,,-
4.8.5 The Anxiolytics
Anxiolytic or anti-anxiety drugs are relatively frequently prescribed,
especially in residential settings but also in the community. Aman and
Singh (1991) note that the Benzodiazepines are prescribed in
approximately 8% to 13% of cases in residential care, while a similar
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figure emerges in the community (8 to 120/0). One of the issues with the
prescribing of the anxiolytics is that they can be prescribed for a host of
different problems such as anxiety primarily, they can also be used as an
anticonvulsant (Diazepam) or they can be used for behavioural control
(this is relatively uncommon however). This class of drugs can
sometimes be administered to clients for the purposes of controlling
muscle spasms although in more recent times this has tended not to be
the case as more effective drugs are currently on the market. Intagliata
and Rinck (1985) found that anti-anxiety drugs were not used primarily
for the treatment of anxiety, but for conditions such as aggression,
hyperactivity and disruptive behaviour. In more recent research, Aman
et at (1995) suggest that there is no clear and specific diagnosis for the
use of anxiolytic drugs, and the prevalence of anxiety amongst those with
LD may actually be under-reported, which is in itself a cause for some
concern.
4.8.6 Other Drugs Prescribed
A host of other drugs are prescribed to the learning disabled population
such as anticholinergics, stimulants and hypnotics. For the purposes of
the present chapter, discussion of these drugs will be brief. In terms of
the anticholinergic class of drugs, they are primarily prescribed due to the
negative side effects of antipsychotic medication. In some reported
studies, there has been an elevated rate of prescribing of anticholinergic
drugs (higher rates than those recommended by the British National
Formulary), but this is inevitably due to a high rate of prescribing of
antipsychotics - especially in residential clients. The same figures for
community clients are far less, some up to one third less than the figures
quoted for residential clients. In terms of stimulants, at one stage these
were prescribed quite infrequently to clients with LD. In more recent
times however, the prescribing rates are increasing due to an increased
number of children presenting with ADD-H (Attention Deficit Disorder
with Hyperactivity) (Gadow, 1992) although concerns have been
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expressed about use of this drug in children and adolescents. Hypnotic
drugs, similar to the anxiolytics have been used to treat a range of
disorders from hyperactivity to aggression, although primarily prescribed
(short term) for disturbances in sleep. Hypnotics are prescribed to a
small number of clients, within the range of approximately 4 to 6%.
4.8.7 Negative Side Effects/"Minimal Effective Dosage"
In more recent times, due to the concern expressed over high rates of
prescribing to clients with learning disability, the emphasis has been on
attempting to withdraw antipsychotic medication in as many cases as
possible and developing guidelines regarding effective use of such
drugs. Drug withdrawal studies have shown that Antipsychotics can be
reduced in many clients without an increase in problem behaviour or
without detrimental effects on social functioning. The work of Fielding
(1980) is applicable in this respect as he introduced the notion of a
"minimum effective dosage" and he works within the framework that
"every attempt should be made to reduce the dosage gradually and
ultimately to discontinue the drugs" (p.772). From research to date, the
one behaviour that Antipsychotics do seem to have a positive effect on is
stereotypy, although far more research is required to ascertain the actual
effects on this behaviour disorder.
Another major problem with prescription of Antipsychotics for both
behaviour disorder and suppression of psychiatric disorders is that in
general, once a client is commenced on such therapy, it is long term
rather than short term. One of the main problems associated with long-
term use of Antipsychotics, especially the neuroleptics are neurological
side effects such as Tardive Dyskinesia - which has detrimental effects
on performance and learning (Lewis et at, 1996). Hence one has to be
very cautious about over-use of Antipsychotics in a population such as
the learning disabled in which many clients are non-verbal and are
unable to report side effects.
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4.9 Current Thoughts on Prescribing
A quote taken from Lewis et al. (1996) sums up the current thinking
about use of drugs in clients with learning disability. "The appropriate
use of medication in people with MR and developmental disabilities
requires a sophisticated and data-based approach. This is especially
true in light of the difficulty many clients have in articulating subjective
experiences and the presence of adverse effects. The risks of treatment
must be weighed against the costs of not using treatment" (p.340).
Two further quotes which sum up the appropriate use of psychotropic'
medication in relation to persons with learning disability are as follows.
Rivinus (1980) states "the same rules that apply to the use of
psychotropic medications in adults and children of normal intelligence
apply to retarded patients. Psychotropic drugs should be used to treat
specific diagnoses, syndromes, or symptoms for which specific drug
efficacy has been scientifically established" (p.195)., while in a similar
fashion Szymanski and Crocker (1989) state, "psychotropic drugs work
in the same manner and should be used in the same way whether the
patients intelligence is average, above average, or below average .•.
psychiatric disorders, not specific symptoms, should be treated" (pp.
1659-1660).
4.10 Medication Monitoring Procedures.
As was mentioned briefly at the start of this chapter, the quote taken
from Kalachnik (1988) emphasised the importance of medication
monitoring procedures. In any monitoring process, there has to be strict
criteria as to what exactly is being monitored and guidelines need to be
set-up as to how the monitoring process is to be achieved. In 1983, in
the States the Accreditation Council for Services for Mentally Retarded
and Other Developmental Disabled Persons (ACMRDD) was set-up for
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the specific purposes of determining the effectiveness of medication use
and to prevent its miss-use. The Council worked under and adopted the
following principles in the development of its standards:
4.10.1 Principles Involved in Medication Monitoring
• Medication is not used as ... a substitute for a programme.
• Drugs used for behaviour management are utilised only as an integral
part of an individual programme plan designed by an inter-disciplinary
team.
• Each programme plan utilising drugs for behaviour management ...
specifies the behaviour to be modified .. and the data to be collected
to assess progress toward the treatment objective.
• The individual's record contains written authorisation for the use of
behaviour modifying drugs, signed by the individual if competent, or
by the individual's parents or guardian.
• Each individual who requires medication receives medical
supervision, which includes regular evaluation of the individual's
response to the medication, including appropriate monitoring and
laboratory assessment ... a drug treatment plan is prepared by the
responsible pharmacist for inclusion in the individuals record and for
use by staff. The plan includes .. a schedule of laboratory tests
necessary to detect adverse reactions ... and ... noting, for the staffs
information, any potential adverse reactions.
(Taken from Kalachnik, 1988, p.233).
Lewis et at (1996) note the importance of ·clinical hypothesis testing" in
the process of drug monitoring. Seeing as there is essentially little
information available and it is highly individualised, the process of
formulating hypotheses regarding the effects a drug will have on an
individual is an essential requirement. The psychiatric disorder or
behaviour problem for which the particular psychotropic drug is
prescribed should be well documented and any changes that occur in the
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behaviour should be collected and analysed. Collecting data regarding
both the positive and negative side effects of a drug is also an important
factor and this data should also be incorporated into the hypotheses
tested when the drug is reviewed. Perhaps one of the most difficult
aspects which occurs in the monitoring of drugs is that many of the side
effects are largely unknown and do not emerge until later on in
treatment.
Any programme designed to assess the efficacy of prescribing
medication will have as its focus the issue of an optimal effective dosage.
If a drug is prescribed at a rate lower than the effective dosage, then the
drug will invariably have a poor effect on the clients functioning. If one
exceeds the optimal dose, then toxic side effects may be witnessed. The
actual relationship between dose and target symptoms has not yet been
fully examined although some research examining this relationship has
been conducted with Stimulants (Gadow, 1992). The use of blood levels
in determining clinical response has proved to be a useful indicator in
certain drugs, but not so in others (Lewis and Mailman, 1988).
4.10.2 Rating Scales used in Medication Monitoring
The use of evaluation systems such as rating scales are used frequently
in drug research and have proved quite useful in same. Rating scales
have included General Purpose informant scales such as the ABC
(Aberrant Behaviour Checklist) (Aman et aI., 1985) the MABS
(Maladaptive Behaviour Scale) (Thompson, 1988), the DBC
(Developmental Behaviour Checklist) (Einfeld and Tonge, 1992), the
Emotional Problems Scale and the Emotional Disorders Rating Scale·
(EDRS-DD) (Feinstein et aI., 1988). General purpose self-rating scales
include the Emotional Problem Scales: Self Report Inventory and the
Adolescent Behaviour Checklist (Strohmer and Prout, 1991) but
unfortunately neither has been fully validated in terms of drug research
while rating scales developed to assess the negative side-effects of
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psychotropic medication have included The Dosage and Treatment
Emergent Symptom Scale (DOTES) (National Institute of Mental Health,
1985a) and the Monitoring of Side Effects System (MOSES) (Kalachnik
and Nord,1985). The two instruments used to assess Tardive
Dyskinesia have been the AIMS (Abnormal Involuntary Movement Scale)
(National Institute of Mental Health, 1985b) and the DISCUS (Dyskinesia
Identification System: Condensed Users System) (Kalachnik and
Sprague, 1993).
To conclude this section, the immense amount of work undertaken on
drug monitoring in the United States has been greatly welcomed by all
countries as there is always the tendency to over-prescribe to clients with
learning disability. In the setting up of any procedures to monitor the
effects of drugs, one has to be realistic in what one wants to achieve. In
this sense, Kalachnik (1988) has stated "drug evaluation procedures
must ... strike a balance between the need for scientific rigor and the
demands of real-world treatment settings. If they are too rigid or
confrontational, they are unrealistic and will not be followed, and
professionals will fight with each other instead of working for the benefit
of the patient. If they are too loose, however, they will be abused and
non-functional" (p.263).
The next and final section of this chapter will look at and examine the
role of the inter-disciplinary team and its importance in reducing the
inappropriate use of psychoactive medications, in improving the clinical
information of clients and to review thoroughly all information pertaining
to a client (behaviour, skills etc.).
4.11 Inter-c:tisciplinary Teams.
Inter or Multi-disciplinary teams are a very important aspect within the
field of Learning disability. The co-operation between the disciplines is
exceptionally important within the learning disability field as there are
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many modes of Service Delivery. Firstly Learning Disability includes
many complex and varied conditions which need the expertise of several
different professionals. Secondly, optimal service delivery and
involvement with parents and guardians requires many different levels of
involvement from each of the various professions which includes
Psychology, Psychiatry, Nursing, Social Work, Child Care, Language
Therapist, Occupational Therapist and possibly others (including
counsellors, paediatricians etc.). Thirdly each of the disciplines and
professions have had a considerable input into research and
experimentation within the field of LD and all workers in the field must
recognise the importance of the contributions that each profession has
made. All professionals must recognise the importance of when to
collaborate with other professionals in order to improve a person's
quality of life by means of reducing inappropriate behaviours, teaching
new skills or alternative methods of treatment (Cullinane and Crocker,
1992).
In terms of the purpose of interdisciplinary teams and medication use,
this is a relatively new area and has only come into being since the
1980's. In 1980, the Accreditation Council for Services for Mentally
Retarded and Other Developmentally Disabled Persons noted that
psychoactive medication be administered as part of an overall
individualised programme plan for the dient with learning disability (Davis
et al., 1998). Lepler et al. (1993) have commented that such teams have
become more and more involved in the decision-making and monitoring
process of psychoactive medication usage.
Although the notion of the Interdisciplinary team largely stemmed from
the fact that there was need to monitor medication in these dients, the
purpose of such teams has grown considerably over the past decade.
Not only are teams now involved in monitoring medication use, they are
also involved in gathering dinical information needed for the purpose of
diagnoses and treatment of disorders. The individual clinician rarely has
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the time to gather all necessary information and compile same whereas
when interdisciplinary teams are in operation this process is made much
easier and far less time consuming. Teams are also involved in the
overall treatment philosophy of Organisations and constant attempts are
needed to update and change philosophies which may often appear out
of date and not to the individual clients advantage. Another purpose of
teams is to help coordinate care for clients living in both residential and
community care. Perhaps one of the major developments in the last two
to three decades has been the move from residential to community living
for clients with learning disability - not only involving more "able" clients
but also for clients with more severe and profound levels of learning
disability (Agran and Martin, 1982; Lepler et at, 1993).
Over the last number of years there has been increasing interest in the
amount of work undertaken on the process of evaluation of services for
those with learning disability. This is an area which has not been paid
much interest over the years but recently it is gaining impetus and many
services are now involved in this process and looking to how services
can be improved for their clients. The interdisciplinary team has a large
part to play in evaluation as "teams can be constituted to provide a
vehicle for enhancing consumer choices and participation with regard to
treatment issues" (Davis et at, 1998). Finally and was noted in the
opening paragraphs of the chapter, with the increasing awareness and
interest of medication use and monitoring at federal level, in the majority
of States in t~e USA, interdisciplinary teams have been introduced to
Organisations in order to audit and monitor the administration of
medication use in clients as such audits are becoming mandatory in
services for the learning disabled client.
4.12 Chapter Summary and Conclusions
To conclude, the present chapter served to address some of the more
pertinent issues within the field of learning disability in relation to the
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prescribing of medication for this population of clients. In an attempt to
understand the rationale behind the prescribing of medication, the
present author looked to the historical perspectives of medication
administration to the learning disabled, the problems encountered and
how such problems shaped the future patterns of prescribing - even to
the present day. Large volumes of data have been published on
prevalence figures of prescribing to date and such studies have
produced clear evidence that in many centres and facilities, over-
prescribing was in evidence in addition to polypharmacy, prolonged drug
administration and irrational drug prescribing procedures. Resulting from
legislation and litigation in the United States in particular, such problems
have now been addressed and stringent guidelines are in operation and
are proving successful. Gradually, such procedures and guidelines are
being implemented in the UK and Ireland, although much work has yet to
be done.
Despite the vast amount of research and experimentation undertaken on
the topic of prescribing for the learning disabled population, definitive
conclusions and recommendations are hard to come by. Aman (1987)
further emphasises such thinking when he states, "after more than 35
years of research, it is regrettable to say that very little can actually be
concluded about the precise nature of psychotropic drug effects in the
mentally retarded" (p.127). Perhaps in a large part, the main problem
lies in the fact that the majority of published reports have examined the
prevalence of prescribing rather than examining effectiveness per see In
addition, a large number of the reported studies prior to the 1980's can
be discounted largely due to problems of methodology. However in the
last number of years studies examining the effects of medication in the
leaming disabled population have become far more methodologically
advanced - for example the development of the Psychotropic Medication
Efficacy Graph undertaken by Spirrison and Grosskopf (1991) and
further developed by Jordan (1994) has contributed greatly to our
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understanding of drug prescribing in scientific terms and typifies the type
of objectivity which is required in the field.
Finally, the issue of psychopathology in relation to learning disability, and
the many theoretical and practical considerations, which have yet to be
addressed, are still a cause for some concern for all professionals
working in the field. Whether or not psychotropic medication should be
administered without the presence of the symptoms of mental illness is
still controversial and there is still much disagreement among
professionals regarding this issue (Deb and Fraser, 1994).
In conclusion, it is hoped that by addressing some of these issues that
interest will be heightened among professionals of all disciplines working
with the learning disabled population. The final two areas which were
briefly examined in the present chapter were the issues of medication
monitoring procedures and the notion of Inter-disciplinary teams which
play such a vital role in the setting-up and constant review of medication
in many facilities for the learning disabled. Although such teams are as
yet in their infancy in many parts of the UK and Ireland, their presence is
very strong in the United States and their work is proving of constant
benefit to the client with Learning Disability who either displays
challenging behaviour or has some form of mental health problem.
Resulting from research and work to date in the field, there is no doubt
but there is now the necessity for Organisations to initiate the setting up
of interdisciplinary review teams to regulate and monitor the use of
medication, while also to develop guidelines regarding its effectiveness.
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CHAPTER FIVE
METHODOLOGY
5.1 Chapter Introduction
In the vast majority of drug prevalence studies, the method of recording
data and information pertaining to A] the client (i.e. demographic data)
and B) information regarding prescribing was obtained by means of
questionnaire-type survey.
For the purposes of the present drug prevalence study, a survey
technique was incorporated, while if any data on medication was absent,
or the author was unsure of medication prescribed nursing staff were
consulted and questioned regarding these queries. The Drug Survey
form used can be seen in Appendix A.
5.2 Aims and Objectives of the present Study.
The main focus of interest for the present study was:
1] To gather information on all clients with the Brothers of Charity
Services, Mid-Western region in both residential and community setting
who were currently receiving some form of psychotropic and/or
psychoactive drug.
2] To compare and contrast the patterns of prescribing for these two
clients groups and to relate the findings achieved to published drug
studies to date.
The present study was designed primarily to gather data on drug
prescribing within an Irish Organisation so as to ascertain patterns of
prescribing for both clients in residential and community settings. The
study also served to contribute to the current knowledge of prescribing
trends for clients with learning disability through screening virtually a
complete population of clients in a residential and community setting.
Such a technique is infrequently used in such research (very often data
is based on sample populations).
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5.3 Setting
The Brothers of Charity Services, Mid-Western Region.
The Brothers of Charity Mid Western region caters for a population in
excess of 315,000. It currently provides a service to in excess of five
hundred clients. This service is provided by means of A] Residential
Placement and B) Community Placement: this incorporates both
Community House Living and Day Placement (Workshop Setting). The
Brothers of Charity run their service in conjunction with the Mid-Western
Health Board and have been in operation since the early 1970's.
5.3.1 Residential Placement
The residential placement is based in Bawnmore Complex. Bawnmore is
also the Headquarters for administration and Professional Services in the
region. The residential programme in operation provides full-time and
respite accommodation for adult clients who are unable to live at home
with their families. It incorporates full attention to all their health and
leisure needs. The Bawnmore residential campus is a village-type
complex and consists of ten modem bungalows in Cedar Drive, five
larger chalet-type bungalows in Ashgrove and Bart Ramsey House,
which caters mainly for clients with more physical/nursing needs.
Bawnmore campus currently caters for approximately one hundred and
forty one clients, male and female, the majority of who have a severe
and profound level of learning Disability.
5.3.2 Community Placement
Community placement (in terms of Community House Living) consists of
a number of houses based in the community, which have been
purchased by the Brothers of Charity. Community placement is based in
the following areas within the Mid-Western region:
Limerick City
Ennis
Newcastle West
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Ki/rush
Foynes
Presently there are approximately one hundred and fifteen clients in all of
the above areas who are in community placement. Each of these clients
who are in community placement (living in a community house) attend a
full-time Workshop/Day Placement in each of the Regional centres
(Limerick city, Bawnmore, Ennis, Newcastle West, Kilrush and Foynes).
These workshop settings cater for, and facilitate clients living in the
community and those clients living at home. The significant majority of
clients who have a Day Placement attend it on a full-time basis, with only
a minority of clients attending on a part-time basis.
5.4 Population Base/Subjects
The Brothers of Charity, Mid-Western region provides a service to in
excess of five hundred clients. Within the Mid-Western region, there are
a total of six regional centres. These centres are 1] Bawnmore (The only
residential facility studied); 2] Limerick City, 3] Ennis, 4] Newcastle West,
5] Kilrush and finally 6] Foynes (all Community.Facilities).
In terms of the population of clients studied in the present study, the
following tables below outline the demographic data obtained in relation
to clients in both A] Residential Facility (Bawnmore) and B] Community
Facilities within the Mid-West region
5.4.1 Demographic Data 1: Population Base Studied
The first table (Table 5.1) outlines the entire population base studied in
each Regional setting. For the purposes of presenting the following
data, both clients in Community Placement, Day Placement and those
living at home and being provided a Day Placement were combined so
that comparison of data would be somewhat clearer. In this respect, the
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two sets of data which were compared were: A] Clients in Residential
Placement and B) Clients in Community and Day Placement (termed
"Community").
From Table 5.2 and throughout the remainder of the chapter, each
Regional Setting (Limerick City, Ennis etc.) will no longer be referred to,
instead "Residential" and "Community" will be the terms adhered to.
From Table 5.1 below, it can be seen that the largest service provided is
based in Limerick city to a total of one hundred and seventy eight clients
(178). The next largest service is that provided by Bawnmore
Residential Placement - 141 clients. Ennis and Newcastle West provide
a service to 92 and 73 clients respectively. The other two Regional
Service areas were Kilrush and Foynes and these two areas provided a
service to 20 clients in each region.
Table 5.1: A table depicting the Population Base within The
Brothers of Charity Services, Mid-Western Region involved in the
present Drug Prevalence Study.
Regional Limerick Bawnmore Enni Newcastle Kilrush Foynes Total
Centre City s West
Total
Number 178 141 92 73 20 20 524
of
Clients
5.4.2 Demographic Data 2: Type of Setting and Level of Learning
Disability
Table 5.2 below shows the collated data in relation to Setting and Level
of Learning Disability. As can be seen from this table the majority of
clients in Community Placement were within the Mild and Moderate
range, while in the only Residential Placement to be examined
(Bawnmore), the majority of clients were within the Severe and Profound
ranges.
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Table 5.2: A table depicting the ranges of Learning Disability (Mild
to Profound) for both Clients in Residential and Community
Facilities.
Level of Learning Disability I
Type of Mild Moderate Severe Profound Total
Setting No.
Residential 3 34 73 31 141
Community 103 228 38 14 383
Total No. 106 262 111 45 524
5.4.3 Demographic Data 3: Type of Setting and Gender
The next table to be examined (Table 5.3) depicts the gathered data in
terms of Setting and Gender. On observing this table, one can see that
in both facilities studied, the ratio of Male to Female clients was greater.
In the case of clients in Residential Placement (Bawnmore), there were
triple the number of male clients in comparison to female clients (106
male to 35 female clients).
Table 5.3: A table depicting the gender of the population base
studied in both Residential and Community Facilities.
I Gender
Type of Setting Male Female Total
Residential 106 35 141
Community 229 154 383
Total 335 189 524
5.4.4 Demographic Data 4: Type of Setting and Age Range
The final set of demographic data to be examined was in relation to
Setting and Age Range. From Table 5.4 it can be seen that the
youngest age of any client within the services is 18 years of age and is in
Community Placement. The oldest client within the services is 75 years
of age and is in residential care. The largest age range in the present
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study falls in Residential Placement with the range being from 19 years
of age to 75 years of age.
Table 5.4: A table depicting the Age Range (In years) for the
population studied in both facilities within The Mid-Western Region.
Type of Setting Age Range in Years
Residential 19-75 years
Community 18-72 years
5.5 Procedure - General
The vast majority of studies with regard to drug prevalence research
have been undertaken using a survey method in conjunction with
interviews with front-line care staff. The major advantage in
incorporating the survey technique in countries such as the USA and
certain regions of Great Britain is that large scale State and Regional
drug databases are kept for all clients currently being provided any form
of Service from and Agency or Organisation. Hence drug prevalence
research can be undertaken routinely and access to all information is
readily available. However in Ireland, such database systems do not
exist in the majority of Organisations and Agencies. Drug Charts/Drug
Kardex (written) are kept for each individual client and are located in the
clients files in whichever setting or placement the client is based.
On account of there not being a Drug Database in operation within the
Brothers of Charity Mid-Western region, all data gathered was taken
from clients Drug Kardex from their individual files.
For any client where data pertaining to drug prescribing and/or
demographic data was missing or unobtainable, the author consulted
with nursing staff in the client's place of residence or Day Placement.
For clients in Residential Placement, the present author examined case
files and Drug Kardex for each client in their respective bungalows (16
101
bungalows in all). All client files were consulted and the relevant data
and information was recorded on hand-written charts (See Appendix A).
For clients in A] Community and B] Day Placement, the author examined
their case files through whichever Day CentrelWorkshop the client was
attending. For clients living at home and clients living in Community
houses, the necessary data is not available through their place of
residence, but rather through their Day Centre. Resulting from this, no
community house or none of the clients homes were visited in relation to
the gathering of any data for the present piece of research.
5.6 Procedure • Data Gathering.
Ethical Constraints
Prior to any data being gathered, there were several ethical constraints
to be considered. Firstly, the research project to be undertaken had to
be overseen by the Brother Superior, Executive Director and Area
Managers/Heads of Department. Once the project was cleared with the
above, letters were sent to any relevant personnel with whom the author
felt would b involved in the project (Group Leaders etc.).
Once the ethical constraints were fully discussed and all staff informed of
the research to be undertaken, data gathering could then take place.
Data Gathering
Data collection took place by means of examining each client Case Files
and Drug Kardex. Demographic data was taken from the main client file,
while information on medications prescribed was taken from the clients
Drug Kardex. Both sets of information were then recorded in the drug
survey form. Where data was missing, unclear or unobtainable, nursing
staff were consulted and questioned regarding such queries.
The following data was extracted from Case Files, Drug Kardex.
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The Clients: Name
Age
Gender
Level of Learning Disability (as per most recent IQ
assessment) .
Type of Service Provided (i.e. Placement - Residential or
Community)
Psychotropic Medication currently prescribed (taken from
Drug Kardex)
Each of the Regional Centres were visited by the author over the period
November 1995 to May 1996 in the Data collection phase of the study. If
any further queries arose regarding medication prescribed, the Director
of Psychiatric services/Medical Director was contacted and consulted
regarding these queries.
Once all Regional Centres were visited and all data was collected data
management and collation took place. All the hand-written Drug Survey
forms were further examined and analysed and condensed into a hand-
written Master-Sheet.
On completion of this Master sheet, the data was then coded and
arranged into Therapeutic Categories according to drug type. A
database was then created in MS Excel, which contained all data
recorded in the Drug Survey Form in its coded form (see table 5.5 below
for the coding system used).
Once the final database coding system was agreed upon, the MS Excel
database was transferred into the SPSS programme (Statistical
software). At this stage statistical analysis then took place using the
SPSS programme.
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5.7 Information and Codes Used in The Bawnmore Drug
Database.
In the present study, for the purposes of statistical analysis the data had
to be coded so as to facilitate this process. A Binary Coding system was
incorporated in the present research. Data for gender was coded as
being either Male (1) or female (0). For placement with service, data was
coded as Residential (1) or Community (2). For data on medication, the
coding system employed was: Present (1) - the client was administered
this form of medication or Absent (0) - the client was not administered
this form of medication. The only variable, which was continuous, was
Age (as it ranged from 18 to 75 years of age) and the clients actual age
was entered into the statistical analysis.
Table 5.5: A table depicting Information and Codes Used in The
Bawnmore Drug Database.
Demographic Data Coding System Coding SYstem
Age Continuous Variable 18 - 75 years of age
Gender Male =1 Female =0
Placement within Residential =1 Community =2
Service
Drug DatalTherapeutic Pmsent=1;Cnentwas Absent =0; Client was
Categories administered the drug not administered the
drug
Under Drug DatalTherapeutic Categories, there were a total of 11
separate categories. In addition to the 7 main drug categories, an
additional 4 categories were included - Other Drugs Administered,
Monopharmacy, Polypharmacy and Copharmacy. Definitions of
monopharmacy, polypharmacy and copharmacy are included below.
Monopharmacy was defined as the administration of one drug only.
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Polypharmacy was defined as the administration of 2 or more drugs from
the same drug class.
Copharmacy was defined as the administration of 2 or more drugs from
different drug classes.
lOS
CHAPTER SIX
RESULTS
8.1 Chapter Introduction.
The first stage of the present thesis was a drug prevalence study, which
was undertaken in the Bros. Of Charity Services, Mid-Western region.
The study examined patterns of prescribing for both residential
(institutional) and community clients with varying levels of learning
disability. The study first looked at the actual rates of prescribing of the
range of drugs administered to residential clients and those administered
to community clients. Demographic factors such as age, level of learning
disability, gender and placement within the services were then examined
to determine whether these variables had an impact on the rates of
prescribing. As was mentioned in Chapter three, the present study
served to address these issues in terms of the study being a "snapshot"
view of prescribing in the present population.
8.2 Data Collection, Management and Analysis.
Drug data for the present study was initially collected on hand-written
charts by the present author in each of the facilities where data was
examined in conjunction with senior nurses or key-workers. The data
was then transferred onto a database in Microsoft Excel. This database
(The Bawnmore Drug Database) initially took several forms, until a final
version was agreed upon, which was also compatible with statistical
analysis. The MS Excel database was then transferred onto the SPSS
programme where statistical analysis took place.
For the purposes of statistical analysis, the data needed to be coded into
various categories so as to accommodate data entry and statistical
analysis. In terms of the variables entered for statistical analysis, there
were a total of 14 variables entered - 3 of these being demographic in
nature (gender, age, level of LD and placement within the Services.
Gender was classified as being either male or female and was given a
coding of "1" for male and "0" for female. Age was a continuous variable
in the fact that the age range stemmed from 18 years of age to 75 years
106
of age - each clients age was entered. Level of Learning Disability had
four distinct categories: Mild, moderate, severe and profound. Each level
was coded as being either a "1" (mild), "2" (moderate), "3" (severe) and
"4" (profound). On initial analysis of the data obtained, there were too
few subjects in the severe and profound ranges (who were currently
being prescribed medication), for successful statistical analysis to take
place. On account of this, the severe and profound categories were
combined into one category before any analysis took place. Resulting
from this, there were a total of three categories of learning disability (mild
=1), (moderate =2) and (severe + profound =3). Placement within the
Services consisted of two main categories - residential and community.
Residential was given a coding of "1", while community was given a
coding of "2".
In terms of the drug data and drug categories analysed, there were a
total of 11 in all. For each category of drug examined, the client was
deemed to be either: A] administered a particular class of drug, or B] not
administered that class of drug. For clients administered a class of drug,
the client was given a coding of 1(drug was present). For clients not
administered a class of drug a coding of 0 was given (drug was absent).
Thus for each variable included in the statistical analysis, all data entered
was by means of the coding system outlined above (i.e. "0", "1", "2" or
"3") - depending on the particular variable in question.
6.3 Demographic Data and Information.
In relation to the demographic data examined in the present piece of
research, Tables 6.1 to 6.4 below outline the relevant data gathered.
The population base, which was studied, consisted of a total of 524
clients with varying levels of learning disability within the Brothers of
Charity Services, Mid-Western region. These 524 clients were provided
some form of Service by the Brothers of Charity by means of Residential
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Placement, Community Placement or Day Placement (workshop).
Within the region studied, there are a total of six regional centres: 1]
Bawnmore (residential), 2] Limerick City, 3] Ennis, 4] Newcastle West, 5]
Kilrush and finally 6] Foynes - each with a population of clients with
varying levels of learning disability, both male and female and all being
from the ages of 18 years to 75 years of age depending on the centre.
Table 6.1 below outlines the population base studied in the present
study.
Table 6.1: A table depicting the Population Base within The
Brothers of Charity Services, Mid-Western Region involved in the
present Drug Prevalence Study.
Regional Limerick Bawnmore Ennis Newcastle Kilrush Foynes Total
Centre City West
Total
Number 178 141 92 73 20 20 524
of
Clients
From the above table it can be seen that the two largest Services were in
Bawnmore (the only residential service provided - 141) and Limerick city
(178), which is part of the Community Service. Ennis and Newcastle
West provided the next largest service - 92 and 73 clients respectively
with Foynes and Kilrush providing a service to 20 clients each at the time
of the study.
The next table (table 6.2) shows the varying levels of the clients Learning
Disability which were involved in the present research. From this table it
can be seen that in the residential setting (Bawnmore), the majority of
clients were in the lower functioning ranges of the category of learning
disability - moderate, severe (mainly) and profound. In comparison, .
clients in Community and Day Placement (termed "Community") were
mainly within the mild and moderate ranges of learning disability.
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Table 6.2: A table depicting the ranges of Learning Disability (Mild
to Profound) for the population base studied in each Regional
Centre.
I Level of Learning Disability I
Regional Mild Moderate Severe Profound Total
Centre No.
Limerick 41 113 20 4 178
City
Bawnmore 3 34 73 31 141
Ennis 24 61 7 0 92
Newcastle 31 37 5 0 73
West
Kilrush 7 12 1 0 20
Foynes 0 5 5 10 20
Total No. 106 262 111 45 524
Gender is the next set of demographic data to be examined. Table 6.3
shows the number of male clients in comparison to female clients in each
of the regional centres studied. From this table it can be seen that in all
except one regional centre (Kilrush), the ratio of male to female clients
was greater. Kilrush differed in that out of a total of 20 clients in this
particular service, sixteen are female while only 4 are male. However in
all other centres examined in this study, male clients greatly
outnumbered female clients, especially in the residential setting
(Bawnmore), as the ratio was 3 male to 1 female client.
Table 6.3: A table depicting the gender of the population base
studied according to each Regional Centre within the Mid-West
Region.
I Gender
Regional Centre Male Female Total
Limerick City 115 63 178
Bawnmore 106 35 141
Ennis 53 39 92
Newcastle West 44 29 73
Kilrush 4 16 20
Foynes 13 7 20
Total 335 189 524
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The final table to be examined is Table 6.4 which looks at the age range
of clients in each of the Regional centres examined. All of the clients
who were involved in the present research were adults above the age of
18 years. The centre with the greatest age range was Bawnmore with an
age range of 19 to 75 years. On the other hand, the smallest age range
was found in Foynes with the age range stemming from 18 years to 35
years.
Table 6.4: A table depicting the Age Range (in years) for the
population studied in each Regional Centre within The Mid-Western
Region.
Regional Centre Age Range in Years
Limerick City 20-72 years
Bawnmore 19-75 years
Ennis 19-54 years
Newcastle West 19-62 years
Kilrush 20-45 years
Foynes 18-35 years
6.4 Overall Rates of Prescribing.
At the time of the study (November 1995 to May 1997) there were a total
of one hundred and forty one clients in residential care within the
Bawnmore complex and the total number of clients living in the
community and at home amounted to three hundred and eighty four.
The number and percentages of clients administered any form of
-- medication out of the total population in the Mid-Western region is
depicted in table 6.5 below:
Table 6.5: A table depicting the number and percentage of clients
administered any form of drug from the total population of clients
studied.
Client Population Total No. and % of No. and % of
Setting Clients Clients receiving
Medication
Residential 141 (100%) 131 (92%)
Community 383 (100%) 73 {19%J
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From the above figures it can be observed that out of a total of 141
residential clients, 131 of these were administered some form of
medication - this amounted to a percentage of 920/0. In comparison the
figures from the survey of community clients showed that only 73 (190/0)
out of a total of 383 clients were currently being administered some form
of medication.
Table 6.6 below shows a breakdown of the number of clients
administered medication according to category of learning disability
(mild, moderate, severe, profound) and placement within the Services
(Residential and Community). From the figures it can be seen that 19
clients out of a total of 103 living in the community with a mild level of
learning disability were administered medication (18.4%). In terms of
clients in the community with moderate learning disability 44 out of a total
of 228 were currently administered some form of medication (19.20/0)
while with only 7 out of 38 clients (18.40/0) with a severe learning disability
were presently administered medication. Out of a total of 14 clients within
the profound range 3 clients were currently administered medication
(21.40/0).
A far larger number of clients in residential care were administered
medication. Table 6.6 outlines the figures obtained for clients in
residential care. Out of a total of 141 residential clients, 131 were
currently administered some form of medication. 2 clients in the mild
range were currently administered medication (1.4%), 47 in the moderate
range (33%) with 65 out of 73 clients in the severe range being
administered some form of medication. Finally 17 out of 31 clients with a
profound level of learning disability were administered medication.
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Table 6.6: A table depicting the number of clients currently
administered one or more forms of medication in relation to
Placement within the Services and Level of Learning Disability.
I Level of Learning Disability
Placement Mild Moderate Severe Profound Total
No. and %
of Clients No. % No % No. % No. % No. %
on
Medication
Residential 2 1.4 47 33% 65 46% 17 12% 131 92%
%
Community 19 4.9 44 11.4% 7 1.8 3 .78 73 19%
% % %
Total 21 91 72 20 204
6.5 Breakdown of Drug Prescribing into Main Drug Categories.
As was noted in the methodology section, all drugs reviewed in the
present study were assigned into therapeutic categories on the basis of
their classification in MIMS & BNF. The main section which the
remainder of this section will focus on is: Drugs affecting the Central
Nervous System. There were a total of seven main categories which
were examined:
Hypnotics
Anxiolytics
Antipsychotics
Antidepressants
Antiemetics
Anticonvulsants
Movement Disorders
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Table 6.7: A Table Depicting the Number and Percentage (%) of
Residential and Community Clients Currently Administered
Medication (from the 7 Categories outlined below).
Drug Category Residential Community
1. Hypnotics 17 (130/0) 4 (5.4%)
2. Anxiolytics 6 (4.5%) 5 (6.7°k)
3. Antipsychotics 103 (78%) 24 (32.40/0)
4. Antidepressants 16 (120/0) 12 (16.20/0)
5. Antiemetics 6 (4.50/0) 0 (00/0)
6. Anticonvulsants 81 (61.3%) 62 (83.7%)
7. Movement 44 (33.30/0) 6 (8.1%)I
Disorders
6.6 Drugs Affecting the Central Nervous System
6.6.1 Hypnotics.
In terms of the first class of drugs, Hypnotics, a total of 17 residential
were administered this class of drug - this corresponded to 130/0 of
residential clients administered any form of medication. When one
compares this figure to clients living in the community, only 4 clients
(5.4%) were administered a hypnotic drug out of a total of 73 clients
currently on medication.
6.6.2 Anxiolytics.
Anxiolytic drugs were administered to 6 clients living in residential care
(5.40/0) and to 5 clients living in the community - this amounted to 6.70/0 of
the community population on medication.
6.6.3 Antipsychotics.
Of the clients currently administered Antipsychotic medication, 103
clients (78%) were administered some form of antipsychotic drug. This
was the largest number of clients on any form of drug in the current
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study. When one examines the corresponding figure for clients living in
the community, 24 out of 73 clients were administered an antipsychotic
drug (32.40/0) - a figure under half the corresponding figure for residential
clients.
6.6.4 Antidepressants.
Similar to the Anxiolytics, in the Antidepressant class of drugs, similar
figures were achieved for both residential and community clients. A total
of 16 residential clients (12%) were administered an antidepressant drug,
while in terms of community clients, 12 individuals were administered this
class of drug (16.20/0).
6.6.5 Antiemetics.
Although the Antiemetics have been included in the present classification
system incorporated, due to their relatively infrequent prescribing, and
largely because they are administered to counter the negative side
effects of the Antipsychotics in particular, their importance in the present
research was minimal. A total of 6 residential clients (4.50/0) and no
community clients were administered this class of drug.
6.6.6 Anticonvulsants.
In the present population of clients studied, a total of eighty-one
residential clients were administered an Anticonvulsant drug - 61.3%. If
one looks to the number of community clients on an Anticonvulsant, this
is the class of drug with the highest number of clients. A total of 62
community clients (83.7%) were administered an Anticonvulsant drug. If
one compares this figure with the Antipsychotic figures, the
Anticonvulsants were administered 2 % times more frequently than
Antipsychotic drugs.
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6.6.7 Movement Disorder Drugs.
The final class of drugs to be examined are the Movement disorder
drugs. Upon examination of the figures obtained, it can be seen that forty
four residential clients (33.30/0) were administered this form of drug,
whereas when one looks to the figures obtained for community clients,
only six clients (8.10/0) were administered same.
6.7 Breakdown of Drug Categories according to Individual Drug
Type.
6.7.1 Hypnotics.
Table 6.8: A Table Depicting the Number and Percentage of Clients
Currently Administered the Hypnotic Class of Drugs.
Name of No. and % of Residential No. and % of Community
Drug Clients Clients
1] Dalmane 5 (3.78%) 3 (4.05%)
2] Mogadon 10 (7.5%) o(0%)
3] Zimovane 1 (.75%) o(0%)
4] Normison 1 (.75%) 1 (1.35%)
From the above data, it can be seen that for residential clients, a total of
four hypnotics were currently being administered. The hypnotic of choice
was Magadon with a total of 10 clients being administered this drug. The
next drug of choice was Dalmane with 5 clients being administered this
drug. The remaining two hypnotics Zimovane and Normison were
administered to one client each respectively. When one looks to
community clients, only two drugs were currently being administered -
Dalmane and Normison. 3 clients were administered Dalmane with only
1 client administered Normison.
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6.7.2 Anxiolytics.
Table 6.9: A Table Depicting the Number and Percentage of Clients
Currently Administered the Anxiolytic Class of Drugs.
Name of No. and % of Residential No. and % of Community
Drug Clients Clients
1] Stesolid 1 (.75%) o(0%)
2] Atensine o(0%) 2 (2.700/0)
3] Valium 4 (3.03%) 3 (4.050/0)
4] Ativan 1 (.75%) o(0%)
A total of six residential clients were administered a range of 3 different
anti-anxiety drugs. As would be expected Valium was the anxiolytic of
choice with 4 clients being administered it. Only 1 client was
administered Ativan and very interesting 1 client was on a current dose
of Stesolid.
Only 2 drugs in this class were administered to community clients.
Valium was administered to 3 clients with the only other drug
administered being Atensine to 2 clients. .
6.7.2 Antipsychotics.
In the present study, there were a range of various Antipsychotics
administered, a total of eight for residential clients and also a total of
eight for community clients.
Table 6.10: A Table Depicting the Number and Percentage of Clients
Currently Administered the Antipsychotic Class of Drugs.
Name of No. and % of Residential No. and % of Residential
Drug Clients Clients.
1] Melleril 53 (40.150/0) 11 (14.86°k)
2] Largactil 11 (8.330/0) 1 (1.350/0)
3] Serenace 28 (21.210/0) 2 (2.700/0)
4] Neulactil 2 (1.510/0) 3 (4.050/0)
5] Clopixol 3 (2.270/0) o(0%)
6] Modecate 2 (1.510/0) 1 (1.350/0)
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7] Sparine o(0%) 1 (1.35%)
8] Stelazine 2 (1.51 %) 4 (5.400/0)
9] Anquil 2 (1.510/0) 0(0%)
10] Depixol o(0%) 1 (1.35%)
As in most drug prevalence studies, Melleril was the first Antipsychotic
drug of choice. 53 residential clients were administered this drug with
only 11 community clients administered it. The next most frequently
administered drug was Serenace and this drug was administered to a
total of 28 residential clients. In terms of community clients, Serenace
was administered to only 2 clients in total and interestingly and as can be
seen from the above table it was not the second drug of choice after
Melleril. For clients in residential care, Largactil was the third drug of
choice with it being administered to 11 clients. Only 1 client in the
community was administered this drug. Clopixol was the next drug of
choice for residential clients - with 3 clients on the drug. No community
clients were administered same. The four remaining Antipsychotic Drugs
were Neulactil, Modecate, Stelazine and Anquil with 2 clients respectively
(4x2) being administered each of these drugs. Interestingly for clients in
the community, the third drug of choice was Stelazine with 4 clients
administered this drug. The drug next in line was Neulactil (3 clients)
with the remaining drugs administered being Modecate (1 client), Sparine
(1 client) and finally Depixol being administered to 1 client only.
6.7.2 Antidepressants.
For residential clients, there was a large range of antidepressant drugs
administered - 7 in total. For community clients, the corresponding figure
was a range of 6 antidepressants.
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Table 6.11: A Table Depicting the Number and Percentage of Clients
Currently Administered the Antidepressant Class of Drugs.
Name of No. and % of Residential No. and % of Community
Drug Clients Clients
1] Prozac 4 (3.030/0) 2 (2.700/0)
2] Surmontil 2 (1.510/0) o(0%)
3] Tryptizol 3 (2.270/0) 2 (2.70°1c»
4] Anafranil 3 (2.270/0) 2 (2.70%)
5] Priadel 1 (.750/0) o (00/0)
6] Camcolit 1 (.75%) o (00/0)
7] Prothiaden 2 (1.51 %) 4 (5.4%)
8]Tofranil o(0%) 1 (1.35%)
9] Seroxat o(00/0) 1 (1.350/0)
For clients in residential care, the Antidepressant drug of choice was
Prozac with a total of 4 clients being administered it. The next two drugs
of choice were Tryptizol and Anafranil with 3 clients being administered
each drug respectively. Surmontil and Prothiaden were the next most
frequently prescribed antidepressants with 2 clients each administered
these drugs. In the present population studied, only 1 client was
administered Priadel with the remaining one client being administered
Camcolit.
For clients in the community, a very different picture emerged. The first
Antidepressant drug of choice was Prothiaden with 4 clients currenUy
administered this drug. The next three drugs of choice were Prozac (2
clients), Tryptizol (2 clients) and Anafranil (2 clients). The remaining two
drugs were Tofranil and Seroxat and 1 client was administered each
respectively.
6.7.5 Antiemetics.
As was mentioned earlier in this section, although the Antiemetics were
included in the classification system used in this study, this category of
drug was not of immense importance in the present piece of research.
The results obtained are included in Table 6.12 below.
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Table 6.12: A Table Depicting the Number and Percentage of Clients
Currently Administered the Anti-Emetic Class of Drugs.
Name of No. and % of Residential No. and % of Community
Drug Clients Clients
1] Motilium 5 (3.78%) o (00/0)
2] Maxolon 1 (.75%) o(0%)
As can be seen from the above table, only 2 Antiemetic drugs were
currently being administered to residential clients - Motilium and
Maxolon. 5 clients were administered Motilium with 2 clients being
administered Maxolon. In community clients, there were no current
administrations of Antiemetic drugs.
6.7.6 Anticonvulsants.
For both groups of clients (residential and community), this was a large
category with it being the largest category prescribed for community
clients and the second largest drug category prescribed for residential
clients. In terms of residential clients, a range of 5 drugs was
administered, with a range of 6 drugs being administered to community
clients. This was the only category of drug in which the drug range was
greater in community clients than in residential clients.
Table 6.13: A Table Depicting the Number and Percentage of Clients
Currently Administered the Anticonvulsant Class of Drugs.
Name of No. and % of Residential No. and % of Community
Drug Clients Clients
1] Tegretol 46 (34.8%) 28 (37.80/0)
2] Lamictal 17 (12.87%) 9 (12.16%)
31 Epilim 14 (10.6%) 16 (21.62%)
4] Rivotril 2 (1.51 %) o(0%)
5] Epanutin 2 (1.51 %) 1 (1.350/0)
6] Frisium o(0%) 4 (5.400/0)
7]Phenobarb. o(0%) 4 (5.400/0)
Tegretol was the first drug of choice for residential clients with 46 being
administered this drug. This was a large percentage of clients in this
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category as the next drug of choice, Lamictal, was administered to 17
clients. Epilim was next in vogue with 14 clients administered this drug.
The remaining two drugs in this category Rivotril and Epanutin (the older
Anticonvulsants) were administered to 2 clients each respectively.
For community clients, Tegretol was still the drug of choice with 28
clients administered it. Whereas Lamictal was the second drug of choice
for residential clients, Epilim was the second drug of choice for 16
community clients, with 9 clients administered Lamictal. Interestingly and
a cause for some concern is the fact that Frisium was administered to 4
clients in the community and also Phenobarbitone (a very old
anticonvulsant and known for its negative side effects) was administered
to 4 clients. Only one client in the community was administered
Epanutin.
8.7.7 Movement Disorders.
This was the final category of drug to be examined. Movement Disorder
Drugs (namely the Anticholinergics) are prescribed primarily to counter
the negative side effects of the antipsychotic drugs.
Due to the high rate of prescribing of the Antipsychotics (especially in the
residential population), the overall prescribing figure for Movement
disorder drugs was quite high (33.3% residential; 8.1 % community). The
breakdown of this drug category is as follows:
Table 6.14: A Table Depicting the Number and Percentage of Clients
Currently Administered the Movement Disorder Class of Drugs.
Name of No. and % of Residential No. and % of Community
Drug Clients Clients
1] Akineton 4 (3.03%) 3 (4.050/0)
2] Cogentin 38 (28.78%) 3 (4.050/0)
3] Disipal 2 (1.510/0) o(00/0)
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t For clients in residential care, Cogentin was the most popular drug as 38
~ clients were administered same. Akineton was the next most popular
} drug with 4 clients on this drug and the remaining Movement Disorder
drug was Disipal- being administered to 2 clients.
Community clients were administered a range of 2 drugs - Akineton and
Cogentin - each being prescribed to 3 clients respectively.
6.8 Monopharmacy, Polypharmacy and Copharmacy Rates of
Prescribing.
Upon completion of the gathering of all drug data, and once initial
analysis had taken place, all drug categories were analysed in detail to
determine the rates of Monopharmacy, Polypharmacy and Copharmacy.
A definition of each category is given below:
Monopharmacy: The prescribing of one drug only from a single class of
drug (i.e. prescribing of a single Antipsychotic drug).
Polypharmacy: The prescribing of more than one drug from the same
class of drugs (i.e. 2 or more Antipsychotics)
Copharmacy: The prescribing of more than one drug from a differing
class of drugs (i.e. 2 or more drugs such as 2 Antipsychotics + 1
Antidepressant + 1 Anticonvulsant).
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Table 6.15: A Table Depicting the Number and Percentage of
Residential and Community Clients Currently Administered
Monopharmacy, Polypharmacy and Copharmacy.
Residential: Percentage Community Percentage
Total No. % Total No. %
Monopharmacy 33 25 34 45
Polypharmacy 43 32.5 20 27
Copharmacy 66 50 20 27
2 - drug 20 30.3 9 45
3 - drug 28 42.4 9 45
4 - drug 10 15.1 1 5
5 - drug 6 9 1 5
6 - drug 1 1.5 0 0
7 - drug 1 1.5 0 0
From the above table of results, it can be seen that differences do
emerge when one compares the rates of Monopharmacy, Polypharmacy
and Copharmacy for residential and community clients. The following
points can be made:
• Upon examination of the rates of monopharmacy, 25% of residential
clients were administered monopharmacy (use of only 1 drug).
whereas 45.9% of community clients were administered
monopharmacy. This shows us that only % of residential clients were
administered a single drug but almost % of community clients were on
single drug therapy.
• The differences in the rates of administration of polypharmacy when
residential and community clients were compared were not as striking
as in the monopharmacy range. 32.5% of residential clients were
prescribed two or more drugs from the same class while the
corresponding figure for community clients was 27.02%. This shows
a difference of just 5% between residential and community clients.
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• Perhaps the most notable difference to emerge was the rate of
prescribing in the copharmacy range. For residential clients, this rate
amounted to just 50% and in community clients the corresponding"
figure amounted to 27.02% (the same figure which emerged in the
polypharmacy range).
Interestingly in the present study, not only was there 2 and 3 drug
copharmacy combinations for residential and community clients, for
clients in residential care the copharmacy rate ranged from 2-drug
combination to a 7-drug combination for one client. A total of 20
residential clients were on a 2 drug copharmacy combination, 28 clients
were on a 3 drug combination, 10 clients on a 4 drug combination, 6 on a
5 drug combination with the remaining 2 clients being on a 6 drug (1
client) and 7 drug (1 client) combination. The corresponding figures for
community clients were: 9 clients administered 2 drug copharmacy, 9
clients administered a 3 drug combination, 1 client administered a 4 drug
combination with the remaining 1 client on a 5 drug combination. No
client in the community setting was on either a 6 or a 7-drug copharmacy
combination.
6.9 Bivariate Analysis.
Prior to statistical analysis taking place, the data was organised into
categories for each of the variables to be studied. For each of the
variables (independent and dependent), the data was classified as either
categorical or continuous - however the only continuous variable was age
- ranging from 18 to 73 years. For each variable examined in the present
study, a coding system was employed for the purposes of statistical
analysis. The coding system used is outlined below:
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4.9.1 Bivariate Analysis: Coding System Used.
Table 4.16: A Table Depicting the Coding System Incorporated for
Statistical Analysis.
Variable Studied Variable Type Character Type Coding System
Used
Gender Male Categorical 1
Female 0
Placement Residential Categorical 1
Community 2
Handicap Mild Categorical 1
Moderate 2
Severe 3
Age (Range) 18-75 years. Continuous Age in years
Drug Category Absent Categorical 0
(11 in total) Present 1
All variables studied were easily categorised and coded. The one
category which did cause a problem was that of learning disability.
Although there were four levels in this category initially, due to small
numbers in the profound range, the "severe" and "profound" levels were
combined together and classified as "severe". Thus for the purposes of
the statistical analysis, there were only three levels of Learning Disability.
In terms of each of the drug categories, the classification system used
was Absent (0) or Present (1). In this respect for each client studied,
they were deemed to be either: Administered the particular drug
(classification = "Present") or Not administered the particular drug
(classification ="Absent").
The dependent variable in each case was the drug category being either
Absent or Present in relation to factors such as gender, placement, level
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of Learning Disability and Age. For each drug category a Model was
created (11 in total) and each of these Models will be examined in tum.
6.10 Bivariate Analysis: Model1A Antipsychotic Drug.
Table 6.17: A Table Depicting the Results of Bivariate Statistical
Analysis Completed on Data Pertaining to the Antipsychotic Class
of Drugs.
Absent Present Test p-Value
Sample Size
Statistic
115 89
Gender:
Male 75 (65.2°/0) 62 (69.7%)
.271 .603 NS
Female 40 (34.80/0) 27 (30.30/0)
Placement:
Community 53 (46.1 °/0) 20 (22.5°/0) 11.170 .0008 **'*
Residential 62 (53.90/0) 69 (77.50/0)
Hand/cap:
Mild 14 (12.2%) 7 (7.90/0) 1.694 .429 NS
Moderate 53 (46.1 °/0) 38 (42.7°k)
Severe 48 (41.70/0) 44 (49.40/0)
Age
Av. Rank 111.56 90.79 4075.5 .0126 *'**
Median 35 32
Of the 204 subjects studied, 89 were administered and Antipsychotic
drug whereas 115 were not. Of the four variables studied, two variables
came out of significance - Placement and Age. Placement was
significant as significantly more residential clients were administered
Antipsychotic drugs when compared to community clients (66 versus 20)
with the p-Value being .0008. The other variable of significance was
Age, with significantly more younger clients being administered and
Antipsychotic drug in comparison with older clients (p-Value .0126). The
other two variables in this model - Gender and Handicap were not of
statistical significance.
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6.11 Bivariate Analysis: Model 1b Hypnotic Drug.
Table 6.18: A Table Depicting the Results of Bivariate Statistical
Analysis Completed on Data Pertaining to the Hypnotic Class of
Drugs.
Absent Present Test p-Value
Statistic
Sample Size 183 21
Gender:
Male 125 (68.30/0) 12 (57.1%)
.618 .432 NS
Female 58 (31.70/0) 9 (42.90/0)
Placement:
Community 69 (37.7%) 4 (19.00/0) ..099 NS
Residential 114 (62.30/0) 17 (81.00/0)
Handicap:
Mild 19 (10.4°k) 2 (9.5°k) 4.698 .095 NS
Moderate 86 (47.00/0) 5 (23.80/0)
Severe 78 (42.60/0) 14 (66.70/0)
Age
Av. Rank 99.91 125.1 1447 .064 NS
Median 33 37
Of the 204 clients involved in the study, 21 clients were administered a
Hypnotic drug, while 183 were not. Of the four variables examined, no
one variable was of significance.
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6.12 Bivariate Analysis: Model 1c Anxiolytic Drug.
Table 6.19: A Table Depicting the Results of Bivariate Statistical
Analysis Completed on Data Pertaining to the Anxiolytic Class of
Drugs.
Absent Present Test p-Value
Sample Size Statistic193 11
Gender:
Male 131 (67.9%) 6 (54.5%) .5099 NS
Female 62 (32.10/0) 5 (45.5%)
Placement:
Community 68 (35.2%) 5 (45.5%) .5276
Residential 125 (64.80/0) 6 (54.5%)
Handicap:
Mild 17 (8.8%) 4 (36.4%) 13.749 .00103 **'*
Moderate 91 (47.20/0) o(00/0) <
Severe 85 (440/0) 7 (63.60/0)
Age
Av. Rank 102.32 105.59 1027.5 .8582 NS
Median 33 34
Similar to the hypnotic range of drugs, a very small number of clients
were administered the Anxiolytic category of drugs. 11 clients were
currently administered an Anxiolytic drug, while the majority of clients
were not (193 Absent). Only one variable was of statistical significance
in this drug category - level of Handicap. The results from this analysis
were interesting in the fact that out of 11 clients administered this
category of drug, 4 clients were in the Mild range, no client in the
Moderate range was administered a drug of this type and in the Severe
range (a combination of Severe and Profound), 7 clients were
administered this drug category. These results were of significance in
the fact that significantly more severe clients were administered such
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drugs in comparison to mild and moderate clients - the p-Value for this
category of significance was .00103. It is of interest to note that no client
in the Moderate range was administered such drugs.
6.13 Bivariate Analysis: Model 1d Antidepressant Drug.
Table 6.20: A Table Depicting the Results of Bivariate Statistical
Analysis Completed on Data Pertaining to the Antidepressant Class
of Drugs.
Absent Present Test p-Value
Sample Size
Statistic
178 26
Gender:
Male 126 (70.8%) 11 (42.30/0)
.7101 .0077 **
Female 52 (29.2%) 15 (57.50/0)
Placement:
Community 62 (34.8°k) 11 (42.3°k)
.275 .600 NS
Residential 116 (65.20/0) 15 (57.7%)
Handicap:
Mild 17 (9.6%) 4 (15.4°k) 1.670 .434 NS
Moderate 78 (43.80/0) 13 (50.00k)
Severe 83 (46.60/0) 9 (34.60/0)
Age
Av. Rank 99.13 125.58 1714 .0327 *
Median 33 38.5
Of the sample of clients studied, only 26 out of 204 were currently
administered an Antidepressant drug. Again two variables were of
significance -Gender and Age. The category of Antidepressant drug was
the only category in which Gender was of significance. What was also of
immense interest was the fact that significantly more female clients were
administered an Antidepressant drug when compared with male clients
(p >= .0077). Again this was the only drug category where gender was
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significant and where significantly more female clients were administered
a drug. The second significant variable was Age - with significantly older
clients being administered an Antidepressant drug than the younger
clients (p >= .0327).
6.14 Bivariate Analysis: Model1e Antiemetic Drug.
Table 6.21: A Table Depicting the Results of Bivariate Statistical
Analysis Completed on Data Pertaining to the Antiemetic Class of
Drugs.
Absent Present Test p-Value
Statistic
Sample Size 198 6
Gender:
Male 133 (67 .2°k) 4 (66.70/0) 1.0 NS
Female 65 (32.80/0) 2 (33.30/0)
Placement:
Community 73 (36.9°k) o(00/0) .090 NS
Residential 125 (63.10/0) 6 (100%)
Handicap:
Mild 20 (1 0.1 %) 1 (16.7%) 5.01 .082 NS
Moderate 91 (460/0) o(00/0)
Severe 87 (43.9°k) 5 (83.3%)
Age
Av. Rank 101.93 121.25 481.5 .429 NS
Median 33 35
As was mentioned before, this particular drug category was not of major
interest for the purposes of statistical analysis. This was the one drug
category with the least amount of clients administered any type of drug.
Only 6 residential clients were administered any form of Antiemetic drug -
no community clients were administered same. As a result of such
factors, no variable was of significance in this drug category.
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8.15 Bivariate Analysis: Model 1f Anticonvulsant Drug.
Similar to the Antipsychotics, there was a high rate of prescribing for the
Anticonvulsants. A total of 96 clients were prescribed 1 or more
Anticonvulsants with 108 clients not being administered this category of
drug.
Table 6.22: A Table Depicting the Results of Bivariate Statistical
Analysis Completed on Data Pertaining to the Anticonvulsant Class
of Drugs.
Absent Present Test p-Value
Sample Size Statistic108 96
Gender:
Male 70 (64.8%) 67 (69.8%)
.367 .54NS
Female 38 (35.20/0) 29 (30.20/0)
Placement:
Community 32 (29.6°k) 41 (42.7%) 3.235 .072 NS
Residential 76 (70.40/0) 55 (57.30/0)
Handicap:
Mild 6 (5.60/0) 15 (15.6°k) 10.229 .006 **
Moderate 58 (53.7°k) 33 (34.4%)
Severe 44 (40.70/0) 48 (500/0)
Age
Av. Rank 117.00 86.19 3618 .0002 ***
Median 35.5 31
From the above data, it can be seen that two variables were of
significance in the analysis conducted. The first variable of significance
. was level of Handicap, with significantly more moderate and severe
clients being administered drugs than clients with a mild level of learning
disability. Hence the more severe the level of learning disability, the
greater the possibility that such clients would be administered this
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category of drug. The p-Value obtained in this analysis was p >= .072.
The second variable of significance was Age, with significantly younger
clients than older clients being administered an Anticonvulsant drug (p>=
0.0002).
6.16 Bivariate Analysis: Model 1g Movement Disorder Drug•
.For this category of drug, a total of 44 clients were administered this drug
category out of the sample of 204 clients. The majority of these clients
were residential clients (38) with the remaining 6 clients being from the
community.
Table 6.23: A Table Depicting the Results of Bivariate Statistical
Analysis Completed on Data Pertaining to the Movement Disorder
Class of Drugs.
Absent Present Test p-Value
Statistic
Sample Size 160 44
Gender:
Male 103 (64.4%) 34 (77.3°k) 2.051 .152 NS
Female . 57 (35.60/0) 10 (22.70/0)
Placement:
Community 67 (41.90/0) 6 (13.6°k) 10.778 .0001 ***
Residential 93 (58.1 0/0) 38 (86.40/0)
Handicap:
Mild 21 (13.10/0) 0(0%) 7.509 .023 *
Moderate 72 (45.0%) 19 (43.2%)
Severe 67 (41.90/0) 25 (56.80/0)
Age
Av. Rank 103.57 98.63 3349.5 .623 NS
Median 33 33
Again two variables were significant in the present analysis - Placement
and Level of Handicap. For the variable Placement, significantty more
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residential clients were administered a Movement Disorder drug than
community clients (p Value = .001). The other variable of significance
was Level of Handicap, with significantly more moderate and severe
clients being prescribed this drug category than clients in the mild range
of Learning Disability. Hence similar to the Anticonvulsants, the more
severe the level of Learning Disability, the greater the possibility that a
client will be administered such a drug - especially if such clients are also
prescribed an Antipsychotic drug.
6.17 Bivariate Analysis: Model 1 h Monopharmacy Drug.
The final three models included in the analysis were Monopharmacy ,
Polypharmacy and Copharmacy Drug. These variables were included in
the statistical analysis in order to determine whether significance
emerged between the factors when the data was combined. Definitions
of Monopharmacy, Polypharmacy and Copharmacy can be found earlier
in this chapter. For Polypharmacy and Copharmacy, overall rates are
reported rather than breaking down each drug category (Antipsychotics
etc.) and then classifying these in Monopharmacy, Polypharmacy and
Copharmacy. -Thus once a client was administered a singe, 2 -drug or
more combination, classification took place on this basis alone.
Table 6.24: A Table Depicting the Results of Bivariate Statistical
Analysis Completed on Data Pertaining to Monopharmacy.
Absent Present Test p-Value
Statistic
Sample Size 144 60
Gender:
Male 95 (66°A») 42 (70%)
.15567 .69318 NS
Female 49 (340/0) 18 (300/0)
Placement:
Community 36 (25°A») 37 (61.7%) 23.20954 .000 ***
Residential 108 (75%) 23 (38.3%)
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<.1
Handicap:
Mild 14 (9.7°~) 7 (11.7°~) 8.04168 .01794 NS
Moderate 56 (38.9%) 35 (58.30/0)
Severe 74 (51.40/0) , 18 (300/0)
Age
Av. Rank 100.59 107.09 4044.5 .4730 NS
Median 33 33.5
From the above table of data, it can be seen that 60 out of the 204
clients were administered Monopharmacy (1 drug for 1 condition). Out of
these 60 clients administered Monopharmacy, 37 were community
clients with the remaining 23 being residential clients. Of the variables
examined Placement was the only variable which reached statistical
significance with significantly more community clients being administered
Monopharmacy than residential clients. This was the only variable in
which significantly more community clients were administered a "drug
category" than residential clients. It has to be noted however that the
Mono, Poly and Copharmacy were not actually "drug categories", and
that Monopharmacy, by its definition, was administration of 1 drug only.
Hence as was expected, significance was reached in this variable by
community rather than residential clients.
6.18 Bivariate Analysis: Model 11 Polypharmacy Drug.
Polypharmacy was defined as "the administration of 2 or more drugs for
the treatment of a single condition/disorder". 62 clients in total were
administered Polypharmacy - with 42 of these being residential and 20
being based in community facilities.
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Table 6.25: A Table Depicting the Results of Bivariate Statistical
Analysis Completed on Data Pertaining to Polypharmacy.
Absent Present Test p-Value
Statistic
Sample Size 142 62
Gender:
Male 95 (66.90/0) 42 (67.7°k)
.000 1.00 NS
Female 47 (33.10/0) 20 (32.3%)
Placement:
Community 53 (37.30/0) 20 (32.30/0)
.287 .592 NS
Residential 89 (62.70/0) 42 (67.70/0)
Handicap:
Mild 15(10.60/0) 6 (9.7°k)
.516 .773 NS
Moderate 61 (43.00/0) 30 (48.40/0)
Severe 66 (46.5%) 26 (41.90/0)
Age
Av. Rank 105.41 95.83 3988.5 .2859
Median 34.0 32
For this category of drug administration, no variables were of statistical
significance. It was thought that placement would be a variable of
significance but a considerable number of both residential and
community clients were administered Polypharmacy so significance was
not reached. Similariy with level of Learning Disability (Handicap), no
significance was reached which showed that Polypharmacy was
independent of level of Learning Disability, no matter what type (drug
category) of Polypharmacy a client was administered.
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'j 6.19 Bivariate Analysis: Model 1j Copharmacy Drug.
~
Copharmacy was defined as "the administration of 2 or more drugs for
the treatment of 2 or more conditions/disorders-. The results of this
analysis are outlined in Table 4.26 below:
Table 6.26: A Table Depicting the Results of Bivariate Statistical
Analysis Completed on Data Pertaining to Copharmacy.
Absent Present Test p-Value
Statistic
Sample Size 82 122
Gender:
Male 55 (67.1%) 82 (67.20/0)
.000 1.00 NS
Female 27 (32.9%) 40 (32.80/0)
Placement:
Community 50 (61.00/0) 23 (18.9%) 36.005 .000 ***
Residential 32 (39.0%) 99 (81.10/0)
Handicap:
Mild . 12 (14.6%) 9 (7.4%) 16.311 .00029 ***
Moderate 47 (57.3%) 44 (36.1 Ok)
Severe 23 (280/0) 69 (56.6%)
Age
Av. Rank 102.22 102.69 4979.0 .9556 NS
Median 32.5 33
Again two variables came out as being of significance - Placement and
Handicap. Placement was of significance in the fact that significantly
more residential clients were administered Copharmacy when compared
to community clients (p Value =.000) and when the Level of Learning
Disability was examined, significantly more moderate and severe clients
were administered Copharmacy than clients in the mild range. Hence
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the more severe the level of Learning Disability, the greater the
possibility that these clients will be administered Copharmacy.
6.20 Bivariate Analyses: A Summary of findings
To conclude this section on bivariate analyses, the table below (Table
6.27) is a summary table which shows each of the significant variables
which emerged for each of the drug categories studied.
Table 6.27: Summary Table of Bivariate Analysis indicating the
Variables of Significance for each Drug Category.
Drua Cateaorv Studied Variables of Sianificance
• Hypnotic/Sedative -------------------------------------------------
• Antipsychotic Drug Placement and Age
• Anxiolytic Drug Handicap
• Antidepressant Drug Gender and Age
• Antiemetic Drug
• Anticonvulsant Drug Handicap and Age
• Movement Disorder Drug Placement and Handicap
• Monopharmacy Placement
• Polypharmacy
• Copharmacy Placement and Handicap
As can be seen from the above table, there were only two actual dasses
of drug in which there was no variable of significance - Hypnotic drug and
Antiemetic drug. Possible explanations for this result are discussed in
the following chapter - chapter five. In addition, upon completion of data
analysis, in the Polypharmacy category there was no variable of
significance. In the remaining drug categories analysed, a variety of
variables came out as being of significance, the most notable of these
being Handicap (Le. Level of Learning Disability) and Placement (i.e.
Placement within the Services) as both emerged on four occasions
throughout the analysis. When the Antidepressant dass of drugs were
analysed, Gender and Age were the two variables of significance and
this was the only occasion when Gender was a significant variable. In
condusion, while many interesting results emerged from bivariate
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analysis of this data set, the author will now report on the findings of
multivariate analysis.
6.21 Multivariate Analyses
While bivariate analyses examines the variables within the data set in
isolation or independently, multivariate analyses examines and analyses
the entire data set in order to determine which variables are of
significance when the complete set of variables are examined together
(and not in isolation as with Bivariate analyses). Multiple regression
allows one to find the best fitting and most parsimonious model to
describe the relationship between the dependent variable and a set of
independent or predictor variables, when the dependent variable is to be
measured at the interval or ratio level (Hazard-Munro, 1993). However
when the outcome measure is categorical, and there are more than two
outcome categories then it is not possible to use multiple regression
analyses. In relation to the usefulness of logistic regression analyses,
Hazard-Munro states "people are reporting logistic regression. especially
when the outcome measure is dichotomous ... logistic regression is
better suited to the data, and the results include odds ratios that lend
interpretability to the data. The odds of an outcome being present as a
measure of association has found wide use, especially in epidemiology,
because it approximates how much more likely (or unlikely) it is for the
outcome to be present given certain conditions" (pp.229-230). In this
respect multivariate analysis examines the predictive effect of a variable
within the context of its covariance with other predictors, in addition to
examining the potential interactions with other variables in the prediction
of psychotropic/psychoactive prescribing decisions.
As can be seen from the above sections reporting the findings from
Bivariate analyses, the outcome measures are categorical in that either a
drug category is "present" or "absent" (i.e. either a person is prescribed a
drug category or they are not). Just as in bivariate analyses and multiple
regression, for the purposes of logistic regression, it was necessary to
137
code the categorical independent variables. Hence "dummy" (indicator)
variables were designed and introduced in order to determine which
actual variables were of significance. For the purposes of the present
statistical analysis, only one set of "dummy" variables were designed and
entered into the equation. The introduction of these set of "dummy"
variables can be seen with the variable "Level of Handicap", in which
there were three levels - Mild, Moderate and Severe. (The category
·Severe" consisted of those clients in both the severe and profound
ranges of disability as there were insufficient numbers in the latter
category for the purposes of the present analyses). Because there were
three levels of handicap, two dummy variables were set-up, Hand1 and
Hand2. On the basis of this, a number of IF-THEN statements were
developed and entered into the statistical equation. For example: IF
level of handicap was equal to 1, THEN this was classified as "mild" in
the statistical equation. However where the dummy variables were
necessary was if level of handicap was greater than 2. In such a case,
the dummy variables were necessary as they acted as a classification
system in themselves. In the case of level of handicap being greater
than 2, then the category of handicap was classified as being the
combination of "severe" and "profound", hence it was classified as
"severe". In this sense, the new variable Hand1 was 0 if the level of
handicap was mild, and 1 if it was not mild, while the new variable Hand2
was 1 if the level of handicap was severe and 0 if it was not severe.
The equations used when dummy variables were incorporated were as
follows:
Standard Equations
IF handicap =1, THEN handicap =1.
IF handicap =2, THEN handicap =2
IF handicap> 2, THEN handicap =3
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Dummy Variable Equations
Hand1 =0 Hand2 =0
IF Handicap> 1, THEN Hand1 = 1
IF handicap> 2, THEN Hand2 =1
,
f
., 6.22 Stepwise Logistic Regression
1
I
~ The method of logistic regression analyses used in the present thesis
.~ was stepwise logistic regression. By this it is meant that each variable
i was taken and entered into the statistic equation in a stepwise manner.
;, Depending on the number of variables that were entered into the
.~ equation, this is what determined the level of significance, when
examined in conjunction with all other variables examined. As an
example "age" could be of significance when "level of handicap" was
entered, but when "Handicap" was removed from the equation, "Age"
may no longer be of significance.
6.23 Stepwise logistic regression analysis: Hypnotic Drug
Table 6.28 below depicts the results upon completion of logistic
regression analysis for Hypnotic Drug.
Table 6.28 A table depicting the results of stepwise logistic
regression analysis for Hypnotic Drug.
Step No. Variable Log Improvement Goodness of fit
entered elf likelihood Chi-square p. Chi-Square p.
Val Val
0 -67.626 100.876 0.980
1 Hand2 1 -65.419 4.413 0.036 96.463 0.990
2 Age 1 -62.199 6.440 0.011 90.023 0.997 '
Interestingly from the above table, in contrast to Bivariate analysis, it can
be seen that two variables were of significance when stepwise logistic
regression was undertaken. These two variables were Hand2 and Age,
which indicate that those in the severe range of learning disability were
significantly more likely to be prescribed this drug category (Chi Square
(1) =4.413; p-value 0.036) than were clients in either the mild or
moderate range of disability. In addition, younger clients were
significantly more likely to be administered this drug category than were
older clients in the service (Chi Square (1) =6.440; p-value 0.011).
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6.24 Stepwise logistic regression analysis: Antipsychotic Drug
Table 6.29 below depicts the results upon completion of stepwise logistic
regression analysis for Antipsychotic Drug.
Table 6.29 A table depicting the results of stepwise logistic
regression analysis for Antipsychotic Drug.
Step No. Variable Log Improvement Goodness of fit
entered df likelihood Chi-square p. Chi-Square p.
Val Val
0 -139.741 182.695 0.002
1 Place 1 -133.478 12.524 0.000 170.171 0.012
2 Age 1 -128.453 10.050 0.002 160.121 0.037
From the above table, it can be seen that in a similar fashion to Bivariate
analysis completed & reported earlier, the two variables which were of
significance were Place 9placement within the services) and Age. The
present findings indicate that clients within the residential services were
significantly more likely to be administered an Antipsychotic drug than
were clients who live in community facilities (Chi Square (1) =12.524; p-
value 0.000). As predicted from the literature, Age was also of
significance in the present analyses, with younger clients more likely to
be administered Antipsychotic medication than were older clients (Chi
Square (1) = 10.050; p-value 0.002).
6.25 Stepwise logistic regression: Antidepressant Drug
Table 6.30 below depicts the results upon completion of stepwise logistic
regression analysis for Antidepressant Drug.
Table 6.30 A table depleting the results of stepwise logistic
I . f An'd 0regression ana lYSIS or tl epressant rug.
Step No. Variable Log Improvement Goodness of fit
entered elf likelihood Chi-square p. Chi-Square p.
Val Val
0 -77.829 120.467 0.755
1 Gender 1 -73.918 7.821 0.005 112.646 0.875
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While bivariate analysis found two variables of significance in relation to
the Antidepressant drug category (Gender and Age), upon completion of
logistic regression analysis, which examined all variables, only Gender
was of significance (Chi Square (1) = 7.821; p-value 0.005). The present
finding indicates that female clients rather than males were significantly
more likely to be administered Antidepressant medication. With respect
to age, which was significant with bivariate analysis, it was not deemed to
be a significant factor upon completion of stepwise logistic regression
analysis.
6.26 Stepwise logistic regression: Antiemetic Drug
Table 6.31 below depicts the results upon completion of stepwise logistic
regression analysis for Antiemetic Drug.
Table 6.31 A table depleting the results of stepwise logistic
regression analysis for Antiemetic Drug.
Step No. Variable Log Improvement Goodness of fit
entered df likelihood Chi-square p. Chi-Square p.
Val Val
0 -27.069 42.990 1.000
1 Place 1 -24.463 5.213 0.022 37.777 1.000
In Bivariate analysis, for the category of Antiemetic drug, no variable was
of significance. In the present stepwise logistic regression analysis, one
variable was of significance and this was Place (placement with the
services), with significantly more residential clients than community
clients being administered this form of medication (Chi Square (1) =
5.213; p-value 0.022).
6.27 Stepwise logistic regression analysis: Anticonvulsant Drug
Table 6.32 below depicts the results upon completion of stepwise logistic
regression analysis for Anticonvulsant Drug.
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Table 6.32 A table depicting the results of stepwise logistic
regression analysis for Anticonvulsant Drug.
Step No. Variable Log Improvement Goodness of fit
entered df likelihood Chi-square p- Chi-Square p.
Val Val
0 -140.921 198.240 0.000
1 Age 1 -135.366 11.110 0.001 187.130 0.001
2 Hand1 1 -132.980 4.773 0.029 182.357 0.002
In the case of the Anticonvulsant drug-category, stepwise logistic
regression yielded two variables of significance. These two variables
were Age and Hand1. In the case of age, younger clients were
significantly more likely to be administered an Anticonvulsant drug than
were older clients (Chi Square (1) = 11.110; p-value 0.001), for the
purposes of the control of epileptic seizures. The second variable of
significance, Hand1, indicates that those clients with a greater than mild
level of handicap were more likely to be administered this form of drug
than were those in the mild range of handicap (Chi Square (1) =4.773;
p-value 0.029).
6.28 Stepwise logistic regression analysis: Movement Disorder
Drug
Table 6.33 below depicts the results upon completion of stepwise logistic
regression analysis for Movement Disorder Drug.
Table 6.33 A table depicting the results of stepwise logistic
regression analysis for Movement Disorder Drug.
Step No. Variable Log Improvement Goodness of fit
entered elf likelihood Chi-square p. Chi-Square p.
Val Val
0 -106.364 128.482 0.570
1 Place 1 -99.629 13.470 0.000 115.012 0.839
2 Hand1 1 -97.074 5.110 0.024 109.902 0.910
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Upon completion of logistic regression analysis for the category of
Movement Disorder Drug, two variables emerged as significant in relation
to this category. Place and Hand1. In relation to placement with the
services, significantly more residential clients were likely to be
administered a movement disorder (or Anticholinergic drug) than were
community clients (Chi Square (1) = 13.470; p-value 0.000). In addition
those clients with a greater than mild level of handicap were more likely
. to be administered this form of medication (Chi Square (1) =5.110; p-
value 0.024). Interestingly, and as will be discussed in the proceeding
Discussion chapter, movement disorder drugs are primarily administered
to delineate the side effects of antipsychotic medication, so it is not
unusual for there to be an association between placement with the
service for the variables of Antipsychotic Drug and Movement Disorder
Drug, as significantly more residential clients were administered
antipsychotic medication than were community clients.
6.29 Stepwise logistic regression analysis: Monopharmacy
Table 6.34 below depicts the results upon completion of stepwise logistic
regression analysis for Monopharmacy Drug.
Table 6.34 A table depicting the results of stepwise logistic
regression analysis for Monopharmacy Drug.
Step No. Variable Log Improvement Goodness of fit
entered df likelihood Chi-square p- Chi-Square p.
Val Val
0 -123.583 183.512 0.002
1 Place 1 -111.457 24.251 0.000 159.261 0.047
2 A*B 3 -107.231 8.453 0.038 150.808 0.082
3 A*B 1 -108.523 2.585 0.108 153.393 0.070
4 Age 1 -110.262 3.478 0.062 156.871 0.054
5 Gender 1 -111.457 2.390 0.122 159.261 0.047
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The category of Monopharmacy Drug, as can be seen from the above
table, is the only category to emerge throughout the present analysis to
show an interaction effect. Upon completion of bivariate analysis, the
only variable to emerge of significance was placement within the
services, with more community clients being administered
monopharmacy than residential clients. However upon completion of
logistic regression analysis, Place, Age and Gender emerged as the
significant variables with an interaction taking place between Age (A) and
Gender (B) (as depicted by A*B). Findings from this analysis show that
significantly more community clients are administered monopharmacy
(one drug only) than are residential clients (Chi Square (1) =24.251; p-
value 0.000). In relation to Age, for the purposes of the present model,
older clients are significantly more likely to be administered
monopharmacy than are younger clients (Chi Square (1) =3.478; p-value
0.062). With the variable Gender, it is significantly more likely that
female clients will be administered one drug only in comparison to male
clients (Chi Square (1) =2.390; p-value 0.122).
A significant interaction effect is also observable from the above table,
between the variables of Age (A) and Gender (B). This can be seen
from the stepwise analysis above with the interaction entering the
equation at step 2 and 3, which indicates that at differing stages
throughout the present analysis for Monopharmacy Drug, the interaction
between gender and age was significant. A possible meaning for this
interaction could be that as age increases, gender becomes a significant
variable in that more older males may be prescribed monopharmacy,
whereas younger males are more likely to be administered two or more
drugs than are older males.
6.30 Stepwise logistic regression analysis: Copharmacy
Table 6.35 below depicts the findings upon completion of stepwise
logistic regression analysis for Copharmacy Drug.
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Table 6.35 A table depicting the results of stepwise logistic
regression analysis for Copharmacy Drug.
Step No. Variable Log Improvement Goodness of fit
entered df likelihood Chi-square p. Chi-Square p.
Val Val
0 -137.455 202.939 0.000
1 Place 1 -118.316 38.277 0.000 164.662 0.025
In terms of stepwise logistic regression analysis for the category of
Copharmacy Drug, only one variable was of significance in the present
model and that was Placement within the services. While bivariate
analysis showed placement within the services and level of handicap as
being of significance, when all variables were taken into consideration
and entered into the statistical equation, only placement was of
significance. Thus there were significantly more residential clients being
administered copharmacy, than there were community clients (Chi
Square (1) =38.277; p-value 0.000). This finding is in line with the
above analysis for Monopharmacy Drug, as in that case significantly
more community clients were administered one drug (monopharmacy)
than were residential clients.
6.31 Chapter Summary and Conclusions
As can be seen from the above set of findings, a different pattern of
results emerged when all the variables were entered into the various
statistical equations in logistic regression analyses. As noted in section
6.21, multivariate analyses examines and analyses the entire data set in
order to determine which variables are of significance when the complete
set of variables are examined together (and not in isolation as with
bivariate analysis).
Table 6.36 below outlines the variables of significance for each drug
category upon completion of stepwise logistic regression analyses.
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Table 6.36 Variables of significance for each drug category upon
completion of stepwise logistic regression analyses.
DRUG CA TEGORY STUDIED VARIABLES OF SIGNIFICANCE
1. HYPNOTIC DRUG HAND2 & AGE
2. ANTIPSYCHOTIC DRUG PLACE & AGE
3. ANTIDEPRESSANT DRUG GENDER
4. ANTIEMETIC DRUG PLACE
5. ANTICONVULSANT DRUG AGE & HAND1
6. MOVEMENT DISORDER DRUG PLACE & HAND1
7. MONOPHARMACY DRUG PLACE, GENDER, AGE,
INTERACTION EFFECT
BETWEEN GENDER & AGE
8. COPHARMACY DRUG PLACE
The usefulness of undertaking multivariate analyses can be seen from
the above table as it shows the reader the actual variables of
significance when all variables were entered into the statistical equation
together, and not in isolation as with bivariate analyses. Rather than
discussing these findings in the present chapter, the following chapter .
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will discuss these findings while also discussing the implications of these
results when compared to previous research undertaken in this area.
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CHAPTER SEVEN
DISCUSSION, CONCLUSIONS AND
IMPLICATIONS FOR FURTHER
RESEARCH
7.1 Chapter Introduction
Following the survey undertaken by Lipman in 1970, there has been a
vast amount of interest generated in the issue of prescribing for people
with a learning disability. The findings from Lipman's survey indicated
that in excess of 51% of all people with learning disability in residential-
type care were receiving some form of psychotropic drug with 39.2%
currently receiving an Antipsychotic drug. Since the research of Lipman
has been published, there have been numerous other publications on
this topic with very similar results to those of Lipman (1970).
Aman and Singh (1991) note that "mentally retarded people are among
the most medicated populations in our society" (p.348). These authors
also note that on average, when one surveys the drug prevalence
literature, between 30% and 50% of people with learning disability are
prescribed some form of psychotropic drug mainly an Antipsychotic, 25%
to 35% receive some form of Anticonvulsant drug, with 50 to 70%
receiving some form of psychoactive drug (Aman and Singh, 1988;
Branford, 1994).
Lynch (1989) notes that for people with learning disability, medication
which affects the Central Nervous System (CNS) is now a commonplace
practice. He states "when people with mental handicaps are considered
as a group, they seem to be at even greater risk than other people of
being placed on medication that acts on the CNS either directly or
indirectly" (p.123). The reasons for this, are as yet, still unknown, but
there are several factors which are of interest and importance. As
Kalachnik (1988) notes, psychotropic drugs are prescribed primarily for
the purposes of treating some form of psychiatric disorder - such as
schizophrenia or alternatively for the purposes of producing behaviour
control. However when one examines this statement, major
disagreement lies with the notion of treating behaviour problems with
medication rchemical restrainf') and how often this is appropriate.
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The number of studies which have examined the factors associated with
drug prescribing are increasing in recent times - the most notable of
these being the study of Aman et al. (1995) in which 1,101 clients were
surveyed in relation to their current medication and its association with
demographic and psychiatric variables. More recently, the study of
Gralton et at (1998) found that on reviewing the use of Antipsychotic
medication in children between the ages of 5 and 18 years, a positive
relationship existed between a diagnosis of Autism and the prescribing of
an Antipsychotic drug. The study of Bates et at (1986) showed that
when psychotropic prescribing was examined in terms of
appropriateness for diagnosed conditions 550/0 of patients were
inappropriately prescribed a psychotropic drug. In terms of the
prescribing of psychotropic drugs for challenging behaviour and
emotional problems, the findings of Tu and Smith (1983) indicate the six
most common problems they found to be associated with psychotropic
prescribing:- Aggressiveness (29%); Hyperactivity (24%); Self-injury
(190/0); Excitability (12°k); Screaming (100/0) and Anxiety (80/0).
Cleariy there is conflicting evidence when one compares the literature on
psychotropic prescribing for A] Psychiatric disorders and B) Behaviour
control/challenging behaviour. Although the rate of challenging
behaviour is quite high amongst the learning disabled population (in
general) especially so for clients in residential care, there is still a
substantial number of clients in community care being prescribed a
psychotropic drug. If one looks to the literature on prevalence rates of
psychiatric disorders amongst those with learning disability, the
prevalence of schizophrenia is not said to be in excess of 4% for clients
in residential care (Reid, 1972; Heaton-Ward, 1977,; Wright, 1982). In
terms of affective disorder, the figure is said to be less than 40/0 (Wright,
1982).
On examining the above figures, Wressell et al. (1990) note that 'here is
a substantial majority of patients receiving neuroleptics who do not have
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an affective psychosis or schizophrenia ... (and) ... while neuroleptics
are commonly used to treat mentally handicapped people with 'problem'
behaviour, it is difficult to draw conclusions about the specific effects of
these drugs" (p.1 01 ).
On the basis of some of the above concerns and due to the fact that the
vast majority of published studies to date have been mainly in the USA
and the UK, while also including New Zealand (White, 1983); Australia
(Sachdev, 1991); Finland (Linaker, 1990) and Canada (Gowdeyet al.,
1984), it was felt that a drug prevalence survey undertaken in an Irish
setting which would examine patterns of prescribing for clients with
learning disability in both residential and community (non-residential)
settings would be of interest and immense value.
7.2 Aims and Objectives of the present Study.
The main focus of interest for the present study was: 1] to gather
information on all clients with the Brothers of Charity Services, Mid-
Western region in both residential and community setting who were
currently receiving some form of psychotropic and/or psychoactive drug.
2] To compare and contrast the patterns of prescribing for these two
clients groups and to relate the findings achieved to published drug
studies to date.
As stated above the present study was designed primarily to gather data
on drug prescribing within an Irish Organisation so as to ascertain
patterns of prescribing for both clients in residential and community
settings. The study also served to contribute to the current knowledge of
prescribing trends for clients with learning disability through screening
virtually a complete population of clients in a residential and community
setting. Such a technique is infrequently used in such research (very
often data is based on sample populations).
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Also of interest is the fact that varying figures of drug prescribing have
been reported in the literature, depending on the country studied. As
was mentioned earlier, Aman and Singh (1991) report an overall figure of
prescribing of between 30 and 500/0, but when this figure is analysed in
greater detail, figures have been either quite high (Intagliata and Rinck,
1985 - 700/0 in Illinois) or quite low at 19% as was shown by the study of
White (1983) in New Zealand. In all of the studies cited in the literature,
no figures are given for any setting (residential or community) in Ireland.
On this basis, it was felt that a comparison with the literature and figures
to date was overdue and necessary.
One of the principle shortcomings of many of the drug prevalence
studies to date is "one of breadth" (Spreat et at, 1997, p.80). By this it is
meant A] studies have looked solely at clients in either residential or
community settings only, and B) perhaps an area that is often not picked
up on is that only certain classes of drugs have been examined (namely
the Antipsychotics). The main problem with failing to examine all drug
categories (i.e. all drugs affecting the eNS) is that comparison of data is
difficult. Similar classes of drugs may be examined and compared in
isolation but when one looks to an "overall" figure of prescribing for this
population, quality "all-encompassing" data is difficult to find.
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By including all of the above classes of drugs, it was hoped that the
present research would be a good indicator of providing a figure for
overall rates of prescribing within the Organisation, as well as providing
figures for each class of drug, while also answering some of the short-
comings of past research.
7.3 Discussion of Results From The Present Study.
In all, 524 clients were reviewed in the present study. This amounted to
a complete population of clients who were availing of a service within the
Brothers of Charity, Mid-Western region. This population comprised of
adults only, with the ages ranging from 18 to 75 years of age. All levels
of learning disability from mild to profound were examined.
The total number of clients in residential care which were administered a
psychotropic drug amounted to 131 out of 141 clients in total (81%). The
corresponding figure for clients in community care was 73 out of 383
(33%).
The present study examined all psychotropic drugs administered to
clients in the Mid-Western region. It was similar to the study of Branford
(1994) in the fact that it examined all drug forms, and not drugs
prescribed solely for the purposes of controlling behaviour - as was the
study of Clarke et at (1990). Therefore this study examined drug
prevalence according to drug groups and not according to reasons for
prescribing that drug.
The figures obtained in this study are consistent with drug prevalence
figures from similar populations of clients undertaken to date. What is of
interest however, is that degree to which psychotropic drugs are
prescribed within our Organisation in the Mid-West. Figures obtained
from the present study indicate that 81 % of residential clients are
administered a psychotropic drug and 33% of community clients are
administered same. When one examines the figures obtained to overall
average figures, one can see that the rates of prescribing are quite
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elevated as average figures from a residential perspective amount to
between 30 and 500/0. From a community perspective, figures have
amounted to between 20 and 36%. Quite clearly the residential figures
achieved are quite alarming in terms of previous research. Figures from
the community are within the average range but are still quite high in
comparison.
Some of the major points of interest which emerged from the study are
as follows:
7.3.1 Antipsychotic Medication.
On examining overall rates of prescribing of the Antipsychotics, figures
have ranged from 30 to 50% (Aman and Singh, 1988). When one looks
to the figures reported in the UK figures have tended to be somewhat
lower - Fischbacher (1987) reports a rate of 320/0, while the study of
Wressell et at (1990) reports a rate of 240/0. Asmentioned previously
Clarke et al. (1990) examined prescribing of psychotropic drugs for
behaviour purposes - they do not however report on the figures obtained
for Antipsychotic drug prescribing.
In the present study, the author expected a high rate of prescribing for
the Antipsychotic class of drugs - largely due to the fact that there is a
high rate of problem behaviour in many of the bungalow settings within
the residential facility. What we did not expect however, was the
frequency in which Antipsychotic drugs were prescribed for these
residential clients. In total 730/0 of our residential clients were
administered some form of Antipsychotic drug. When one looks at this
flQure in some detail, it can be seen that out of the 141 clients in
residential care, 103 were prescribed an Antipsychotic drug. When one
looks to those residential clients who were administered any form of
psychotropic drug (this amounted to 131 out of the 141 clients), the
percentage of clients which were prescribed an Antipsychotic drug was
780/0. The corresponding figure for community clients was 32% or 24
clients in total.
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1 There is no doubt but this figure is alarmingly high and is one of the
~ highest figures of Antipsychotic drug prescribing to be witnessed for
some time. When one examines the figures of Lipman in 1970, great
concern was expressed over the high rates of prescribing of psychotropic
drugs in residential clients at the time. Lipman's findings showed that in
excess of 51 % were receiving some form of psychotropic drug and in
terms of Antipsychotic drug prescribing, the figure was 39.2%.
Therefore, the present findings for antipsychotic prescribing in our
sample of residential clients raise many questions in terms of the
following:
Aj Why the Antipsychotics wel8 pl8scribed with such a high frequency.
Bj the l8asons for their use - behavioural or for mental illness??
Cj the efficacy ofpl8scribing such drugs to such a high degl8e.
Dj On the basis of such I8SUItS, there now seems to be a definite need
for a formal 18view process to ascerlain whether such drugs are required,
whether they al8 advantageous to the client or whether such clients
would benefd from alternative therapies.
These are the questions which need to be addressed with some urgency,
in particular for residential clients.
In a similar fashion to similar studies published to date, the Antipsychotic
drug which is most widely used is Thioridazine (Melleril) for both
residential clients (White, 1983; Fischbacher, 1987; Wressell et at,
1990) and clients living in the community (Aman et at 1985; Intagliata
and Rinck, 1985; Lepler et at, 1993). The figures obtained in the
present study for the use of Thioridazine for residential clients was
40.15% (53 clients) and for community clients 14.86% (11 clients). The
two other Antipsychotics which were used quite frequently were
Chlorpromazi~e (Largactil) and Haloperidol (Serenace), a finding again
consistent with previous studies to date (Branford, 1994b).
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7.3.2 Anticonvulsant Medication.
Figures cited for the prescribing of Anticonvulsants have ranged from 25
to 45% on average (Aman and Singh, 1989). UK figures to date show
prevalence rates from 24% (Sheppard et at, 1987),36% (Fischbacher,
1987) and Lynch (1989) found that on reviewing prescribing patterns
from 1978 to 1987, the rate of Anticonvulsant prescribing increased from
480/0 to 51 % in that 9-year period. Oi Mascio (1975) reports a figure of
90% receiving 1 or more Anticonvulsant drugs.
Present figures obtained from the population base studied showed that
of the 141 clients in residential care, 81 clients were currently receiving 1
or more Anticonvulsants drugs - when one examines this figure in terms
of those receiving any form of psychotropic medication, the figure
amounts to 61 %. The corresponding figure for clients in community care
amounted to 62 out of 383 or 160/0 overall. Out of the 73 community
clients on any form of psychotropic drug, 62 clients (or 83.7%) were
administered an Anticonvulsant. This figure shows that epilepsy is by far
the most common problem/disorder which requires medication as
epilepsy is one of those conditions for which medication is required or
"essential" for the control of seizures.
Some Anticonvulsants, most notably Carbamazepine (Tegretol) has
strong psychotropic properties and this drug is very often used as a
means of "behaviour control" or for problem behaviour, because of such
properties. In many studies because this drug is classified within the
Anticonvulsant class of drugs, interpretation of prevalence figures can be
problematic because of its variety of uses. In the present study however,
this problem did not arise because any Anticonwlsant prescribed in this
study was for the purposes of seizure control and not for problem
behaviour.
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In terms of the Anticonvulsant drugs prescribed, for both residential and
community clients, Carbamazepine was the first drug of choice with
Lamotrigine and Sodium Valproate being the next most frequently
prescribed drugs. On a positive note, drugs such as Frisium and
Phenobarbitone were not administered to any residential client, but in the
community, these drugs were administered to a total of 8 clients (such
drugs being noted for their negative side effects).
7.3.3 Hypnotic and Anxiolytic Medication.
In the present study, Hypnotic drugs were prescribed to 17 residential
clients, with only 4 clients in the community being administered same. Of
the variables examined in relation to this class of drug, none were of
significance. This finding was also borne out by the study of Branford
(1994a).
The Anxiolytic drugs were prescribed to an even lesser extent in the
present population. Only 6 clients in residential care, and 5 clients in the
community were administered any form of Anxiolytic drug. Present
findings would suggest that a greater proportion of severe and profound
clients were administered such drugs in comparison to the higher ranges
of leaming disability.
The Committee on Safety of Medicines (1988) - CMS has expressed
some concerns over dependency on such drugs and the problems
associated with withdrawal. The study of Aman et al.(1995) found a lack
of specific diagnosis in relation to the prescribing of Anxiolytic drugs -
they state that "the absence of an association between anxiety disorders
and the use of Anxiolytics is curious and raises the question of whether
practitioners tend to discount intemalising problems in people with
mental retardation" (p.507). In this sense, it could be the case that the
rates of anxiety disorder may be grossly underrepresented in this
population, although it is strange that in the population studied, the
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variable which was of significance was level of learning disability in that
people with a more severe level of LD were more likely to be
administered an Anxiolytic.
7.3.4 Antidepressant Medication.
As was mentioned earlier, gender is a variable which is generally not of
significance in terms of psychotropic prescribing. This said however, the
present study found an association between the prescribing of
Antidepressant medication and gender. Age was also of significance.
Gender was a significant variable in that significantly more females were
administered this class of drugs in comparison to males.
Age was of significance in this study in that older clients were much more
likely to be administered an Antidepressant than were younger clients. A
possible interpretation of such a finding could be that there is a greater
occurrence of depressive-type disorders in older clients - especially in
clients with Down's Syndrome where there is a higher prevalence of
Alzheimer like changes. Despite such a finding, caution is urged as the
present study is a single isolated study, bearing in mind that the majority
of research to date has found no relationship between prescribing (of any
form of drug) and gender.
7.3.5 Movement Disorder and Antiemetic Medication.
The Antiemetic class of drugs were administered to only 6 clients in
residential care, with no client in the community being administered
same. Hence no variables were of significance in relation to the
Antiemetics.
In relation to the Movement Disorder class of medication, this category of
drug consisted solely of the Anticholinergics - drugs prescribed in order
to counteract the extrapyramidal side effects of the Antipsychotics. As
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was expected, because there was a high rate of prescribing of the
Antipsychotics, there was a considerable number of residential clients
administered such drugs - 44 in total. Only 6 clients in the community
were administered such drugs. On the basis of this result, Placement
was of significance as more residential clients were administered
Anticholinergic medication in comparison to clients in the community. In
addition significantly more moderate and severe clients were on such
medication in comparison to those within the mild range of leaming
disability.
7.4 Chapter Summary and Conclusions.
There has been widespread concem over the use of psychotropic
medication for people with leaming disability. Such concem has grown
due to the fact that many clients were being grossly overmedicated (over
prescribing), the practice of polypharmacy was, and still is widespread,
irrational prescription practices are frequently in practice and due to
inadequate reviews of medication, prolonged and unnecessary drug
treatment is still in operation (Fan, 1991).
Despite the vast amount of research and experimentation conducted into
the effects of psychotropic medication, and especially Antipsychotic
medication, there remains little evidence that such drugs are of benefit to
clients with challenging behaviours. However, the fact remains that the
Antipsychotics are widely prescribed to clients with challenging
behaviour as a means of trying to reduce such behaviours.
The present study was undertaken in order to gather information on all
clients within our Service who were currently receiving any form of
psychotropic drug. We then wanted to compare and contrast the
pattems of prescribing for residential and community clients and to relate
the findings to previous research.
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Several points of interest emerged from the present study. If one looks
to each drug class examined, the present findings are similar to many
other studies to date. The Hypnotics and Anxiolytics were prescribed to
a minimal degree. Whether such findings are an accurate reflection on
the presence or absence of Anxiety disorders remains to be seen in this
population of clients. However these results are consistent with the
findings in the UK of Branford (1994) and Aman et al. (1995) in the USA.
The use of Antipsychotics in this population needs to be addressed with
some urgency. The fact that 103 out of a total of 141 clients in a
residential setting are prescribed one or more Antipsychotics certainly
raises many questions with regard to the efficacy of such frequent use.
Clearly there is a great need to develop specific guidelines and review
procedures in terms of the prescribing of Antipsychotic drugs.
In relation to Antipsychotics and the present study in general, one of the
major flaws and methodological failings was that "reason for use" of any
medication prescribed was not collected. The Antipsychotics are one
class of drug whereby it would have been necessary and essential to
collect such information. The question now remains whether clients are
prescribed Antipsychotic medication as a means of controlling behaviour
or to alleviate the symptoms of mental illness. Either way, Antipsychotic
medication was prescribed to clients in residential care to a very high
degree. Whether such a rate of prescribing could be seen to be
excessive remains to be answered. What is now required is a study to
determine whether such prescribing is both necessary and appropriate,
and if not, how it can be reduced.
Resulting from the high rate of Antipsychotic drug prescribing, there was
also a high rate of prescribing of Anticholinergic medication in our
residential clients. Drug studies to date have tended not to report the
figures for Anticholinergic medication, so comparison of results is
extremely difficult. Branford (1994a) reported a rate of Anticholinergic
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prescribing of 24 and 29% (for 2 different settings). Findings from the
present study showed that for residential clients, 44 out of 141 were
administered such drugs, while for clients in the community, the figure
was just 6 clients (8.10/0). The study of Hill et al. (1985) which examined
a sample of community clients found a rate of Anticholinergic prescribing
of 4.20/0. Other studies to date have reported rates of between 2%
(James, 1983) and 15.4% (Fischbacher, 1987).
In respect to Anticholinergic prescribing, it would be of interest to see if
the rate of prescribing of these drugs would fall in proportion to a
decrease in Antipsychotic prescribing. A point also worth receiving
interest is that the Antipsychotic drug Thioridazine is a drug associated
with a minimal amount of extrapyramidal side effects (Branford, 1994a).
This if Thioridazine is used as the Antipsychotic drug of choice (as is the
case in the present study), there is less need for the presence of
Anticholinergic medication and due to these two factors, Branford
(1994a) states that these "should both be predictors of a low prevalence
of Anticholinergic drug prescribing" (p.584). However in the case of the
present study, this does not seem to be the case as there is both a high
prescribing rate of the Antipsychotic drug Thioridazine and the
Anticholinergic class of drugs.
The Anticonvulsants are a drug class which are often prescribed to a
high degree in the leaming disabled population. These drugs are seen
as "necessary" in the fact that they are required in the control of seizures.
Withdrawal of such medication will invariably lead to an increase in
seizure pattem. The main problem with regard to the Anticonvulsants is
that there is a high rate of polypharmacy (2 or more drugs) and the need
for same is very often not warranted.
Rather than examining rates of polypharmacy (2 or more drugs from the
same class) and copharmacy (2 or more drugs from a different drug
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class) for each individual drug class, we examined the overall rates for
each.
Again comparison of results from research to date is difficult as different
definitions of polypharmacy and copharmacy have been used. For
example if polypharmacy is defined as administration of 2 or more drugs
in the treatment of one condition, it can have a very different result than if
polypharmacy is defined as the administration of 2 or more drugs from
the same drug class. In the present study the latter definition was
adopted largely because we were not able to ascertain the reason for
use of each drug for all individuals in the study. In this respect, it is
difficult to compare the present results achieved to research to date.
If one examines the rates of copharmacy in our population, one can see
that copharmacy extended up to, and included a 7-drug combination for
one client in residential care. For those in the community, the majority
were administered 1 drug only (monopharmacy - 45%), with 1 client
being administered a copharmacy of 5-drugs. The rate of copharmacy
administered is another area which needs to be highlighted and
addressed urgently and one needs to be cautious in terms of which
definitions one incorporates in future research of this kind.
To conclude many issues have been highlighted in the present piece of
research. The most notable of these is the fact that a high percentage of
clients in residential care are administered Antipsychotic medication and
the prescribing of such medication to such a degree must be called into
question.
Very different patterns of prescribing emerged when clients in the
community were compared to clients in the residential facility. In all drug
classes examined, there was a greater percentage of residential clients
administered each drug in comparison to clients in the community. Such
a finding is consistent with the many drug prevalence studies to date.
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Perhaps the point, which must be emphasised most, is that there is a
great need for the setting-up of an interdisciplinary team in order to
undertake formal reviews of all medication prescribed.
Whereas much of the research to date has focused on the
Antipsychotics, the present study shows that there is widespread
prescribing of all types of medication, some to a greater degree than
others, especially in residential clients. Constant reviews are required in
order to determine if such prescribing is excessive, appropriate or
necessary for the clients in our care.
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PART TWO
CHAPTER EIGHT
ISSUES IN MEDICAL DECISION MAKING
8.1 Chapter Introduction.
The issue of decision-making is a very significant element in relation to medicine
and, the topic under study in the present thesis, prescribing and mental health.
Not only has the mental health professional to assess and diagnose the patient,
but they also have to plan an appropriate treatment plan for that patient. The
patient on the other hand has to decide whether he or she wants to seek help for
their problem in the first place, and secondly depending on the course of
treatment suggested, the patient may, or may not adhere to the treatment plan
formulated and suggested by the mental health professional. At all times during
the above process, decisions have to be made on the part of the professional
and on the part of the patient and this decision process is a combination of a
complex inter-play of factors. All decisions which are made, have an impact and
they determine the quality of care provided for the patient and at what cost to the
service, to the state or to the individual.
The present chapter reviews the current literature on decision-making in health
care. It seeks to provide an overall basis for issues addressed and discussed in
later chapters of this thesis, specifically chapter nine. While the present chapter
should not be viewed as an all-encompassing overview of medical decision
making, its specific aim is to provide the reader with a brief overview of this topic,
prior to discussing specific studies of prescribing in general practice, in the
fOllowing chapter, chapter nine. Although a limited literature exists on the topic
. of decision-making within Psychiatry and learning disability, the author will refer
to a number of studies whereby similarities may be drawn between prescribing
for the general population and prescribing for persons with learning disability. In
essence it is vital to have an understanding of the concept of decision-making
and its theoretical underpinnings in attempting to understand and study decision-
making as applied to specific populations. The present author will firstly give an
Overview of research in decision-making. Secondly the issue of shared decision
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making in medicine will be discussed before moving onto a discussion of team
decision making, a process which is frequently used, yet poorly researched
within the field of learning disability.
8.2 Elements of Medical Decision-Making.
Chapman &Sonnenberg (2000) distinguish between three different forms of
decision research - normative, descriptive and prescriptive models. Normative
decision research asks the question of how best decisions can be made. The
descriptive question asks how decisions are actually made, while the prescriptive
question asks how decision theory can be utilised to improve decision making
(p.3). For the purposes of the present thesis, the author is specifically interested
in how decisions are made and the psychological aspects of this decision
making. In making any decision, the clinical is armed with a host of information
about the patient, ranging from the patients history, their behaviour and in many
instances results from psychometric assessments or laboratory tests. In forming
a decision, the clinician has to use all the information provided and balance "the
severity of a possible bad outcome with its low probability" (Chapman &
Sonnenberg, 2000). Where relevant all the available information must be used in
order to formulate a diagnosis for that patient and plan a treatment programme.
In cases where contradictory evidence may appear, differential diagnosis should
be undertaken and alternatives ruled out. Especially in the case of decision-
making in mental health, many difficulties arise in terms of difficulties with
diagnostic accuracy, how best to use the information at hand and how best to
plan a course of treatment. Very often, the clinician is relying on third-party
reports, which are well known for their inaccuracy and many seemingly
standardized assessment tools have been criticised for their poor reliability and
validity (Faraone &Tsuang, 1994). In such cases making appropriate and
accurate decisions can be difficult and subject to many biases (Miller et al.,
2000). These issues will be discussed later in the present chapter. Firstly the
author will present an overview of the many elements that are part of medical
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decision making. Figure 8.1 below (taken from Chapman &Sonnenberg, 2000)
gives a graphic representation of the elements of medical decision making.
Figure 8.-1: Diagrammatic representation of the elements of Medical
Decision Making.
, ,..., "1\'8......SIraMPI
From the above figure, it can be seen that many elements exist in the above
equation. Resulting from a decision is an action which may be a specific
treatment, a fonn of test or a combination of the two. In coming to a decision, a
number of specific factors may come into play. In a large number of cases,
decisions may be made in an ad hoc manner, where the clinician relies upon his
or her knowledge or their experience in treating similar cases, what it is their
colleagues do within their service and what their level (and style) of training has
been. In addition to such factors, clinicians are guided by clinical guidelines,
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policies and procedures, patient-centred approaches and knowledge-based
systems (Chapman & Sonnenberg, 2000). For each decision model employed
there are a number of direct inputs which may be alternatives, probabilities or
utilities. Probabilities may arise directly from expert opinion (which may be
subject to biases), clinical research, or clinical research which has been modified
by predictive models or meta-analysis. Utilities in tum may be obtained from
databases of outcome measures rather than scientific research per se.
8.3 Decision Analysis in Medical Decision-Making.
Decision analysis is increasingly used to address difficult medical problems. It is
an effective technique which over the past two decades, has been receiving
increasing interest in the medical literature but perhaps more importantly is being
utilized more frequently in terms of clinical practice (Sarasin, 2001; Pauker &
Kassirer, 1987; Eckman &Kassirer, 1991, Sarasin et aI., 1995 and Bennett et at,
1997).
Clinical decision analysis has been defined as "an explicit quantitative,
prescriptive approach to decision making under conditions of uncertainty. The
process breaks the problem into its component parts which are represented in
the form of a decision tree. The likelihood of chance events is represented by
explicit probability values. The desirability of outcomes is expressed by utility
values. Using this structure, the component parts of the problem are analysed
and recombined in a systematic way to suggest a decision" (Dawson &Cebul,
1990, p.52).
Essentially decision analysis is the quantitative application of probability and
utility theory to decision making under conditions of uncertainty. Within the
dinical practice of medicine, many decisions involve little doubt and the resulting
treatment or test employed reflects a "tried and true" approach which is based on
a SOund clinical and empirical rationale. However as is noted by Sarasin (2001)
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if the "optimal approach" is unclear, or the scenario faced by the clinician is a
unique one, then a formal analysis in the form of clinical decision analysis is
warranted. In such cases where a difficulty arises, decision analysis can
examine the "~ade-off' between the risks and benefits of testing (Bennett et at,
1997), of subsequent treatment (Eckman &Kassirer, 1991), while also
synthesizing data from diverse sources and considering multiple attributes of
health outcomes. As stated by Sarasin (2001) decision analysis "provides insight
into the dynamics of a decision problem and allow us to analyse the impact of
changes in either our assumptions or the data used in the analysis" (p.172).
Quantitative techniques have been used increasingly to aid clinical decisions for
both individual patients and also for groups of patients. Such techniques have
also been used in formulating health policies and advances in these techniques
have given a greater fidelity to the many problems that they simulate (Dawson &
Cebul,1990). Advances in clinical decision analysis has allowed for far more
detailed analysis of complex medical problems and with the advent of decision
trees and sub-trees, models which are far greater in scope and depth can be
generated.
In many complex medical decision making cases, physicians may perform poorly
if they rely on their own clinical judgement. The concept of relying on one's own
intuition will inevitably lead to a bias and over-simplification as the clinician
cannot simply incorporate all components of a decision at once (Dawes et aI.,
1989; Kassirer, 1989). Hence the usefulness of clinical decision analysis.
Clinical decision analysis involves a total of seven steps. These seven steps
taken from Sarasin (2001) can be summarized as follows:
1. The question is framed precisely and explicitly.
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2. The problem is structured in a type of flow diagram called a decision tree,
which consists of three basic types of events (choices, decision points),
chances and outcomes.
3. For each chance event, estimate the probability or range of probability of it
occurring.
4. Place all outcomes on a single scale to provide a relative ranking of their
utility or disutility.
5. Calculate the best strategy using two rules:- when a choice is possible,
take the option with the highest expected utility; at chance events, assign
the utility to be a weighted average of the utility of all possible outcomes,
In which the weighing factors are the probabilities of each event's
component.
6. Examine all the assumptions of the analysis and vary the central ones
over clinically plausible ranges to determine whether this affects the
apparent best choice. This is termed a sensitivity analysis.
7. Interpretation of results.
In terms of the interpretation of results, in the case of prescribing a certain drug
type, the clinician may decide on the basis of the above steps to either a)
prescribe the drug, b) withhold the prescribing of the drug or c) a very dose call
in which case it makes little difference which option is chosen. In deciding on an
option, one has to take into account the size of the difference between the
OPtions in the equation. In cases where there is very little difference, it is then
between the patient and the physician to weigh up the options and determine
which is best for the patient. Resultant outcome values may be expressed as life
years, quality-adjusted life years (CALV's), causes of the disorder or
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complications prevented or utilities. A utility may be defined as "a measure of a
decision makers relative preference for an outcome, expressed as a single value
between zero and one, usually assessed relative to two extremes" (Sarasin,
2001, p.173).
As a tool in decision making, decision analysis is being used more frequently
over the past two decades. It has not however, been without its criticisms. Initial
concerns included the excessive amount of time that decision analysis can take
In forming a decision, the use of incomplete or inappropriate data and the failure
to use meaningful utilities (Schwartz, 1979, Cebul, 1984; Dawson &Cebul,
1990). However each of these criticisms during the 1980's has since been
rectified with the use of large computer databases, the development of computer
programmes to assist decision analysis, and while the issue of utilities may be
difficult, they are superior to clinician perceptions (Elstein et at, 1986). The
assumption that utilities remain constant over time has also been challenged and
the debate still continues as to whether this is the case or not (Chapman &
Sonnenberg, 2001).
In essence the purpose of research in medical decision making is to ascertain
how decisions are made and to inevitably improve the outcomes of decisions for
patients. To study clinicians or physicians as information processors is important
as the majority of decisions are made by clinicians based on their judgements. If
one knows how such decisions are made then it is possible to study how such
decisions may be imprOVed. In addition, by studying how experts make
decisions or judgements, it is possible to further comprehend what elements of
the decision problem experts' focus on. Such research has implications not only
In terms of the treatment strategy employed but also in terms of estimates of
prognosis and predictions of disease.
To conclude this section on clinical decision analysis, what has been presented
has been an overview of the technique of decision analysis. Decision analysis
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has proved most useful in settings where there is greater than usual uncertainty,
poorly established efficacies of treatment, situations where a patients
preferences are critical and unique or rare instances where novel problems are
encountered (Plante et at, 1986). Although the aim of the present section was
not to provide the reader with a detailed overview of the literature, it does give a
broad overview of the technique of clinical decision making and its usefulness as
applied to medical decision making. The next section to be examined is the area
of shared decision making. This will be discussed prior to discussing decision-
making processes within the discipline of psychiatry or team decision-making,
which is commonly undertaken within the field of learning disability.
8.4 Shared Decision Making.
The opening sections of the present chapter are largely based on the more
traditional paternalistic model of decision making, which place emphasis on the
doctor making the decision for the patient. This model of decision-making is
increasingly becoming outdated (Stephenson et al., 2000) and the role of the
patient in this decision-making process is becoming more emphasized, through
patient-centred models of care. Shared decision making may be defined as "8
process by which patients and providers consider outcome probabilities and
patient preferences and reach a health care decision based on mutual
agreement. During the process the provider-patient dyad considers treatment
options and consequences and explores the fit of expected benefits and
consequences of treatment with patient preferences for various outcomes·
(Frosch &Kaplan, 1999, p. 285).
Over the past number of decades there has been a significant emphasis placed
on the patient becoming more involved in decision making. While more
paternalistic models of decision making do not involve the patient, shared
decision making moves away from this model and places emphasis on the role of
the patient in the decision process. While informed consent and providing the
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patient with facts about the procedure to be undertaken are essential
components of any treatment plan, shared decision making involves informing
the patient about all treatment options and consequences and how these options
fit with the patients preferences. Once all these options and consequences are
discussed, a treatment decision can then be made on mutual agreement
(Charles et at, 1997).
While shared decision making has many similarities with patient centred
medicine, the main difference between the two approaches is that shared
decision making includes the patients active involvement in any treatment
decision (Katon &Kleinman, 1981; Coulter, 1997; Charles et al., 1997). The
main characteristics of shared decision making may be outlined as follows:
1. the atmosphere must be conducive to active patient participation.
2. the physician must make patients feel that their contributions are valued.
3. Patients need to be honest about their preferences and goals for
treatment
4. the physician assists the patient in determining how the patients goals fit
with available treatment options.
5. an agreement is reached on which treatment option to implement.
Although not all patients may wish to be involved in decision making about their
condition, it is still very important to get the views and wishes of the patient and
take these into consideration prior to a decision being made (Guadagnoli &
Ward, 1998).
8.4.1 Patients Involvement In decision making.
In taking into account the above factors, it raises the question of the extent to
which patients wish to be involved in the decision making process. Studies from
the early 1980's onwards have examined the extent to which patients wish to be
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involved in treatment decisions. The study of Cassileth et at (1980) examined
the extent to which patients with cancer wished to be involved in decisions about
the treatment. While most patients expressed a wish to be involved, dear age
differences emerged. 87% of those aged between 20 and 29 years expressed a
preference to be involved in decision making while in those aged 40 to 59 years,
this figure fell to 620/0. In those aged over 60 years, this figure amounted to 51 %.
In addition patients who had feelings of hopelessness and despair were less
likely to be involved in decision making about their condition.
Strull et al. (1984) studied hypertensive patients with a mean age of 59 years
regarding decision making about their condition. Of those studies 19%
expressed a wish to be involved in this process of decision making. 41 % of
participants in the study would have preferred more information about their
condition and overall physicians were found to be poor judges about their
patients need for information and discussion about their condition. In 28% of
patient-physician encounters, the physician underestimated the patients desire
for discussion regarding treatment. Interestingly in terms of socio-economic
statues, the study of Pendleton and House (1984) found that low-income inner
city diabetic patients had little interest in decisions about their medical treatment
for their condition and in a similar fashion Ende et al. (1989) found that their was
a low level of interest in medical decision making among general practice
outpatients, as assessed by means of a questionnaire. Of these patients
studied, younger patients showed a greater interest in medical decision making
than did older patients. In a follow-up study, Ende et al. (1990) studied
preferences in medical decision making when the patients themselves were
physicians. While statistically significant differences emerged between
Physician~patientsand non-physician controls, findings were deemed as of
-minor importance-. In the above two studies, the authors conduded that as the
medical condition under study became more serious, the desire to become
inVolVed in decision making declined.
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In 1997, Mazur and Hickam studied patients desire to become involved in shared
decision making, when treatment involved an invasive medical procedure such
as surgery. 680/0 of patients studied showed a preference for shared decision
making and similar to the studies discussed earlier, interest in shared decision
making declined with patient age. The study of Waterworth & Luker (1990) found
that patients were not interested in becoming involved in shared decision making
and based on interviews conducted with twelve patients, these patients preferred
to comply with their physicians judgments in order to avoid negative
repercussions by other hospital staff.
Upon reviewing these studies on shared decision making, there is a substantial
volume of evidence to suggest that shared decision making is not feasible in
many cases, while in others, patients simply do not wish to be involved in this
process. On reviewing such findings, Debar (1994a, 1994b and 1996) suggests
that many such studies fail to recognize the differences between medical
problem solving and medical decision making. In the case of medical problem
SOlving, the treatment of any medical problem involves diagnosis and formulation
of treatment alternatives. These specific tasks require much expertise on the
part of the physical and such tasks are the role of the physician and precede
actual decision making. Medical decision making on the other hand involve the
criteria outlined earlier in this chapter and such criteria involve both the physician
and the patient. Hence in this respect, many of the studies which have
apparently examined shared medical decision making, have in fact not
differentiated between medical problem solving and medical decision making.
On this issue Kaplan (1991) distinguishes between treatment outcomes - which
shOUld be in the control of the patient, and means to these outcomes - which is
the role of the physician (treatment options).
Of those studies which have found that patients are not interested in the process
of shared decision making, few if any, have recognized that most lay people feel
that medicine is an exact science and that there may in fact be a number of
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possible treatment options, rather than just one. Many patients may feel that the
option which was outlined to them by their physician is the only option available.
As a result there is a need to educate patients regarding treatment choices and
how such choices can affect their treatment outcome (Barry et at, 1995).
To conclude this present section on shared decision making, there is conflicting
evidence regarding the extent to which patients wish to be involved in shared
medical decision making. While a considerable number of patients do wish to be
involved in this process, a significant number do not wish to do so. The
distinction between medical problem solving and medical decision making is an
important one, and one which needs to distinguish between the technical aspects
of problem solving (which are the role of the physician) and the decisions which
involve treatment outcomes (involving both patient and physician). Interestingly
what can be drawn from the literature is the fact that younger patients seem to be
more involved in the decision making process than older patients, and this finding
has important implications as life expectancy increases. On a positive note, the
research of Greenfield et al. (1985; 1988) has shown that patient attitudes in
medical encounters are readily changed and increased participation in medical
decision making has a positive effect on treatment outcome. Such studies
showed that where patients were more involved in decision making, they were
more assertive with their physician, elicited more infonnation from their physician
and Ultimately had an improvement in subjective well-being and lost fewer days
of work to their illness. The increasing use of decision aids for patients and
shared decision programmes is proving useful but there is a need undertake
systematically designed randomised trials in order to detennine their true
effectiveness. In addition shared medical decision making under stress and
shared medical decision making involving the family has not been addressed in
any great detail. Interestingly for the purposes of the present thesis, this is an
area of interest as in many clients with leaming disability, shared decision making
does not occur frequently and where family members are involved, it is often
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after the dedsion has been made, either by an individual or by the team, that
family are involved or informed.
As a result of this the next area to be addressed in this chapter is the issue of
team medical decision making and how groups make dedsions.
8.5 Team medical decision making.
While a large volume of research and data has been produced on how
individuals make dedsions and the factors which are involved (Elstein et at,
1978; Miller et at, 1982), in more recent times, there has been growing interest
into dedsion making in the group context and whether dedsions made in groups
are superior to those made by individuals (Christensen &Abbott, 2000). One of
the principle implications of the question of whether group decision making is
superior to individual decision making is whether organizations should place
more emphasis on group decision making. From the research to date, it has
been strongly supported that group decision making does out-perform individual
decision making (Hill, 1987; Vollrath et at, 1989; McGrath, 1984), although
Christensen &Abbott note that in relation to group dedsion making "decisions
are often not as good as they theoretically might be" (p. 268).
On reviewing the literature on the topic of whether groups make more accurate
decisions than individuals, Kerr at at (1996) found that there is no answer to
such a question. While a "gold standard" (or agreed upon outcome) might apply
to certain areas of medical dedsion making, this is not the case within decision
making in psychiatry (Farone and Tsuang, 1994). Kerr and colleagues found that
the biases that occur in individual decision making also apply to team decision
making and the presence or error was based on a number of factors induding a)
size of the group, b)magnitude of the individual bias, c) location of the bias, d)
definition of the bias, e) the normative ideal and finally, f) the nature of the group
process (Kerr et ai, 1996; Christensen &Abbott, 2000).
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When examining team decision making, as opposed to individual decision
making, two factors are of significance. Firstly in team decision making there is a
far greater emphasis on distribution of information as instead of being undertaken
by on individual, within a team it is carried out by different persons. Hence
workload is shared and a larger amount of information may be disseminated. In
a similar fashion to what was mentioned in shared decision making, the issue of
medical problem solving is now undertaken by a group of physicians or dinicians,
each with their own areas of expertise and each with their own information about
a particular case. It is the sharing and integration of all this information which is
important in team decision making. In integration all this information, it raises the
issue of shared versus unshared information about a patient. In the case of
shared information, all physicians would have read all information about a
particular patient, whereas with unshared information, perhaps only one or two
physicians in the team have read all the information. Research to date has
suggested that team decision making over-relies on shared information, while
unshared information is not discussed in as much detail, and may not be
considered in the decision making process (Larson et at, 1994; Stasser, 1991;
Stasser &Titus, 1987).
The other important factor in team decision making is the issue of each team
members characteristics. In any team, 8 wide variety of expertise and
backgrounds are brought together. Different team members have had different
levels of training and build up expertise in a range of different dinical settings.
Ones status within the group is an important factor and is generally based on
one's level of training and subsequent experience. As is noted by Christensen &
Abbott (2000), although status is no guarantee that effective decisions will be
made, the evidence to date does suggest that high status groups have more
influence than low status groups (Davis, 1980; Kirchler & Davis, 1986).
The dynamics of the group are also of significance in how decisions are made.
Gender and ethnic background are increasingly impacting on team decision
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making. The greater number of female graduates in medicine has changed the
more traditional group dynamics in medicine, while the research on ethnic
background has suggested that culturally diverse groups make more
conservative decisions than do culturally homogenous groups when examined
from a non-medical perspective (Watson &Kumar, 1992). This has important-
implications in everyday practice as there are an increasing number of ethnically
diverse groups operating within the medical services and also within medical
training facilities.
8.5.1 Team decision making and disability issues.
The issue of disability, be it physical or learning disability is an area where team
decision making is very much in evidence. Despite mUltidisciplinary team
decision making taking place, this is an area which has largely been ignored by
the scientific literature up until recently. In particular the issue of disability
assessment is an area which involves the multidisciplinary team (Davie, 1993;
Rosenfield &Gravois, 1999; Ysseldyke et at, 1982). According to Bartolo et al.
(2001) "the recommended assessment procedure is transdisciplinary, consisting
of the simultaneous assessment of the child by professionals by different
disciplines. This should lead to a comprehensive undertaking of the child's
difficulties, involve the parents dosely, and be linked to intervention" (p.499).
Salvia &Ysseldyke, (1991) note the importance of team decision making in the
assessment of disability as such decision making has important implications for
the child's life opportunities and indeed for the parents of the child. Such
decisions need evaluation not only in terms of life opportunities but also in terms
of cost effectiveness for such teams (Gutkin &Nemeth, 1997). While much of
the research to date on this topic has been based on inconsistency, bias and
unhelpfulness of team decision outcomes, dear objective outcomes are needed
(Glaun et at, 1998).
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Such naturalistic team assessment decisions according to Woods (1993) are
better evaluated on the basis of the quality of the decision making process rather
than on any other criteria. The issue of ecological validity in any such
assessment is of importance as laboratory-type research has not taken into
account such ecological issues (Zsambok, 1997). The research of de Mesquita
(1992), Ysseldyke et at (1982) and De Bruyn (1990) have criticized team
decision making processes for not following rational organizational group
decision making procedures. These authors suggest than such processes such
as case conferences should follow the sequential diagnostic procedure of:
Complaint -> Problem -> Diagnosis -> Treatment. They suggest that many
teams do not follow this logical sequence of steps and so their team decision
making may be inaccurate, may not take into account all possible altematives
and may decide on a particular placement despite such a placement being
rationally inconsistent with clinical findings (Zsambok, 1997).
To quote Elstein (1995) "clinical decisions will continue to be made by clinicians
using their best judgement, and it is crucial to understand their judgement and
decision processes better" (p.1). In this respect there is a need for further
research on the topic of decision making, not only in the assessment of disability
but also in terms of many other areas of disability, such as placement issues
(deinstitutionalisation) and more specifically in relation to the present thesis, how
decisions are made in relation to mental health issues - both diagnosis and
treatment issues.
Moving on from the issue of team decision making, the author will now briefly
review issues pertaining to decision making in psychiatry and the many problems
Which emerge in relation to diagnosis of psychiatric problems in the general .
population. Such a discussion will prove useful in light of the fact that many of
the problematic issues which are inherent in psychiatric diagnosis in the general
population are also very much in evidence in persons with leaming disability, and
possibly to an even greater extent. Hence as mentioned in chapters two and
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three of the present thesis, diagnosis of mental health problems in persons with
learning disability is exceptionally difficult and how decisions are made in relation
to mental health problems in the general population is important in our
understanding of decision making for persons with learning disability.
8.8 Issues In diagnostic decision making in psychiatry.
Since the advent of the Diagnostic and Statistic Manual for Mental Disorders
(DSM), published by the American Psychiatric Association, there has been much
debate as to the many imperfections in the nosologies and the diagnostic tests
which are used in psychiatry (Zarin & Earls, 1993). There are two schools of
thought regarding the issue of whether psychiatric disorders are distinct entities
in themselves or not (Kendell, 1989). Some theorists argue that this is the nature
of psychiatric disorders, that they are discrete entities, hence they are not
amenable to improvement. Others feel that the way psychiatric disorders are
conceptualised and the tools used in psychiatry are inaccurate, hence there is
room for improvement in regard to diagnostic decisions, and how subsequent
treatment decisions are based on such decisions. The present section will
review issues regarding diagnostic decision making and methods used in this
process, while the following chapter, chapter nine will review in more detail,
studies which have examined drug prescribing in the general population and how
such findings inform practice and may be of use in studying decision making in
the learning disabled population.
Earlier in this chapter, the author discussed the principles involved in decision
analysis in medical decision making. Decision analysis has been used effectively
in the areas of clinical problems (Kassirer et at, 1987; Braun, 1980 and Pauker,
1976) and also in the area of addressing policy issues (Berwick et al., 1980).
However it is only relatively recently - since the mid-1980's that decision analysis
has been applied to the psychiatric literature (Mossman &Somoza, 1989;
Murphy et at, 1987; Weinstein et al., 1989 and Berwick et aI., 1991). The
179
studies of Zarin & Pass (1987), Landau et at (1991) and Fombonne (1991) have
addressed specifically the issues of decision making in specific psychiatric
problems in adults and adolescents, most notably, bipolar mood disorder.
Despite the effective use of decision analysis in psychiatry, psychiatrists in
general have been slow to appreciate the vale of decision analysis and they
continue to routinely use both formal and informal clinical interviews to assess
patients, add to their existing body of knOWledge on that client, and form
diagnoses, which in tum inform subsequent treatment. Diagnostic decisions
faced by psychiatrists have much in common with therapeutic decisions which
face other areas of medicine. These diagnostic decisions share the following
features: a) several strategies may be delineated, b) the possible consequences
of each strategy are known in general, but the specific consequences are more
difficult to determine and c) the implications of each outcome can be assessed.
Zarin &Earls (1993) put forward a case example of such diagnostic decision
making when they state • consider a therapeutic decision that involves the
treatment of a depressed person. The possible strategies might be as follows:
treat with antidepressant medication alone; treat with psychotherapy and
antidepressant medication; or treat with psychotherapy alone. The outcome with
each strategy could be determined as the percentage of people who recover
without untoward side effects within a given amount of time. The best strategy
would then be the one associated, on average, with the best outcome" (p.198).
Alternatively a diagnostic decision involving the identification of depression in a
client, may involve use of a number of diagnostic tools and alternative
approaches to scoring them. The outcome of such a diagnostic decision is to
identify correctly whether the patient has a particular disorder, such as
depression, or to differentially diagnose another disorder.
The issue of the absence of a "gold-standard" of evaluation within psychiatry is of
importance here. Although the concept of a gold standard is somewhat idealistic,
any medical diagnostic procedure is subject to error. This is especially true
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within psychiatry and the mental health professions, as both human error and
technical error is unavoidable. Despite the absence of a gold standard however,
Faraone &Tsuang (1994) call for the validity of psychiatric diagnoses through the
process of diagnostic accuracy analyses. Diagnostic accuracy according to
these authors may be defined as "the degree to which a diagnostic procedure
correctly classifies people who are truly ill and those who are nor (p.650).
Although such research on the accuracy of psychiatric diagnoses is still in its
infancy, the fruits of this research will prove useful in terms of our understanding
of how accurate diagnoses can be made and how such diagnostic information is
used to plan treatment strategies for individual clients.
8.7 Chapter conclusions.
The principal purpose of the current chapter was to provide a brief overview of
issues pertaining to medical decision making. While a comprehensive overview
of the literature, focusing on all aspects of medical decision making was beyond
the scope of this chapter, the author chose to highlight a number of key areas of
interest to the present thesis. Firstly an overview of the elements of medical
decision making were presented and discussed briefly. Secondly, the area of
decision analysis in medical decision making was discussed. Decision analysis
provides a number of structured steps in formulating a decision. This technique
has proven useful, not only in relation to medical decision making but also in
relation to policy issues and policy planning. The next area of interest was the
issue of shared decision making. Shared decision making is increasingly been
seen as an effective alternative to the more paternalistic model of decision
making seen in medicine. The use of shared decision making in general practice
has proven useful and with the advent of informed decision making and
advocacy for persons with learning disability, this model of decision making
should be introduced for all persons with learning disability. The issue of team
medical decision making, and the factors involved were then discussed.
Interestingly, and as will be discussed later, team decision making is a common
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mode of decision making within learning disability, although considerably less is
known about team decision making in learning disability as opposed to the field
of medicine. The final area to be addressed relates to the area of diagnostic
decision making within psychiatry. The author discussed some of the many
problems inherent in diagnostic decision making in psychiatry and why there is a
need to determine the accuracy of such diagnoses. If these diagnoses are not
accurate, then subsequent treatment regimes may in fact be inappropriate,
based on the underlying diagnosis.
A discussion of these issues has proven useful, as in the proceeding chapter
entitled prescribing and decision making: perspectives from general practice, the
author will review the literature on issues regarding prescribing in general
practice and the difficulties encountered in decision making. Many of the issues
discussed in this chapter will be of relevance in chapter nine, and those issues of
relevance will be further discussed, in terms of their implications for practice in
the final chapter of this thesis.
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CHAPTER NINE
PRESCRIBING AND DECISION-MAKING:
FINDINGS FROM GENERAL PRACTICE
9.1 Chapter Introduction.
As a mode of treatment, prescribing of medication can be said to be the
mainstay of medical treatment. From the findings drawn from chapter
two of this thesis, considerably little systematic research has been
conducted on the factors affecting prescribing for persons with learning
disability. Where any such research has been undertaken, it has been
based primarily on the issue of drug prevalence and more recently on
issues regarding the appropriateness of such prescribing. Despite the
emphasis of the research shifting from drug prevalence to drug
appropriateness, the number of such studies are relatively small, they
suffer from problems of methodology and they still fail to account for the
significant variation in prescribing of psychotropic medication for persons
with learning disability. Even more interesting is the fact that these
studies, whose primary aim is to study appropriateness of prescribing, fail
to draw on findings from the general population, where a literature does
exist which examines appropriateness of prescribing from a general
practice perspective. Although prescribing of medication from a general
practice perspective is considerably different from the perspective of
those prescribing for the learning disabled population, the same basic
principles of appropriateness should be applicable. In addition it should
be noted that quite a number of General Practitioners do in fact prescribe
for persons with learning disability, and such prescribing should be no
different than prescribing for the general population.
Throughout the present chapter a number of issues will be addressed.
The first of these will examine how we define and examine
appropriateness of prescribing from a general practice viewpoint and how
such principles may be applied to the learning disabled population.
Although quantity of prescribing has been examined in detail in chapter
two, the author will briefly make reference to the issue of prescribing
quantity from research conducted within the general population. Of more
interest to the present chapter is the issue of quality of prescribing and
how this may be examined and determined in any patient being
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prescribed medication. The issue of quality of prescribing is linked
directly with appropriateness of prescribing. However in determining the
quality or appropriateness of any prescribing, it is necessary to examine
the factors which underlie the decision making processes around
prescribing. A number of studies have been undertaken in general
practice which examine the process of decision making in prescribing.
However within the field of learning disability, no such attempts of a
similar nature have been conducted or as yet attempted. This served as
the impetus for the present piece of research, while also serving the need
to account for the findings from part one of the thesis.
9.2 Appropriateness of Prescribing - A Definition.
If as Rivinus (1980) has stated "the same rules that apply to the use of
psychotropic medications in adults and children of normal intelligence
apply to retarded patients. Psychotropic drugs should be used to treat
specific diagnoses, syndromes or symptoms for which specific drug
efficacy has been scientifically established" (p.195), then the same
principles which apply to appropriateness of prescribing for the general
population, should apply also to the learning disabled population.
However from examining the literature to date, where appropriateness of
prescribing has been the core issue of studies, reference has not been
made to research conducted from general practice. The reasons for this
are as yet unclear, but it may be due to the fact that studies examining
appropriateness or effectiveness of psychotropic medication in the
learning disabled population have tended to originate in the States
(Aman et ai., 1995), and considerably less research has been conducted
in the UK, while studies examining appropriateness of prescribing in
general practice have originated in the UK (Parish, 1973, Barber, 1995,
Buetowet ai., 1996).
Barber (1995) notes that "there are few reports on what constitutes 'good
prescribing'. What is more, the existing guidance tends to imply that right
184
answers exist, rather than recognising the complex trade offs that have to
be made between conflicting aims" (p. 923).
If one looks to Parish's (1973) definition of good prescribing, it states
that prescribing should be "appropriate, safe, effective and economic"
(p.213). According to Parish, "appropriateness" in its original sense
meant that the drug prescribed should suit the patient. Regarding
"safety" and "effectiveness", such terms imply absolutes which are
probably not possible in prescribing (for any population), while
"economic" is a term which is not easy to define in itself. Granted for the
purposes of prescribing in certain populations, economics is an important
aspect, but there are many ways to determine and assess the costs of
medication and how to assess their outcome. In this sense, a number of
criticisms can be made of Parish's definition. Prescribing is a complex
phenomenon and to apply anyone definition across time (Parish's
definition is now twenty-seven years old) is by no means an easy task
and any definition must be subject to change and modification due to the
complex facets involved.
Barber (1995) suggests an alternative to Parish's definition. Rather than
seeking a definition of good prescribing, Barber believes prescribers
should be attempting to produce a definition of what a prescriber is trying
to achieve. In this respect he defines what constitutes good prescribing
in terms of four main aims, as follows: "to maximise effectiveness, to
minimise risks, to minimise costs, to respect the patient's choices"
(p.923). Taking these two definitions as a starting point, one will now
examine the literature in terms of quality of prescribing how this relates to
appropriateness of prescribing.
9.3 Quality of Prescribing.
Bradley (1992a, b, c) provides a comprehensive and interesting literature
review on the topic of prescribing and decision making processes. In his
review he focuses on issues of quality, decision making processes which
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include the drug selection process and finally the decision of whether to
treat or not. Despite Bradley focussing on general practice perspectives,
the findings may be also applied to prescribing in the learning disabled
population. The present author will aim to apply the studies undertaken
in general practice to the field of learning disability and tease out
common variables of interest and significance.
The study of Mapes (1977) investigated prescribing of medication in
terms of effectiveness and safety of the medication being prescribed by
young doctors. In the study prescribers were assigned into two main
categories of either "conservatism" or "incautious" based on the
medications they prescribed and determined as "effective" by means of
standard texts of pharmacology (British National Formulary (BNF) for
example). "Incautious" prescribing was judged to occur when the
medications prescribed had unwanted side effects and where a more
suitable alternative existed. Findings from the study indicated that fIVe
factors were associated with the author's measure of prescribing quality.
These factors included gender of the prescriber, the proportion of
prescriptions written by the doctor themselves, membership of the Royal
College of General Practitioners, the number of prescriptions written with
no instructions or inadequate instructions and finally the prescribers use
of commercial sources of drug information. A positive relationship
existed between a better quality of prescribing and male gender and
membership of the Royal College of General Practitioner's, while the
remaining variables were associated with incautious prescribing.
Eaton &Parish (1976) used as a measure of quality (in addition to
patient questionnaires) - the proportion of drugs used after their
introduction within the first year, the proportion of proprietary medications
prescribed and completeness of instructions given to the patient.
Findings from the study indicated that London graduates used less
proprietary medications than foreign doctors, while doctors practicing for
a longer period of time tended to use a higher number of medications for
proprietary reasons.. :
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Taylor (1978) created an index of quality determined by means of the
number of prescriptions which were deemed undesirable, those drugs
which could be prescribed and which were deemed appropriate in limited
circumstances and finally those drugs which were deemed to be
obsolete. Each category of drug was given a weighting dependent on its
undesirable effects and doctors were scored on their prescribing
behaviours of these drugs. Interestingly the study found no relationship
between Taylor's index of quality and doctor or patient variables studied,
and in addition the index was not associated with cost of medication. .
An alternative criteria for assessing quality of prescribing has been
posited by Van Zwanenberg et al. (1987). These authors quality criteria
were 1] the proportion of doctor-patient consultations which did not arise
in a prescription, 2] the proportion of drugs written in their generic form
and finally 3] those drugs which were included in a general practice
essential drugs list. Of the twenty-one practitioners studied, there was a
high variation in the prescribing rate and after the introduction of
education regarding rational prescribing, the prescribing behaviours of
these doctors changed towards a more improved quality of prescribing.
Studies conducted in the USA on quality of prescribing have yielded
similar results to studies conducted in the UK. Common problems
emerging in drug prescribing were excessive quantity of a drug,
prescriptions being issued too frequently, while in addition it was noted
that multiple prescriptions (polypharmacy) were being issued, for which
no indications were given on possible drug interactions or unwanted side-
effects (Marande et at, 1971).
Haayer (1982) conducted an interesting study in which doctors were
given eight case studies and asked whether they would prescribe for
each case or not. If so, participants were asked to complete a full
prescription for the case involved. Prescribing rationality was based on
whether doctors had prescribed a first-line or second-line drug, whether
the drug prescribed was deemed to be of dubious safety or finally
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whether the drug was deemed very unsafe. Dosage and duration of the
drug prescribed was also taken into consideration by a panel of expert
general practitioners and clinical pharmacologists. Interesting results
were achieved in that: a] younger doctors, b) doctors who refer to, and
read more professional journals and c) doctors who relied less on drug
company resources were deemed more rational prescribers. '
More recently the study of Buetow et al. (1996) examined inappropriate
long-term prescribing in general practice over a fifteen-year period. The
authors reviewed sixty two studies of appropriateness of prescribing, and
generated five dimensions of how appropriateness can be examined.
These five dimensions covered indication, choice of drug, drug
administration, communication and review (Buetow et at, 1996). The
authors also note that "lack of consensus among doctors about the best
way to practice medicine may help to account for the unexplained
variations as general practice lacks accepted standards of appropriate
prescribing" (p.1371). Findings from the study indicated that prevalence
of prescribing varied according to indicator and chronic condition. The
highest rates of inappropriateness were related to drug dosages outside
of the therapeutic range specified for that drug. In terms of the first
dimension -Indication, nine studies either failed to state the indications
for treatment or they were invalid, long-acting Benzodiazepines were
prescribed and there was also an under-reporting of prescribing for some
conditions (asthma, hypertension). Relating to the second dimension-
Choice of drug, the authors noted an underprescribing of generic
medication, prescribing of unsafe or hazardous drugs, concurrent
prescribing of Benzodiazepines for long term use, while also
contraindicated drugs were being prescribed. Drug administration issues
included underprescribing resulting in death, inappropriate drug dosages
were prescribed, while excessive durations of Benzodiazepine
prescribing were reported.
Communication, the third dimension, tended to be reported as poor due
to patients poor understanding of their condition (particularly asthma),
while very often instructions written on prescriptions were inadequate and
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included errors. With respect to medication reviews, the final dimension,
the principal flaws were failure of a drug to control certain conditions
(hypertension and asthma), failure to review repeat prescriptions for
elderly patients which included drugs for severe asthma, anticonvulsants
drugs and the mood stabiliser Lithium. Findings from the study
acknowledged that while it is difficult to determine what is deemed
appropriate prescribing in general practice, under the dimensions
studied, there was widespread inappropriate prescribing taking place in
the UK between the years 1980 to 1995.
In a similar study conducted in Canada with general practitioners,
Lexchin (1998) attempted to ascertain whether Canadian GP's were
prescribing in an appropriate fashion. Means used in the study to
examine appropriateness included assessing appropriateness of
prescribing against predefined criteria, while in addition the author used
an existing administrative database to evaluate prescriptions received by
populations. Findings from the study showed that a level of inappropriate
prescribing does take place among Canadian GP's in terms of
maximising effectiveness and minimising risks, while in terms of
respecting the patient's choices, Canadian GP's fell short in terms of their
level of communication with their patients. In an attempt to further
examine the process of prescribing and how to improve it Lexchin (1998)
found that two principal causes of inappropriate prescribing related to the
physicians knowledge base and the physicians practice patterns.
Physicians knowledge base was concerned with the range of drugs being
prescribed by GP's and their familiarity with these drugs and with newer
novel medications, while physicians practice patterns was concerned
with whether the GP was employed in a Government funded community
health centre (which was associated with more appropriate prescribing)
or in fee-for service group practice (associated with a lesser degree of
appropriate prescribing).
From the evidence produced on quality of prescribing in General
Practice, there seems to be no doubt but there is a level of inappropriate
prescribing taking place, not only in the UK but also in countries such as
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the US and Canada where studies have been conducted. However a
word of caution is necessary when interpreting the findings of such
studies on inappropriateness of prescribing. As Bradley (1991) has
noted it is difficult to ascertain a single criterion of prescribing quality due
to the complex nature of the phenomenon under study and due to the
many facets associated with prescribing. Of the studies cited above,
many of the criteria used to determine appropriate prescribing were novel
in nature and were not subject to rigorous scientific validation. In
addition, differing measures of appropriateness will be required across
different populations in order to measure accurately appropriateness of
prescribing. Finally as Bradley (1991) states uit is probable that all
doctors are guilty of inappropriate and sub-optimal prescribing from time
to time and the propensity may differ between one therapeutic class and
another for each doctor rather than being an overall characteristic of the
doctor. It is also true that the current state of understanding of some
therapies in general practice is insufficient to allow judgement to be
passed" (p.278).
9.4 Decision-Making Factors in the Prescribing Process.
Reviewing the literature on appropriateness of prescribing from a
General Practice perspective has been useful for the purposes of the
present thesis. Not only does it give researchers and clinicians in the
field of learning disability a perspective from where and how to initiate
such research, but it has outlined a useful frameworK of the means of
how to examine appropriateness, other than those already in existence
(i.e. Aman et at, 1995 - which has relied primarily on the links between
psychotropic prescribing and the presence of a diagnosis or diagnostic
label).
Despite this however, we are no nearer in accounting for the findings
from Part One of this thesis. Determining the quality of prescribing is a
far more theoretical process and it still does not account for the huge
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variation in the types and ranges of psychotropic drugs prescribed for the
learning disabled population.
In this respect, the author again draws on research from General
Practice relating to the decision making processes that are involved in
prescribing. Drawing on such research allows the researcher or clinician
an alternative means of examining prescribing behaviours and the
theoretical assumptions which may underlie such prescribing. It also
takes into account the more complex factors (other than pharmacological
factors) which may determine whether a drug will be prescribed or not.
Essentially there are three types of decisions that are highly influential
from a General Practitioners perspective. These are as relevant for
Consultant Psychiatrists in the field of learning disability as they are for
the General Practitioner. These considerations are as follows:
1] The decision on whether or not the presenting condition should be
treated by means of prescribing a drug.
2] Once the decision to prescribe has been taken, the prescriber now
needs to make decisions about what form of medication(s) need to be
prescribed.
3] Other decision processes which need to be made over a time period
and not necessarily within one consultation - issues such as whether to
start a newer drug, drug reduction or drug cessation.
9.4.1 The Decision of Whether to Treat or Not. '
Research on decision-making processes around the issue of whether or
not to treat is quite sparse. Historically, research on prescribing from a
General Practice perspective has tended to examine decision-making
processes pertaining to the types of drugs prescribed rather than on
examining the rationale of whether to prescribe a drug or not. There are
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many complex facets associated around the decision to treat. In a sense
many people go to the GP in order to receive a prescription. If a
prescription is issued, the patient feels satisfied that something has been
done. From a research dimension as Bradley notes "once a prescription
has been issued there is something tangible to study" (1991, P. 284). In
this respect past research has focussed on issues around types of drug
prescribed and the reasons for their prescription rather than why a
prescription was not issued. The other principal reason for the lack of
research on this issue is related to the opening sentence of the current
chapter which states - prescribing of medication can be said to be the
mainstay of medical treatment. In this sense, the author takes note the
more traditional perspective of the "medical model" of which prescribing
is one of its core components. If a patient is presenting with a problem
then a prescription is issued. Finally, and relating to this second point is
the fact that the literature on this topic is medically orientated and based
on research conducted in hospital settings, again where prescribing is
frequent and routine. The option of not prescribing is seen to a far lesser
extent in such a setting.
Where research has been conducted on the decision making processes
around the decision to prescribe (or not), the findings are of immense
interest. One of the first researchers outside of the medical field to
examine this area was Parsons (1952). Parsons noted that
approximately three quarters of those who go to their doctor leave with a
prescription being issued. From a sociological perspective Parsons
found this of interest and posited a role-relationship between the patient
and the prescriber. Each has a role and a responsibility - both the
patient and the prescriber. The patient's role is to seek help and visit the
doctor, while it is the obligation of the doctor to help the patient. The
issuing of a prescription is powerful in its symbolic sense and both the
patient and the prescriber are living up to the role in society. .
Despite Parsons model being of interest, it has been criticised on severat
grounds. The first of these criticisms has come from Bloor & Horobin
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(1975). These authors note that Parsons model fails to account for the
potential for conflict which arises between the patient and the doctor.
The issuing of a prescription according to Bloor &Horobin will result in
the resolution of any conflict between the two. Hall (1977) further
elaborates on the model posited by Parsons (1952) in that both the
doctor and the patient are obliged to give and to receive gifts. As Bradley
(1991) states "the prescription functions as a gift and a doctor is obliged
to both give and receive gifts. Refusing to give is the same as refusing to
accept" (p.284).
A further criticism of Parsons model is that it fails to take into
consideration the issue of uncertainty, which is commonplace in medical
practice. A doctor may be faced with many complex decisions
throughout the course of a day-to-day practice and the issuing of a
prescription leads the doctor to avoid this uncertainty and hence he
avoids discomfort (Scheff, 1963).
However what any of these models fail to take into account is the issue of
the patient influencing the doctor to prescribe. Although Parsons (1952)
model does recognise the relationship between the doctor and patient, it
does not take into account the fact that very often a patient has
expectations prior to a consultation. In the study of Stimson and Webb
(1975), the authors interviewed patients regarding what they expected
from consultations prior to meeting with the doctor. While patients
expected a prescription in 51 % of cases, they received one in 660/0 of
consultations. However due to methodological problems with the study,
caution is urged in accepting these findings at face value as there are
numerous other reasons for an individual visiting a doctor other than the
treatment of a particular condition or disease.
In a more recent study Britten & Okoumunne (1997) investigated the
influence of patients hopes of receiving a prescription on doctors
perceptions and their decision to prescribe. The study aimed to measure
the expectations of patients and how such expectations affect General
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Practitioners decision to prescribe. The methodology employed was a
questionnaire type survey in which doctors were asked to complete a
brief questionnaire and the end of each consultation. Information
included in the questionnaire related to demographic data, whether the
doctor perceived that the patient wanted a prescription, whether the
doctor felt under pressure to prescribe and if a prescription was written
details about same and whether "the prescription was 'strictly indicated
on purely medical grounds'" (p. 1506). Each patient was issued with a
questionnaire which asked them for demographic details, details
pertaining to the presenting condition(s) and whether they had an
expectation of receiving a prescription from the doctor on that day.
Results from the study indicated that 67% of patients hoped for a
prescription to be issued while 650/0 expected a prescription to be issued.
From the perspectives of the doctors involved in the study (which
spanned over 15 General Practitioners) doctors perceived that 560/0 of
patients wanted a prescription and these perceptions were strongly
associated with patients hopes of a prescription. Resulting prescriptions
amounted to just over 590/0 which meant that one quarter of those
patients who hoped for a prescription did not receive one. The findings
of this study were comparable to a study conducted in Australia by
Cockburn & Pit (1997) using a similar methodology.
The study of Weiss et at. (1996) examined pressures on GPs to
prescribe and decision making factors which are involved. The authors
examined GPs prescribing in relation to four main indices - GPs sense of
bUrden, financial constraints and incentives, prescribing as a coping
strategy and finally patient demand. Findings from the study indicated
that General Practitioners were concerned about pressures to prescribe
although the only variable strongly associated with actual prescribing was
the possible adverse effects of financial constraints on medical decisions
which resulted in prescribing. Practitioners did note however that
burnout was common amongst GPs in addition to low morale which was
associated with public expectations of the practitioners themselves. This
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invariably led to feels of hopelessness, powerlessness and frustration.
Other factors which practitioners felt were influential in the prescribing
process were patient demand and expectation to prescribe - however
these variables were not of significance in the study.
What was of immense interest was the issue of the influence of
workload in relation to prescribing. Many studies from General Practice
have reported a relationship between workload, lack of consultation time
and an increase in prescribing rates (Bandyopadhyay et at, 1994; lliffe &
Munro, 1993; Keeley, 1993; Hope et at, 1993; Gilley, 1994; Howie et at,
1989 and Bradley, 1992a, b, c). However the study by Weiss et at did
not find a similar result. In relation to this the authors have noted: "many
GPs acknowledged their use of a prescription to cope with workload
although, with the current emphasis on 'rational prescribing', many GPs
felt guilty about using a prescription in such a 'non-pharmacological'
manner" (1996, p.437).
Following on from the earlier studies of patients influence on prescribing
&doctors expectations of same, the study of Stephenson et al. (1999)
examined General Practitioners perceptions of patient influence on
prescribing by means of interviews with twenty one GPs. In the interview
GPs were asked about their perceptions of patients expectations in
addition to influences on their costs of prescribing and any means by
which they had reduced such costs. Findings from the study showed that
a relationship did not exist between GPs beliefs that their patients
expected a prescription and whether they were over their budget or
under their budget. All GPs interviewed in the study mentioned that they
had experienced pressure to prescribe from patients and they prescribed
"when they would not otherwise have done so" (p.260). Finally as the
authors have stated "this study indicates the multi-faceted nature of GPs
views of patients expectations for a prescription ... the influence of GPs
perceptions of patient demand is complex, yet the effect of patient
demand itself may not only be overestimated but also perpetuated by
doctors' belief in its existence" (p.260).
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From the research to date, numerous reasons have been put forward for
the issuing of a prescription apart from the actual need to prescribe.
Some of these reasons include the ending of a consultation, to impress
the patient, to fulfil a need, as a means of coping with uncertain or
complex cases, to comply with the wishes of another doctor or as a
means of satisfying the urge to give (Melville, 1980; O'Hagan, 1984;
Ryde, 1981and Drury, 1984). Despite the vast amount of reasons given,
little empirical evidence exists as support for such reasoning.
To conclude this section on whether to treat with a prescription or not,
much evidence has accumulated with regard to the non-pharmacological
factors which influence prescribing. If one turns to the work of Parish in
the 1970's, he notes that prescribing is as much a social entity as it is a
medical one. The General Practitioner is possibly the first person that a
patient comes to see and this in itself is a complexity as there is a sense
of pressure or responsibility to be seen to do something. Whether this
results in a prescription or not is dependent on a host of factors, many of
which are not purely medical. Many of these issues have just been
discussed and later in the conclusion of this chapter it will become
evident how such research is of interest to prescribing within the filed of
learning disability, which should be subject to the same principles of
rational prescribing as in the general population.
The next issue to be examined is in relation to the second decision-
making consideration as outlined above. This is the issue of drug choice
and selection once the decision to prescribe has taken place. Let us now
tum the focus of attention to the literature on this topic.
9.4.2 Drug Choice & Selection (once the decision to prescribe has
taken place).
As was mentioned at the outset, the vast majority of the literature
included in the present chapter has been taken from research conducted
with the field of General Practice. No such similar attempts have been
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published in the literature on leaming disability, despite the similarities
existing between the two areas. For the purposes of the remainder of
this section, the author will focus on issues relating to drug selection and
the factors influencing same in General Practice.
As a means of attempting to understand the factors involved in
prescribing (once the initial decision had been taken to prescribe), the
research focussed on studying why doctors prescribe certain drugs for
individual cases.
The study of Zelnio (1982) examined the influences on doctors
prescribing and how such influences were related to the influences of
other doctors. Participants included 250 doctors in the US who were
asked to rate the importance of eight criteria in the choosing of a drug
related to a paired comparison method. The eight criteria included:
efficacy, side effects, contraindications, dosage forms available, source
of information on the drug, cost, manufacturers reputation and frequency
of administration. Findings from the study indicated that of the eight
criteria above, efficacy, appropriateness and safety were judged by
practitioners to be most important. Issues such as the therapeutic class
of the drugs were also seen as important to doctors while the issue of
brand were deemed of less relevance. In relation to these criteria, the
study found two groups of doctors emerging based on their responses.
There were those doctors who attached more significance to efficacy,
safety profile and frequency of administration of a drug, while the other
group were concemed with drug information and issues relating to the
manufacturers reliability and reputation. As Bradley (1991) has stated
'his study agrees with others that doctors, when asked, attach greater
importance to the efficacy and safety of drugs than to their brand
characteristics such as cost. However, how this relates to actual
prescribing behaviour is not clear' (p.281).
As a means of attempting to understand the findings of Zelnio (1982), the
work of Knapp & Oeltjin (1972) is of relevance. In their study the authors
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constructed four hypothetical cases of hypertension of which all patient
variables were similar apart from the degree of hypertension. A
hypothetical drug was then devised which resembled the types of drugs
then available for hypertension. Doctors involved in the study were
asked how they would change their management of the case if the
potential risk or benefit of the drug had changed. In this respect the
issues studied were the seriousness of the disease, the risk of side
effects, the probability of benefrt of the drug prescribed and the speciality
of the doctor. From the analysis results showed that disease
seriousness and speciality of the doctor were of significance in terms of
decision-making process regarding the drug.
Similar to the criticisms made earlier regarding hypothetical cases, the
above studies may be criticised on such grounds. A case of prescribing
in the real-world setting may employ far different decisions in comparison
to those made for hypothetical cases and caution must be urged in taking
the findings of such research at face value. The study of Helper et al.
(1982) aimed to overcome some of the shortfalls of the earlier research
on drug selection. In their study the authors examined real cases of
prescribing in an attempt to gain understanding of the decision making
processes employed. The study related to the prescribing of antibiotic
medications within an acute medical inpatient setting. Prescribing of
antibiotics were assigned into the categories of - prophylactic,
therapeutic and empiric, with empiric being defined as "antibiotic
prescribing where the prescriber believed there to be an acute infection
and proceeded to prescribe without awaiting the results of culture and
sensitivity" (Bradley, 1991, p.281). Over the course of in excess of six
thousand patient days, a total of 103 instances of such "empiric"
prescribing arose. As a follow up the authors interviewed the majority of
prescribers associated with such prescribing in an attempt to gain their
rationale for prescribing in this way. Prescribers were asked their
reasons for prescribing, their reasons for choice of drug and for the
dosage they chose to use.
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Findings from the study showed nine themes emerging. The majority of
these themes were related to the prescriber's beliefs about the treatment
and outcome of prescribing with the drug. Other themes of interest were
related to issues such as information sources, level of training and
reference to the literature. Such themes were linked to a classification of
"past clinical experience" (Helper et at, 1982), in that prescribers tended
to use perceptions of outcomes related to the beliefs about the links
between the actions of the drug prescribed and its outcome for the
patient in choosing a drug. In this respect the authors tended to see the
data as fitting a cognitive model of prescribing rather than a more
traditional behavioural model (where the prescribing would be seen as
more habitual). Where the behavioural model fails to account for the
data is with respect to the prescriber's beliefs and values, hence the
value of the cognitive model in attempting to explain prescribing of
antibiotics in this study.
Leading on from such research and the introduction of both behavioural
and cognitive models of prescribing, the research of Segal and Helper
(1982) proposes a theory of prescribing termed the "Drug Choice Model".
This model is based on the cognitive model above and is based on the
premise that choice of drug would be influenced by the doctor's belief
about the possible effects of the drug and the value associated with
possible outcomes. The authors interviewed twelve doctors regarding
the possible outcomes associated with drug treatment choices and on
initial analysis formed seventeen possible outcomes, leading to six main
outcomes. These outcomes included control of the disease, patient
compliance, cost to the patient, side effects, satisfying patient demand
and criticism from colleagues. A further sample of fifty doctors were
asked to rate each possible outcome (in a hypothetical case of
hypertension) on a twenty point scale ranging from "avoid at all cost" to
"most valued", in addition to a final open ended question about how they
would treat the patient.
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The study yielded interesting results in that the drug choice model
predicted in excess of 70% of the doctors responses, which is well above
average. In essence what the study tells us is that although the drug
choice model is useful in its predictive sense, the choice of treatment
made by a doctor is influenced by what they may think might happen
with a given treatment in addition to they way they may feel if the
outcome actually comes about (Segal and Helper, 1982).
In a later study Segal and Helper (1985) further expanded on their earlier
research on the drug choice model. In the study the authors were
interested in further elaborating and testing their model. The authors
used both real and hypothetical cases (based on actual cases) of the
treatment of diabetes and hypertension by forty doctors. Findings
showed that predictive value was again strongly associated with the
model and that the outcomes for hypothetical cases was similar to real
cases presented. In this respect the doctors perceived probability was a
strong enough indicator in itself to predict actual drug choice in practice.
Building on the work of Segal and Helper (1982, 1985, Denig et al.
(1988) have developed a model around prescribing and decision-making
tenned the "Expectancy-Value Model-. In this model the authors sought
to get doctors' beliefs about outcomes in tenns of likely risks and
benefits. The conditions used for the purposes of the project were renal
colic and irritable bowel syndrome and the authors interviewed 169
general practitioners from Holland. In addition to questioning doctors
about their beliefs of possible outcomes they also questioned doctors
about the six outcome measures of the study of Segal &Helper (1982).
The responses obtained were then compared to replies from an open
ended question of how these doctors were currently treating such
conditions in practice. Results showed high levels of prediction for renal
colic but poor predictive value for irritable bowel syndrome. However the
authors note that irritable bowel syndrome is a complex condition for
which there is no effective treatment, unlike hypertension or renal colic
for which effective treatments exist.
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Producing a model as a means of attempting to explain and predict
prescriber's behaviour is a useful process in that it allows one to examine
and study the underlying influences which lead to the prescribing of a
particular drug. Although the models discussed to date in this chapter do
fall short in some respects, they do provide a useful insight in the
decision making processes that general practitioners engage in.
Although these models are formed around general practice and for
specific drug categories and conditions, they provide a useful framework
on which to build further theories. Of particular interest to the present
thesis is the study of Raynes (1980). It is of interest in that she examined
psychotropic prescribing in terms of attempting to develop a behavioural
model around this. Although findings from the study supported the notion
that prescribing was not related to diagnosis, it was however related. to
the doctors routine for questioning their patients. In this respect Raynes'
findings posit a largely behavioural model but it comes under scrutiny .
and criticism in that although it may be a behaviour which is learnt, but it
may also be related to flawed cognition.
Later in the chapter the author will review briefly two further
theories/models around the issue of decision-making in prescribing, a
·Clinical Judgement Analysis· - based on the work of Harries et al.
(1996) and the Actor-Spectator Paradox as developed by Lilja et al.
(1997).
The third consideration in the prescribing decision making process is the
issue of other decision processes (which need to be made over a longer
period of time than a single consultation and which are complex
decisions around addition of a newer drug, drug withdrawal or drug
cessation). Such considerations will now be discussed.
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9.4.3 Other Drug Decision Processes (decisions made over the
course of numerous consultations pertaining to drug
introduction, reduction or cessation).
Studies examining other drug decision processes have tended to look at
issues pertaining to drug innovation and early adopters of novel drugs.
We will now examine briefly the literature on this topic.
Coleman et al. (1966) investigated drug innovation by examining the
introduction of a new drug to general practice and the social variables,
which were influential in this drug being prescribed by doctors. In the
study doctors were asked to name those persons whom they most often
turned for advice when needed, those whom they discussed they cases
with each week and those whom they were friends with from their
colleagues. Findings from the study showed that those doctors who
were mentioned by their colleagues in answering the above questions
used the novel drug more frequently and earlier than those who were not
mentioned. Where the drug was used, the findings pointed to the
influence of professional contacts in the early initiation and prescribing of
the drug. The role of friendship was seen as being influential later on. In
the case of doctors who had not prescribed the drug by the sixth month
of the study, the impact of networks was said to be of minimal impact.
A second major finding of the study was the identification of prescribers
who were seen as "innovators" - in that they prescribed the novel drug
from a very early stage. The authors portray an innovator as a heavy
prescriber of certain types of drugs, a reader of professional journals and
those who were interested in medicine as a science, although they were
not dubious in using novel drugs. The process of "adoption" involved two
stages for doctors. Stage 1 involved increasing awareness surrounding
the drug in which doctors relied heavily on information from the
pharmaceutical industry, while stage 2 involved legitimisation of the drug
and doctor colleagues played a large part in this process. Hence early
adopters went through these phases quite slowly issuing relatively few
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prescriptions of the new drug while late adopters went through the
process faster and thus issued more prescriptions.
In contrast to the study of Coleman et at (1966), Marshall (1973)
undertook a similar study across a broad range of drugs being
prescribed. Results showed that although eariy and late adopters could
be seen for particular individual drugs, this did not apply across a broad
range of drug categories. Hence doctors could be eariy adopters for
some drugs and late adopters for others dependent on the type of drug
prescribed.
Williamsons' (1975) study pointed to the non-pharmacological factors at
work in terms of a novel drug being introduced to doctors. In the study
doctors were asked whether or not they would adopt a new drug in terms
of the degree of perceived risk, and if they would adopt the drug based
solely on information received from a commercially sponsored source.
Doctors indicated that where there was a low degree of perceived risk,
they were willing to prescribe based on commercially sourced
information. As the degree of perceived risk increased, doctors relied
more heavily on professional sources for advice. Interestingly drugs that
were British were associated with a lesser degree of perceived risk than
those that were foreign and if the drug had a novel mode of action, it was
again associated with a higher degree of perceived risk.
As mentioned before, Williamsons study was based on hypothetical
questions, so it does lead one to question the applicability of the findings.
The study of Peay &Peay (1988) does lend some credibility however to
Williamsons study. The authors examined the degree of perceived risk
of the introduction of Tamazepam in Australia and found that throughout
all stages of drug adoption the role of the drug representative is
paramount, and placed less emphasis on the role of professional sources
as was indicated in the study of Williamsons (1975).
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Studies of drug relinquishment ("the dropping of a drug which
professional journals and official agencies no longer consider to be safe
or desirable and its replacement with an alternative which medical
consensus considers to be superior" (Mapes, 1977, p.619» have proved
useful in the study of decision making processes. Mapes (1977)
examined the prescribing behaviours of twelve young doctors in terms of
psychotropic prescribing and relinquishment of hypnotic medication.
Findings showed that doctors who referred to pharmacological
references tended to relinquish quicker than those with a greater patient
value orientation at the time.
The study of Taylor & Bond (1991) combined the study of drug adoption
and relinquishment in a sample of Scottish general practitioners. Over
the course of one year, practitioners, whenever they issued a
prescription, made a duplicate copy and indicated whether the
prescription was for an "established" drug, a drug new to their practice, or
for a drug, which was superseded by a newer drug. Results showed that
drug innovation was comparatively rare (one in one thousand face to
face consultations), while the impact of drug company representatives
influenced just over 17% of prescriptions issued for a specific class of
drug in particular (anti-infectives). In terms of other influences, general
practitioners saw their hospital colleagues as having a more influential
role in prescribing of all drug categories, than fellow general practitioners
or patients. Overall, findings from the study show that the profile of those
general practitioners who perceived themselves to be influenced by a
commercial source tended to be higher prescribers of novel drugs while
also prescribing a wider range of these drugs. They also saw
themselves as being more clinically autonomous and being less affected
by economic issues in prescribing and on this basis Taylor &Bond
developed the prescribing profile of a "developer" or a "conserver"
(1991 ).
In conclusion, one can see the wider social influences that come into
being when one examines in detail the prescribing behaviours of doctors.
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Not only do some general practitioners base their prescribing on
perceived risk, but this perceived risk may be based on information from
those sources supplying these drugs. In the case of the introduction of a
novel drug, this does warrant caution. Perceived risk in itself is not
sufficient evidence on which to base a prescription. Although a number
of the studies cited here did rely on hypothetical cases, much of the
evidence comes directly from actual cases of prescribing.
From the evidence provided on the three aspects of decision making in
prescribing, there is no doubt but prescribing is a complex process and is
subject to many social variables, or at least, many variables which are
non-pharmacological in nature. The next issues to be examined related
to the development of recent models around prescribing. These will be
reviewed briefly for the purposes of the development of a model of
prescribing based on the findings of the present thesis in relation to
prescribing and learning disability. Finally before concluding this chapter,
the author will review a number of recent studies specific to the present
thesis based on methodological similarities.
9.5 Recent Models of Prescribing - A discussion of their
Usefulness?
9.5.1 Clinical Judgement Analysis.
The first of these models to be examined is that of Harries et al. (1996),
originally developed by Hammond in the 1960's, which is termed "Clinical
JUdgement Analysis". This model of decision making in prescribing is
based on the principles of Social Judgement Theory as developed by
Brehmer & Joyce (1988). Social Judgement Theory when applied to a
medical context is termed Social Judgement Theory and it has been
used by a number of authors within the medical context (Wigton, 1988),
Stewart and Joyce (1988) and Engel et at (1990). It involves subject
being involved in a large number of multi-cue judgements which are then
SUbjected to statistical analysis in order to identify the implicit or tacit
policies underlying the judgements that subjects make. Although this
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model has been in existence for some time, it is relatively new to the field
of medicine and the study of Harries et at (1996) explores its usefulness
when applied to prescribing decision processes in general practice. The
authors note than on reviewing the literature in terms of medical decision
making, many of the studies having failings in terms of their methodology
used, as they have attempted to study medical decision making from a
"conventional" perspective. They note "this points to an important but
inconvenient conclusion for the study of medical decision making:
conventional methods of investigation based on questionnaires or other
means of self-report, may be of limited practical value" (p.88). On the
basis of this conclusion, Harries et al. utilised the clinical judgement
analysis in an attempt to further understand the prescribing decision
processes of general practitioners, by asking them to make judgements
about their likelihood of prescribing a drug. The study differed from other
studies which used the technique in that the authors were interested in
considering management decisions rather than just focussing on
diagnosis.
Subjects consisted of thirty five general practitioners from the Plymouth
region in the UK. The study involved presenting doctors with cases in
which they were asked to make judgements on. There were three
possible tasks for doctors to complete, each with 130 cases, which
differed on thirteen distinct cues. The two main tasks included
information regarding Upid and Migrane treatment and each differed in
the number of cues provided (the Lipid sequence having more cues
available to doctors). For each of the two tasks, doctors were asked to
indicate the likelihood of them prescribing either a lipid lowering drug (in
the case of Lipid), or the likelihood of them prescribing a prophlactic
treatment in the case of Migrane. The third task was related to HRT
(hormone replacement therapy) and not all doctors completed this task.
Findings from the study showed that the number of cues presented was
significant in terms of prescribing decisions made by general
practitioners. The more cues presented, especially for more complex
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conditions (such as the Lipid task in this study), the easier the decision
making process. The degree of insight that doctors had also yielded
interesting results in that doctors tended to have limited insight. As the
authors have noted "this finding is of considerable importance ...
indicating that doctors have insight into what cues they do not make use
of, but have poor intuitions about the cues they actually use. In other
words, when a doctor says they are using a cue they mayor may not be
using it" (p.1 06).
On reviewing briefly the clinical judgement analysis as applied to the
study of prescribing decisions of general practitioners, one can see that
although it is of interest, it does seem of limited value largely due to a
number of criticisms. The first of these draws on earlier points made
relating to hypothetical cases presented to doctors. Harries et al. (1996)
acknowledge this in relation to the goodness of fit between "real world-
cases and those which are hypothetical. It is a failing of the present
study that hypothetical cases were presented, hence the findings are
limited. The second main failing of this model relates to their
methodology. Although scientifically elaborate in the use of computer
technology, it did involve quite a lot of time for doctors to complete in
addition to it being largely experimental. In the real world setting of
general practice, doctors have very different consultation styles, while
also being constrained in tenns of consultation times (DiCaccavo & Reid,
1995). Hence the value of the clinical judgement analysis is limited in its
present context, largely due to its highly experimental nature, but it is of
value in tenns of highlighting the psychological and social processes at
work in decision making in prescribing.
9.5.2 The Actor-8pectator Paradox Model of Prescribing.
The actor-spectator paradox model of prescribing examines prescribing
in tenns of the relationship and communication between the prescriber
and patient. Whereas traditionally prescribing was examined solely in
terms of the prescriber's decision making process, this approach has
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since been superseded with the era of shared decision making or patient
centred approaches (Stephenson et at, 2000) in which the patient
actively takes a role in the consultation.
The actor-spectator paradox as posited by Lilja et at (1997) takes into
consideration the cognitive systems employed by both doctor and patient
within a medical encounter. In their model the authors examine the
usefulness of this model in terms of psychotropic prescribing in general
practice. Not only is there relatively little research on the area of
psychotropic prescribing as applied to general practice, but this model is
particularly useful for the present thesis, due to psychotropic prescribing
being the core issue under examination.
The actor-spectator paradox has as its central concepts the issue of
communication and cognitive processes in the medical consultation. In
terms of cognitive processes, one must look to the metacognitive
processes of those involved in the consultation. These metacognitive
processes can be subdivided into two categories, each belonging to the
same person - 1] the individuals thoughts about his/her own cognitions
(internal metacognitions) and 2] the individuals thoughts about another
persons cognitions (interpersonal metacognitions) (Lilja et at, p.1177).
These are central to our understanding of this model as we examine the
communication and cognitive processes of both the actor and the
spectator in the consultation process. Figure 9.1 below outlines an
overview of the Actor-Spectator paradox model taken from Schneider et
at, 1979, and cited in Lilja et at (1997) p.1179.
Figure 9.1 A figure depicting an overview of the Actor-8pectator
Paradox model of Prescribing
The interpret- The
ation by the focusing focusing interpret-Spectator of ... The actor's .... ation by the
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Lilja et al. (1997) applied the actor spectator paradox model of
prescribing to the study of psychotropic prescribing amongst general
practitioners where patients were suffering from what the authors termed
"common psychological symptoms such as nervousness, anxiety,
sleeplessness and depression" (p.1176). Not only is psychotropic
prescribing controversial within the field of learning disability, but it has
also generated much interest and concern amongst the general
population (Hemminki, 1977; Renaud et aI., 1980; Cooperstock et aI.,
1983 and Smith, 1985). In particular there has been much debate
around the prescribing of Benzodiazepines, with numerous arguments
both in favour and against such Widespread prescribing of these drugs.
The debate is based on the relationship between mind and brain, with
one argument being materialistic in nature (parallelism between mind and
brain is assumed) and the interactionist perspective (whereby the mind
and brain are seen as distinct interacting entities).
Larsson &Lilja (1992) applied the actor spectator paradox to
psychotropic prescribing in order to determine its usefulness. In their
studies the authors showed pre-recorded video-vignettes to a sample of
both patients and health care professionals and asked them to
recommend ways of dealing with the problems shown. In this respect the
doctors and general public who were involved in the study acted as
spectators in the study. Findings from the study showed that doctors
viewed the video-patient as having a more serious problem than did the
general public, more doctors recommended use of psychotropics than
did the general public and finally the attitudes of doctors and the general
public varied considerably in their views towards psychotropic drugs, with
both doctors and members of the public viewing psychotropic prescribing
as positive and negative.
The implications of adopting the actor-spectator paradox of prescribing in
general practice may be summarised as follows:
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1. If practitioners were to adopt this model, it would place emphasis
on those issues which could be empirically studied - side effects
associated with particular classes of psychotropics.
2. The general public could focus on value judgements pertaining to
psychotropic prescribing, rather than holding the attitude that non-
prescriptive methods of treatment are sufficient in themselves to
deal with complex problems.
3. Empirical evidence is required for both practitioners and the public
in order to form the basis of their attitudes and opinions on
psychotropic prescribing.
4. The issue of dependency on certain psychotropic drugs (Le.
Benzodiazepines) is viewed differently by practitioners in
comparison to patients. While patients view dependency in terms
of difficulty in stopping taking a drug, practitioners view
dependency in terms of pre-defined criteria (as outlined in DSM for
example).
Given these considerations, Lilja at al. (1997) develop their model of
prescribing as follows:
Figure 9.2 A figure depicting the Actor-8pectator Paradox as
applied to the decision processes in psychotropic
prescribing in General Practice.
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Overall the Actor-Spectator Paradox model of prescribing offers us a
unique insight into the communication process between prescriber and
patient. Presently no other model offers the reader the insight into this
phenomenon as applied to the process of prescribing. One of the most
useful applications of this model is to the researcher and how they go
about investigating the prescribing process. In essence the emphasis of
research to date has been placed solely on the prescribers perspective
and to a lesser degree on the patients perspective. Hence future
research (certainly within general practice) should examine the
discrepancies between the cognitive systems employed by both parties
involved in this complex interaction and evaluate how this impacts on the
communication between prescriber and patient.
9.6 Specific Studies in General Practice - Their Usefulness in
Studying Prescribing in the Learning Disabled Population.
Throughout the present chapter the author has drawn on research
undertaken in general practice, which has investigated issues around the
prescribing process and the variables involved - be these
pharmacological variables or variables of a social nature. It is necessary
for the purposes of the present thesis to outline the rationale behind such
studies as Part Two of this thesis attempts to use the literature outlined
earlier to gain an understanding of prescribing for the learning disabled
population. The last section of this chapter will examine a number of'
recent studies of particular interest to the present thesis due to
similarities in the methodologies used by both.
The research of Bradley (1991, 1992a, b, c) is of particular interest to the
present thesis. Bradley (1992c) outlines a methodology which has
proved useful for a more in-depth understanding of the decision making
processes involved in prescribing in general practice. As a rationale
Bradley (1992,a) states "any attempt to influence the prescribing
behaviour of doctors ought to be based on a thorough understanding of
how prescribing decisions are actually made" (p.294). In order to
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understand the decision processes in prescribing, Bradley has utilised a
methodology known as the ·critical incident technique", a technique
originally developed by Flanagan (1954). Although the critical incident
technique will not be explained in detail in the present chapter, the author
will examine the usefulness of this technique in the following chapter,
which outlines the methodology used (and rationale for same) in Part
Two of this thesis.
Bradley (1992a, b) undertook to investigate those factors which were
influential in the decision of whether or not to prescribe in general
practice. Focussed Interviews were conducted with a total of seventy
four doctors (five in training) in which the focus of the interview was to
gather information regarding discomfort around prescribing decisions.
The analysis conducted was based on the critical incident technique and
involved a panel of experts in order to generate categories obtained from
the interview material. Bradley (1992a) states ·incidents are deemed to
be critical when the purpose of the action and the outcome of the incident
are reasonably clear and relevant to the phenomenon under study ... a
key feature of this method is that the categories are derived purely from
the data and not on the basis of preconceived theories" (p. 294).
Upon analysis of the data, information was obtained about factors which
affected doctors in whether or not to prescribe (Bradley, 1992b) and
about those incidents which caused discomfort when prescribing was
initiated (Bradley, 1992a). Findings from the study indicated that
discomfort arose most frequently when prescribing took place primarily
for respiratory disorders, skin problems and psychiatric conditions and
this discomfort arose across all drug types induding cardiovascular
drugs, antibiotics, non-steroid anti-inflammatory drugs and the
psychotropics (Bradley, 1992b). Patient age and ethnic origin also
tended to cause some level of discomfort, as doctors felt uncomfortable
prescribing for elderly patients and especially for children. Other patient
variables, which resulted in discomfort, were the social class of the
patient, patients with a good knowledge of medical matters, how well
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known the patient was to the doctor - with frequent attendees' causing
more discomfort than others.
Doctor factors which resulted in discomfort tended to arise around the
issue of drugs used - with the most common source of discomfort
relating to side effects and then cost of the drug, and possible adverse
side effects. Interestingly compliance was well done the list as only 4.3%
of doctors cited this as a source of concern. Other factors of interest
included doctor's expectations of themselves (in that they found it hard to
refuse giving a prescription), they felt a need to do something or give
something and there was also an issue of the prescription serving to "get
rid of the patienr. The issue of being unable to form a diagnosis arose in
discomfort for a considerable number of doctors in the study.
Findings from the studies of Bradley (1992a, b) have indicated the
usefulness of the qualitative approach to the study of prescribing
decisions in general practice. Not only do these studies point to the
influential factors in decisions regarding whether to prescribe or not, they
also provide a useful insight into the reasons that doctors feel
uncomfortable when issuing a prescription. Interestingly a considerable
amount of this discomfort arises from the point of view of patient
variables (hence the earlier discussion) in addition to variables
associated with the drugs prescribed (largely pharmacologically driven
concerns). These studies have again pointed to the influence that non-
pharmacological factors play in the prescribing process. As Bradley
(1992b) has stated "while all analyses of prescribing data have disclosed
evidence of drug usage that is pharmacologically illogical it is still
improbable that doctors are being deliberately irrational. The problem for
the doctor is that the criteria of 'rational' prescribing must be balanced
against considerations of the patients obvious suffering and the need to
maintain a good doctor-patient relationship" (p.457).
Other studies which have made use of qualitative methods as a means
for understanding prescribing in general practice are the studies of
Dybwad et al. (1996), Sleath et al. (1997) and A1lery et al. (1997).
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However these studies, unlike the research of Bradley, are specifically
associated with either a specific drug type - Benzodiazepines and minor
opiates in the study of Bjomer et al. (1996), or with changes in clinical
practice as discussed by the study of Allery et al. (1997). In this respect
they are beyond they scope of the present chapter, but they do
emphasise the usefulness of qualitative techniques in the study of the
process of prescribing and changes associated in prescribing techniques.
9.7 Chapter Conclusions & Implications for the Present Thesis.
The present chapter sought to examine the existing literature in respect
to prescribing decisions and factors affecting prescribing in general
practice. Although this literature in one respect may be seen as being
somewhat removed from the present thesis, it is central to our
understanding of the factors which affect prescribing and the decision-
making processes involved.
In order to account for the findings from Part One of this thesis and to
further explore the prescribing behaviours of Consultant Psychiatrists in
learning disability, it is necessary to draw on the findings from prescribing
patterns in general practice and relate such findings to the present thesis.
Much of the research undertaken in general practice affords this study
the opportunity to use existing methodologies in an attempt to
understand the rationale in prescribing for persons with learning
disability.
The present chapter has examined issues around appropriateness and
rational prescribing. Ever since the development of a definition of
rational prescribing by Parish (1973) and its elaboration and re-definition
by Barber (1995), general practitioners have had a framework on which
to base their prescribing. If prescribers are unsure of what constitutes
appropriate or rational prescribing, they can assess their behaviours in
terms of these guidelines. The remainder of this chapter was dedicated
to examining decision-making processes that are involved in the process
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of prescribing, namely whether or not to treat the condition with a
prescription, issues around the drug selection process and other more
long-term decisions regarding introduction of newer drugs or drug
reduction. In addition the author examined two models of decision
processes - the Clinical Judgement Analysis (Harries et al., 1996) and
the Actor-Spectator Paradox Model (Lilja et at, 1997) in an attempt to
ascertain the usefulness as applied to the present study.
The final issue examined in this chapter relates to studies of specifIC
importance in relation to the present thesis. It examined the work of
Bradley (1992a,b,c) and how the research methodology used by Bradley
may be incorporated to the study of prescribing within the field of learning
disability. The qualitative method known as the critical incident technique
proved useful in the research of Bradley (1992a) and it is this technique
which is utilised in Part Two of this thesis, in an attempt to gain
understanding of the prescribing behaviours of consultant psychiatrists in
learning disability.
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CHAPTER TEN
RATIONALE FOR METHODOLOGY
10.1 Chapter Introduction
The role of qualitative research methods has grown considerably over the
past two to three decades and such methods are employed frequently by
healthcare researchers, be these Sociologists, Psychologists or members of
the Medical profession. The present chapter will examine the growing
impetus of research that has been investigated by means of qualitative
research methods and how qualitative methods have been employed
successfully by healthcare professions.
Part One of this thesis employed strictly quantitative methods as a means of
determining factors associated with psychotropic prescribing in the learning
disabled population. This first phase of the thesis proved useful in that it
offered the author the opportunity to compare drug prevalence figures
gathered within this study to similar studies conducted within the UK, Europe
and the US. However the major problem lay in how to account for the
findings obtained in Part One of this thesis. Reviewing the literature on
psychopathology proved useful to the author in that pursuing the avenue of
research which would investigate the links between psychopathology and
psychotropic prescribing would prove of little use in understanding the
reasons behind prescribing. Quite clearly there are links between
psychopathology and prescribing but they offer little in gaining an
understanding of why such high figures of prescribing took place.
As a result of examining the literature on psychopathology and learning
disability and trYing to account for the drug prevalence findings obtained in
this thesis, the author turned his attention to qualitative methods and how
such techniques may prove beneficial in the current project. In addition to
turning his attention to qualitative methods, the author also reviewed the
literature outside of learning disability in an attempt to see whether a
literature existed on prescribing, and if so, what techniques were employed
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as a means of study and understanding this phenomenon. The results
proved useful on both counts as firstly qualitative methods have been
employed in the study of prescribing and secondly an extensive literature
exists which examines prescribing in General Practice. kl chapter eight the
author has reviewed the literature on prescribing in General Practice and its
usefulness in developing a methodology which will firstly allow the
researcher to research this most complex phenomenon and secondly by
employing a similar methodology to that used in General Practice, it will
allow a greater understanding of prescribing in learning disability and aid in
further research in this field.
The remainder of this chapter is devoted to a discussion, critical evaluation
and rationale Why qualitative research methods have been used in the
present thesis, by outlining the principle components of qualitative
techniques and a specific discussion of the technique of Grounded Theory
(Glaser &Srauss, 1967). Part Two of this thesis has employed the
technique of Grounded Theory in analyzing the findings obtained from the
study. To conclude this chapter the author will outline and discuss a unique
qualitative research tool known as The Critical Incident Technique
developed by Flanagan (1954) and subsequently used in healthcare
research more recently by Bradley (1992a,b, c).
10.2 Underlying Principles of Qualitative Research
Within the field of Psychology, the use of qualitative techniques can be said
to be somewhat novel largely due to their relatively short use, in comparison
for example to the field of social Anthropology which has routinely employed
such methods for a considerable length of time. Despite the growing
interest in qualitative techniques since the 1960's, it is not until quite recently
that such techniques have begun to impact on the field of psychology
(Richardson, 1996) and more widely healthcare research. Richardson
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(1996) quotes from the UK governments Economic and Social Research
Council (1992) which declares its intention to devote work on all research
methodologies, by stating "giving equal attention to qualitative and
quantitative methods and seeking to promote appropriate methodological
development in all social science disciplines" (p.28 cited in Richardson, p.3).
Over the last number of years it can be said that a paradigm shift has
occurred by many Psychologists working and researching in the field of
healthcare. There has essentially been some discontent that traditional
approaches to research have failed to shed an understanding on some of
the many complex phenomenon under study. Such traditional approaches
based on laboratory studies and strict experimental design have been
severely criticized based on their narrowness (Smith et al., 1995). Many of
the more traditional experimental-type studies, although methodologically
rigorous and scientifically valid, failed to account for "real-world" experiences
and in this respect could be said to be "flawed" on ecological validity
grounds.
In this respect the discipline of psychology has expanded into a more real
world setting where ecological validity is of the utmost importance. More
broadly within the domain of healthcare research such research has
expanded considerably and now focuses on areas, which were difficult to
study prior to qualitative techniques. The area of prescribing could be said
to be one such area where quantitative techniques have offered little in the
way of understanding of this phenomenon. Other examples, which have
benefited from qualitative techniques, include the study of asthma (Adams at
aI., 1997) and cardiac problems (Ruston et at, 1998).
On the issue of a paradigm shift occurring within how psychological
research is conducted, Smith (1995) makes the following statement: "in
order to be able to conceive of itself as truly embarked on a post-positivist
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paradigm, psychology needs to find new methods, methods which are more
appropriate to the questions it now wants to ask and to the settings in which
it wants to ask them" (p.4). Taking this quote at face value and practical
level, one has to develop a methodology which will be effective in gathering
the type of data which the researcher feels will be of benefit and answer the
questions that one is positing, within the real-world setting that the behaviour
occurs in. This is the task of qualitative research methods.
10.3 Qualitative Research - What Does It Involve?
Whereas traditional quantitative research methods involve the use of
experimental design and statistical analysis of numerical or quantitative
data, qualitative research methods do not involve any of the above
procedures. Strauss &Corbin (1990) define qualitative research as "any
kind of research that produces findings not arrived at by means of statistical
procedures or other means of quantification" (p.17).
Typically quantitative research methods involve the use of numerical data
gathered from psychometric means such as a psychometric test or checklist.
Such psychometric assessments involve the use of pre-defined aiteria into
which the researcher is consumed if one decides to follow this route. Hence
8 study is conducted which involves the use of an assessment tool, data is
gathered within the confines of the aiteria of the assessment and the
researcher bases their conclusions on the basis of data that has been
gathered and analyzed. Although such research may be scientifically
rigorous and empirically validated, many other issues may underlie the
results obtained from such an approach. Because the participants are
completing a psychometric assessment tool, they are merely answering the
questions that are laid in front of them. Participants may have many
comments to make on the related areas, but because of the research design
employed they are not given the opportunity to discuss their comments.
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Qualitative research techniques on the other hand do not employ a set of
pre-defined criteria into which the researcher is attempting to place data. A
study typically involves the researcher asking a series of questions related
to the topic of interest. Such questions emerge from the researchers area of
interest, previous work undertaken on the topic and areas, which have not
been explored previously. Invariably such questions are open-ended and
the participant is offered the opportunity to speak freely and openly about
his/her opinions on the topic being researched. For example for the
purposes of the present study, the author was interested in the area of
psychotropic prescribing for persons with learning disability. While the data
gathered in part one of the thesis was quantitative in nature, employing a
quantitative methodology would have offered little in the way of an
understanding of the factors which influence prescribing. On this basis, and
due to the fact that the author did not find a suitable quantitative
methodology to employ, a qualitative methodology needed to be
incorporated into the study.
In incorporating a qualitative methodology, the author was interested in a
number of avenues of scientific enquiry related to psychotropic prescribing.
On the basis of this, a number of questions were developed in order to
account for the findings from part one. These questions were developed
into five open-ended questions rather than a list of twenty closed questions
- which would not have yielded valid answers, due to their construction and
due to the sensitive nature of the research topic.
As a means of undertaking qualitative research and gathering data,
qualitative methods incorporate a range of techniques. These techniques
inclUde observational methods, interviews, documentation, the use of video
and books. For the purpose of the present thesis, data gathering took place
by means of a Prescribing Checklist (adapted from the Critical Incident
Technique) and a focused interview with prescribers.
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A question which is asked by many researchers new to qualitative research
is why use qualitative techniques when a large array of quantitative
techniques are available? The answer to this question is simple and brief
and for those involved in the study of complex areas of healthcare research,
there is no doubt but employing qualitative techniques has proved of
immense benefit largely due to their being no suitable quantitative
techniques available. Essentially as Strauss & Corbin (1990) have put it, the
answer to this question is related to the nature of the topic under research.
While many researchers come from a background of social anthropol()Qy,
which routinely employs qualitative methods, many researchers come from
disciplines such as medicine and psychology, which do not routinely use
such techniques. Despite this however, such disciplines do study complex
phenomenon and there is a need to employ qualitative techniques to
research areas in which quantitative techniques have failed to address. As
Strauss & Corbin (1990) have stated: "qualitative methods can be used to
uncover and understand what lies behind any phenomenon about which
little is yet known. It can be used to gain novel and fresh slants on things
about which quite a bit is already known. Also qualitative methods can give
the intricate details of phenomena that are difficult to convey with
quantitative methods" (p.19).
10.4 Introducing Grounded Theory as a Qualitative Research Tool
There are a number of qualitative research methods employed by
healthcare researchers. These include protocol analysis, ethnography,
discourse analysis and constructionist approaches and finally grounded
theory. Depending on ones discipline and the topic under study any of the
above approaches may be used in qualitative research. For the purposes of
the present section the author will present an overview of an approach
known as grounded theory, due to its usefulness in analyzing the present
set of results and fonnulating theory based on these findings.
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A brief historical background of the development of grounded theory is the
best possible starting point.
Grounded theory emerged within the 1960's and was developed by Glaser
and Strauss (1965, 1967) who were two sociologists. As was mentioned
earlier in this chapter qualitative methods have been used extensively by
disciplines such as sociology and anthropology. However the principle
methods employed by such disciplines included ethnographic fieldwork and
case studies (Charmaz, 1995). Despite such methods being employed by
these disciplines, the quantitative method of research was gaining
dominance over such qualitative techniques and essentially qualitative
techniques were used as a means of strengthening quantitative research
tools. In addition at the time, as Charmaz (1995) notes, despite quantitative
research being undertaken, little was happening in the way of theory
construction.
On the basis of the backgrounds of these two authors, and in particular
Anselm Strauss, five major contributions can be said to have been influential
in the development of grounded theory. These five developments taken
from Strauss & Corbin (1990) are as follows:
1. The need to get out of the laboratory setting and into the field setting if
one wants to understand the topic under investigation.
2. The importance of theory, which needs to be grounded in reality in the
development of a discipline or the topic under study.
3. The nature of one's experience and undergoing as continually evolving. .
4. The importance of the role of the person in shaping the world around
them.
5. Emphasizing the role of change and process and the complexity of life.
6. The inter-relationship between conditions, meaning and action.
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The above five points are central to gaining an understanding of grounded
theory and the underlying principles which are involved. In developing their
grounded theory methodology, Glaser and Strauss (1967) emphasized the
role of specific analytic procedures to be employed while undertaking such
research. Up until this point many qualitative researchers relied upon
fieldwork or experience and mentoring in informing their qualitative
practices. The authors challenged such notions by offering researchers a
set of written gUidelines for undertaking qualitative research. Such an
approach could be said to be based on the theoretical background of Glaser
who trained in quantitative techniques and on the background and
contributions of Strauss.
One of the main points of interest to the present author, and one which
Glaser &Strauss (1967) emphasize in their original theory is the fact that
grounded theory can be used by numerous disciplines. Hence grounded
theory is not discipline dependent and so it covers a range of phenomenon
studied by differing disciplines. For the purposes of healthcare research and
the present topic of research, this is positive step towards gaining
understanding and developing theory.
10.5 Characteristics & stages involved in the grounded theory
approach
Charmaz (1995) defines grounded theory methods as -a logically consistent
set of data collection and analytic procedures aimed to develop theory.
Grounded theory methods consist of a set of inductive strategies for
analyzing data- (pp.27-28). In essence the principle features or
characteristics of grounded theory are that it is grounded in the data and
theoretical in nature - in that a theory must be developed from the data
which is more than just a descriptive account of what the data represents
(Chamberlain,1999). The data analysis and collection phase of the study
go hand in hand, so that as one is collecting data, one is also analyzing it so
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as to develop further avenues of research and expand the research topic
under study. In terms of the core characteristics of grounded theory as
developed by Glaser &Strauss (1967) &Strauss &Corbin (1994), these are
outlined by Charmaz (1995) as follows, and include the following points:
1. Simultaneous involvement in data collection and analysis phases of
research.
2. Creation of analytic codes and categories developed from data, not
from preconceived hypotheses.
3. The development of middle-range theories to explain behaviour and
processes.
4. Memo-making, that is, writing analytic notes to explicate and fill out
categories, the crucial intermediate step between coding data and
Writing first drafts of papers.
5. Theoretical sampling - sampling for theory construction, and finally,
6. Delay of the literature review (p.28)
In collecting data, the researcher refers to point five above - theoretical
sampling. For the purposes of the grounded theory approach the
researcher is not interested in population representativeness, rather they are
interested in how theoretically representative the topic under discussion are
to the construct being studied. For example in the present study, the issues
discussed in the interview material are very relevant to psychotropic
prescribing in the learning disabled but because this is such a clinically ,
defined area, there are a relatively small number of participants involved in
the study, largely due to its discrete nature. Hence due to the nature of the
topic under study, the present author was not interested in population
representativeness, as it would not be applicable in this case.
In terms of the data collection phase of the study, this can be undertaken by
a number of different techniques as discussed earlier - observation,
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interview etc. For the purposes of the present study the author made use of
a Prescribing Checklist (which served to gather critical incident of
prescribing) and a focused interview with prescribers. In analyzing the data,
Chamberlain (1999) distinguishes between three levels of coding - open
coding, axial coding and selective coding (p.185). Once data has been
collected (in whatever form) and transcribed (for the purposes of interview
material), open coding takes place. This is the first phase of analysis and it
involves the researcher identify codes or overall categories on the data. In
essence it means the data is broken up and chopped into little pieces - each
piece being a code or category. The next phase of analysis is termed axial,
secondary or focused coding. This procedure involves investigating other
data or interview material, which confirms or elaborates on the existing
codes identified in the first phase of analysis or to identify relationships
between codes. This phase of the analysis also serves to determine if the
codes used are suitable or if they should be replaced with alternatives.
By using the method of constant comparison of data, the researcher is
enabled to redefine or check the usefulness of codes and categories. As
Charmaz (1995) states -a major contribution of grounded theory methods is
that they provide rigorous procedures for researchers to check, refine and
develop their ideas and intuitions about the data" (p.28). Once axial coding
has been undertaken, this allows the researcher to engage in the final phase
of analysis known as selective coding or the development of core
categories. In this stage of analysis, the author is attempting to verify that
the theoretical account generated to date is -saturated" and includes all
concepts generated earlier. By this stage, by means of constant
comparison, the researcher should be in a position to generate core codes,
which will lead to the development of a theory around the topic under study.
The use of memo's and diagrammatic representation of the research topic
aid greatly in the development of theory - the use of memo's will be seen in
chapter 11, while in the final chapter of this thesis, the author will outline a
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theory of prescribing, grounded in the data gathered from the interview
material. The author will now examine briefly the issue of reliability and
validity in the grounded theory approach.
10.6 Assessing validity In qualitative research
To quote Smith (1996), "qualitative research should be judged against
criteria appropriate to that approach. In other words, qualitative research
should not be evaluated in terms of the canons of validity that have evolved
for the assessment of quantitative research, since these have different
epistemological priorities and commitments· (pp.191-192).
There is the tendency for researchers who predominantly use quantitative
techniques to be critical of qualitative techniques. This is understandable
due to the fact that qualitative techniques are very different to quantitative
techniques and based on different philosophical understandings. What we
mean here is that many researchers are still within the old paradigm of
research being solely quantitative - the furthering of science involves far
more than quantitative research methods. If one takes the view that science
is about confirming disconfirming hypotheses, then clearly qualitative
research methods do not fall within this realm, as the process of qualitative
techniques is not about disconfirming hypotheses.
In an attempt to develop a framework around validity in qualitative research,
Smith (1996) posits five possible criteria or ·suggestions" for assessing
validity, which are as follows: 1] Internal coherence, 2] presentation of
evidence, 3] independent audit, 4] triangulation and finally 5] member
validation. Smith argues that if the researcher applies these criteria to the
topic under study and the methodology employed, one may have the means
to assess the validity of the study. Smith notes that at the time, the criteria
presented are in their infancy and subject to further evaluation. Despite this
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however, the present author feels that these criteria offer a useful critique of
the methodology employed.
Internal coherence is concerned with the study positing a coherent argument
- if the study fails to take into account variation amongst participants or
aspects of the study difficult to identify, then it may be said to have poor
internal coherence. On the other hand if the study represents a good global
view of all aspects of the study and is coherent in its rationale, internal
coherence may be said to be good.
Presentation of evidence refers to the researcher having ample raw data to
support the argument and theory being formulated. In this criterion, the
reader of the study should be presented with ample evidence (raw data) so
as to Minterrogate- the data themselves and take an integral part in
interpretation. The researcher in this case should present ample evidence
to support the theory being formulated, rather than merely presenting third-
party reports or anecdotal evidence.
Independent audit: this refers to all data and notes or memos being subject
to an audit as it were, by someone other than the researcher. If one were to
adopt this strategy, then it would involve an independent person reading all
information regarding the study and determining if the final conclusions were
appropriate and credible for the data collected. Independent audit as Smith
(1996) states Mis not attempting to suppress alternative readings or
necessarily to reach a consensus; it is attempting to validate one particular
reading- (p.193).
Triangulation as a criterion involves the use of differing methodologies as a
means of attempting to gain a similar result. For example one may use two
different methodologies in order to study a phenomenon. If the two
methodologies Yield similar results then these results could be said to be
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valid, whereas if different results emerged, one would have to call the
methodology used into question. Triangulation when used appropriately will
add richer information in addition to strengthening the study.
The final criterion Smith discusses is that of member validation. This
involves seeking more democratic research practices, where the researcher
takes the findings back to his/her participants to discuss and comment on
the researchers interpretation of the data. Needless to say there are
problems involved as it may not necessarily be a democratic process, and
the participants may not be in agreement with the interpretations of the
author.
To conclude this section on validity of qualitative approaches, what has
been presented is an overview of possible ways of examining validity when
using qualitative techniques. As yet there are no defined criteria or ground-
rules for examining validity when using such an approach. In essence, this
could be said to be the main criticism of qualitative techniques. However if
one takes the view of Smith (1996) that a paradigm shift has occurred by
means of the techniques used to undertake research within the discipline of
psychology, such criticism is overshadowed by the proven benefits of
qualitative research. One will now tum the focus of attention to the
qualitative research methods employed in the present study.
10.7 Qualitative research methods & the present study
Due to the complex and sensitive nature of the topic under study, the
present author employed qualitative techniques in order to study the
decision-making processes of consultant psychiatrists prescribing for
persons with leaming disability. From reviewing the literature on decision
making and prescribing in general practice, the author was faced with a
dilemma in that no suitable quantitative techniques have been developed to
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date which would assist the author in gaining an understanding of this
complex phenomenon. As a result of this, and from the research
undertaken in the area within general practice, the author has opted to
research the area by employing qualitative techniques as a means of
gaining and understanding and building a theory of prescribing. The
techniques used are the Critical Incident Technique (Flanagan, 1954) and
as a means of analyzing the data and theory building, the author uses
grounded theory (Glaser & Stra.uss, 1967). The author will now examine the
usefulness of the Critical Incident Technique in this area of research.
10.8 The Critical Incident Technique
The critical incident technique was developed by psychologist John
Flanagan during the second world war. The critical incident technique can
be said to have developed from research undertaken in the aviation
psychology programme of the United States Army air forces dUring the time
of the Second World War. The development of the critical incident
technique began with research into the reasons why pilots were failing to
learn to fly and from their elimination from flight school. In analyzing the
reasons for these pilots failure to learn to fly, numerous reasons were given
which were based on stereotypes and cliches. Flanagan found this of
immense interest but noted that there was a need to develop a systematic
means of gathering information regarding such "incidents", be they factual or
otherwise. Follow-up studies collected specific data regarding incidents
which occurred for pilots be these failed bombing missions (Flanagan, 1947)
or disorientation while flying (Wickert, 1947). With a number of research
studies now completed, the critical incident technique was developed further
and given its present title (Flanagan, 1954).
Since its official emergence in 1954, the critical incident technique has been
used widely in healthcare research (Hubbard et at, 1965; Hayes et at,
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1979; Caiman and Donaldson, 1991, Bradley, 1992a, b, c, and Allery et at,
1997 amongst others). A critical incident may be defined as follows: "by an
incident is meant any observable human activity that is sufficiently complete
in itself to permit inferences and predictions to be made about the person
performing the act. To be critical, an incident must occur in a situation
where the purpose or intent of the act seems fairly clear to the observer and
where its consequences are sufficiently definite to leave little doubt
concerning its effects" (Flanagan, 1954, p.327).
Despite this definition being over forty-five years since its development, its
relevance in the present day has not diminished in any way. In fact if one
applies it to the present study, the critical incidents of prescribing which were
gathered from prescribers could be defined within this framework. An
incident of prescribing is an observable human activity, which is subject to
inference and prediction. In order for an incident of prescribing to be critical,
the incident of prescribing must take place in a specific situation (the
consultation) where the intent or purpose of the prescribing is clear to the
observer, with clear consequences for the client. Hence this framework acts
as a definition of a critical incident of prescribing for the purposes of the
present study.
One of the principal advantages of the critical incident technique is its
adaptive nature, which allows the researcher to collect data in the form of
critical incidents for the topic under study. In this sense it is not a rigid
methodology with fixed ideas and rules. Flanagan himself emphasizes this
notion, when he states, "it is clear that the critical incident technique is
essentially a procedure for gathering certain important facts concerning
behaviour in defined situations. It should be emphasiZed that the critical
incident technique does not consist of a single rigid set of rules governing
such data collection. Rather it should be thought of as a flexible set of
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principles which must be modified and adapted to meet the specific situation
at hand" (p.335).
The critical incident technique has three principle characteristics and is said
to be based on the following underlying assumptions: Firstly it is based on
factual accounts of real events which take place which have clear
consequences. Secondly, the interview, which is conducted, is focussed on
specific reasons for actions and behaviours. Finally, the incidents, which
are collected, are categorised using inductive judgements rather than
placing any predefined criteria or theories upon the data (Bradley, 1992c,
p.99).
These are the essential components and criteria for an understanding of the
critical incident technique. This procedure proved very useful in gathering
data in the present study. The author, through the use of the critical incident
technique gathered critical incidents of psychotropic prescribing for persons
with learning disability. These incidents rather than being collected solely by
interview were collected initially by means of a Prescribing Checklist (a brief
checklist devised by the author) and followed up and expanded upon by
means of a focussed interview with the author. In utilising the critical
incident technique, It afforded the author to gather rich data on a highly
sensitive topic and to further expand on the collected incidents by means of
interview. A more detailed discussion of the methodology and procedure
employed will be discussed in the following chapter - chapter ten.
10.9 Chapter conclusions
To conclude, the present chapter sought to give an overview of the
usefulness of qualitative research within the healthcare setting, and how
such techniques were applied to the present study. By giving an overview of
the principles of qualitative research, the author noted how essentially a
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paradigm shift has begun to take place within the discipline of psychology,
and indeed within healthcare research, as qualitative techniques are being
extensively within the last two to three decades as a highly useful research
tool. The second focus of attention within the present chapter was to
examine the usefulness and applications of grounded theory (Glaser &
Strauss, 1967) and the critical incident technique as developed by Flanagan
(1954). These two techniques were used in the present thesis and they
proved highly beneficial to the author in researching the area of psychotropic
prescribing in the learning disabled population due to their flexibility and
adaptability to all areas of research, in particular healthcare research. As
the final rationale for using qualitative research methods in the present
study, the author will take a quote from Green and Britten (1998), in which
the authors emphasize the usefulness and value of such methods in this
type of research. The authors state, "qualitative research can investigate
practitioners' and patients' attitudes, beliefs, and preferences, and the whole
question of how evidence is tumed into practice. The value of qualitative
methods lies in their ability to pursue systematically the kinds of research
questions that are not easily answerable by experimental methods·
(p.1230). It is due to such reasons that the present author employed
qualitative techniques in the study of psychotropic prescribing for persons
with learning disability.
232
CHAPTER ELEVEN
METHODOLOGY
11.1 Learning Disability Services: The Irish Perspective
Learning Disability Services in the Republic of Ireland have grown
considerably over the past number of decades. The vast majority of these
services are of a voluntary nature and are run by a religious Order. Typical
examples are the Brothers of Charity Services, The Daughters of Charity
Services and the Sisters of Charity of Jesus and Mary. The Brothers of
Charity and Daughters of Charity are the two largest Service providers
within the Republic of Ireland at present.
Within all services for persons with learning disability, a multi-Disciplinary
team is in existence. These teams generally consist of Psychology, Social
Work and Psychiatry as the core disciplines. Other disciplines such as
Speech and Language Therapy, Physiotherapy and Community Nursing
may be in existence in some services but whether they are seen as part of
the Multi-Disciplinary Team or part of the wider Multi-Disciplinary Services is
a matter of Organisational Service structure and policy. These teams vary
considerably in number and discipline orientation across services and
indeed across regions. For example in terms of Psychiatric and Medical
input, some services have only one Consultant Psychiatrist in conjunction
with one Registrar covering a population base in excess of six hundred.
For the purposes of the present thesis, the author was interested in a range
of issues relating to the prescribing of psychotropic and psychoactive
medications for persons with learning disability. Hence access to those
persons undertaking prescribing was the central feature of Part Two of this
thesis.
11.2 Participants
The core topic of interest in Part Two of this thesis relates to issues
regarding the prescribing of Psychotropic and Psychoactive medications for
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persons with learning disability. Although Part One of the thesis
concentrated on patterns of prescribing for persons with learning disability
within the Brothers of Charity Mid-West Region, it was felt by the researcher
that a broader perspective was required in order to account for the wide
variation in prescribing witnessed in Part One. In this respect the author
required access to those persons who are "actively" prescribing for persons
with learning disability within the Republic of Ireland.
Within Services for persons with learning disability in Ireland, prescribing of
psychotropic and psychoactive medications is undertaken by Registrars
(Junior and Senior) and primarily by Consultant Psychiatrists. From
observing the drug charts, by means of which data was collected for Part
One of this thesis, it was observed that the majority of prescribing is
undertaken by Consultant Psychiatrists, with Registrars responsible to a far
lesser degree for prescribing, and General Practitioners also involved
(usually for those living in community facilities). Hence it was decided to
gather the views of Consultant Psychiatrists throughout the Republic of
Ireland on a range of issues regarding prescribing for persons with learning
disability. For the purposes of the present stUdy it was decided not to
involve Registrars or General Practitioners for the following reasons:
• Consultant Psychiatrists are involved in decision-making regarding
service users (i.e. at case conference level) at a greater frequency than
registrars.
• Within the majority of learning disability services within the Republic,
"rotating schemes" are in operation for registrars, whereby they are on
placement for a period of twelve months duration. In this respect
registrars are essentially gaining experience in learning disability and their
level of familiarity with services and service users is limited.
• Where registrars are faced with potential discomfort around prescribing
decisions or complex issues arise, due to the nature of their training
placement, they will consult with their senior Consultant Psychiatrist.
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• Hence, the final decision regarding prescribing will rest with the
Consultant Psychiatrist, placing emphasis on their experience in
prescribing.
• In the case of General Practitioners who may prescribe for persons with
learning disability, their role in the prescribing process is more clearly
defined, as they tend to prescribe for conditions such as asthma and skin
conditions, rather than prescribing psychotropic or psychoactive
medications. Where they do prescribe a psychotropic medication, it is
generally in consultation and in conjunction with the Consultant
Psychiatrist.
On this basis, the author sought the list of Consultant Psychiatrists who
were members of the Royal College of Psychiatry while also being members
of the Learning Disability Section. It should be noted that while all practicing
Consultant Psychiatrists are members of the Royal College of Psychiatry, it
is only those that are actively working in the field of learning disability that
are members of the Learning Disability Section. In addition a number of
Consultant Psychiatrists may be prescribing for persons with learning
disability who are not in learning disability services (i.e. a number of persons
with mild learning disability may be in psychiatric care and not in a learning
disability service per se). These consultants are not members of the
Learning Disability Section.
The author contacted the secretary of the Learning Disability Section of the
Royal College of Psychiatry and outlined the rationale for the proposed
stUdy. A full list of the names (including addresses and phone numbers) of
those Consultant Psychiatrists who are members of the Section was
forwarded to the author. In total there were twenty-four Consultant
Psychiatrists who were members of the Learning Disability Section within
the Republic of Ireland.
Participants in the present study were eight Consultant Psychiatrists who
were members of the Learning Disability Section of the Royal College of
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Psychiatry. One of the prerequisites of the study was that any participants
were required to be "active prescribers" for persons with learning disability.
By this it is meant, they had to be employed within the field of learning
disability and prescribing on a regular basis. As will be seen in the
Procedure Section, the first task in the study was to complete Prescribing
Checklists (Appendix B) - hence if prescribers were not "actively"
prescribing, they were automatically excluded from the study.
On the basis of this prerequisite, four names were automatically excluded
from the list, based on telephone conversations with the Consultant
Psychiatrists. These consultants were retired (one), the nature of their work
was largely managerial and research orientated (one), they were employed
as Clinical Director and hence were not actively prescribing (one) and finally
one consultant was on long-term sick leave due to illness. In this respect
the population base on which the present study was based, consisted of
twenty Consultant Psychiatrists in Learning Disability.
Of the eight consultants who partook in the study, five were female (62.5%)
and three were male (37.5%). An age range was not obtained for the
purposes of the present study, rather a ·prescriber profile" was sought,
where each consultant indicated on the Prescribing Checklist how long they
had been prescribing (in general terms and specifically within learning
disability), and whether they were presently prescribing primarily for adults
with learning disability, children with learning disability or a combination of
both. In terms of those involved in the present study, three female
prescribers were ·job sharing", one female prescriber was allocated to two
different services (a split post), while the remaining four were full-time in the
service where they worked. Table 11.1 below outlines the prescriber profile
for the present study.
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Table 11.1: A Profile of Prescribers Involved In the Present Study.
MALE FEMALE
Gender 3 5
0-5vrs 6-10vrs 11-15vrs 16-20vrs >20vrs
Length 0 1 2 0 5
prescribing
Do you prescribe Adults with Children with Combination of
mainly for: Learning Learning Children &
Disabilitv Disabilitv Adults
5 0 3
11.3 Materials.
Materials for the present study consisted of a Prescribing Checklist (see
Appendix B), A Focussed or Semi-Structured Interview (see Appendix C), a
Sankyo tape recording device with internal microphone and a set of TDK 90
minute recording tapes. Upon completion of the interviewing, data was
transferred (by means of transcribing) onto a PC using Microsoft Word 2000
C. A copy of ATLASti Version 4.1 @ (Muhr, 1997) - a qualitative software
package was used for the purposes of data management and analysis (PC
version) upon completion of transcribing the interviews.
11.4 Constructing the Interview Schedule.
For the purposes of the present study the author has used a semi-structured
or focussed interview schedule. While in most qualitative research projects
the term ·semi-structured interview" is used, Bradley (1992a) prefers the
term "focussed interview" as it reflects the focused nature of the researcher
to the topic at hand. In the case of used a semi-structured or focussed
interview, respondents are not given a set of possible answers as in a
structured interview, rather the respondents are free to answer in whatever
manner they choose. In this respect the semi-structured interview is a far
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-looser" process in terms of the researcher asking broad questions and the
respondent answering them in a free-flowing manner. As Smith (1995)
states "with semi-structured interviews, the investigator will have a set of
questions on an interview schedule but the interview will be guided by the
schedule rather than be dictated by ir (p.12). This was an important aspect
for both the present thesis and also for the researcher who was new to
qualitative research methods.
Smith (1995) also outlines a number of procedures for producing the
interview schedule. These procedures were kept in mind at all times while
the present interview schedule was being designed. The following stages
outline the development of the present ·Prescribing Interview Schedule-:
• As part one of the thesis had been fully completed and analysed, the
author needed to produce an interview schedule, which would both
attempt to answer the questions posed from part one of the study (i .e.
how does one account for the wide variation in prescribing for persons
with learning disability), while doing so in an ethical and ·unchallenging-
way (the author who is a Psychologist would be interviewing members of
a discipline other than his own (the medical profession), therefore
caution was urged and questions needed to be posed in a ·politically
correcr manner). The five core issues which required answering were
related to: typical incidents which result in prescribing, common
presentations which give rise to prescribing, complex factors in
prescribing, links between challenging behaviour and prescribing and
finally discomfort arising from prescribing.
• An initial list of approximately twenty questions was generated. However
upon review, many of the questions included were either value-laden or
they were extremely sensitive (in that respondents would feel them far
too sensitive and difficult to answer). These twenty questions were then
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loosely categorised into five core issues, which the author felt would
probe the area under investigation and yield interesting material for the
purposes of the study.
• Once the core categories emerged, five "open-ended" questions were
generated. Once this task had been completed, these questions then
needed to be put in sequential order, with the initial questions being
more general while the final questions were somewhat more sensitive in
nature - in particular the issues of discomfort around prescribing
decisions was a particularly delicate or sensitive area for prescribers.
• It could be said upon reViewing the present interview schedule, all the
questions generated were somewhat sensitive - in that the author was
essentially questioning each prescriber about their prescribing practice.
However, it was felt by the author that such questions were required in
order to generate meaningful discussion material, while also gathering
data which would account for the findings of part one of the thesis. In
this respect a number of probes and prompts were designed for each of
the five core questions - these were a series of "mini-questions" in
themselves, which would be asked when it was felt that a response was
either sluggish, not enough information was obtained from the broader
question, or where the respondent questioned the interviewer, or was
unsure of the question being asked. Typical examples of such prompts
were "could you tell me a little more about thar, "that's interesting, could
you describe another case where this happened" and "does this [a
particular incident] happen frequently".
11.5 Research Design.
The design of the present study is descriptive in nature. The literature to
date from the perspective of general practice has shown the value of
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qualitative techniques in the study of prescribing decision-making (Bradley,
1991, 1992a,b, c). At present there is no empirical or psychometric
technique, which may be used to assess or gain an understanding of such a
complicated phenomenon as prescribing. In this respect the author chose to
use qualitative techniques in an attempt to gain an insight into the
prescribing behaviours of Consultant Psychiatrists in leaming disability. The
study used the technique of Grounded Theory methodology (Glaser &
Strauss, 1967). The Interview Schedule, which was utilised, afforded the
author to gain rich data from the prescribers into complex, controversial
issues, which would have otherwise been difficult to gather by means of
more traditional approaches. In addition, due to its interactive nature in all
aspects including data collection and analysis, it gave the author the
opportunity to generate theoretical models of prescribing based on data
obtained through the interview technique.
11.8 Procedure.
The present study involved three distinct phases. These included:
1] Targeting Consultant Psychiatrists.
2] Consultant Psychiatrists completing the Prescribing Checklist, and finally,
3] Interviewing the Consultant Psychiatrists
Targeting the participants was undertaken by means of the author making
contact with the secretary of the Leaming Disability Section of the Royal
College of Psychiatry, who herself is a Consultant Psychiatrist. A brief
meeting took place in early October 1999 in which the author outlined the
purposes of the study and the reasons for obtaining the list. At the time of
the initial meeting, the secretary was aware that the author was a PhD
student and was researching in the field of leaming disability.
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Within approximately two weeks of the initial meeting a list was forwarded
to the author, which included the names, addresses and phone numbers of
all those Consultant Psychiatrists who were members of the Learning
Disability Section. The author then made contact with all names on the list
by means of an initial cover letter, which outlined brief details regarding the
author, the rationale behind the proposed study and what the study would
involve. - completion of Prescribing Checklists in conjunction with a twenty
to thirty minute recorded interview with the author on issues relating to
prescribing and learning disability. A copy of the letter is attached in
Appendix D. The letter concluded that within the following ten to fourteen
days the author would make contact with each individual consultant by
telephone to further explain the study while also answering any queries that
consultants had regarding the study. Cover letters were sent via registered
mail (in late November) so as to guarantee delivery.
Prior to the fourteen days expiring, there were a number of queries from
consultants interested in the study. Any queries were duly answered and
the rationale for the study was further outlined. Textbox 11.1 below outlines
some of the positive comments made regarding the study:
Textbox 11.1: Initial Comments from Consultant Psychiatrists
Interested in Partaking In the Study (transcribed directly via phone
conversation).
• I think it makes for a really interesting study ... prescribing definitely
needs to be looked at.
• Yeah of course I'd like to be involved ... sure it's only an interview, no
problem, it should be good.
• Yes - definitely count me in, no problems at all. Just make contact
with me after the Christmas holiday and we'll arrange a time to meet.
• I think we should be involved at this end ... my colleagues in (location
x- are going to be involved ... I was just talking to them this morning,
so yes I would like to be involved.
241
Within the fourteen days, the author made contact with the majority of
consultants on the list (approximately twenty out of the twenty four). For
those who were not contact prior to Christmas 1999, contact was made in
early January 2000. The author failed to make contact with two consultants,
despite numerous phone-calls and two cover letters being sent at various
times.
Of the twenty-four consultants on the list, twenty were deemed eligible for
the study due the prerequisite mentioned in the Participants section
(consultants had to be Mactive" prescribers within the field of learning
disability). Based on the information included in the initial cover letter and a
fOllow-up phone-call, approximately fifteen to sixteen (70%) of the remaining
twenty consultants were interested in, and agreed to partake in the study.
Those consultants who had expressed interest in partaking in the study
were sent copies of the Prescribing Checklist - this was a brief checklist
designed by the author for the purposes of the present study. It included
brief sections to be completed by the prescriber on service user
demographic data, information about the service users presenting
symptoms/behaviours, situational factors of significance, the resulting
prescription(s) and finally some information about the prescriber themselves
(Mprescriber profile").
Consultants were asked over the course of a five-day period, to complete a
separate Prescribing Checklist for every third service user for which any
form of medication is prescribed. A specific time period was not allocated to
the consultants involved - by this it is meant that due to other commitments,
consultants were free to choose any five-day period in which to undertake
this phase of the study. It was felt that if consultants were specifically
directed to complete the Prescribing Checklists within a specified week, it
may result in a poor response rate. Consultants were asked not to send the
completed Prescribing Checklists via post, due to the sensitive nature of the
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material recorded, rather they were asked to keep the checklists until the
time of interview with the author and they would be collected at this point.
Once consultants had completed this phase of the study, contact was made
once again via telephone by the author. In general the consultants had
asked the author to ring back within four to six weeks as they felt this was an
appropriate time-span in which to complete the Prescribing Checklists.
Despite sixteen consultants being interested in the study, nine participants
completed the Prescribing Checklists and wished to be interviewed.
The final phase of the study involved the author meeting face to face with
the individual Consultant Psychiatrists who wished to be interviewed. All
interviews were conducted in the consultant's place of work. Prior to
conducting each interview, the author introduced himself in full, outlined the
purposes of the study (in brief) while establishing a rapport with the
consultant to be interviewed. Once each consultant was briefed in full, they
were asked if they had any questions prior to the interview being recorded.
If any questions were asked, these were answered in full (any questions
asked were generally related to how long the interview was scheduled for,
and were not regarding specific details of the study). The first of these
interviews was held in Mid-February while the final interview was conducted
in early June. Prior to the study being initiated, a focussed/semi-structured
interview schedule was developed by the author. The aim of the interview
schedule was to ask consultants about specific issues of relevance to
prescribing for persons with learning disability. The complete interview
schedule (including prompts) is attached in Appendix C. The principle
issues covered in each interview were based on the follOWing five questions
- (for question one, consultants were asked to refer to their completed
Prescribing Checklists when answering):
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1. Can you describe a recent case in which you prescribed medication?
2. From your experience in the field of learning disability, what are the
common presentations which give rise to prescribing?
3. What factors do you feel influence the complexity ofprescribing?
4. What issues do you feel are important in relation to prescribing and
challenging behaviour?
5. Can you describe a case in which you felt "uncomfortable" about
prescribing?
Each interview took approximately thirty to forty minutes to conduct. All nine
interviews were recorded in full with the permission of all participants. Prior
to completion of the interview, while still being recorded, consultants were
asked if there were any ·other" issues which they felt were of importance to
the study. This was an open-ended question designed to give consultants
the freedom to raise any issues they felt were of significance or which they
may have forgotten to mention earlier in the interview. Most consultants in
the study raised novel topics or re-iterated some of the significant points
made earlier in the interview. Once the interview was completed, the
recording device was stopped and each consultant was thanked for his or
her contribution to the study and complete confidentiality was assured. In
general an informal conversation then arose regarding the research prior to
the departure of the author. Completed Prescribing Checklists were
collected by the author at this point.
11.7 Some Ethical Considerations.
Part Two of this thesis has a number of ethical considerations, which are of
importance when taking the f",dings of this thesis into consideration. These
ethical considerations may be seen as primary and secondary ethical
dilemmas faced. Each will be discussed in tum.
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Primary ethical considerations take into consideration the highly sensitive
topic being researched - in this case prescribing for persons with learning
disability. The participants in Part Two of this thesis were Consultant
Psychiatrists within the field of learning disability. Throughout the interview
they gave the author in-depth information about their prescribing practices,
their own viewpoints on aspects of their work and most importantly they
discussed individual cases where they were prescribing medication. These
areas are highly sensitive and warrant extreme confidentiality. The following
primary ethical procedures were put in place, both prior to the study
commencing and upon its completion.
• Prior to the study commencing, each consultant was ensured complete
confidentiality - both in terms of their own identity and also regarding the
identity of any cases discussed.
• The Learning Disability Section of the Royal College of Psychiatrists was
aware that the study was taking place, and broadly what the aims of the
study were.
• Prior to each consultant being involved in the study, they were informed
in full what the study involved (completion of Prescribing Checklists and
an interview). Each consultant was informed by means of written letter
and telephone conversation.
• Consultants were informed in advance that the interviews would be
recorded in full and then transcribed by means of computer.
• Regarding participation in the study, due to its sensitive nature, each
consultant made his or her own decision to participate or not. A
collective decision from the Learning Disability Section was not sought
(despite some consultants wishes for this approach to be used).
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• Upon completion of Prescribing Checklists, each consultant was asked
not to send any information by post. All Prescribing Checklists were
collected by the author in person upon completion of each interview.
• Once each interview was completed, it was transcribed within a two-
week period. Once fully transcribed, each individual tape of the interview
was destroyed. Consultants were made aware of the fact that tapes
would be destroyed upon transcribing. The author was the sole person
which undertook all parts of the study (including transcription). At no
point was secretarial support sought.
• Upon completion of each interview, the consultants were given full
contact details for the author's place of work. This included address,
phone and fax numbers and e-mail address, for the purposes of
contacting the author if any queries regarding the study arose.
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CHAPTER TWELVE
DATA ANALYSIS, PRESENTATION AND
DISCUSSION
12.1 Core Issues Analysed and Discussed.
For the purposes of the present chapter, the author will display the core topics
analysed in conjunction with a discussion of the issues raised by each. While
many authors present their analyses and discussion independently, it was felt by
the author that presenting data analyses and discussion together would make for
8 far more coherent overview of the topic under research. It also served to avoid
8n overlap of issues to be analysed and discussed.
As can be seen from Chapter ten, there were five core issues under study in Part
Two of this thesis. These core issues were as follows, and the present chapter
will adhere to the order of presentation as outlined below:
1. Criticsllncidents of Psychotropic Prescribing.
2. Common Presentations which give rise to prescribing.
3. Factors influencing the complexity ofprescribing.
4. Links between prescribing and challenging behaviour.
5. Uncomfortable prescribing decisions.
For each core issue under study, line-by-line coding took place followed by
focused coding. In terms of data presentation in the present chapter, the author
will attempt to provide as coherent a perspective as possible for each core issue,
given that throughout the analysis a certain degree of overlap is present. This
overlap represented participants raising similar issues in different stages of the
interview, each being of relevance to the particular core issue under discussion.
In order to decrease this possible overlap, the author will attempt to analyse and
present the core issue giving line by line cores where appropriate in conjunction
With focused codes followed by direct quotes from participants. Data presented
and analysed in this manner follows logically the technique of Grounded Theory
(Glaser &Strauss, 1967). Finally where relevant the author has generated
conceptual models of prescribing which have been "grounded" in the interview
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material. Such models are of importance in that they provide the reader with a
diagrammatic overview of how prescribing takes place in terms of the prescribing
practices of the consultants under study.
12.2 Critical Incidents of Prescribing.
For the purposes of this section the author will provide the reader with a series of
tables (tables 12.1.1 to 12.1.7) which present an overview of the critical incidents
of prescribing collected from consultants upon completion of the Prescribing
Checklists. There were three main topics of interest gathered from these critical
incidents. These related to service user demographic information (age, gender,
level of learning disability and living environment), presenting symptoms which
played a part in prescribing (medical/physical symptoms, behavioural symptoms
and situational factors), and finally resulting medication prescribed (main drug
category prescribed (anxiolytic, antipsychotic etc). Despite no critical incidents of
prescribing for children being given, such incidents of prescribing represented the
core issue under investigation - prescribing for adults with learning disability. As
can be seen from the Medication Prescribing Checklist (Appendix B), prescribers
had the opportunity to record information pertaining to children's cases. However
none were collected and it avoided the issue of accounting for developmental
level in the broader realm of prescribing. However information was gathered
from some prescribers throughout the interview on issues pertaining to
prescribing for children. Such issues will be discussed later in the chapter. In
addition it must be noted that not all prescribers completed prescribing checklists
and so the present section is based on a total of twenty-two critical incidents
gathered from seven consultants.
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Table 12.1.1 Critical incidents of prescribing gathered from Dr. A.
Demographic Information Presenting Symptoms I
Case Gender Age LO Living Medical/ Behav. Sit.! Meds.
Range Envir. Physical Other Prescribed
1 Male 18-30 Sev Comm
-
4,8,
-
Anxiolytic
Other Antipsychotic
2 Male 31-40 Sev Res
-
4 2 Anxiolytic
Antipsychotic
Antidepressant
Table 12.1.2 Critical incidents of prescribing gathered from Dr. B.
Demographic Information Presenting Symptoms I
Case Gender Age LO Living Medical/ Behav. Sit.! Meds.
Range Envir. Physical Other Prescribed
3 Male 41-50 Sev Res
-
1,3,8 2 Antipsychotic
anticonvulsant
4 Male 31-40 Mod Res 6 3,8 - Anticonvulsant
(x2)
5 Female 51-60 Mild Comm. - 3,5 - Antipsychotic
Antidepressant
6 Male 31-40 Sev Res
-
1,3,
- Antipsychotic
other (x2)
7 Female 18-30 Mod Comm 6 1,2,3, - Anticonvulsant
other (x2)
Table 12.1.3 Critical incidents of prescribing gathered from Dr. D.
Demographic Information Presenting Symptoms I
-Case Gender Age LO Living Medical/ Behav. Sit.! Meds.
Range Envir. Physical Other Prescribed
8 Female 18-30 Mild Home - Other - Antipsychotic
9 Female 31-40 Mod Comm - 5,6, - Antipsychotic
Other Antidepressant
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Table 12.1.4 Critical incidents of prescribing gathered from Dr. E.
Demographic Information Presenting Symptoms
Case Gender Age LD Living Medical/ Behav. Sit.l Meds.
Ranae Envir. Physical Other Prescribed
10 Male 18-30 Sev Res 2,6 1,2,3, 3 antipsychotic
4,8,9
11 Female 31-40 Sev Res 4 1,2,3, 4 anxiolytic
4,6,8,9
12 Female 31-40 Mod Res 2,8 1,4 1,4 Anxiolytic
Antipsychotic
13 Male 41-50 Mod Res 2,6,9 5,6,9 - anxiolytic
antidepressant
14 Male 41-50 Sev Res 7,8,9 4,8
-
Anxiolytic
Antipsychotic
Table 12.1.5 Critical Incidents of prescribing gathered from Dr. F.
Demographic Information Presenting Symptoms
Case Gender Age LD Living Medical/ Behav. Sit.l Meds.
Range Envir. Physical Other Prescribed
15 Female 31-40 Sev Res 6 1,3,4, 2 Antipsychotic
other Antidepressant
16 Male 31-40 Sev Res 9 1,2,8,9, 2 Anxiolytic
other Antipsychotic
Anticonvulsant
Table 12.1.6 Critical Incidents of prescribing gathered from Dr. G.
Demographic Information Presenting Symptoms I
I-
Case Gender Age LD Living Medical/ Behav. Sit.l Meds.
Ranae Envir. Physical Other Prescribed
17 Male 31-40 Mod Home - 1,6 1 Antipsychotic
18 Male 41-50 Mod Res 5 1,3 3 Antipsychotic
19 Male 18-30 Sev Res - 3,4,5 2 Antipsychotic
Antidepressant
I-.. Anticonvulsant
20 Male 31-40 Mild Res 5 3,6, 1 Anxiolytic
I-.. Other
21 Male 18-30 Mod Comm
-
3,6,8, Other Antidepressant
.... Other Stimulant
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Table 12.1.7 Critical Incidents of prescribing gathered from Dr. H.
Demographic Information Presenting Symptoms I
Case Gender Age LD Living Medical/ Behav. Sit.! Meds.
Range Envir. Physical Other Prescribed
22 Female 31-40 Mod Home
-
Other
-
Antipsychotic
Legend for Tables 12.1.1 to 12.1.7 (categories as per prescribing checklist
In Appendix B).
Medical/Phvsical Legend Behavioural Legend Situational/ Legend
.~onditions Other
Viral infection 1 Hitting/kicking 1 Recent change 1
I-. staff/peers of environment
Respiratory 2 Damage to property 2 Shortage/change 2
J!!.sorder of staff
Sexual disorder 3 Screaming/shouting 3 Medication 3
requested by
I-... staff
I Pain disorder 4 Self-injurious 4 Client 4
""-- behaviour expectation
Cardiovascular 5 Depression 5
J!J!order
Neurological 6 Anxiety 6
~rder
Skin disorder 7 Withdrawal 7
Allergic disorder 8 HystericaUhyperactive 8
! Gastrointestinal 9 Sleep problems 9
,diSorder
i Nutritional disorder 10
Not only did the Prescribing Checklist serve to gather critical incidents of
prescribing for persons with learning disability, it also served as a tool for
consultants in answering question one of the interview schedule, which related to
a recent case of prescribing where medication was issued. When answering this
initial question, consultants were asked to refer to the completed checklists and
give an overview of a recent case, which resulted in prescribing. Textbox 12.1
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below gives an example of one consultant talking about a recent case, which
resulted in a prescription.
Textbox 12.1 Extract from one consultants interview (Dr. A) regarding
question 1: Can you describe a recent case in which
you prescribed medication for a person with learning
disability.
Dr. A: Right, one of the cases which I would have been prescribing for quite
recently was somebody who was a male adult, who is functioning in the severe
range of learning disability and his problem would have been self-injurious
behaviour. He would have been tried already over a number of years on
behaviour modification methods, and this had been unsuccessful. So he was
actually on a combination of antipsychotic and anxiolytic drugs, and he was
noted to be drowsy by staff so the last time I reviewed him I reduced his drugs.
He has benefited from the reduction in terms of his drowsiness but his self-
injurious behaviour has not changed.
For the purposes of the above quotation, which related to question one a total of
six line-by-line codes were generated, which resulted in two focused codes being
employed. Textbox 12.2 below will give an example of the interview extract, the
line-by-line codes employed and finally the focused codes, which emerged from
the data. From this point onwards, the author, only where relevant will give
examples of line-by-line codes as the number of line by line codes per interview
ranged from a minimum of sixty-eight to one hundred and ten codes. For the
purposes of the present analysis, a detailed analysis of all line by line codes
Would be far too time consuming and would be far beyond the scope of the
present research project. Rather, the author will examine in detail focused codes
Which emerged from the data and discuss these in detail. Due to the sensitive
nature of the topic under discussion, prescribers only gave permission for the
author to quote from their interviews in the present chapter. However they did
not Wish for their interviews (in full) to be cited or included in the appendices as it
may identify the prescriber in question. Hence, they are not included in the
appendices of this thesis.
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Textbox 12.2 Extract taken from Dr. A's interview including line by
line coding and resulting focused coding which emerged.
Interview Transcript Line-by-line coding Focused coding
Dr. A: Right, one of the cases
which I would have been Demographic data
prescribing for quite recently preceding "diagnosis"
was somebody who was a male
adult, who is functioning in the
severe range of learning Problem area Identifieddisability and his problem would
have been self-injurious
behaviour. He would have been Failure of behavioural
tried already over a number of approach resulting in
years on behaviour modification prescribing
methods, and this had been
unsuccessful. So he was
actually on a combination of Polypharmacy being
antipsychotic and anxiolytic routinely prescribed
drugs, and he was noted to be Reduction In drugs due
Drug reduction
drowsy by staff so the last time I relating to side
reviewed him I reduced his to side effects effects not
drugs. He has benefited from Reduction benefiting condition
the reduction in terms of his side effects but not
drowsiness but his self-injurious behaviour
behaviour has not changed.
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The focused codes, which emerged above are solely related to the extract
taken from the interview. It depicts how line-by-line codes emerge from
the data itself and how in tum broader categories emerge. At all times the
author is striving for codes which are readily apparent in the data and not
simply placing "labels" or pre-defined criteria on the interview material.
The next step in the analysis of the first core issue is to examine all the
focused codes, which emerged from interview material pertaining to the
critical incidents of prescribing.
Table 12.2 Core Issue 1: recent case in which you prescribed
medication (critical incidents of prescribing) - Emergent
Focused Codes & Categories.
Core Issue 1: Recent case in which you prescribed medication
Emergent Focused Codes:
1. Demographic data impacting prescribing
2. Constant striving for a diagnostic label
3. Prescribing rationalized by presence of a "diagnostic label"
12.2.1 Demographic Data impacting prescribing
Despite demographic data being included as a heading and section in the
Medication Prescribing Checklist, all eight consultants made reference to
the level of learning disability when discussing recent cases of
prescribing. Upon transcribing, analysing and coding the interview
material, the author felt that consultants tended to find the presence of a
label such as "severe learning disability" a useful aid in prescribing. It
tended to give prescribers a free hand to prescribe at will, just because
there was a label present. It is interesting to note that from Table 12.1
above almost all cases of prescribing recorded were for service users
within the moderate to severe level of learning disability. Only two cases
out of the twenty-four were of mild learning disability. In this respect
prescribers made note during the interview that the majority of their
service users had a severe or profound level of learning disability and that
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this in itself made them more susceptible to conditions such as
challenging or disturbed behaviour.
One prescriber (Dr E.) at the very outset of the interview, prior to
discussing any case makes the following statement:
Dr E: Well most of our residents here are within the severe to profound level of
learning disability and over 60% have an overlying behavioural or psychotic
condition so that there is a high degree of co-morbidity. So most patients I
would prescribe for would have been disturbed - by that I would mean that they
would be disturbed by means of a condition manifesting itself like self injurious
behaviour or externally directed aggression or hyperactive purposeless
behaviour, disruptive behaviour or they may have had a mood disorder,
hypomanic disorder or they may of had a depression - an overlying depression
or they may have had an overlying psychotic disorder such as schizophrenia or
whatever.
The prescriber in this respect is setting the scene for the author in that he
goes on to discuss a number of cases where he prescribes on the basis
of purely behavioural indicators, while constantly making reference to
"diagnostic labels" such as "psychosis", "manic disorder". He describes
one of his cases as follows: .
Dr E: Now the first person - she is a female, between 18 and 30 years of age,
severely learning disabled and residential. An associated respiratory disorder-
asthma, neurological disorder - epilepsy and skin disorder - he had schoriasis.
The behavioural aspect was really - I ticked off hitting and kicking staff or peers,
damage to property, screaming and shouting, self-injurious behaviour,
hyperactive and skin problems.
The resulting medication, which is prescribed, in this case is an
Antipsychotic and she is put on both a routine dose while also being
prescribed a pm dose.
One female prescriber makes reference to level of learning disability as a
means of trying to apply a diagnostic label. She makes note that a
service user is in the mild range of learning disability (although not sure)
and due to this fact she is verbal and can talk about her condition.
Dr H: Well she would have actually thought that people were talking about her
and it was while she was preparing for her 21 st birthday- that was really it, she
felt that others were talking about her. She said that they are laughing at me.
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Now it wasn't me that took the original case - there was no agitation, she had
also said that somebody put poison or drugs into her food, so that was another
thing and she said that people in the centre were trying to harm her and were
talking about her, and that was the first time that it came on acutely, and it has
responded and she is an articulate lady and she is probably low mild.
In this respect from the evidence produced, prescribers constantly make
reference to level of learning disability while making decisions about
whether or not to prescribe. This may work in a positive fashion if the
person is within the upper ranges of learning disability, however if they are
in the lower ranges and are non-verbal, this certainly does have an impact
on prescribing.
12.2.2 Constant striving for a diagnostic label
This is a key issue within the present thesis as all prescribers in the study
constantly make reference to a "diagnostic label" prior to issuing a
prescription. In a sense it can be said from reviewing all interview
transcripts that there is a striving to find a diagnostic label for the
purposes of rationalizing the treatment method employed. This not only
relates to the issuing of a psychotropic drug but it also relates to non-
pharmacological approaches. The author will now give some typical
examples:
Dr B: Lets see, it would be a male in his 30's, with moderate learning disability,
presenting with a long history of hyperactivity and intermittent aggression
towards objects and screaming and shouting. His learning disability is of
unknown origin and he also has some physical problems for which he is on
gastrointestinal drugs.
In the example above the prescriber makes reference to two labels -
hyperactivity and intermittent aggression. Further on in the interview the
prescriber further elaborates on the issue of hyperactivity and how it
relates to prescribing and the management of this service user:
Dr B: It takes a lot ofstaff input because he is on the move all the time,
especially around mealtimes and that's the time when he can be destructive at
objects and to things around him and he is also at risk himseff from a tea
drinking point of view as he will take a pot of hot tea and try and drink it if he
could get the chance. Am, we have looked at him in various paradigms of
mental illness because he seemed to have some characteristics of manic illness
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but really when one goes back to his history he seems to have a constitutional
hyperactivity. He would have a broad diagnosis ofpervasive developmental
disorder and the management problem is due to his hyperactivity and the
aggression is secondary to his hyperactivity [J He is on major tranquillizer and
that really hasn't made a great deal of difference to him. We have tried him on
mood stabilizers, sodium Valproate, we tried him on lithium, and once again that
hasn't made a great deal of difference to him. That's about it, we're
contemplating what we should do next and I suppose looking at the literature
there is some evidence that Nalporoxone which is an opiate blocking agent may
be helpful in children with pervasive developmental disorder and hyperactivity so
we're just reviewing his health from the point of view of trying that.
As will be further elaborated on in the next section, the presence of a
diagnostic label in itself seems to justify the prescription of psychotropic
medication. Note how the "paradigm of mental illness" is now drawn into
the interview in conjunction with pervasive developmental disorder.
Another male prescriber who discusses a male service user with
hallucinations and delusions again discusses the paradigm of mental
illness. The author notes once again the emphasis on the use of labels
and the need for a diagnosis:
Dr G: Am this next one is a middle aged man, he would be in his mid thirties and
he is again, in fact he is within the mild range, low mild range of learning
disability. He is on the medical side of things, he would have a minor cardiac
problem, but it doesn't require any interventions - medication wise. On his
behaviours, I would have ticked screaming and shouting, and anxiety. But the
most prominent symptoms that he has in fact are, he has delusions and
hallucinations. He has fixed delusions about people getting at him basically, and
hallucinations - he would hear voices in his head on an ongoing basis.
This prescriber again places emphasis on the notion of behavioural
indicators pointing to the presence of an underlying psychopathology.
Interestingly the prescriber goes on to note that medication has not been
effective in this clients but it is used in order to control the symptoms:
Dr G: , have known him over the years and' have had him on various
medications and the diagnosis here would be schizophrenia. We don t - he has
never responded to them (the medications) very well. So the medication has
been more to control his symptoms for the moment rather than treating, well we
certainly have not successfully treated his direct delusions and hallucinations.
Despite pharmacological interventions not being effective, the prescriber
makes reference to the presence of hallucinations and delusions in
conjunction with anxiety as a means of later justifying his prescribing.
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The following case discussed with a female prescriber (Dr H) makes
reference to a number of labels and conditions for which the prescriber
seems unsure of what exactly is going on. She makes reference to
numerous "diagnostic labels" without any apparent justification or
presenting evidence.
Dr H: ... but the problem was that she was very anxious, she was ill at ease in
her mental state. She had low mood, she was crying, she was irritable, her
energy was up but her sleep was down and they felt that it was coming on over
the last year and there was a query about auditory hallucinations.
From this extract one can see again the constant striving for a diagnostic
label. If a label does not seem to be forthcoming, all possibilities are
thrown out in an attempt to find a suitable diagnosis. In such cases
prescribers made reference to the complexities of some conditions in
which it was difficult to apply a label readily. In this respect it could be
said to be and "either-or" type of diagnosis. Signifying uncertainty on the
part of the prescriber.
Dr H: I have written here query schizo-affective ... [ J ... So this is a lady who
either has a very severe depression that is psychotic but she wasn't actually
saying anything, and she was laughing so you would wonder if she is
schizoaffective. So she is on both and I was quite happy that she was
depressed, and there is a family history ofschizoaffective, both schizophrenia
and affective disorder.
12.2.3 Prescribing rationalized by presence of a diagnostic label.
As can be seen from the above section, prescribers in a sense "have a
need" to find a diagnostic label that they can place on a cluster of
behaviours. We can see this occurring in everyday practice whereby
classification systems such as DSM-IV and ICD-10 are in constant use
and aid in the process of labelling. Interestingly however, throughout all
eight interviews no r~ferencewas made to any form of psychometric tool
in aiding diagnosis. A possible explanation of this could be accounted for
by the fact that the consultants under study felt themselves to be "experts-
in the area of diagnosis and thus did not rely on psychometric aids.
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Once a diagnosis had been placed on the client, it seemed to serve as a
justification for the resultant prescribing. In this respect, if I place a
diagnosis of depression on this person, I have then rationalized my
method of treatment in that I will prescribe an antidepressant. A number
of examples of this can be seen from each of the interviews conducted.
Dr A: The second case I think is quite similar. { J ... Again it is someone who
has lived here for quite a long time and he is in his late thirties and he actually
was self injuring also. He has quite significant self-injury - he is blind and there
is an obsessional quality to it and he was on a drug that has an anti-obsessional
characteristic to it and is also an antidepressant.
In this example the prescriber has placed a diagnosis of self-injurious
behaviour on the client. The rationale behind pharmacological treatment
is in terms of firstly the diagnosis made (self-injury) and secondly in order
to further rationalize the treatment, the drug prescribed has "anti-
obsessional" properties in conjunction with being an antidepressant. In
this respect the prescriber feels she has rationalized fully the prescribing
of this psychotropic drug for the clients condition.
In the case of the male with hallucinations and delusions discussed
above, again the rationale for his pharmacological treatment lies in the
diagnostic label applied to him. The prescriber rationalizes the treatment
regime as follows:
Dr G: I Just put here delusions and hallucinations are ongoing, he would be
anxious as a result of these delusions and then at times, he would respond to
these voices by screaming and shouting as well as threatening. { J The most
recent change ofmedication has been more as an anxiolytic medication which Is
Diazepam which he was on 5mgs three times a day, but I decreased it to 4mgs
three times a day. {J He is on a variety of different medications for his
psychosis - he is on Clopixol 400mgs weekly, he is on Respiridol 4mgs twice 8
day, so he on a lot of neuroleptic medication. And then in addition to that he is
on Prozac 20mgs and Cogentin for the possible side effects from the
neuroleptics.
Not only does the prescriber rationalize the issuing of a change in this
mans anxiolytic medication but he also rationalizes the administration of
mUltiple drugs (polypharmacy) through the presence of labels such as
psychosis, hallucinations and delusions and the severity of his agitated
behaviour.
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Other examples include the diagnosis of obsessional-compulsive disorder
and depression in a woman with Downs Syndrome. Again the prescriber
(Dr D) rationalizes the treatment in terms of the underlying diagnostic
label.
Dr 0: [ J ... her presenting behaviour would have been some obsessional-
obsessive compulsive behaviour. That was really what it was and I felt it was
secondary to depression because in the past she had been depressed and she
has had sleep disturbance and appetite disturbance with it. On this occasion
she had the Obsessive-compulsive behaviour without those. So I prescribed
Seroxat (Piroxetene [prescriber unsure of the drugs chemical name}) - it doesn't
really matter. It is an antidepressant - an SSRI.
Finally on the issue of prescribing being rationalized by the presence of a
diagnostic label, one prescriber (Dr H) clearly states the importance of
finding a diagnosis and relating this to treatment. She states:
Dr H: [ J ... literature would say that you cannot diagnose schizophrenia in an IQ
of less than 50. but you can pick up signs that suggest that the person is
hallucinating. Or they may come out with something very strange which would
suggest that they are deluded about something and in that case, if there does
not appear to be any affective component - if they are eating well, if they are
sleeping well, they are still interested in things despite, as long as these other
strange things do not interfere, I would put a diagnosis ofschizophrenia on them
and give them a trial of antipsychotic.
Likewise in the case of "depression", the prescriber (Dr C) notes the
importance of the behavioural indicators leading to a diagnosis, which in
tum rationalizes the prescribing of an antidepressant. Note the added
complexity of patients who are elderly and who may be diagnosed with
depression. This issue will be discussed later in the chapter.
Dr C: Then if there is, depending on how able the person is, if there is clear
signs that they are depressed, in other words, if there is a loss of interest in
things, if there is a loss of weight, or increase in weight, less sleeping or
increased sleeping, and general crying or they have basically lost interest in
things, or they have slowed down or whatever. Again depending on their profile,
if they are very elderly, and again you have to rule out organic in all of this. You
presume that they have been checked over physically and that there is nothing
physical wrong with them, that is the first step in making a diagnosis. And then
in that case you are probably talking about a depression.
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12.2.4 Concluding Remarks regarding Critical Incidents of
Prescribing - Formulation of a Conceptual Framework of
Prescribing.
Although only twenty-two critical incidents of prescribing were collected in
the present study, they generated quite a number of issues regarding
prescribing for persons with learning disability. The first section of the
current chapter has been devoted to examining the initial criteria used to
both formulate a diagnosis which in tum formulates or justifies the
treatment rationale. It was difficult to discuss the emergent categories
within this section as they essentially were somewhat derived from
predefined criteria set out in the Medication Prescribing Checklist.
Despite predefined criteria existing in the checklist, the author feels that
rich and useful data was gathered by means of completed checklists in
conjunction with interview material based on the checklists. Hence from
this analysis, three core categories of interest emerged - how
demographic data impacts on prescribing, constant striving for a
diagnostic label on the part of prescribers and then in tum how prescribing
is rationalized by presence of a diagnostic label. Each has been
discussed in tum with relevant examples taken from interviews.
What has emerged from a discussion of these categories is a conceptual
framework outlining part of the rationale behind the prescribing of
psychotropic medication. However these three core categories only give
us partial evidence into the decision-making processes of consultant
psychiatrists in learning disability. A number of other factors come into
being, many of which are yet to be discussed in the present chapter. With
this in mind it is possible to generate an initial conceptual framework
which gives us an understanding of prescribing in its broadest context.
What were presented in Tables 12.1.1-12.1.7 above are actual cases of
prescribing taken from a typical five day period. In this sense they are
"real world" examples of prescribing and the factors which were taken into
consideration when these prescriptions were being made. The
conceptual framework outlined below provides a diagrammatic
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representation of the core categories in conjunction with other factors of
interest (to be discussed at a later point in the chapter).
Figure 12.1 Generation of an Initial Conceptual Framework of
Prescribing Including core categories and other factors
of Interest.
Core Categories:
Demographic
Data being
influential
Constant striving
for a diagnostic
label
Impact of staff
perceptions &
reports on
diagnostic label
Issuing of a
prescription
being
rationalized by
presence of a
diagnostic label
As can be seen from this initial framework many factors impact on the
core categories which can lead to substantial changes in prescribing. For
example as will be discussed in the sections that follow, reliance on third
part information from direct-care staff may indeed have an impact on the
diagnostic label, which is placed upon the individual. The issue of
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placement is a factor, which is significant in terms of prescribing as the
findings from Part One of this thesis have shown. Hence if a service user
is in residential care, they have a greater probability of being placed on
psychotropic medication than do those service users in community
facilities. Finally the other factor of importance included within this
framework is the issue of dangerousness or distress caused by the
individual. This factor although not discussed in the present section was
raised by a number of consultants due to its impact on prescribing. It will
be discussed in the next section of the present chapter devoted to
examining common presentations, which give rise to prescribing.
12.3 Common Presentations which Give rise to Prescribing.
The next core issue to be analysed and discussed relates to common
presentations which give rise to prescribing. Whereas the first core issue
was solely related to the prescribers practice and involved real wortd
cases which resulted in prescribing, the following core issues were largely
theoretical and the author was attempting to gain an understanding of the
other complex factors that are involved in prescribing decision-making.
The present section builds upon the issues discussed in the first sections
of this chapter. Prescribers still made reference to the three categories
mentioned above and throughout there was still the sense that at all times
prescribers were either striving for a diagnosis and once this was obtained
prescribing was rationalized and justified according to the diagnostic label
placed upon the person. The author will now discuss the core categories
which have emerged from interview material relating to this second
section.
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Table12.3 Core Issue 2: Common Presentations which give rise to
prescribing - Emergent Focused Codes and Categories.
Core Issue 2: Common Presentations which give rise to Prescribing.
Emergent Focused Codes & Categories.
1. Psychiatric Diagnosis
2. Challenging behaviour/behaviour problems
3. Prescribing based on dangerousness & level of distress •
"theory to practice hypothesis of prescribing"
4. Diagnosis based on third party reports
12.3.1 Psychiatric Diagnosis.
This core category follows on from the issues raised in the first section of
the present chapter. In this respect all consultants asked this question
dUring the interview brought up issues pertaining to "psychiatric diagnosis"
or "an underlying psychiatric diagnosis". On the basis of this, it helped to
further strengthen the prescriber's rationale for issuing a prescription.
Hence if I have a diagnostic label then this justifies my resultant
prescribing.
It is interesting to note that almost all the prescribers involved in the
present study were very clear-cut in answering this question. They felt it
was an "either-or" situation. Two prescribers make reference to this
immediately once the question is asked:
Dr D: but I mean really if you are talking about the formal mental illness which is
schizophrenia or affective disorder or this disturbed behaviour - these are the
main ones.
Dr G: I think they come into two main categories - those with clear obvious
psychiatric illness (which I mentioned above) - maybe like schizophrenia, wh61'8
the person is clearly psychotic and where they may be depressed. The other
group would be those with more or coming under the term challenging
behaviour.
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Either the person had a psychiatric diagnosis or a behaviour
disturbance. As will be discussed in the latter part of this section, many
consultants felt that the term "psychiatric diagnosis" was a broad term
used to incorporate the issue of challenging behaviour. Hence some
prescribers saw the challenging behaviour itself as a psychiatric
diagnosis.
Specifically on the issue of psychiatric diagnosis, the service user
generally presents with signs of "problematic behaviour", which
immediately result in prescribers attempting to find a diagnostic label. An
example of this is given below.
Dr C: /t's rare that someone starts with disturbed behaviour and If they do then
you are really looking for a diagnosis. Usually it can be a depression or it can be
a psychosis
Within this example, the prescriber is saying that essentially she feels if
someone is presenting with disturbed behaviour, then there must be an
underlying psychiatric condition. Hence the striving to find an appropriate
diagnostic label as again outlined below.
Dr E: I suppose I would also prescribe for adults who would have a bi-polar
disorder, and who have a schizophrenic illness.
One prescriber makes reference to the historical perspectives of
prescribing for the leaming disabled population. Again this prescriber
(female) makes use of labels and attempts to justify prescribing from a
historical perspective where perhaps "someone got it (the diagnosis)
wrong" and thus this accounts for the high frequency of prescribing of
Antipsychotics.
Dr B: One of the difficulties with the learning disabled population is when they
present with behaviour problems it is not always easy to identify the psychiatric
disorder if there is one. I think that is a big problem and I think that is why a
number ofpeople in the past were prescribed Antipsychotics and then left on
them and then people assumed that they had a schizophrenic illness or
something and then kept them on the medication.
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Finally on the issue of psychiatric diagnosis, one prescriber goes on to
relate psychiatric diagnosis to the underlying brain damage that the
person with learning disability has. In this respect, the perspective of the
prescriber is very biological in nature relating any conditions to the
underlying brain injury, which may not be an accurate reflection of the
cause of a condition. In addition he makes reference to the need for more
secure environments while also relating the condition (or diagnosis) to the
prescribing or "need for more medication".
Dr B: And also I think there will be a few people who are going to present with
extreme behavioural problems who will need medication and more secure
environments, the same as there are in our general population. nmay be a
higher amount because of the amount of brain damage. We do know that most
things like personality disorders, psychosis are related to brain damage and so
are obviously a complication of brain damage, by virtue of the fact that is why
they are here.
MEMO BOX 12.1 - THE AUTHORS THOUGHTS ON PSYCHIATRIC
DIAGNOSIS.
Quite clearly the consultants feel that challenging behaviour falls under
the umbrella of "psychiatric diagnosis". My reasons for stating this are
two-fold. Firstly although they clearly define the two categories, they
devote far less to a discussion of psychiatric diagnosis per se, than they
do to challenging behaviour. At all times they refer to the difficulties
associated with finding this diagnosis - although they do label, they do so
from the point of view of behavioural indicators - it's like the clustering
effect. Just because this number of behaviours are present, I will label
the persons as being [ ]. Secondly, they tend to refer to the complexities
in finding this diagnosis, things like the person being non-verbal or the
behaviours being difficult to classify. Its as though they see the person as
having challenging behaviour, but this disruptive behaviour just points to a
psychiatric diagnosis. The interview material makes for really interesting
listening - on one hand there are two categories for which medication is
prescribed but really when it comes to it, there is only one - challenging
behaviour. The use of labels in a sense helps to justify this. I will further
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analyse this later in the section when I refer to the "theory to practice"
hypothesis" of prescribing, which will involve other complex issues.
The next core issue to be analysed and discussed is the issue of
challenging behaviour as a common presentation which gives rise to
prescribing.
12.3.2 Challenging Behaviour/behaviour problems.
As mentioned above in the Memo box, the author felt that although
prescribers felt psychiatric diagnosis was a common presentation which
gave rise to prescribing, essentially challenging behaviour or behaviour
problems are the most common reason why psychotropic medication is
being prescribed. Prescribers tended to "gloss over" the issue of
psychiatric diagnosis and certainly they did not discuss it as frequently as
the issue of challenging behaviour. Although the present section, devoted
to the discussion of the core category of challenging behaviour/behaviour
problems a range of terms were used to describe it. Prescribers tended
to primarily use the term challenging behaviour or behaviour problems,
but terms such as difficult behaviour, problematic behaviour and
behaviour that challenges the system were also used. The present
section will analyse and discuss the findings obtained relating to this core
category.
At the outset one prescriber makes reference to the historical perspective
where people with learning disability were prescribed medication purely
for the purposes of challenging behaviour, and how he feels things have
changed (in respect of the "underlying condition") more recentty on this
issue.
Dr B: I think historically, and as we know, people with learning disability tended
to get put on major tranquillizers for aggression and aggression in inverted
commas. I think what we're now hopefully taking a more in-depth look at why
People are presenting with behavioural problems and the assessment looks at
what's causing it and hopefully determining what's causing it with medication
rather than treating it with just signs that are presenting.
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As an aside to this analysis, although still forming part of it is the issue of
the terminology used by different prescribers. Note above the use of the
term "major tranquillizer". Essentially this term has since. been replaced
with the term antipsychotic, which the majority of prescribers used
throughout the interview. It is interesting to note however that some
prescribers still refer to the older terminology, despite such terminology
being out of date.
On the positive side of things, the above prescriber makes reference to
attempting to ascertain what is causing the challenging behaviour. This is
positive in that he does not believe in treating symptoms, but it may mean
that again he is striving to find a diagnostic label, which will rationalize the
resultant prescribing behaviour.
Again another prescriber (Dr A) talks about prescribing psychotropic
medication for those who either have challenging behaviour which may be
part of a psychiatric diagnosis or for those who she feels do not have a
psychiatric diagnosis. In this respect she states:
Dr A: The second group then' suppose where psychotropic medication may be
used is probably in the whole area of managing behaviour difficulties. Now that
can be two groups - that can be where there can be an association with a
psychiatric illness anyway, and you are talking about acute management there.
And then there is the other group who have different features of behaviour which
is seen as challenging. And it really dePends on what that is for the individual.
Again we see the relationship between challenging behaviour and
psychiatric diagnosis once more. At this point it seems as if prescribers
tend to have two classification systems in their own heads - those
persons with learning disability who have challenging behaviour which
may be associated with a psychiatric diagnosis and those for which a
relationship between psychiatric diagnosis is poorly understood. This
classification framework would tie in with the earlier discussion on "striving
for a diagnostic label" in that prescribers are more comfortable prescribing
psychotropic medication where a diagnostic label does exist, whereas if
the relationship between challenging behaviour and psychiatric is poorly
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understood and thus a label is not placed on the person, this results in
some discomfort for the prescriber. In this respect the author terms it the
'heory to practice" hypothesis of prescribing whereby in theory
prescribers are not happy prescribing just for "purely" challenging
behaviour, but in practice they do prescribe for challenging behaviour.
This will be discussed in the next section.
Other prescribers make reference to challenging behaviour as a common
reason for prescribing as follows, emphasizing the difficulties
encountered.
Dr A: Self-injurious behaviour is a hard one to call at times, as to whether it does
reflect an underlying psychiatric condition, or with any of the behaviours, I
suppose it's hard.
The extract taken from an interview outlined below clearly outlines that
this prescriber (male) prescribes medication solely in terms of challenging
behaviour - based on its dangerousness.
Dr 0: The other group would be those with more or coming under the term
challenging behaviour, severe behaviour disorder where it is not clear why the
person is behaviour like they are but what is definite is that they are a danger to
themselves or to others and there would be a significant number ofpeople that I
see where medication and I would have to choose medication in those
circumstances.
The same prescriber outlines that at times he comes away "unhappy"
when he has to prescribe for challenging behaviour in the absence of an
underlying psychiatric diagnosis, while to conclude he rationalizes the
prescribing in terms of it seeming beneficial.
Dr 0: Sometimes with the challenging behaviour group it is difficult to know Is
there an underlying condition - in one of the cases that I mentioned, the man
had severe autistic disturbed behaviour, he was depressed and he was injuring
himself and the medication did seem to have some benefits - he did gain some
benefits from it. There is a bit of trial and e"or but I would say that even in some
cases where there is no obvious psychiatric diagnosis, you don't come away
particularly happy but whether it is their agitation or they are acting out
behaviours, you are treating maybe the symptoms, rather than an illness as
such. And it seems to benefd them.
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Finally one female prescriber (Dr A) classifies behavioural problems a.
being the primary or most common reason for her prescribing, in
particular self-injurious behaviour. Note the issue of dangerousness or
distress being influential in terms of prescribing, although it is not clearly
stated here.
Dr A: I suppose the commonest would be behavioural problems and they would
be in the residential population here. Aggressive behaviour be it self inflicted -
self-injurious behaviour or towards other staff members. I think that would
probably be the main one.
Finally on this issue a male prescriber (Dr E) again makes reference to
challenging behaviour (primarily self-injurious behaviour) as being a
common presentation which results in prescribing. Not only does this
prescriber mention self-injurious behaviour per se, but he also makes
reference to the behaviour as a being a manifestation of a possible
underlying condition, further emphasizing the points made earlier.
Dr E: Well now speaking for this place here, the most common problems which
give rise to prescribing are really disturbed behaviour - be it self directed or
externally directed. These are the two most common and they seem to be very
prevalent. And there is a high degree of co-morbidity and it manifests itself as
disturbed behaviour.
To conclude the present section it is interesting to note the interaction-
effect between the concepts of psychiatric diagnosis and challenging
behaviour. Where the challenging behaviour may be related to a
psychiatric diagnosis, it again tends to justify the prescribing behaviour,
whereas if the challenging behaviour is not viewed within the "paradigm of
mental illness", it tends to leave prescribers feeling unhappy about issuing
a prescription, largely due to the absence of a label other than
·challenging behaviour".
12.3.3 Prescribing based on dangerousness & level of distress •
"theory to practice hypothesis of prescribing"
It was largely due to the preceding core category "challenging behaviour"
than the present core category emerged. From the discussion above, it
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can be seen that prescribers routinely prescribe for challenging behaviour,
even in the absence of an underlying psychiatric diagnosis. However not
only is the presence of the label of challenging behaviour of significance,
it is strongly related to the type of challenging behaviour displayed by the
individual and most importantly it is related to the dangerousness (for the
individual or for other individuals) or level of distress displayed by the
individual. The present section will elaborate on these issues further.
The prescriber below clearly outlines his rationale for putting a service
user on medication - it is because the person has challenging behaviour
which is of such significance that they are a danger to themselves or to
others. Hence the emphasis on level of dangerousness displayed.
Dr G: [ J ... but what is definite is that they are a danger to themselves or to
others and there would be a significant number of people that I see where
medication and I would have to choose medication in those circumstances. In
some cases you require a fairly small dose of the medication, maybe you need
vel}' little, but it can be just enough to work to help.
The extract taken from the prescribers interview below, outlines part of
her decision-making process in terms of balancing the risk between
prescribing and not prescribing, resulting in injury to either the service
user or those around him.
Dr A: Balancing that with the risk to the individual and to others around them, so
I look at it in terms of are they going to injure themselves, whether they show
aggression towards objects, or aggression towards others, in the context of the
level of learning disability that they have and what their environment is.
Within this extract the prescriber also makes reference to the importance
of environmental factors within the process of prescribing. She goes on to
state a number of interesting points in relation to the environment and
other factors discussed already such as placement within the services
and level of learning disability.
Dr C: The environment can playa huge part. The individuals we look after do
not choose to live with who they live with if they are particularly disabled, when
they are a little bit less disabled, they are more likely to explain to people that
they don't like a or b, those that are sharing the house with them and they may
move, particularly in a community setting. But certainly in the residential setting,
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where people are more disabled, its harder for them to make choices and some
individuals are stronger willed than others and make their feelings known, maybe
by being aggressive. So you have to take that into account and in saying that,
medications may be used.
The issue of service users being non-verbal or their lack of ability to
communicate will be further discussed under core issue number 3 -
factors affecting the complexity of prescribing.
The issue of level of dangerousness, be it internal or external is further
emphasized by another prescriber below. She states (and I extract three
distinct quotes from her interview material):
Dr 0: So with regard to factors which influence my prescribing certainly I think
the degree of distress the actual patient is in and the actual staff are
experiencing as a result of the behaviour problems as well. I do feel influenced
by staff's responses to behaviour and what they feedback to me.
The following quote introduces the prescribers "sense of responsibility"
into the prescribing equation, in that if a person is injured or the client is
self-injuring, the prescriber feels a sense of responsibility in conjunction
with the "need to do something". These are clearly stated as influential
factors in prescribing. _
Dr 0: But I would say that with regard to challenging behaviour as I may have
said earlier, { J... injuring a staff would be one of the reasons that I would
prescribe - injury to another staff member, or self-injury - those two. I see these
as factors which would definitely influence me to prescribe.
Dr 0: So I think I do feel responsible when, I have a sense of responsibility for
staff and for patients when injury comes into it. The level ofdangerousness is
the key here - dangerousness.
From the evidence produced to date, one can see a type of
transformation occurring in respect to the common presentations which
give rise to prescribing. In the opening pages of this chapter, the author
discusses the prescribers constant striving for a diagnostic label in order
to rationalize prescribing. In this respect prescribers were attempting to
keep within the realm of objectivity and scientific practice. If they were
able to diagnose a particular condition and place a label on a service user
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because they were presenting with a number of symptoms which pointed
to a diagnosis, then in a sense this was rational and objective and was
well within the realm of the medical model.
However what the author has just presented here is evidence to the
contrary grounded in what prescribers themselves have said. In essence
for a number of prescribers one of the key issues in whether they are to
prescribe or not is the issue of level of dangerousness displayed by the
person - be this internally directed aggression (SIB) or externally directed
aggression towards others. The author terms this the 'heory to practice
hypothesis of prescribing", where two differing perspectives emerge,
those of a theoretical nature and those relating to practice. Rather than
discussing these issues in the current section, the author will provide
some further evidence throughout other sections of the present chapter
relating to other core categories and further discuss them in the
concluding section of the present chapter.
12.3.4 Diagnosis based on third party reports
From reviewing Chapters two and three of the present thesis, one can see
that due to the many difficulties associated with the learning disabled
population, quite frequently diagnosis are formed around third party
information. The major problem with diagnoses being based on third
party information is that very often the information received is inaccurate
and unreliable. The present section sought to examine these issues in
relation to prescribers involved in the present study.
From the material analysed and discussed to date in the present chapter,
there is an emphasis on diagnosis in an attempt to rationalize prescribing.
In respect of diagnoses being formed however, prescribers in the present
stUdy clearly outline the subjective elements associated from basing
diagnoses on third party reports, while also outlining that their diagnostic
labels formed were reliant on these third party reports. One prescriber (Dr
A) states:
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Dr A: Issues around the complexity of diagnosing mental health problems can be
a complexity - you are very reliant on an historian at times and the best
historians are often family. But sometimes it can take somebody else outside the
family to recognize something, certainly in the community attendees.
She further elaborates on this point, emphasizing the role of the primary
carer in aiding the diagnostic process, when the service user is unable to
report on how they are feeling.
Dr A: You are very reliant depending on their ability level on the people that care
for them to give you the information, apart from members of the clinical team
which might be involved. And if you are dealing with the community, you have to
link in very much with primary carer.
The following prescriber (Dr F) places emphasis on the role of the carer in
observing any changes in their behaviour in conjunction with offering
information to the prescriber about the pattern of behaviour observed by
the carer.
Dr F: You are relying on knowing the people quite well or talking with people who
know them quite well, who see another change in how they actually are.
Dr F: Getting information from third party reports is very helpful and it is usually
very genuine. Ideally if the staff know the person very well, then that's the
important thing - if they have known them over time, so they know them well
enough to actually see a change.
Although this prescriber is noting that information received from direct
carers is genuine, she does not question whether or not the information
obtained is accurate and reliable. In this respect the formation of a
diagnosis may be based on inaccurate information.
One prescriber takes the information from staff as being reliable and
bases her diagnosis of depression largely based on the fact that staff
have said this lady is depressed
Dr F: but from reports from staff, they are mainly saying that she is depressed.
Interestingly one female prescriber (Dr H) makes a strong statement
about the issue under study and feels that if the client is non-verbal and
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unable to tell the prescriber how she is feeling, then it is a very imprecise
science.
Dr H: [ ] .. .we use the interview and the very person we need to interview we
cant. So it is a/l speculation unless the person is mild and has good articulation
and comprehension. Other than that if they are non-verbal or if they are poor
verbal abilities, it is all speculation and conjecture. You are dependent on the
carers telling you and that is imprecise and very difficult.
Interestingly this prescriber feels that diagnoses based on third party
information are quite imprecise. If she is unsure of a diagnosis she
makes reference to giving a trial of a drug and if there is no improvement
she will cease to prescribe this drug.
Dr H: I see them [staff reports] as being imprecise, and as I keep saying I give 8
trial ofsomething and if it doesnY work... [ ] ... So I am very very cautious
about it because I actually like to actually give a drug and know why I am giving
it, and know that there is an improvement, and if there is no improvement, there
is no point.
Most prescribers however do not seem to be as cautious in taking third
party reports from staff for granted. Likewise they acknowledge the
difficulties associated with diagnosis when clients are non-verbal and rely
on nursing reports in conjunction with their own observations.
Dr F: It is hard to diagnose when the person cannot communicate clearly and a
lot of the time a lot of them - the patients cannot verbalize, but they will- it's a
matter of monitoring their behaviour pattern and trying to decide as best you can
from nursing reports plus your own observations and what exactly is the whole
problem, ifyou can get to that. And then prescribe as appropriate you know.
Finally one prescriber (Dr C) makes note that direct-care staff are the
-best observers" of clients behaviours and she values the
information/observations received from staff. An extract emphasizing this
point is taken from her interview.
Dr C: Well somebody who looks depressed, that is the first thing and staffare
the best monitor of this because they will tell you about this - someone is not
sleeping well- maybe a first sign, maybe they are not interested if they are in 8
workshop, they are not interested in television, like a general lack of interest -
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only on a more difficult scale than an ordinary person who can tell you I'm this,
this and this ... It is observation on the part ofstaff mainly.
12.3.5 Concluding Remarks regarding common presentations which
give rise to prescribing
To conclude this section, one can see the issues that prescribers feel are
common presentations which give rise to prescribing. Although
prescribers themselves feel these can be generated into two distinct
categories - psychiatric diagnosis and challenging behaviour, there is
more going on that just the presence or striving for a diagnosis. While
prescribers do strive to find an appropriate diagnostic label in order to
justify their prescribing, evidence points to the fact that the diagnoses
made are most certainly over-reliant on information received from third
party reports. Although some prescribers make reference to observing
nurses reports and undertaking their own observations, such observations
commonly take place within the consultation session and not within the
person's real-world or "home" environment (be this in a residential or
community house).
The fact that most prescribers in the study made reference to
dangerousness and level of distress as the key factor which influenced
their decision to prescribe raises some caution. Not only do prescribers
base their decision to prescribe on dangerousness or distress, but also
this is most often conveyed to them by means of staff reports. Quite
clearly what one staff may consider or perceive as dangerous behaviour
may be perceived completely differently by another staff member. Hence
justifying prescribing based on what staff report to the prescriber is a
dangerous practice and is subject to numerous ethical considerations. As
one prescriber (Dr C) has stated in relation to getting a different picture
from different staff:
Dr C: ... [ J Maybe getting one story from one staff and another story from
another would make it very difficult for as until you know the staff awfully we"
and you can balance that up between the two of them, it is very difficult. You get
two different pictures.
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As a result of the present discussion, prescribing from the perspective of
the prescribers themselves is very often a trial and error process and is
SUbject to a wide range of elements outside those of a strictly
pharmacological nature.
12.4 Factors Influencing the Complexity of Prescribing.
Factors influencing the complexity of prescribing was the third core issue
of interest in Part Two of this thesis. Although what has been presented
to date in the current chapter has included many of the complex issues in
prescribing as outlined by prescribers themselves, this section focuses on
the specific issues which prescribers felt were complex in relation to
psychotropic prescribing. Even though quite a number of issues emerged
as complexities, these were categorized into four main categories which
will now be analysed and discussed.
Table 12.4 Core Issue 3: Factors influencing the Complexity of
Prescribing - Emergent focused codes and categories.
Core Issue 3: Factors Influencing the complexity of prescribing.
Emergent Focused Codes a Categories.
1. Whether or not to prescribe psychotropic medication - a trial
a error approach.
2. Drug profile & side effects - the risk benefit ratio.
3. Ruling out physical/underlying causes.
4. Expectation element on the part of others (staff a family) - the
magic bullet.
12.4.1 Whether or not to prescribe psychotropic medication - a trial
a error approach.
In the last section the author makes reference to the "theory to practice
hypothesis of prescribing", where in theory prescribers were saying they
were unhappy prescribing for challenging behaviour but in practice they
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were actively prescribing for challenging behaviour where there was no
presence of an underlying "psychiatric diagnosis". The present section is
somewhat similar in that prescribers feel the process of prescribing rather
than being an objective science is more to do with trial and error, hoping
that the prescription will be of some benefit to the client. A number of
prescribers make reference to this "trial and error approach" to
prescribing.
Dr G: Well there is always the complexity ofdeciding whether it is worth while
putting somebody on medication or not and a lot of the time it is a trial and error
approach and for instance I saw someone recently and she was ADHD I felt this
was the diagnosis with her, but the use of Ritalin for her did not have any
benefits for her.
In this case the prescriber is again guided by the fact that a diagnosis of
Attention Deficit Disorder with Hyperactivity is present. Although he does
not state whether this is a child or adult, children are frequently prescribed
Ritalin for the purposes of controlling ADHD, but in this case it has proved
of little benefit. He goes on to further this point by stating.
Dr G: And then you are looking at, what in any other medication would be of
benefit for her, so there is the complexity of which medication to use sometimes
- should you use that or should you use major tranquil/izers or antidepressants -
SSRl's may sometimes be beneficial. So on the diagnosis it can be varied as to
what medications might be beneficial
Many other prescribers have the same perspectives regarding the trial
and error approach to prescribing and how this in itself can lead to
discomfort in prescribing.
Dr 0: There is a bit of trial and error but I would say that even in some cases
where there is no obvious psychiatric diagnosis, you don't come away
particularly happy.
The prescriber below (Dr D) makes reference to using or "trying" multiple
drugs in an attempt to find the one of most benefit. In these cases it is the
prescribing of a series of medications which can lead to polypharmacy, if
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the initial drug is not withdrawn upon commencement of the add-on
medications.
Dr D: I suppose in a number ofcases here, you are often trying a whole series d
different medications and that can be hard particularly for the families and for
staff.
On the issue of medication being ineffective for some conditions, one
prescriber reiterates this point in relation to prescribing for self-injurious
behaviour, noting the complexity of the length of time it may take to
withdraw medication.
Dr D: ... let me see, well for severe se" injury I mean sometimes medication Is
ineffective anyway, so you make the decision sometimes that you just dont use
it, you might try it but you don t keep people on it, because it doesn t work but it
takes a while to take People off it. Sometimes that can take a while as well,
years in some cases.
As was mentioned above, prescribing multiple medications in an attempt
to ascertain which is most effective or beneficial may increase the
likelihood that polyphannacy will result. This is a common cause of
concern for those clients with epilepsy and a number of prescribers make
reference to epilepsy as a complex condition in prescribing. One
prescriber makes reference to epilepsy as a 'riple handicap" - epilepsy in
association with the presence of a dual diagnosis. The prescriber outlines
the difficulties which emerge when prescribing for the person with
epilepsy.
Dr G: [ J I have mentioned brain damage, which leading on to that of course /s
that a lot of the patients I see have more that a dual diagnosis, they have a triple
diagnosis in that they have epilepsy as well. So that leads to complexities in
several ways. One is the epilepsy will affect mood and behaviour, Secondly the
epileptic drugs will affect mood and behaviour and thirdly the drugs that we use
to treat anxiety, depression, mania will also affect the epileptic. So you can get
into a cycle ofone thing leading to another .••
Specifically on the issue of whether or not to prescribe, a female
prescriber (Dr D) states in one of her critical incidents that she has
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increased a dosage of Lamictal (an anticonvulsant) in an attempt to see if
the increased dosage will "make a difference".
I increased his Lamictal. He had been on 75mg twice a day and I increased that
to 100mg in the morning and then 75mg in the evening because he is having
continuous seizures so I want to get him up to 100mgs just to see if that will
make a difference.
Another female prescriber (Dr C) makes reference to getting two varying
reports from staff and how this can lead to a trail and error approach,
resulting in this prescriber relying on her own judgement of whether to
commence medication or not and a "hoping for the besr type of
approach.
Dr C: [ J ... but it does hapPen and you would kind of wonder should I walt
another fortnight before medication or does this person really need it, so you go
by your own judgement at the end regardless and just hoPe for the best that you
are right.
Finally on this point another female prescriber (Dr H) makes reference to
medication being a "muddle" as people with learning disability are tried on
numerous medications without any awareness of which one is of benefit.
Dr H: Again you try them with the neuroleptics, now more recently people have
started using Lamictal, and the use the antiepileptics like Valproate and Tegretol
and they are thrown in, [J ... SO it is a muddle as far as I am concerned -
medication.
In this respect prescribers feel that not only is the decision to prescribe
imprecise and largely a trial and error approach, but once prescribers
have initiated psychotropic prescribing, the choice of drug and dosage
may change in a purely ad hoc manner in an attempt to see if the
medication is being of benefit. This is indeed a complexity. The following
section will examine further the issue of drug profile and side effects as a
continuing complexity.
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MEMO BOX 12.2 - FROM OBJECTIVITY TO SUBJECTIVITY .. ~
Now I feel we are really getting down to basics. The first two core issues
were a little difficult to analyse in that prescribers were being very
theoretical. I form a diagnosis and I treat. Simple as that. However now
that the questions have become a little more abstract and prescribers feel
they have a "therapeutic alliance" with the author, they are opening up.
The fact alone that they are telling a Psychologist that prescribing is
difficult, not always scientific and based on conjecture tells a picture in
itself. There is no doubt but the data being gathered is extremely rich and
novel. At the start I didn't feel they were going to open up this much.
Long may it continue.
12.4.2 Drug Profile & side effects - risk-benefit ratio.
This section relates to the more pharmacological aspects of prescribing.
Now that prescribers have made the decision to prescribe a number of
issues emerge which relate to the core category of drug profile & side
effects - risk-benefit ratio. This core issue is far more grounded in the
pharmacological aspects of prescribing than some of the other core
categories which have been discussed but they still raise quite a number
of interesting factors.
One male prescriber (Dr G) during the interview speaks of the limitations
of prescribing certain psychotropic medications due to their profile and the
severe consequences which may follow if the medication is not reviewed
properly.
Dr G: ... [ J ... side effect profile - one has to be vety careful to see especially
with medications such as Lithium, where there is a certain level that you tty to
attain and do not go any higher because it can be vety dangerous, could result
in death.
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This prescriber goes on to mention the complexity of clients who are non-
verbal not being able to communicate how they are tolerating their
medication.
Dr G: Yes, I think one of the difficulties in prescribing for the severely mentally
handicapped is their inability to firstly tell you how they are tolerating their
medication [and] ... If they cannot communicate the side effects, if they are
suffering side effects, then I would rather not prescribe that particular
medication. So that's one of the complexities.
The complexity of drug profile is a difficulty not only if the person is non-
verbal but also if they are verbal, the client may not be able to tell the
prescriber how they are feeling or if how they are feeling is related to the
medication prescribed. Another prescriber makes reference to the
difficulty of persons with learning disability tolerating their psychotropic
medication and urges caution when she herself is prescribing.
Dr F: I suppose just one thing to mention I think Is the fact that people with
learning disability who are being prescribed psychotropic medications they tend
to be more sensitive to the adverse side effects and so on and what it means
really is that it takes quite a bit of time and attention because of that and to be
aware of that. That their tolerance is not as good as others and they are more
inclined to have idiosyncratic reactions to them. They are more vulnerable to
medications really so its really important to look at it hard.
One prescriber (Dr H) makes note of a recent case (prior to her being
appointed to the service) which resulted in death, which the prescriber felt
was related to medication.
Dr H: And the other thing of course is that definitely was an influential factor Is
that there was a death - now thankfully it was before I came but it was in or
around the time that I took over. And they were all scared witless that it was due
to the drug and it probably was, but that is neither here nor there. It was
inconclusive and the lady died, a young woman, and as you know with all the
neuroleptics, major tranquillizers, they slow the heart, they are dangerous drugs.
This prescriber goes on to talk about the issue of "tweaking" medication -
upping the dose and decreasing the dose when clients are on
polypharmacy. This prescriber is quite unhappy with polypharmacy and
the expectation from staff was that she was going to continue this
practice. Due to drug profile, her own expectations and the increased risk
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associated with this practice, the prescriber was reluctant to engage in
this practice.
Dr H: ... and the expectation was that I would do what my predecessor would
have done and that was to tweak the medication, but they are already on
polypharmacy, so in other words they have got more disturbed, quick we will
increase this or decrease.
Specifically on the issue of side effects, one prescriber (Dr D) makes note
of the complexity of side effects and their reduction with prescribing a low
dose of medication.
Dr 0: you have to always be aware in the case ofpeople with learning disability
that they are more prone one would have to say to the side effects of
medications, more so even than those who do not have a learning disability.
And so that is an important factor and I think certainly from my experience is that
you do always start with a low dose no matter what you are trying, you always
start like so, more so than you would in the general population. It is ofno use
getting to a high dose quicker, so you have to be patient with that and go for low
doses in the use of the medications.
It is interesting to note that this prescriber feels that initiating prescribing
on a low dosage regime is a seemingly good practice. What he does not
make reference to here is that although psychotropic medication may be
commenced at a low dosage, it rarely stays this way and invariably the
dosage increases.
Despite the problems and complexities encountered with drug profile and
side effects, almost all the prescribers in the present study made
reference to the newer drugs on the market being used in an atypical
fashion. Although many of these medications may have psychotropic
qualities associated with them, they are not licensed as psychotropic
medications per 88. Prescribers in the present study make reference to
using the newer anticonvulsants (Lamictal) for example in treating
conditions other than epilepsy.
Dr 0: ... or else you can hOPefully use some of the medications which are vital If
the person has never received those to treat other problems such as mood
disorder. And I think some of the newer epileptic drugs are showing a lot of
hoPe here.
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Another prescriber (Dr E)refers to the anticonvulsant Carbamazepine,
which he may use on occasions as a mood stabilizer where psychotropic
medication has been ineffective or not used due to side effects.
Dr E: Well we would use the mood stabilizing agents such as Carbamazepine -
It can be effective especially if there is mood swinging and It is bi-polar and we
would tend to use those but as I was saying there are times when they may
become acutely disturbed and Carbamazepine is for long term use - its not for
acute disturbance, its to level out the mood
Finally on the issue of drug profile, one female prescriber (Dr H) questions
the issue of drugs becoming "broader in their profile" in that drugs are not
become more selective, rather they are becoming broader and used for a
wider array of conditions, for which she feels some discomfort.
Dr H: Sure even if you start looking at the antidepressants, It muses me
personally that they started off the SSRl's saying they were so selective and that
was their forte. Now all of a sudden you have the SNRI or something - which
affects seratonin and noreadrenalin and because it includes noreadrenalin as
well, it's better than the SSRl's. so you are back to the full circle.
In respect to the core category of drug profile & side effects, the main
issue of concern for prescribers is the issue of persons with learning
disability having a poor ability to tolerate medication. The other source of
concern for prescribers is if clients are non-verbal, they are unable to
state how the medication is affecting them. Perhaps the greatest
complexity and difficulty for prescribers is the possible side effects of
medication on the people they prescribe for. Only two of the eight
prescribers made reference to death or very serious side effects such as
neuroleptic malignant syndrome as possible serious side effects. These
issues will again be discussed in the final section on uncomfortable
prescribing decisions.
12.4.3 Ruling out Physical/underlying causes
This was a core category which was of significance to almost all the
prescribers in the present study. Prior to prescribing, prescribers deemed
it as a necessity to rule out all possible physical and underlying causes.
Physical causes although not specifically stated related to issues such as
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Alzheimer's disease in elderly patients who prescribers felt may have
been depressed and underlying causes were typically related to the
presence of epilepsy, which may not have been picked up on. One
prescriber (Dr E) at the outset noted that one lady with learning disability
also had epilepsy and this was a significant variable in how this lady was
treated.
Dr E: She has organic brain damage secondary to meningitis and she also
suffers from epilepsy.
The extract taken from a female prescriber below (Dr C) makes reference
to ruling out physical causes as the first step in "diagnosis" as she states
for elderly patients in particular.
Dr C: Again dePending on their profile, if they are very elderly, and again you
have to rule out organic in all of this. You presume that they have been checked
over physically and that there is nothing physical wrong with them, that is the
first step in making a diagnosis.
One prescriber makes reference to ruling out physical or underlying
causes first but adds that there is an added complexity when prescribing
for these underlying or physical conditions.
Dr E: Other issues then would relate to individual cases where there might be
associated disabilities, they might be sensory impairments, when you are
prescribing any additional medications, it always causes a problem and also
physical disease and we would have a lot ofpeople with associated physical
disease, so prescribing of any extra drugs is always going to cause more
problems.
The prescriber below (Dr B) gives an example of a client with self-
injurious behaviour which is related to the underlying condition of an ear
or chest infection. Because the client is low functioning, he has no way of
communicating how he is feeling and so engages in self-injurious
behaviour. The prescriber notes that if he were to have "rushed in" with
medication, it would have been purely to treat the symptoms and not the
underlying condition. Getting the balance is important for this prescriber.
Dr 8: Another thing to is to always role out the physical cause if somebody
becomes this way. I have just seen a man there now who is self injurious and Is
very low functioning and his self injurious behaviour - nine out of ten times, it
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seems to be related to some kind ofear infection or chest problems or
something like that. He does not obviously take to discomfort well and so he self
injures, so the use of medication other than antibiotics would not be appropriate.
You have to, there is a danger of rushing in and using inappropriate medication.
So you have to balance it right and get the balance right.
In a similar fashion another prescriber (Dr E) makes reference to that
problem of lack of mobility for some persons with learning disability in
conjunction with physical illness and prescribing for these can have added
complexities.
Dr E: And then of course a lot of the people we have, have problems around
mobility and the presence of increased physical illness and thus medications on
top of these can cause behavioural problems.
Finally on this issue the prescriber below (Dr E) makes reference to the
association between physical illness and learning disability and a high
mortality rate amongst these persons. He sees this as a complexity in his
role as prescriber.
Dr E: ... we have one ward here which is for profoundly handicapped persons
and they are People who have an associated physical disabiHty such as
quadriplegia or it could be any physical disorder and most of them are vety vel}'
ill and they have a potentially high mortality rate.
MEMO BOX 12.3 -IMPORTANCE OF RULING OUT PHYSICAL &
UNDERLYING CONDITIONS PRIOR TO
PRESCRIBING.
Prior to moving on to the next section, I am glad that most prescribers in
the study place emphasis on ruling out physical causes prior to
prescribing. But on reflection, this would stem from their medical training.
It is interesting that most of the prescribers brought this issue up under
complexities - only one of the eight prescribers mentioned an underlying
physical cause when they spoke about recent cases of prescribing. It
could have been that physical causes were not an issue in these cases or
the alternative is that it is a case of "theory to practice" once again.
Prescribers may know that they should be looking for underlying causes
in theory but in practice this may not be the case. It warrants further
investigation .•••
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12.4.4 Expectation element on the part of others (staff & family).
Similar to the findings from General Practice, client and family
expectations played a large part in the process of prescribing in the
present study. All but two of the prescribers in the present thesis made
reference to client and/or family expectations, be these expectations or
pressure to prescribe or expectations that medication would not be
withdrawn. Each will be discussed in tum.
The majority of the eight prescribers felt pressure from families or
relatives to prescribe. Prescribers noted that families felt that prescribers
possessed a "magic bullet" and that prescribing would solve all of the
problems encountered by them. One prescriber (Dr B) notes this by
saying:
Dr B: families will be looking for an instant cure for something that would
respond better to a behavioural approach and it's vety hard to get them to
engage in a behavioural approach when they think ofa magic bullet. So it's a
matter of ttying to bring a balanced approach to the individual that you're treating
This prescriber also notes the opposite happening where families are very
much against the issue of psychotropic medication, despite the prescriber
outlining the rationale for medication use.
Dr B: The family issues around medication are huge because some families will
not hear of medication even when you try to show how their logical approach of
some one being on medication
On the contrary two prescribers felt that staff or family expectations did
not playa "major" role in the prescribing process. Interestingly these two
prescribers were male and had been prescribing for over twenty years.
Whether it was a matter that they themselves felt that they were not
pressured into prescribing by staff or families or whether they did not
attribute their prescribing on the basis of what staff said or observed is a
complexity yet to be further analysed. Interestingly however one of the
prescribers (Dr G) when discussing a recent case of prescribing noted
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that it was staff that brought the case to his attention and it resulted in
medication being prescribed. The extract below highlights this fact.
Dr G: The situational factors - medication specifically requested by staff
members - it was the staff who brought it to my attention. This is a recurrent
condition - this behavioural thing for that particular person. The resulting
medication prescribed was an antipsychotic
In this case the client was seen by the consultant based on the staff
bringing the case to his attention. The Mend-product" of this consultation
was that the person was prescribed an antipsychotic. Later on in the
interview the prescriber when asked about client, family or staff
expectations, feels that although expectations are present, they do not
represent Mnot a major problem". The text box below depicts an extract
from this prescribers interview.
Text Box 12.3 Extract from Prescribers Interview (Dr E) -
Expectations to Prescribe
Extract From Interview
R =Reporter R You mentioned there Dr. about a client expectation,
would you find that happens often ... from a client or
from family or staff ...
P =Prescriber P Oh yes, mentally handicapped people in the
(Dr E) community, the problem arises when they become
adolescent and when they become big and strong and
awkward and they go through that that phase and they
very commonly, they can become quite disturbed and
their parents cannot manage them because they are no
longer children and the parents cannot really cope with
them and you get requests for residential care or respite
care or in some extreme cases the GP would refer them
on, with the expectation that something would be
prescribed to ameliorate their behaviour.
R Would you see this as being quite 8 problem, these
expectations ...
P Ah not really, the matter ofprescribing would be up to
the consultant who see the person, obviously if there are
other strategies, then we don't prescribe we use what is
applicable, so its not really a majorproblem.
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In this case although the prescriber does not see pressure to prescribe as
a major problem, he still comes in contact with it and it may indeed have
an impact of his prescribing practice.
In a similar fashion, the other male prescriber mentioned above (Dr G)
does not see pressure or expectations to prescribe as influencing his
prescribing, rather he sees them as having an impact on containment of
those with challenging behaviour. He does mention the issue of staff
shortage in the wider context of treatment of persons with learning
disability.
Dr G: Oh yes, and particularly recently, and that seems to be country wide now.
We have a significant problem here with staff shortage and I don't think it has,
funnily enough, added to the problem. There is always the feeling if you do have
staff shortages, you find yourself using more medication to try and control or
manage situations. I don't think really that that has hapPened and I don't accept
that but there is always that worry that you are going to end up having to be
more containment and having to use that.
Rather than prescribing a routine dose of psychotropic medication, this
prescriber sees the use of PRN medications as being more effective.
Although in one sense he does not feel staff have an expectation of the
prescriber to prescribe but on the other hand by writing the client up for
PRN medication it is giving the staff leeway to prescribe in an ad hoc
basis as they see fit.
Dr G: The other side and something that comes to mind for me is that the use of
PRN medication is something that is very beneficial and to give the staff leeway
to give medication to somebody when required within a 24 hour Period to
manage his behaviour if they become difficult, rather than having to put the
person on ongoing medication. Sometimes we can put a number ofpeople on
this sort of medication and usually we put them on ongoing medication, but on a
PRNbasis.
If one looks to long term PRN medication as a prescribing practice in
itself, it may lead to staff becoming overly dependent on administering this
form of medication whenever things "begin to get rough". Staff
perceptions of when the client may need PRN medication will also vary
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considerably which invariably will lead to more frequent prescribing, often
without the knowledge of the prescriber themselves.
Finally the prescriber below (Dr D) describes how she feels both
influenced to prescribe by means of staff reports and how they "handle"
challenging behaviour within the residential setting, while in the
community settings, it tends to be family members that place pressure on
the prescriber.
Dr 0: I do feel influenced by staff's responses to behaviour and what they
feedback to me. In the residential population sometimes I feel there is pressure
to prescribe as well and it is not always easy to be scientific about it in those
situations. In the community it is usually family members
However this pressure comes not only to prescribe medication but also
not to withdraw medication in certain conditions.
Dr 0: but in fact my eXPerience has been that it is in withdrawing medication
tends to be the bigger problem in the learning disabled than prescribing itself.
The problem here tends to lie in the fact that it is not the withdrawal in
itself that is the problem, it is related to the possible negative impacts if
withdrawal is unsuccessful.
Dr 0: sometimes there are fears that they are going to get worse and one ofmy
rationale for withdrawing a drug is when their behaviour is no different on the
drug [ J... But there is a response then from staffor from the family, well ifyou
withdraw it, they are going to get worse.
This prescriber goes on to discuss a recent case where there was
resistance from staff and the GP to withdraw anticonwlsant medication.
The fear on the part on the family and the GP was that if the medication
was withdrawn or reduced, it would affect the clients' seizure frequency
and would result in a recurrence of seizures. As a result of this pressure,
the prescriber did not withdraw the medication.
Dr 0: staff have a lot ofproblems around that [anticonvulsant withdrawal] - they
have a lot of fears ofseizures recurring if you withdraw. I have someone in the
community at the moment who I am trying to withdraw, who I had planned to
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withdraw from, and I had huge resistance from staff, from the GP, so as a result,
they are still on the same. So it is an added complexity.
From the perspective of prescribers, staff and family expectations or
pressures to either prescribe or withdraw represent an added complexity
to the process. Most prescribers felt it was a complexity, although two
prescribers, while acknowledging its presence, did not feel it impacted on
their prescribing behaviours. Client expectations and pressures, to a
lesser degree have an impact on prescribing, that is for those who are
verbal and have an understanding of why they are being prescribed
medication.
12.4.5 Concluding remarks regarding factors influencing the
complexity of prescribing.
From the above sections presented, one can see that a number of
complexities have an impact on the prescribing behaviours of consultant
psychiatrists. These complexities have ranged from decisions regarding
whether they should prescribe or not, to more pharmacological
considerations of drug profile and risk benefit ratio of psychotropic
medication. In true "medical model" fashion, almost all prescribers felt
that physical or underlying conditions such as epilepsy very often put
prescribers in a dilemma and there is the need to rule out any physical
causes prior to prescribing. It was interesting in itself that this category
emerged as being a complexity due to many conditions having an organic
basis. Finally the issue of expectations and pressure to prescribe was
discussed. Prescribers presented numerous cases where they felt
pressured to either prescribe or not to withdraw medication. The issue of
withdrawal presented an interesting facet in that it tended to hinge on the
issue of epilepsy, which is seen by prescribers as being a complexity in
itself.
We will now tum out attention to the next core issue of interest - the links
between challenging behaviour and prescribing.
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12.5 Links between Prescribing and Challenging Behaviour.
Although the issue of challenging behaviour has been discussed in some
detail under the core issue of common presentations which give rise to
prescribing, all prescribers were asked their views on what they felt were
the links between challenging behaviour and prescribing. Many of the
core categories taken from the above sections also relate to the present
section. Hence prescribers feel that prescribing is ultimately based on the
level of distress displayed by the client plus the level of dangerousness
exhibited and the treat to others based on dangerousness. Prescribers
also feel that although they dislike prescribing for purely challenging
behaviour in the absence of a diagnostic label, this happens quite
frequently.
The main purpose of having such a question on the interview schedule as
"what do feel are the links between prescribing and challenging
behaviour" was to tease out any further issues that prescribers felt were of
significance in terms of challenging behaviour. Now that prescribers were
talking "openly" about issues such as prescribing being based on
speculation and prescribing being a trail and error approach, it was hoped
other issues of interest would emerge by asking such a question.
Prescribers in this instance still spoke about reliance on third party reports
in the formulation of a diagnostic label and on issues regarding
dangerousness and distress. However three new core categories did
emerge which were not spoken about prior to asking this question.
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Table 12.5 Core Issue 4: Links between Prescribing and
Challenging Behaviour - Emergent Focused Codes &
Categories.
Core Issue 4: Links between prescribing and challenging behaviour.
Emergent Focused Codes & Categories.
1. Global role of multi-disciplinary team In prescribing.
2. Theory to practice hypothesis of prescribing - prevention and
control.
3. Classification of challenging behaviour.
12.5.1 Global role of multl-disciplinary team In prescribing.
Most prescribers in the study made reference to the role of the multi-
disciplinary team. However the role of the multi-disciplinary team tended
to be in its broadest context and related more to the collection of clinical
information that it did to the actual process of prescribing. In this respect
the author has termed this core category "the global role of the multi-
disciplinary team".
One prescriber (Dr G) makes reference to the global role of the multi-
disciplinary team placing emphasis on the role of the nurse in dealing with
challenging behaviour. He notes that people tend to see the multi-
disciplinary team in its narrowest context and not take on board all those
members of the team.
Dr G: Yes I think that it is just crucial {the multi-disciplinary team] and we just
have to do it and it goes beyond that and when people talk about multi-
disciplinary teams too they can talk in a very narrow kind of way. By that I mean
that they talk about the psychiatrists, psychologists and social worker, but I think
that it should be much broader than that, particularly with the nurse. The nurse
Is well grounded and perhaps has the skills that one needs for interventions and
we need to bring them on board much more than we do - they can tend to stay
separate and I don't think that's good.
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This prescriber goes on to talk about the role of the multi-disciplinary team
in dealing with other issues and not just with challenging behaviour. He
believes it is not "an all or nothing approach".
Dr G: Well I just would repeat that I don't think that it is an all or nothing as - its
either medication or use of behavioural intervention for challenging behaviour. I
think that the combination is very important to use both in challenging behaviour
- you certainly don't use medication on its own. But I would even apply that to
not only challenging behaviour but to those with clear psychiatric illness as weN
and I think that often people have the view that just because someone has
depression or schizophrenia or manic depression that medication is just the
answer.
Another prescriber (Dr B) mentions the issue of having a "balanced
approach" in any treatment rationale for persons with learning disability.
Dr B: So It's a matter of trying to bring a balanced approach to the indMduai that
you're treating and a multidisciPlinary team approach as well to the situation.
This prescriber feels that the discipline of psychology undertaking a
functional analysis is similar to what the discipline of psychiatry
undertakes, in that both are looking for the underiying causes of the
behaviour as a rationale for treatment. Again this statement may signify
the prescribers striving for a diagnostic label as' a justification to prescribe.
Dr B: Well I think the kernel is a functional analysis - a proper psychologists
functional analysis is the very formulation, but I think what psychiatrists do is
related to the functional analysis and we are looking at what aspects of our area
ofexpertise are causing the challenging behaviour - the challenging behaviour
been seen as the sign ofsomething - like a pain in the head is the sigh of the flu
- thus challenging behaviour is the sign ofsomething and we need to try and
find out what it is.
It could be said that in the true sense of the medical model, this prescriber
is attempting to find a diagnostic label (perhaps under the paradigm of
mental illness), which will explain this clienfs behaviour. By a
psychologist undertaking a functional analysis, it serves as the collection
of clinical information so as to place a label on the client
Finally this prescriber states the authors assumption above and
rationalizes psychotropic medication where the challenging behaviour,
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which is now labelled in tenns of a mental illness, has not been
responsive to behavioural approaches, or which he feels will not be
responsive to a behavioural approach.
Dr B: So medication should be used in challenging behaviour if you can
delineate a reasonable reason for putting someone on medication - like there is
anxiety, depression mania or else if there is something which should be worked
on with a behavioural approach - maybe something is blocking it, so the person
is too anxious to respond to a behavioural approach.
In a similar fashion another prescriber (Dr E) makes reference to the
"supplementary notion" of medication, used in conjunction with
behavioural techniques.
Dr E: I think a lot ofbehavioural regimes which can be used for challenging
behaviour - we have psychologists and behaviour therapists here working with
challenging behaviour. Sometimes they may need a low dose ofsupplementary
medication while they are going through these behavioural therapies.
Other prescribers have made reference to the usefulness of the multi-
disciplinary team to the prescribers, the clients and the people caring for
those with challenging behaviour - hence its "global role".
Dr A: ... certainly for issues around challenging behaviour it is vel)' helpful to
work in the team. It's helpful for ourselves, its helpful for the client and its helpful
for carers because we generally try and talk out of their own hymn book, and
that's helpful too.
One prescriber (Dr F) talks of getting "tunnel vision" if one doesn't have
access and work with a multi-disciplinary team.
Dr F: I would I think it is terribly important because I think you can get tunnel
vision if you just work on your own and you may become dependent on just
drugs or if you are a psychologist may on behaviour therapy or something. But I
think a mix, I think a lot ofPeOple and a team effort is very good.
Finally to conclude this section on the global role of multi-disciplinary
teams, all prescribers in the study felt that a team approach was
necessary in assessing and treating persons with challenging behaviour.
However the multi-disciplinary team was not closely related to the process
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of prescribing, rather it tended to work in conjunction with prescribing of
psychotropic medication.
12.5.2 Theory to Practice Hypothesis of Prescribing - Prevention &
Control.
This next section covers the issue of the theory to practice hypothesis of
prescribing and how prescribers see psychotropic medication in terms of
either preventing challenging behaviour or trying to control it. Although
some prescribers are adamant that they do not like to prescribe for
challenging behaviour in the absence of an underlying psychiatric
condition, other prescribers are now saying that they prescribe
psychotropic medication as a means of prevention and control of
challenging behaviour. Hence in theory they say they do not prescribe for
challenging behaviour but in practice a different picture emerges.
. One prescriber (Dr H) clearly states that she does not like to prescribe for
challenging behaviour and feels that challenging behaviour should be
dealt with by means of behavioural techniques
Dr H: I don" like prescribing for challenging behaviour. "at all possible It should
be dealt with through trained staff and I think behaviour therapy is the answer
there.
On the issue of theory to practice, another female prescriber (Dr D)
makes reference to initially viewing challenging behaviour as being
treated by means of behavioural techniques, but then seeing the risks
involved begins to intervene and prescribe psychotropic medication based
on dangerousness of the behaviour displayed.
Dr D: I think when I came info learning disability { J... I very much took the view
that behavioural problems were to be managed and managed by behavioural
therapy and as time went on , begun to realize that it didn't always work and that
there were too many risks to be taken in terms of staff safety and clients safety
not to prescribe. But I would say that with regard to challenging behaviour as I
may have said earlier, , would look at other methods first ofdealing with it and
injuring a staff would be one of the reasons that I would prescribe - injury to
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another staff member, or self-injury - those two. I see these as factors which
would definitely influence me to prescribe.
On observing the above extract one can see how this prescriber's
perspective on challenging behaviour has changed since she has begun
to work with persons with learning disability. Her theoretical perspective
at one point was that challenging behaviour was treated by means of
behavioural techniques but once the element of dangerousness or injury
entered the equation, she felt responsible and thus began to prescribe on
this premise.
Another prescriber (Dr F) makes reference to the issue of the threat of
injury to others, and the difficulties in treating challenging behaviour where
there is no "underlying psychiatric condition". In such cases prescribing
may be complex and quite unclear.
Dr F: , think where cha11enging behaviour is a reflection ofan underlying
psychiatric condition, I think you are obviously treating the psychiatric condition
and that can be fairly clear. I think that people with learning disability, if they
have a psychiatric condition they deserve to be treated for it. I think where it is
more difficult is where the challenging behaviour doesn't obviously reflect a
psychiatric condition and yet the challenging behaviour in some way poses a
threat to the person with learning disability themselves or to others.
On the issue of the use of psychotropic medication as "preventative
method" and in calming the person, the above prescriber makes the
follOWing comments.
Dr F: With self-injurious behaviour, this is a sort ofdilemma you get caught into -
that you are really trying to prevent people from very often seriously injuring
themselves.
sometimes the level of the self-injurious behaviour is so compe11ing that you do
need to do something to just calm the person down to try and prevent it. I'm
thinking of one other man who is in that same group of houses who has a lot of
autistic features and his level ofself injurious behaviour can be so high at times
that in his own interest really you try and prevent it by using some kind of
sedative to calm him down.
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Finally one prescriber (Dr E) sees behavioural techniques as being very
effective in treating challenging behaviour and sees these techniques as
being used far more frequently than psychotropic medication.
Dr E: ... a lot of challenging behaviour here is, a great deal of it here ;s treated
by means ofbehavioural regimes rather than by psychotropic medication.
Interestingly prior to discussing his critical incidents of prescribing this
prescriber made the following statement regarding the frequency of his
psychotropic prescribing, stating:
Dr E: ... [ } .. .over 60% have an overlying behavioural or psychotic condition so
that there is a high degree of co-morbidity. So most patients I would prescribe
for would have been disturbed - by that I would mean that they would be
disturbed by means ofa condition manifesting itself like self-injurious behaviour
or externally directed aggression.
This prescriber then goes on to state that he feels it is best to try and
prevent challenging behaviour rather than using psychotropic medication
to control or "dampen down" the behaviour. Quite clearty these are
conflicting views on the part of the prescriber, and conflicting prescribing
practices also.
Dr E: Wen challenging behaviour in the long term it is better to try and prevent
challenging behaviour rather than using something to try and dampen it down •••
Finally on this issue one psychiatrist (Dr B), although he does prescribe
for "challenging behaviour" when there is an associated undertying
condition, feels that psychiatrists are called in at the last moment in order
to deal with a crisis and this in itself results in the prescribing of
psychotropic medication.
Dr B: Often, I think there has been a habit in Ireland and maybe the U.K of
psychiatrists being called in at the last moment, when things are really bad and
we have to do something whereas if the psychiatrists and the behaviour analysts
were together at the start - looking at an integrated approach. So you don't
really see that kind of thing happening. It should be but •..
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On this point the prescriber feels that a multi-disciplinary approach is
required well in advance of a crisis situation occurring, which in itself may
result in psychotropic medication being prescribed to a lesser degree.
To conclude the present section, prescribers in the study felt that although
there was a need to "prevent" challenging behaviour - this was their
theoretical perspective, in practice, prescribers were prescribing
psychotropic medication in order to control or suppress the behaviour. If
one looks to the literature regarding suppression of challenging behaviour,
this is a practice which is very much frowned upon in present-day practice
for persons with learning disability. We will now tum the focus of attention
to the last core category, which examines how a number of prescribers
have attempted to classify challenging behaviour.
12.5.3 Classification of Challenging Behaviour.
This was an interesting core· category to emerge as it related to the
prescribers views on challenging behaviour as being a "stand alone"
classification in itself - unrelated to psychiatric diagnosis or whether they
felt it was part of an underlying psychiatric diagnosis. Although the author
has referred to this issue in earlier sections of the present chapter, a
number of prescribers made reference to this issue when asked about the
links between challenging behaviour and prescribing.
All but one of the prescribers in the present study felt a strong association
between challenging behaviour and a psychiatric condition. Most often
prescribers felt that where a client was presenting with challenging
behaViour, it is in some way related to an underlying psychiatric condition.
The prescriber below (Dr F) makes reference to this.
Dr F: I think where challenging behaviour is a reflection ofan underlying
psychiatric condition, I think you are obviously treating the psychiatric condition
and that can be fairly clear. I think that people with learning disability, if they
have a psychiatric condition they deserve to be treated for it. I think where it is
more difficult is where the challenging behaviour doesnt obviously reflect a
psychiatric condition
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In this case the prescriber feels that where a psychiatric diagnosis exists it
results in a clearer approach toward prescribing, whereas if a psychiatric
diagnosis is not present or a label is difficult to determine, it results in a
level of discomfort or complexity for the prescriber.
The prescriber below (Dr G) sees the presence of challenging behaviour
as a symptom of an underlying condition and classifies it in this way.
Again prescribers are striving for a diagnosis and not examining the
behaviour and the function it may be serving.
Dr G: certainly in the area ofchallenging behaviour, it is behaviour, it is not an
Hlness, it's a symptom ofsomething, and that's the way I like to look at it.
On the difficulties of ascertaining the relationship between challenging
behaviour and psychiatric diagnosis, one prescriber, (Dr C) notes that it is
a difficUlty in that she feels a relationship exists but is not sure of what
diagnostic label to place on the condition.
Dr C: But it is a difficult area - there can be associations between challenging
behaviour and psychiatric disorders. It can be part of a depressive illness or it
can be part ofa schizophrenic iI/ness or a psychotic illness.
One prescriber (Dr H) who was quite outspoken on a number of points
raised the issue of the term "challenging behaviour" and how she dislikes
using this term. She also makes reference to psychiatry still dealing with
syndromes and how this is an imprecise science and the difficulties
associated with getting to the underlying condition.
Dr H: Challenging behaviour is not a diagnosis, al/ it is saying is that whatever
behaviour is presented it is a challenge to the system. [ J ... The other thing to
say is that in psychiatry we are dealing with syndromes, no other area of
medicine to my knowledge deals with syndromes, except genetics.
Dr H: We are still caught in psychiatry, well they present with - they're hearing
voices, but we don't know the origins and we are in a totally different ballgame
and I think that people think that some of the time we are in the same ball game
as our physician counterparts and that we can use medication as precisely.
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Finally on this issue, two distinct perspectives emerge from two
prescribers on the issue challenging behaviour and how it may be
classified or whether an association exists between challenging behaviour
and psychiatric diagnosis.
On the one hand one male prescriber (Dr G) feels that the presence of
challenging behaviour due to its impact on the individual and the service,
it should be viewed as a psychiatric diagnosis in itself due to the
intervention required in treating them.
Dr G: ... its hard to put a specific diagnosis down for them, in fact I would
consider them within the psychiatric diagnosis if they have a severe challenging
behaviour and they are requiring my attention on a regular basis. I would
include that under the psychiatric disorder in that they need intervention ofa
major nature. I mean I don't like the term challenging behaviour
In this case the prescriber feels that challenging behaviour should be
classified as a psychiatric disorder based on intervention required. It is
difficult to ascertain where such a viewpoint has emerged as many
persons with learning disability who do not have challenging behaviour
still require a substantial input in terms of time and staffing. This may be
associated with discomfort around prescribing for challenging behaviour
per se and the need for a label to be present in order to justify his
prescribing practice.
A totally opposing viewpoint is offered by a prescriber (Dr C) who feels
that challenging behaviour and psychiatric conditions are totally unrelated.
She feels that challenging behaviour should be treated by means of
strictly behavioural techniques and not by the use of psychotropic
medication. She also states that she feels it is rare to see a "psychotic·
condition in a person with learning disability.
Dr C: I feel behavioural disorders are not part of an underlying psychiatric
diagnosis. I think it is rare that you get it - a psychotic illness in people with
learning disability. Behaviour disturbance is largely behavioural and it can be
treated as such - without drugs or very little anyway.
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This perspective is in stark contrast to the views held by most prescribers
in the present study. Whereas most prescribers were striving to find an
appropriate label to place on the client and the majority of times this label
pointed towards a "psychosis" or "psychotic condition", this prescriber
feels that such instances of labelling a person as psychotic are rare. In
this respect she does not feel there is an association between challenging
behaviour and "psychosis" although earlier in the interview she made
reference to prescribing a range of psychotropic medication to persons
with learning disability, including the Antipsychotics.
Dr C: [ } ... yes you would use them here for vel}' disturbed people and that
could range from Melleril to I suppose Ativan maybe but that is only pre-med and
that would lead to Valium. I would use this to relax them.
From observing both these interview extracts we can see that although
this prescriber feels that challenging behaviour is not part of an underlying
psychiatric condition, she does prescribe the usual range of psychotropic
medication to the learning disabled population. Hence providing further
evidence for a theory to practice hypothesis of prescribing in itself.
12.5.4 Concluding remarks regarding links between
prescribing and challenging behaviour.
The core categories which emerged from this section proved useful in our
understanding of prescribing for persons with learning disability. On a
strictly theoretical perspective, many prescribers feel there is a sense of
inappropriateness about prescribing for challenging behaviour. In order to
distance themselves from inappropriate prescribing, most prescribers look
for an appropriate diagnostic label to place on the person, usually from
the paradigm of mental illness. If such an "appropriate label" can be
foUnd, then the sense of inappropriate prescribing is no longer in
existence and the resulting prescribing seems rational and appropriate.
What the current core categories and evidence have shown is that there
are many times when prescribers fail to place a diagnostic label on some
clients with challenging behaviour and thus prescribers in such instances
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are prescribing purely for the purposes of controlling or suppressing the
behaviour in an attempt to alleviate injury and dangerousness, be it self
directed or externally directed.
12.8 Uncomfortable Prescribing Decisions.
The final core issue under study relates to uncomfortable prescribing
decisions that were discussed during the interview. Prescribers made
reference to a number of dilemmas which resulted in "discomfort" when
issuing a prescription or prior to prescribing during consultations. Broader
theoretical issues also emerged. For the purposes of the present analysis
and discussion, the author will refer to the four core categories, which
emerged throughout analysis.
Table12.8 Core Issue 5: Uncomfortable Prescribing Decisions -
Emergent Focused Codes and Categories.
Core Issue 5: Uncomfortable Prescribing Decisions.
Emergent Focused Codes & Categories.
1. Discomfort arising from side effects and drug profile -
polypharmacy.
2. Crisis intervention & resource implications.
3. Expectation/pressure element on the part of others.
4. Issues of consent.
12.8.1 Discomfort arising from side effects and drug profile -
polypharmacy.
Not only were drug profile and side effects significant issues in terms of
factors influencing the complexity of prescribing, these issues also
emerged as core categories within the present section. Prescribers felt
discomfort around issues such as side effects of particular medications
and how those clients prescribed such medication would tolerate same.
Drug profile was also a consideration as in some cases due to the
unwanted side effects of particular medications (in particular some
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Antipsychotics), certain medications could not be prescribed and so an
alternative psychotropic medication was required. One prescriber in
particular (Dr E) makes reference to this issue in terms of neuroleptic
malignant syndrome and how this caused discomfort on his part.
Dr E: Yes, I'm trying to think. Yes one comes to mind - two in fact come to
mind. Two people who developed neuroleptic malignant syndrome and as you
know it's a syndrome where you cannot prescribe phenothiazines or you cannot
prescribe the major neuroleptics, which would include the phenothiazines. That
poses a problem if that person who develops neuroleptic malignant syndrome,
it's a side effect, it's a sensitivity reaction to a major neuroleptic, and its lifelong,
it doesn't always but can remit but the danger is when you recommence
neuroleptics, you are always afraid that they will redevelop it as it is a life
threatening illness and people have died from it and they can go into renal
failure, cardiovascular problems - it's a hazardous condition.
In this case the prescriber has a sense of discomfort, which has arisen
from the side effects of particular medication. It places the prescriber in a
dilemma in that this condition has emerged from prescribing neuroleptic
medication and if he were to recommence such medication it could have
serious implications for the individuals.
This in tum has the "knock-on" implication for these individuals in that it
places the prescriber in the difficult situation of deciding which medication
is suitable (other than the neuroleptics for example) for the individual. In
this case it resulted in the prescriber prescribing the anticonvulsant
Carbamazepine, largely based on the psychotropic properties of this drug.
As a practice, although the prescriber was in somewhat of a dilemma, it
must be questioned on ethical grounds, as this drug although it has
psychotropic properties it is not routinely prescribed where neuroleptic
medication is not warranted.
Dr E: Well we would use the mood stabilizing agents such as Carbamazepine -
it can be effective especially if there is mood swinging and it is bi-polar and we
would tend to use those but as I was saying there are times when they may
become acutely disturbed and Carbamazepine is for long-term use.
Most prescribers throughout the interview made reference to their dislike
of polypharmacy. The majority of prescribers in the study felt that one
drug should be prescribed where necessary and in the case of two or
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more drugs being prescribed, they would question this as a practice.
Where cases were presented to prescribers where the individual was on
polypharmacy, this presented with some discomfort and difficulty,
particularly in attempting to withdraw this medication.
Dr 0: Yes I prefer one drug and that is another area. I try to use the minimum
dose of the most effective drug, the safest drug and most effective drug in a
particular situation. If someone is on medication already this can be a difficulty
withdrawing generally speaking.
As a matter of individual prescribing practice, the above prescriber makes
the following statement when a new medication is being tried.
Dr 0: I would add-on a drug and then withdraw the other drug and this would be
the way I would do it. If I start them on a newer antidepressant, I would withdraw
the other gradually.
As mentioned earlier as a complexity, the issue of epilepsy (as an
underlying condition) also results in some discomfort when medication is
being prescribed - as there is the tendency to prescribe polypharmacy as
a means of controlling seizures (which may often be irrational). The
prescriber below (Dr D) notes how she has "not had the courage to
withdraw" due to implications for seizure pattern.
Dr 0: In the area ofepilepsy it Is more complicated and this is an area I would
feel is maybe less educated in because I am not a neurologist I am a
psychiatrist. None the less I know I would treat a lot of them, but the newer
antiepileptics like Lamictal- in fact it has been shown to be effective as
monotherapy but I have not as yet used it as in the population that I work with,
who have been on a number ofanticonvulsants over a number ofyears, I have
not had the courage really to withdraw, I might have withdrawn one of the others
but I usually use two - I have them on two anticonvulsants. It often has the
added complication that ifyou withdraw it will affect their seizure frequency - it
often does.
Another prescriber (Dr H) has discomfort around the issue of "inherited
POlypharmacy" - where sh~ is new to a service and clients are already on
a combination of psychotropic medications, for which there is a poor
rationale.
Dr H: In relation to the place I have inherited, I am uncomfortable around that
because I am trying to rationalize the medication and I am bringing it down but it
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is during a stage - and if it goes wrong then I am waiting for that and [ J ... I am
vel}' uncomfortable with what I have inherited and I have refused to tweak the
medication and what has resulted is that people have had to go into hospital,
because I have refused to go any higher.
This situation of "inherited polypharmacy" has left this prescriber to
withdraw medication, due to there being a poor rationale on the part of the
previous prescriber. There is some pressure to "tweak" medication but
the prescriber feels discomfort around this practice and will not give way
to such pressure.
Finally on the issue of atypical sensitivity to side effects (which was
discussed earlier) one prescriber (Dr F) feels this is an area which gives
rise to discomfort on the part of prescribers.
Dr F: [ J ... people with learning disability who are being prescribed
psychotropic medications they tend to be more sensitive to the adverse side
effects and so on and what it means really is that it takes quite a bit of time and
attention because of that and to be aware of that. That their tolerance is not as
good as others and they are more inclined to have idiosyncratic reactions to
them. They are more vulnerable to medications really so its really important to
look at it hard.
Again similar to the issues raised relating to complex issues in
prescribing, prescribers felt these complexities were often issues which
arose in discomfort. Getting the "right balance" between the person and
the drug is a complex issue in itself and warrants much caution on the
part of the prescriber. If prescribers get this balance incorrect or the
person with leaming disability has a poor tolerance of a particular drug,
prescribers are uncomfortable about prescribing such a drug. The
dilemma is then raised as to whether the drug needs to be withdrawn and
replaced with a "safer" and "more effective" drug or whether the person
continues with this medication with the possibility of serious side effects
developing into a condition as neuroleptic malignant syndrome, as was
discussed by one of the prescribers in the study.
The next issue to be discussed is that of crisis intervention and resource
implications as a source of discomfort to prescribers.
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12.6.2 Crisis Intervention & resource Implications.
The issue of crisis intervention and resource implications in the
prescribing process was mentioned by a number of prescribers in the
present study. Although these two issues are somewhat distinct,
throughout the interview material prescribers made reference to these
issues as a combination of factors. Largely due to limitations in staffing
and overall resource implications, a sense of pressure was placed on
prescribers which they felt was related to "crisis intervention prescribing-
which arose in a significant amount of discomfort. One prescriber (Dr F)
makes reference to the fact that the potential is always there for
discomfort relating to crisis intervention.
Dr F: Weill think the potential for that is always there. I suppose what makes
me uncomfortable is hen there is a lot ofpressure coming to sort out a situation
which you feel maybe much better managed in terms ofhaving appropriate or
better staffing levels or different environment.
In this example the prescriber feels that a crisis situation has occurred
and it may have been handled at an earlier stage by means of
behavioural or alternative approaches. She goes on to talk about the
resource implications when undertaking behavioural assessment
(functional analysis) or intervention.
Dr F: Or where maybe a more sort of thorough behavioural analysis or
something may be helpful but we may not just have the resources for that or I
suppose it is like any other sort of work, it is when you feel that the pressures are
coming on you to do something and it isn't specifically and the answer doesn't
specifically lie in the area ofmedication.
In relation to discomfort arising from crisis intervention this prescriber
goes on to mention that such situations may occur at specific times dUring
the year - especially at holiday times when staff are away and resources
are not as plentiful as usual.
Dr F: So It can happen in specific situations and maybe at specilic times. Uke
holiday times for other people tend to not to be great times.
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One prescriber (Dr D) made reference to a case she felt uncomfortable
about when the client was resident in a community house. The prescriber
was called in to give inter-muscular medication due to the seriousness of
the behaviour. As mentioned earlier many cases of prescribing are based
around the issue of dangerousness and this was a typical case of crisis
intervention essentially based on level of dangerousness.
Dr D: I think I am just remembering a case which comes to mind, but it has been
in the past two weeks or so, but that was a difficult situation. It was someone
with a learning disability who has a personality disorder and has had chronic
behavioural problems now living in a community house and used to be living in
residential care here and obviously there were a lot of issues around the
community house being able to deal with the challenging behaviour and the lack
of the facility here to re-admit and in a situation like that where the behavioural
methods that were employed were not working there was continuous aggressive
behaviour towards staff members, and I certainly felt under pressure and in that
instance I did prescribe an inter-muscular, which I had a lot of difficulties with.
Certainly the inter-muscular medication I would have a lot of difficulties with.
In this sense the prescriber administered inter-muscular medication but
with a significant amount of guilt and discomfort.
Dr D: So I would have a lot ofguilt about that at the time largely due to the fact
that I generally don't prescribe inter-muscular medication
On the issue of depot medication another prescriber (Dr G) notes that he
dislikes prescribing depot medication and as part of his practice does not
routinely prescribe this form of medication as he feels it is not good
practice and very often such emergency cases can be dealt with be
means of behavioural interventions such as seclusion.
Dr G: ... [ J.. .we do not, and it has been many many years since I have given
inter-muscular medication for emergency management, not for depot medication
- somebody becoming highly disturbed, I think we rarely, it is very rare that
somebody cannot be either placed in a seclusion area or where you are able to
deal with them from a behavioural approach or by way ofmedication but we
don't do that. That's only highly disturbed people.
Another prescriber (Dr A) clearly states her dislike for depot medication
and where depot medication is prescribed, a very balanced approach
must be taken.
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Dr A: The other area where I tend not to use too much in terms ofprescribing is
depot medication, basically because of the issues around consent, so there
would be very few people on injections, but again that is a very individual thing
and you have to balance it, but in general I would put very few people on depot
medication.
Interestingly this prescriber makes reference to the issue of consent when
prescribing medication. Only two prescribers made reference to issues of
consent through the interview. This issue will be dealt with in the final
section on uncomfortable prescribing decisions. We will now tum our
attention to discomfort relating to expectations and pressure to prescribe.
12.6.3 Expectation/pressure element on the part of others.
In a similar fashion to factors influencing the complexity of prescribing, the
issue of expectations and pressure to prescribe was a source of
discomfort for prescribers in the present study. In was interesting to note
that this category emerged as a core category in these two core issues
under study. Almost all prescribers in the study made reference to this
issue as a source of discomfort. One prescriber (Dr D) makes specific
reference to pressure coming from staff in the residential services to
prescribe and this may result in prescribing becoming "unscientific".
Dr 0: I do feel influenced by staff's responses to behaviour and what they
feedback to me. In the residential population sometimes I feel there is pressure
to prescribe as well and it is not always easy to be scientific about it in those
situations.
This prescriber also makes reference to a case where parents placed
pressure on the prescriber to change the medication for their child. These
parents came equipped with information which they received from the
Internet on the types of medications prescribed and the prescriber in this
case was extremely uncomfortable with the pressure which was placed
upon her to change the medication.
Dr 0: I have actually felt under pressure by parents there to prescribe and I felt
very uncomfortable in one situation where pressure was put on me to change
the medication to move onto another and then another by the parents and I was
faced with a dilemma. I felt uncomfortable and they got their information from
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the Internet so they knew all the drugs that could be used and I felt
professionally undermined by their attitude coming in and sort of making the
suggestion that this drug should be used. So that would be the other area which
can generate an uncomfortable decision.
In this case the prescriber felt very uncomfortable with the situation that
arose and notes how she felt "professionally undermined" by a family who
wanted medication changed.
As mentioned earlier the case of the prescriber who felt pressure to
"tweak" medication feels this is a very uncomfortable area that many
prescribers are subjected to. Her rationale when faced with such
uncomfortable decisions is rather than tweaking the medication, she will
prescribe PRN medication as a means of overcoming this situation.
However as mentioned earlier this is a questionable practice as it may
result in PRN medication being prescribed routinely and as a long-term
solution.
Dr H: That has been difficult, but as I say maybe at the beginning I would have
tweaked it up or down a bit, but how I would do that is put them on pm and then
re-manage it. But enough was enough and I said that I cannot be doing this any
more, so we have begun to start talking about it and they are on board now - but
there was an issue.
Interestingly one male prescriber (Dr G) notes that he does not feel any
uncomfortable prescribing decisions but he does feel that junior doctors
and registrars may feel uncomfortable about some prescribing decisions
largely based on their inexperience in handling pressure from staff.
Dr G: No I cannot say that I have found that - Perhaps the registrars do find it or
run into that or a junior doctor coming into the system - he or she may be
approached by the nurse and there is this problem and they want to treat it
immediately.
Although this prescriber has not felt any discomfort around prescribing
decisions for some time, his policy regarding pressure or expectations to
prescribe from staff is to avoid rushing in to deal with the situation
immediately by means of prescribing. Most importantly he states that a
record should be kept of behavioural observations and if medication has
to be prescribed it should be prescribed in small doses.
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Dr G: No not for myself but I certainly know that registrars have been
approached and they do face a dilemma sometimes, and I would always say to
them, in fact it is one of the first things I say to them that do not rush in to give
medication - keep behavioural recording beforehand and ifyou are going to give
medication, give it in small doses initially.
It is interesting to note that while prescribers in the study made reference
to expectations and pressure from others as a source of discomfort, not
all prescribers felt that it was applicable to themselves personally. The
comments from the last prescriber above emphasize this point stating that
although he does not feel uncomfortable around any prescribing
decisions, his junior doctors or registrars may feel pressure to prescribe.
A possible explanation for this lies in the fact that all prescribers in the
present study were very experienced and had been prescribing for a
number of years. In this respect the level of experience could be said to
counteract the effect of pressure and expectations from others to initiate
psychotropic prescribing.
12.6.4 Issues of Consent.
Of the eight prescribers involved in the present study, only one prescriber
(Dr A) made reference to the issue of consent when prescribing for
persons with learning disability. The issue of informed consent is
receiving increased interest in recent times in Ireland for persons with
learning disability as the new Mental Health Act is soon to be introduced
and there is no doubt but it will have implications for persons with learning
disability, especially those with mental health problems and those who are
being prescribed psychotropic medications. Currently in many services -
both residential and community, prescribing of psychotropic medication
takes place without informed consent taking place. Although the person
with learning disability in many cases may not have the ability to
understand the implications of treatment, consent should be sought from
the client's guardian or family member. In this respect in many cases
clinical practice falls short in respect to theoretical perspectives on
consent. This could be seen as another example of the theory to practice
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hypothesis of prescribing where consent should be sought prior to the
prescribing of any medication but in practice it does not always take
place.
It was interesting to note that only one prescriber felt uncomfortable
around the issue of consent when prescribing psychotropic medication.
This female prescriber (Dr A) noted that the issue of consent was her
main source of discomfort in its broadest sense.
Dr A: I suppose it is always difficult prescribing for someone who cannot give
their consent, I suppose that is the main issue.
Later in the interview this prescriber makes reference to the issue of depot
medication as discussed earlier in terms of crisis intervention, but
presently in relation to consent and the dilemma of trying to find a
balanced approach to prescribing. She states:
Dr A: The other area where I tend not to use too much In terms ofprescribing is
depot medication, basically because of the issues around consent, so there
would be very few people on injections, but again that is a very individual thing
and you have to balance it, but in general I would put very few people on depot
medication.
Despite this prescriber feeling uncomfortable around the issue of consent,
as a means of "over-coming" this discomfort, rather than seeking consent
for those she is prescribing for, she seeks approval from her colleagues
as a means of justifying her prescribing behaviour and adhering to a "best
practice" model of prescribing. In this respect she makes reference to
getting a second opinion from a colleague or expert in the field.
Dr A: You do what is best practice - I would tend for some cases to actually get
8 second opinion, because I am single handed, so any particular areas where I
feel uncomfortable, I get somebody else to look at the person - somebody who
would be an expert in this sort ofarea.
Clearly in this case the prescriber is faced with a dilemma which she
resolves by asking a colleague or expert in the field for a second opinion
rather than firstly seeking consent from either the client themselves (if
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possible) or from a family member or guardian and then getting a second
opinion regarding the type of medication to be prescribed. Although only
one single case is presented here based on a single prescriber, it would
be interesting to gather information on psychotropic medications
prescribed over a set period of time and how many of these were issued
without the prescriber seeking consent. In such cases where consent is
not sought, this clearly warrants caution as the legal implications of such
prescribing may be called into question. However for the purposes of the
present thesis, the evidence to further elaborate on this issue is lacking
and there is certainly the need for further research on the issue of
consent, rights of the persons with learning disability and the information
which is given to them on the risks associated with psychotropic
medication prior to the prescribing of same.
12.6.5 Concluding Remarks regarding uncomfortable
Prescribing decisions.
When asked about uncomfortable prescribing decisions all but one of the
prescribers stated incidents whereby they felt uncomfortable when issuing
a psychotropic medication. From the four core categories which
emerged, only two of these categories could be said to be strictly
·pharmacological". That is to say issues such as drug profile, side effects
and the issuing of depot medication could be said to be pharmacological
in nature. The other categories such as expectation from others and
issues of consent are broader social variables which although arose in
some level of discomfort for prescribers are essentially non-
pharmacological. Most of the prescribers within the present study at
some point felt uncomfortable in relation to one or more of the four core
categories. Where a prescriber stated that he did not feel uncomfortable
prescribing psychotropic medication, he did note that some junior doctors
or registrars may feel discomfort due to expectations from others or from
staff pressure. The fact that this prescriber noted such an example may
indicate that the level of experience in prescribing psychotropic
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medication for persons with learning disability may have an impact on the
types of situations which result in discomfort for prescribers.
12.7 Chapter Conclusions.
Unlike the study of Bradley (1992a) which examined uncomfortable
prescribing decisions among General Practitioners, the present study had
a number of avenues of interest. Not only did the author examine issues
around discomfort which resulted in prescribing for persons with learning
disability, rich and valuable data was obtained on a number of issues
regarding psychotropic prescribing for this population. By means of
utilizing a methodology known as the Critical Incident Technique, the
• author was able to gather "real world" and everyday examples of
psychotropic prescribing and the range of factors which influence such
prescribing. Further questioning enabled the author to gather data on
issues which are highly emotive and controversial and under review by
many services to the present day (Coughlan, 2000a).
What is presented in the current chapter is an in-depth analysis of the
findings from the present study. The author, through use of grounded
theory, has developed focused codes and core categories for each of the
principle topics under study. Through the use of grounded theory all core
categories which have emerged are grounded within the interview data
which was generated from the eight interviews undertaken. The main
advantage of such an approach is that the author becomes immersed in
the data and all resulting core categories are not merely a set of pre-
conceived categories which are applied to the data. From reviewing the
literature on prescribing for persons with learning disability and the
literature from General Practice, such an approach is quite novel and
certainly within the learning disability field is one of the first studies of its
kind.
Throughout the presentation and analyses of results in the present
chapter, the author also embarked on a discussion of the relevance of
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these findings. By means of constant comparison and evaluation (key
elements of the grounded theory approach) the author was able to further
question and elaborate on issues discussed by prescribers in the present
study. However comparison of results generates some difficulties for the
author as no such similar approaches have been utilised within the field of
learning disability to date. However it is hoped that the present study will
act as a catalyst for further research of its kind, while in addition
generating interest in the advantages of using qualitative research
methods in healthcare research and specifically within the field of learning
disability.
Although the present chapter served multiple functions in that I have
presented analyses of results and a discussion of same, it is necessary to
conclude this thesis with a chapter which will examine the practical
implications of the present study in addition to limitations of previous
research and directions for future research of this kind.
The final chapter of this thesis is entitled General Discussion and
Conclusions - Implications of the Present Study. This final chapter
discusses the broader implications of the present study and how it serves
to address the topic under study - prescribing for persons with learning
disability.
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CHAPTER THIRTEEN
GENERAL DISCUSSION AND
CONCLUSIONS - IMPLICATIONS OF THE
PRESENT STUDY
13.1 Chapter Introduction
Prescribing of psychotropic and psychoactive medications for persons with
learning disability has had an emotive and controversial history and this
continues to the present day with many clients being prescribed multiple
medications for a variety of conditions. These conditions include the
presence of an underlying mental illness in a proportion of clients, additional
handicapping conditions such as epilepsy or autism, or perhaps more
controversially challenging behaviour in the absence of an underlying
psychopathology. The author uses the term ·controversial" in that there are
no clear guidelines regarding prescribing of psychotropic medications for
persons with learning disability who display challenging behaviour, yet
medications such as the Antipsychotics are routinely used for the purposes
of behaviour control.
In addition to prescribing being undertaken for clients who display
challenging behaviour in the absence of stringent guidelines, such
medications are prescribed with a high frequency, especially in clients living
in larger residential-type facilities in comparison to those living in smaller
community-type facilities. The rationale for such prescribing is poorly
understood and despite the vast array of studies undertaken on prevalence
of prescribing, such studies have tended to focus solely on prevalence and
have offered little in the way of an understanding as to the reasons why
such prescribing takes place.
In an attempt to gain an understanding of the process of prescribing for
persons with learning disability, the present author undertook to examine the
rates of psychotropic medication prescribed within the Brothers of Charity
Services, Mid-West region. This drug prevalence study examined the rates
of prescribing of all psychotropic medications for persons with learning
disability in both residential and community settings and it acted as the first
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phase of the present thesis. The second phase of this thesis has deviated
somewhat from the published research to date. Rather than attempting to
account for the findings from part one of the study by means of examining
the associations between prescribing and psychopathology, the present
author has employed a novel methodology in attempting to understand the
process of prescribing, the factors affecting prescribing and the rationale
why such medications are prescribed in the fashion they are for this
population. Hence as the title of this thesis shows, the author investigates
and reports on both quantitative and qualitative perspectives of prescribing I
within the learning disabled population.
The final chapter of this thesis is devoted to a discussion and concluding
remarks regarding the implications of the present thesis. The author is
faced with the dilemma of discussing the present piece of research within
the confines of the field of learning disability and prescribing, where
traditionally the literature has been of a quantitative nature and has not
expanded beyond this point. Part one of this thesis fits -neatly" within the
realm of published literature on the topic at hand, due to its quantitative
framework. The author suggests that this is the principle strength of the
study and its adds to our understanding of the demographic variables which
impact upon prescribing. Part two of this thesis however presents a more
formidable challenge to the author in terms of a discussion of its implications
due to the novel means by which the author undertook the study. This is the
first study of its kind, which uses qualitative techniques in order to gain a
meaningful understanding of psychotropic prescribing within this population.
Hence the difficulty arises of how to relate the present findings to previous
research, as there have been no efforts of a similar nature to conduct this
type of research. What the present chapter will attempt to undertake is a
discussion of the usefulness of the methodologies employed, how they
relate to the existing literature and how they may be incorporated and
expanded upon in future research in this area.
317
13.2 Prevalence of pharmacotherapy - the need to question?
Throughout the writings of the present thesis the author has attempted to
give a detailed overview of the current status of pharmacotherapy within the
field of learning disability. Chapter one of this thesis gives an overview of
the relevant issues in the field of learning disability and perhaps the principle
theme of the chapter is one of the complexity of the condition of learning
disability. Despite there being unified definitions of what constitutes learning
disability (AAMR, 1992, WHO, 1992) and the fact that in these definitions
the importance of adaptive behaviours are highlighted, one must view this
condition in its broadest sense for each individual. This is of importance, not
only in terms of assessment and diagnosis, but also in terms of treatment.
Hence the core issue under study within this thesis is the issue of treatment,
and in particular, treatment with psychotropic and psychoactive medications.
Chapter two specifically deals with the issue of pharmacotherapy in learning
disability and the author presents an overview of recent research within this
highly specialized area. Not only is this a highly specialized area, but as
stated in the opening paragraph of the current chapter, it is an emotive and
controversial one. In researching this area from a psychological
perspective, one is at a unique advantage in terms of the way one wishes to
study the area. The field of psychology has traditionally been a distinct
discipline and has much to offer the field of learning disability, not only in
terms of diagnosis but also in terms of treatment methods employed. The
use (and advantages) of behavioural techniques within this field have long
been recognized and more recently cognitive approaches are proving
beneficial. In this respect, the discipline of psychology has not studied the
phenomenon of prescribing behaviours among doctors and psychiatrists
within the learning disability field. Hence the present thesis offers a unique
scientific, objective perspective of prescribing in the learning disabled
population from a discipline other than psychiatry.
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In attempting to provide a rationale for the studies employed within this
thesis, the author feels there is the need to question the underlYing
principles of pharmacotherapy, not only in terms of the prevalence of
prescribing but also in terms of the rationale for their use. Gadow (1999)
puts forward a series of questions regarding drug therapy in children and
adolescents. These questions are as relevant for the field of learning
disability as they are for the general population. In relation to psychotropic
prescribing Gadow asks "how common is the medical prescription of such
drugs at the moment? Is it too little or too much? Does clinical application
precede scientific verification of safety and efficacy? Are recommendations
for patient management generally followed in everyday clinical settings?"
(p.51 ).
If one turns one's attention to the present thesis, similar questions are being
asked. Although the first phase of this thesis is concentrated on drug
prevalence, the objective of the exercise is much more than simply "head
counting". To date no published figures are available for psychotropic and
psychoactive medications within Irish residential or community services for
persons with learning disability. This was the first aim of part one of this
thesis - to examine patterns of prescribing within an Irish context and
compare them to the existing published studies to date. The second aim
was to examine a range of demographic variables and determine whether
they were of significance .in terms of prescribing for this population. Not only
did study one examine patterns of prescribing for an entire population base
of residential clients, it also served to study an entire population base of
community clients within this same region in Ireland. Hence the present
study has overcome many of the limitations of published drug prevalence
studies to date - the problem of lack of breadth (Spreat et aI., 1997),
problems inherent in the sampling procedures employed and the range of
medications studied (study one investigated all drug categories affecting the
eNS and not just psychotropic medication).
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From the published research to date, one fact is clear and this is highlighted
by almost all studies of prevalence - ·people with mental retardation
constitute one of the most heavily medicated segments of our population-
(Gadow, 1999, p.56). Hence if one asks the question whether persons with
learning disability are being over-medicated, the answer is a most definite
yes. Within part one of this thesis, this question has been posed once
again. The author feels that the figures obtained from the study speak for
themselves. Of the residential population studied, 81% of clients were
administered some form of psychotropic or psychoactive medication, with
the corresponding figure being 33% for clients in the community. If one
turns to the residential figure again, antipsychotic prescribing amounted to
73%. Quite clearly this is a high figure, within present day circumstances
and the author urges caution in prescribing to such a high degree. Rather
than examining the entirety of results once again, the reader is referred to
chapters four and five for a detailed analyses and discussion on the findings
of the study. However one of the principle conclusions from part one of this
thesis is that a] psychotropic and psychoactive medications are prescribed
frequently and at a high rate to the population under study, b) multiple
medications are prescribed for a sizeable number of clients - both
polypharmacy and co-pharmacy, and c) the rationale for such medications is
poorly understood, with medications not being matched to specific
diagnoses or symptoms.
In attempting to account for such findings, one must again begin to ask
questions. Now that one has produced evidence to support the notion that
persons with learning disability are prescribed medication to a high degree,
how does one gather information pertaining to why such medications are
prescribed. One question which is often posed is: are there medications
being reviewed and monitored appropriately? The answer to this question is
difficult and clearly beyond the scope of the present thesis. However from
the published literature on litigation and legislation in this area, it is clear that
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psychotropic and psychoactive medications are very often not being
monitored effectively in many states and countries (Schouten & Duckworth,
1999). Part two of this thesis did pose many questions. However the
questions posed were not specifically regarding whether medications were
being prescribed appropriately or not, or whether monitoring procedures
were being employed, they related specifically to decision-making
processes, factors which affect prescribing and determinants of prescribing
,
for persons with learning disability.
The author will now turn the focus of attention to part two of this thesis and
how it has attempted to account for the findings obtained in part one.
13.3 Accounting for the findings - do qualitative techniques fulfil this
role?
Attempting to account for the findings from part one of this thesis is by no
means an easy task and it is probably beyond the scope of the second part
of this thesis to account for these findings in full. However despite its
limitations, part two of this thesis offers a unique picture of the prescribing
behaviours of a number of prescribers, whose role is prescribing for persons
with learning disability.
From reviewing the literature on pharmacotherapy in learning disability and
on prescribing within general practice, the author felt there was a need to
put in place a methodology, which would serve two principle functions. The
first of these functions was to answer many of the questions which remained
from completing the first phase of this research project and which could not
be answered from the findings obtained. The second function was to gain a
deeper understanding of the decision-making processes which are
employed by prescribers prior to issuing a prescription and what factors
might influence these decisions.
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From reviewing the literature on prescribing (from both the perspectives of
general practice and learning disability), one factor is common to both.
Prescribing is a complex phenomenon and is based on the knowledge of the
practitioner, the symptoms displayed by the patient and a host of social
factors, many of which are not easily identifiable nor SUbject to scientific
study. In the words of Werry (1999) "the act of prescribing a drug is a
complex human transaction set in a social field at a particular historical time
•
and subject to a variety of unseen influences. If one believes that Home
Sapiens is at least in part a rational being, knowledge of these factors may
lead to better prescribing by practitioners and more informed participation by
consumers in the process" (p.11). If one examines the factors involved in
prescribing, considerably less is written about the social influences in the
prescribing process, than for example demographic factors. The primary
reason for the lack of research in this area is due to the inherent difficulties
in studying the social processes at work in prescribing. By utilizing a
qualitative methodology, the present author was able to objectively study
some of the social processes at work when prescribing for the learning
disabled population.
Utilising a qualitative approach to the study of prescribing in learning
disability has proved more useful in gaining an understanding of the
processes at work and determinants of prescribing than it has in attempting
to account for the findings from the present drug prevalence study. Despite
this however, from the responses obtained from the prescribers in the
present study, they do, in particular, go a long way in accounting for the high
rate of antipsychotic prescribing. From part two of this study prescribers
tended to rationalize their prescribing in terms of the diagnoses they
formulated. From chapter twelve one can see that a diagnosis is the
cornerstone on which any later treatment regime is implemented. If the
diagnosis falls within the paradigm of mental illness, prescribers in the
present study tended to rationalize and justify their prescribing on this basis.
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On the other hand, if the label of "challenging behaviour" was placed on the
person, prescribers were not as content prescribing for this condition.
Despite this however, and based on the critical incidents of prescribing
gathered, many prescribers do prescribe solely for the purposes of
challenging behaviour, even in the absence of an underlying
psychopathology. In the formulation of a model of prescribing as discussed
in chapter twelve, this is what the author terms the "theory to practice
hypothesis of prescribing" - where in theory prescribers say they do not
prescribe for challenging behaviour, but in clinical practice, and on the basis
of evidence produced in this second study, they do prescribe for the control
or suppression of challenging behaviour.
Another example of this can be seen in terms of polypharmacy or indeed
copharmacy. From part one of this thesis, It can be seen that both
polypharmacy and copharmacy are a commonplace practice for clients In
residential settings. One can .again account for the discrepancy between
prescriber's theoretical perspectives and what happens in clinical practice,
by examining the model of prescribing in conjunction with the critical
incidents of prescribing gathered. From the case histories outlined by
prescribers throughout the interview material, they tended to add-on
medication in an ad-hoc manner, without any scientific evidence regarding
the rationale for it. Prescribers rationalized this by means of a drug being
relatively ineffective for the person and so an add-on medication was
required. This type of prescribing practice tended to be more for complex
conditions where the existing medication was deemed ineffective and where
the prescriber found it difficult to formulate an accurate diagnosis. Any
subsequent diagnosis may be made in terms of the atypical presentations of
many conditions seen in learning disability. Much of the present research in
psychopharmacology is concentrating on atypical presentations of many
conditions not readily identifiable by means of the DSM and ICD
classification systems (Verhoven & Tuinier, 1997, 1998).
323
Finally, on answering the question of whether qualitative techniques account
for the findings of the first phase of this study, one must examine the type of
material gathered when undertaking qualitative research. Unlike part one of
this thesis, which was quantitative in nature, very different information was
gathered in part two of this thesis. From analysing the interview material
and generating a model of prescribing by means of the grounded theory
approach, it enabled the author to gain an understanding of the complexities
involved in prescribing, while also outlining the factors influencing decision
making amongst prescribers. If one takes this information and applies it to
the quantitative data gathered it does offer the author an explanation as to
Why psychotropic and psychoactive medications were presaibed to such a
high frequency. In addition it also sheds some light on the rationale of why
these medications were prescribed, both in terms of mental illness but also
and perhaps more importantly, in terms of the presence of challenging
behaviour. In such instances prescribers felt a sense of responsibility, and
the "need to be seen to be doing something", regardless of whether the
prescribing was rational or otherwise. The implications of such prescribing
behaviours will be discussed later in this chapter. Prior to this discussion
however, the author feels it necessary to discuss issues regarding
methodology, and ethical considerations in carrying out research of a similar
nature to the present project.
13.4 Methodological considerations
The methodology utilized in part two of this thesis is a somewhat unique
methodology in the study of prescribing for persons with learning disability.
As mentioned earlier in this chapter research to date on pharmacotherapy in
this population has traditionally been of a quantitative nature. However in
order to gain a more meaningful insight and understanding of this most
complex area, the author felt the need to explore avenues which to date
have not been explored. In addition the use of qualitative techniques in
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addition to the quantitative techniques used in part one provide a more
global perspective on prescribing in the field of learning disability.
Within the field of healthcare research generally, the vale of qualitative
techniques is being increasingly recognized by both researchers and
clinicians in tum. Qualitative techniques prove most useful where the
subject under study is complex and not readily studied by means of more
traditional quantitative or experimental methods (Green & Britten, 1998). In
terms of the advantages of qualitative research methods in terms of their
usefulness in clinical practice, Green and Britten (1998) outline four points
regarding the usefulness of such techniques in evidence based medicine, by
stating:
1. qualitative methods can help bridge the gap between scientific
evidence and clinical practice.
2. qualitative research findings provide rigorous accounts of treatment
regimens in everyday contexts.
3. this can help us understand the barriers to using evidence based
medicine and its limitations in informing decisions about treatment.
4. recognizing the limits of evidence-based medicine does not imply a
rejection of research evidence but awareness that different research
questions require different kinds of research.
The above points are useful to our understanding of the present thesis. By
applying traditional experimental techniques to the study of
pharmacotherapy in learning disability, it enabled the author to compare
prevalence figures from an Irish context to similar study conduded
elsewhere. However, by then incorporating a qualitative element to the
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study, it has added considerably to the literature on this topic by means of
the type of information presented in part two of this thesis, while also
presenting a conceptual model of prescribing for this population. Despite
this model being a tentative conceptual model, it is the first of its kind
developed within the field of pharmacotherapy and learning disability.
Perhaps one of the principle strengths of this thesis from a methodological
perspective is the fact that by incorporating both a quantitative and
qualitative technique, it enabled the author to research an area from a
psychological perspective, which traditionally has been notoriously difficult to
study - difficult from the methodological point of view, but also from the point
of view of a discipline other than psychiatry researching this area. This has
also lead to some difficulties with the study and these issues will be
discussed in the next section entitled ethical considerations.
Another strength of the study lies in the diversity of areas discussed by
prescribers in part two. Whereas qualitative studies in general practice have
tended to concentrate solely on one area such as uncomfortable prescribing
decisions (Bradley, 1992c) or changes in clinical practice (Allery et at,
1997), part two of this thesis had several foci of attention. This was an
important aspect in generating a global impression of prescribing practice for
persons with learning disability. By means of gathering critical incidents of
prescribing (in the real world setting) this enabled the author not only to
gather important information regarding factors affecting and impinging upon
prescribing as outlined in the prescribing checklists, it also enabled the
author to discuss these issues more thoroughly throughout the interview
process. Hence in this respect prescribers discussed issues regarding
assessment and diagnosis of mental health problems, the issues they
themselves as prescribers felt were important in prescribing, how
prescribing relates to challenging behaviour and instances where they may
have felt uncomfortable around prescribing decision made. By discussing
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such broad issues within the confines of the study, it thus enabled the author
to generate the current model of prescribing put forward in chapter eleven of
this thesis. This model of prescribing clearly goes some way towards our
understanding of prescribing and does account in part for why psychotropic
and psychoactive medications are prescribed to the frequency with which
they are in many services throughout Ireland.
Despite the advantages of qualitative techniques within part two of this
thesis, there were also disadvantages with this technique. The first of these
relates to the technique of interviewing and the type of material generated
throughout. Prior to commencing study two, the author had to give
assurances to all prescribers involved in the study that the interview material
generated would remain anonymous. The fact that all interviews were
recorded (and consent was agreed upon prior to interviews) did generate
some dissatisfaction amongst a small number of participants, particularly
once the study was completed. Prescribers were informed beforehand that
the methodology was qualitative in nature and that extracts from interviews
would be used but despite this there was some concern once the study was
completed. This concern was voiced by a number of prescribers who wrote
and telephoned the author in order to ·see what was being done with the
data". Although not easily explained, this concern seemed to grow out of
the "apprehension" of those prescribers not involved in the study. These
issues will be discussed in the next section but such concerns due warrant
discussion within the context of methodologies for future research.
The present author believes that it was not the research techniques used or
the recording of the interview which was the root of the problem but how this
material was going to be used. Essentially those prescribers who were not
involved, did not participate due to a discipline other "than their own"
researching an area with many complexities. From discussing the study
with a number of prescribers prior to commencing the research, their
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apprehensions lay within the realm of the discipline of psychology
researching this area. Some prescribers felt that the discipline of psychiatry
should be involved in implementing a suitable methodology, while others felt
the discipline of psychiatry should be implementing an independent audit of
prescribing behaviours. It should be noted that while these are valid
criticisms of the present study and despite the author welcoming any
suggestions from the discipline of psychiatry regarding implementation of
the study, all prescribers at the time were not interested in actively partaking
In an inter-disciplinary approach to any such study.
13.5 Ethical considerations
As discussed above there was some discontent amongst the discipline of
psychiatry within the Republic of Ireland regarding implementation of the
second study of this thesis. Interestingly there was little, if any comments
regarding the discipline of psychology undertaking a drug prevalence study,
a research process traditionally undertaken by psychiatry. The fact that an
independent review of all psychotropic and psychoactive medications was
welcomed by the authors employing organization (and ethically approved)
may have been highly advantageous to the author. Within the era of audit,
litigation and legislation surrounding medication administration for persons
with learning disability in many countries, the implications and applications
of the first study should not go unrecognised and the fact that a drug
database now exists for all service users within the region is highly
advantageous for future research and audit efforts.
The fact that the second study grew beyond the confines of the author's
organization and incorporated a cross section of the discipline of psychiatry
within learning disability in Ireland, was perhaps the greatest source of
concern for some prescribers. By incorporating consultant psychiatrists
from a number of different service providers for persons with learning
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disability, the profile of the study was raised considerably in addition to the
possible recommendations from conducting such research. The fact that
the author was not known by many prescribers also generated some level of
discomfort regarding inclusion in the study. Hence this may in part account
for a 40% final inclusion rate for the study.
A discussion of the ethical considerations within the confines of the present
study is not only important in taking the findings of the study into account,
but it is also important in terms of future research in this area. As mentioned
earlier above, the main sources of concern for prescribers grew from the
views of prescribers not involved in the present piece of research. Hence
from "colleague communication", prescribers discussed among themselves
the nature of the research, the discipline undertaking such research and the
possible implications of same. The fact that the study was a novel means of
studying prescribing behaviour within the context of learning disability may
have also added to their concerns, despite the methodology being employed
previously within general practice.
In addition to the above point on "colleague communication", an interesting
point regarding the study emerged upon completion of all interviews. Those
that participated in the second study of this thesis did so willingly and were
interested in receiving feedback on the findings from the study. Those that
were not involved in the study essentially comprised of two distinct groups -
those that were uncomfortable with a discipline other than psychiatry
studying the process of prescribing and those that wished to consult with
their colleagues at the learning disability section meeting (a meeting which
takes place approximately once every six months attended by members of
the Royal College of Psychiatry - learning disability section). The first group
refused to participate in the study due to "ethical problems" - this was
conveyed to the author via telephone conversation. At no time were any of
the concerns of prescribers forwarded to the author by means of writing and
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hence the notion of "ethical problems" was not explained to the author at
any time. Those comprising of the second group were not willing to partake
in the study on the basis of "not having enough information about the study"
and "wishing to consult with colleagues regarding participation in the
research". Quite clear1y both groups were very uncomfortable with the
discipline of psychology studying prescribing, but members of the second
group essentially wished to place a veto on the study, so that the learning
disability section (as a group) would have to form an opinion of whether all
members would be involved or none. In this respect it was an "all or nothing
situation" regarding participation in the study.
Not only was this a worrying aspect for the author and researcher of the
study at the time, but also the issue of ·vetoing" research goes beyond this
single isolated study and has implications more broadly for research of this
kind. As the author was expecting some level of discomfort from prescribers
regarding the study, those that were willing to complete prescribing
checklists and be interviewed were asked to partake in the study
immediately. Hence prior to any learning disability section meeting taking
place, the author had completed a total of nine interviews with consultant
psychiatrists. Data was also collected for the consultants who completed
prescribing checklists at this point. On the basis of this learning disability
section meeting taking place and the authors research project being on the
agenda and actively discussed at this meeting, one prescriber corresponded
with the author and asked that all information be withdrawn from the study.
The reason given for withdrawal of this prescriber's information was due to
ethical problems regarding involvement in the study. On the basis of this
prescribers wish to be withdrawn from the study the analysis conducted and
reported here has been based on the responses and data gathered for a
total of eight prescribers.
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The issue of attempting to place a veto on research conducted by different
members of the multi-disciplinary team is a worrying sign in terms of the
health care profession. Granted the present thesis was conducted on a very
sensitive and complex topic, but at all times confidentiality and ethical
considerations were of paramount importance. What has been presented in
this section is a cautionary tale for future researchers attempting to research
a sensitive area such as prescribing. It is disappointing however that
members of different professions do not realize the value of other disciplines
in studYing areas of relevance and significance to themselves. The issue of
·professional rivalry" is still unfortunately very much in existence, not only in
terms of clinical practice but also in terms of research. How this will be
overcome has yet to be given some thought but for the purposes of the
present thesis, perhaps by implementing a more inter-disciplinary approach
to the framework by which the study was developed may have helped to
overcome levels of discomfort while also increasing participant numbers.
13.8 Theoretical & practical implications of research to date.
Research undertaken to date in the area of medical decision making and
general practice have offered much to the present thesis. Not only has such
research given the author a number of theoretical frameworks by which to
study the area of prescribing, such studies have also served to address a
number of questions with regard to the practical applications of undertaking
such research. Regardless of what professional background one has
trained in, there is the need to further understand the processes by which
prescribers made decisions. While a substantive volume of literature exists
in the area of shared decision making within general practice, considerably
less is known about this in the area of learning disability. Even in terms of
shared decision making in general practice, little is known about why
patients may be reluctant to share their preferences (about medication) with
their doctor. Granted there are those who will share their preferences
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openly with their practitioner, but there is also a considerable number of
patients who do not wish to engage in this process.
On the other hand, much of the research, such as the studies of Bradley
(1992, a,b,c) have focussed on the complexities around prescribing. From a
theoretical perspective, perhaps this is the most significant contribution that
these studies have brought to the present thesis. The decisions around
whether to prescribe or not are both complex and multi-faceted. If one
examine the literature in detail, both from a general practice perspective and
also from a learning disability perspective, on the basis of Parish's and
Barber's definitions of rational prescribing, there is no doubt much
prescribing is irrational. However one must also take into consideration the
dilemmas which practitioners face when contemplating whether to prescribe
or not. What is particularly problematic is the issue of prolonged drug
treatment, without appropriate review. In dealing with suc~ issues of
irrational prescribing, recent professional efforts have been directed at
reducing such irrational prescribing by means of educating prescribers. This
is an important theoretic and practical implication of the research from
general practice. It is also an issue which not only faces general
practitioners but all practitioners prescribing medications including
psychiatrists. Education around when not to prescribe a medication is
equally as important as education around when to prescribe appropriately.
The issue of cognitive dissonance is of relevance here in attempting to
formulate an educational programme for prescribers in all discipline of
medicine. On this issue Allery et al. (1997) note the importance of
researching the beliefs of clinicians in an attempt to gain a deeper
understanding of the strategies involved in changing doctors prescribing
patterns. These authors note that "education providers should develop
more multifaceted strategies, integrating their activities with the broad range
of other factors which affect changes in clinical practice" (p.873).
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In terms of the practical implications of the research from general practice,
and indeed the pharmacological research from the area of learning
disability, firstly, it was possible to develop a protocol regarding the issues to
be studied, but perhaps more importantly, these studies provided the author
with the means of how to go about such research. While quantitative
techniques have proven useful in a wide variety of areas, the value of
qualitative techniques cannot be over-emphasised in researching how
clinicians make, and rationalise decisions around their prescribing. Much of
the work from general practice has utilised qualitative techniques in order to
get a snapshot view of how clinicians make decisions, or indeed how and
why they change their prescribing behaviour.
The author will now review some of the implications of the present study,
with regard to issues in learning disability, mental health services, and more
specifically, implications for our understanding of psychotropic and
psychoactive prescribing for this population.
13.7 Implications of the present study In understanding learning
disability
Throughout the twentieth century there have been significant advances
made regarding the way persons with learning disability have been
supported and treated (MH-SIRG, 2000). Methods of treatment have
changed considerably over this time to the advantage of those with learning
disability. As new research emerges, different approaches are utilized in the
treatment of this population. The issue of treatment in terms of psychoactive
and psychotropic medications however still remains controversial due to the
efficacy of using such medications for challenging behaviour in the absence
of any underlying psychopathology. As stated by Santosh and Baird (1999)
-there is no consensus about the use of these drugs for the control of
aggressive and disturbed behaviour, hyperactivity, and stereotypical
behaviour, in the absence of mental illness" (p.234). Even when a diagnosis
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of mental illness has been made, the area of assessment and classification
systems utilized are fraught with difficulty (Moss, 1999).
The present thesis examined issues relating to drug prevalence and
decision making factors regarding the prescribing of such drugs for persons
with learning disability. Implications of these studies are wide-ranging and
go beyond the realm of research within this field. They have implications for
mental health services for persons with learning disability, not only in terms
of service provision but also in terms of dinical practice in the treatment of
this population.
13.7.1 Implications for mental health services for persons with
learning disability
Although the principle focus of attention of the present thesis was
concentrated on prescribing, issues pertaining to mental health services for
persons with learning disability are of paramount importance to our
understanding of the process of prescribing. Chapters six and seven of this
thesis have been devoted to a discussion of mental health issues in this
population. Elsewhere the present author has critically analysed the use of
models such as ICD and DSM in diagnosing mental health problems in the
learning disabled population (Coughlan, 2000b) and the problems
associated with such models developed for the general population.
Throughout the second phase of the study, many prescribers made
reference to the inherent difficulties associated with making a diagnosis
within this population. The most common cause of concem for prescribers
was the dient's lack of ability to verbalise what they were feeling. Rather
than utilizing the existing psychometric tools, prescribers tended to make
their diagnoses based on third party reports. Although there are many
problems associated with these existing psychometric tools, they do prove
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useful in gathering information regarding the client in question. However at
no point did any prescriber within the study make reference to utilizing such
tools. Rather they made their decisions regarding the client's diagnosis on
the basis of third party reports, which many prescribers reported to be
inaccurate and speculative.
Quite clearly there is a dilemma faced here, the implications of which are of
a very serious nature. Diagnoses are being made by prescribers on
seemingly dubious grounds and such diagnoses are commonly being
treated by means of psychotropic medications. The evidence of this
statement has been presented in chapter eleven and is clearly grounded
within this interview material as discussed earlier. The fact that prescribers
have suggested that the third party information, which they rely upon, is
·speculative- and inaccurate raises a number of considerations. As
discussed in earlier chapters the pathway to mental health services is a
difficult process but once a client reaches this service, one would hope for
an effective model of service delivery based on scientific merit and not
merely on clinical speculation on the part of the professional. Evidence
presented throughout this thesis suggests that this is not the case in many
services throughout Ireland, based on the responses of prescribers in this
study.
Hence not only is there problems in the detection of mental health problems
in the learning disabled population but there are also problems in terms of its
assessment and more importantly treatment. It was interesting to note that
a number of prescribers felt that ·education- plays a vital role here. In
particular education of direct-care staff who are the one's responsible for the
clients needs on a daily basis. In the opinion of the author, this is merely a
starting point and the role of education goes beyond the direct-care worker
and involves all members of the multi-disciplinary staff working with this
population. Thus the implication here is that the process of assessment,
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diagnosis and treatment of mental health problems should be a multi-
disciplinary process and be subject to critical evaluation at all times. As
stated by a recent report compiled by the Special Interest Research Group
on Mental Health (September, 2000) "the complexity of the potential
problems that arise invariably requires a multi- or inter-disciplinary approach.
Different disciplines apply their theoretical perspectives in attempting to
arrive at a comprehensive understanding ... in many instances,
comprehensive assessment will indicate the need for interventions
characterized by a combination of several of these strategies· (p.18).
13.7.2 Implications in understanding psychotropic and
psychoactive prescribing in learning disability
On reviewing the current status of literature at the end of the 1980's, Aman
and Singh (1991) made the following statement: ·we have now witnessed 35
years of drug research in this field, and it is disappointing that more cannot
be gleaned with some degree of confidence from the existing literature"
(p.364). On reading this statement one could adopt quite a pessimistic view
of the research undertaken, up until this point. However the present author
feels that a far different picture exists at the end of the 1990's, the period
during which the present thesis was conducted. The author will now
examine the current status of research and dinical practice in this field and
outline some of the implications of the present piece of research.
In terms of prevalence studies, the most positive development to date has
been the change in the impetus of these types of studies. Recent efforts
have been based more towards effectiveness of prescribing rather than
prevalence per 88. In addition from recent drug prevalence studies
published the rates of prescribing are decreasing (Kiernan et aI., 1995,
Aman et aI., 1995), while many papers tend to examine the effectiveness of
multi-disciplinary teams in reducing such medication (James, 1983, Jauemig
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and Hudson, 1995, Jordan, 1994, Findholt and Emmett, 1990 and Lepler et
al.,1993). Such research efforts have changed considerably the
perspective from which psychopharmacological research in the present era
is conducted, while also proving beneficial in terms of clinical practice in
many services worldwide.
Although part one of this thesis reports the findings solely in terms of
prevalence of prescribing, it was a useful undertaking in our understanding
of prescribing. As mentioned earlier no published studies undertaken in an
Irish context are available at the time of writing. Hence this study was of
particular usefulness in comparing Irish patterns of prescribing to studies of
a similar nature conducted in the UK, the USA and elsewhere. Part two of
this thesis has afforded the author the opportunity to research a particularly
sensitive and complex area of prescribing - factors affecting prescribing and
how decisions are made by prescribers themselves. Although prescribing of
medication must be seen within its "medical" context, there are also a host
of social variables which impact upon prescribing, and there is no doubt but
this area is poorly researched within the field of learning disability, in
addition to other areas such as paediatric pharmacotherapy rNerry, 1999).
The aim of the present thesis was to gain a deeper understanding of the
many variables at work when prescribing for persons with learning disability.
Perhaps one of the most significant implications of the present thesis is the
fact that the author has undertaken research and produced findings, which
from a psychological perspective have implications for prescribing practice
in addition to mental health services for the learning disabled population.
One of the main values of this thesis lies in the presentation of the many
complexities prescribers face when prescribing for this population. Unlike
general practice (where a significant volume of research on prescribing
exists), many clients with learning disability do not have the capacity to
understand their condition, nor do they have the capability to subjectively
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report how they are feeling. Hence the prescriber is faced with the dilemma
of attempting to extrapolate information from carers or family members. As
discussed earlier, there are many problems with this approach, not only in
terms of diagnosis but also in terms of treatment.
Due to the global nature of the topics covered throughout this thesis, it
affords the author the unique ability to understand the complexity of
conditions presented prior to prescribing, the types of dilemmas faced by
prescribers and the decision making processes employed by the present
sample of Irish prescribers. To date no such similar efforts have been
undertaken from either 8 quantitative or a qualitative perspective.
Similar to the studies of Bradley (1992b) and Howie (1976), decisions made
by prescribers seem to be based on an interplay of social and clinical
factors. However in terms of the social factors involved, prescribers in the
present study were not faced with the dilemma of damage to the doctor-
patient relationship if they did not choose to prescribe. Rather they were
faced with the dilemma of further pressure from families or staff to prescribe
a -magic bullet" in order to treat the condition. In other instances in the
present study, where prescribers were involved in crisis intervention, they
felt under pressure to prescribe, due not only to staff or family pressure, but
also due to prescribers themselves having a sense of responsibility to lido
something-. This interplay of factors seems as pertinent to consultant
psychiatrists in leaming disability as it does to general practitioners, and as
supported in the general practice literature to date (Kuipers, 1988).
On the basis of all data collected within this thesis, the following main points
of interest emerge, which may be considered the principle findings of the
study:
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1. Psychotropic and psychoactive medications are widely prescribed to
service users within the Brothers of Charity Services, Mid-West
region. Residential figures are significantly higher than those
obtained for community facilities.
2. The rationale for such prescribing is poorly understood in terms of
psychiatric diagnoses or specific target behaviours. Prescribing
within this study seems to be based on clinical impressions rather
than on_scientific evidence.
3. Selection of target behaviours for the purposes of treatment by
medication were not apparent at any stage of the study. Nor wel8
they reported.
4. Polypharmacy and copharmacy were widely used, especially in
residential service users. The rationale for multiple drug usage was
not reported.
5. Long-term prescribing of medication for many clients was in existence
with older drugs such as Phenobarbitone and Primidone being
prescribed to a small number of service users in the community (five
in total).
On a more global scale and in line with part two of this thesis, the principle
findings are outlined as follows:
6. All prescribers noted the many complexities involved in making a
diagnosis in the learning disabled population. This stems from poor
verbal abilities and the atypical presentation of many conditions.
7. Prescribers tended to strive for a diagnosis and once they formed a
diagnosis, this rationalized their later prescribing. Very often
diagnoses were based on third party reports, which many prescribers
felt wel8 inaccurate and speculative.
8. The decision of whether to prescribe or not lays solely with the
pl8scriber and decision-making tends not to be multi-disciplinary.
The role of the multi-disciplinary team tends to be seen by prescribers
as a more global role. Hence the author uses the term "clinical
information gathel8rs".
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9. The factors influencing the complexity ofprescribing included drug
profile and side effects, having to rule out underlying physical causes
and pressure from others to prescribe.
10. Prescribers did not feel comfortable prescribing solely for challenging
behaviour yet in practice this is a common occurrence.
11. Prescribers felt particularly uncomfortable when they are called for
crisis intervention and feel prescribing is the last option left.
12. Although prescribers felt uncomfortable with prescribing two or more
medications (polypharmacy or copharmacy), in clinical practice this is
a routine practice.
13. Despite litigation and legislation around the issue of informed
consent, one prescriber felt this to be a source of discomfort.
14. No prescribers in the study made reference to guidelines regarding
appropriate prescribing. In terms ofan educational model of mental
health & psychopharmacology, prescribers felt this necessary for
front-line staff and not members of the multi-disciplinary team.
From the above synopsis of findings of this thesis, an overall underlying
theme emerges, and this relates to the application of guidelines regarding
appropriate prescribing for the learning disabled population. To date in
many organizations there are no guidelines in place which regulate the
prescribing of such medications. This is an area which requires urgent
attention on the part of service providers in Ireland as in many countries
such as the UK and USA such guidelines are implemented and enforced
(Kalachnik et at, 1998).
Elsewhere the author has reviewed the implementation of such guidelines
and the importance of a multi-disciplinary approach in prescribing. To
condude this section, the author will present a synopsis of the fourteen
guidelines of appropriate prescribing as developed and discussed by
Kalachnik and colleagues (1998). The importance of further developing
these guidelines for
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Irish learning disability services will be discussed in the final section of the
current chapter.
Table 13.1: A table outlining a synopsis of Kalachnik et at's (1998)
Psychotropic Medication Guidelines. Taken from Coughlan (2000c)
Synopsis of Kalachnik et at (1998) Key Elements.
Psychotropic Medication
Guidelines.
1. Know the purpose of the drug being Psychotropic versus psychoactive
prescribed medication - refer to Aman &Singh's
(1991) definitions.
2. Any medication prescribed should not Medication as a means of chemical
be used in excess, or in place of any restraint - utilise other treatment
other form of treatment for purposes of methods if appropriate &applicable
convenience.
3. Medication should be prescribed as The multi-disciplinary team of
part of a multi-disciplinary team professionals should decide the best
approach. possible treatment plan for each
individual.
4. Any prescription should arise from a Hypotheses should be generated as to
thorough functional analysis and the individual's condition and underlying
psychiatric assessment. causes.
5. Written informed consent must be Informed consent of the individual or
obtained. his/her guardian must be obtained prior
to the use of any agent.
6. Importance of Index behaviours & Index or target behaviours need to be
Quality of Life measures specified and measured throughout
treatment.
7. Side effects need dose monitoring Importance of the use of a standardised
rating tool to monitor any possible side
effects of medication.
8. Monitoring of Tardive Dyskinesia Tardive Dyskinesia may develop in
some individuals treated with certain
psychotropic medications (Dopamine
blocking agents). This needs careful
monitoring.
9. Systematic & regular review of Regular reviews are essential is order to
psychotropic prescribing should take determine if medication is having its
place. desired effect.
10. Minimal Effective Dosage should The minimum effective dosage of any
always be used. drug should be used in the treatment
process. Avoid excessive dosages.
11. Avoid frequent changes in Frequent changes of medication should
medication be avoided at all costs due to processes
of pharmacokinetics and
pharmacodynamics.
12. Avoid PolypharmacY Polypharmacy (use of two or more
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medications) should be avoided if
possible. Where an "add-on" drug is
needed, a taPering off process (for the
initial drua) is needed.
13. Aim for a "best-practice" model of Avoid older medications where newer
drug treatment. "atypical" medications may be more
effective, avoid excessive dosage, avoid
long-term use of PRN, avoid use of
drugs where negative side effects are
known.
14. External or Peer review should take All prescribing should be subject to Peer
place - clinical audit. or external review so as to maximise
effectiveness and avoid excessive
Drescribina
13.8 Chapter conclusions: The need for confirmatory follow-up
research and the implementation of prescribing guidelines
The present thesis, comprising of two studies addressed the issue of
prescribing for persons with learning disability from both a quantitative and
qualitative perspective. Hence a global picture of prescribing within Irish
services was ascertained by means of conducting this piece of research.
Not only does this thesis provide a unique understanding of prescribing for
the learning disabled population, it also highlights the issues within this field
which need to be addressed not only from the clinical practice perspective
but also from the perspective of future research endeavours. The purpose
of the final section of this thesis is to highlight the need for follow-up
confirmatory research within this area in addition to the development and
implementation of prescribing guidelines within Irish services for persons
with learning disability.
On the issue of follow-up research of this nature, there is now the need to
Undertake confirmatory-type research in order to further validate and
develop many of the ideas expressed within this thesis. Although part one
of this thesis is based on traditional quantitative research techniques and is
strongly supported by previous studies of this kind, part two of this thesis
must be viewed within its current limitations. Although qualitative research
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techniques are not new to healthcare research, no similar studies of this
kind exist within the field of learning disability at the time of writing. As a
result comparison of studies is difficult, and the author discusses the
findings within the context of similar research from general practice and how
the findings of such studies have implications for prescribing in learning
disability. Not having an extensive literature on this area in which to
compare and contrast findings could be said to be the most significant
limitation of this study. However this is true of all novel or unique studies
and it is the role of future research to further elaborate on the ideas and
theories expressed in the writings of this thesis.
Regarding the development and implementation of prescribing guidelines in
Irish services, most services fall somewhat short in this area. This is not to
say that services are not actively seeking the implementation of such
gUidelines, but they are certainly in their infancy in the vast majority of
services. Guidelines for the use of psychotropic medications put forward by
Kalachnik et al. (1998) offer a useful starting point in developing appropriate
and useful guidelines for Irish services. Rather than such guidelines
developing from legislation and litigation as in the USA, a more appropriate
framework would be for each service to independently review such
guidelines and apply those of most relevance, prior to any such litigation.
However, whether this will happen in practice remains to be seen. As a
starting point research of a similar nature to the present thesis is required in
order for service providers to be aware of the frequency of prescribing for
clients in their care and the factors, which impinge upon prescribing. In this
respect the development and implementation of guidelines should be
-rational (controlling principles and underlYing reason) and empirical
(capable of being verified or disproved by observation)" (Kalachnik et al.,
1998, p.68).
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13.9 Final Comments
To conclude, many exciting developments are continuing to emerge within
the field of learning disability in recent years. Perhaps the one area where
this is particularly evident is in the provision of mental health services to
persons with learning disability (Moss, Bouras and Holt, 2000) and how
services respond to the needs of such individuals (Day, 1994, Bouras, 1999
and Jacobson, 1999). Recent publications suggest further development of
existing models of service provision so as to accommodate the complex
needs of those with dual diagnosis (Moss et at, 2000) and the development
of specific guidelines for assessing and diagnosing mental health problems
in this population (Einfeld and Tonge, 1999, Clarke and Gomez, 1999). A
typical example of such an approach is the development of the -matrix
model- of mental health services as developed by Thomicroft and Tansella
(1999) for the general population, and further elaborated on, and developed
by Moss et al. (2000) for the learning disabled population.
The implication of such developments for the present thesis lies in the
usefulness of adapting models and theories from the general population and
examining their usefulness for the purposes of the learning disabled
population. Although perhaps as yet in their conceptual stages, they do .
represent a challenge for the future, not only in terms of the mental health
needs of this population but in terms of the interventions used to treat
conditions. After all it is the process of assessment, diagnosis and
formulation that guides the treatment regimens used (MH-SIRG, 2000).
In conclusion the present thesis outlines the usefulness of both quantitative
and qualitative perspectives in understanding the process of prescribing for
persons with learning disability. Quality evidence-based research is
continually required in order to make progress in this area, which will in tum
have implications for clinical practice. It is hoped that by addressing these
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issues the present thesis will stimulate interest among professionals of all
disciplines working with the learning disabled population.
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APPENDIX A
DRUG SURVEY FORM
DRUG SURVEY FORM
Client Name:
-----------------
Client ID:
---------
Gender:
---------
Date of Birth: _ Age:
Level of Learning Disability: _
Residential/Community House: _
Address:
Psychotropic Medication currently prescribed:
1. Dosage:
2. Dosage:
3. Dosage:
4. Dosage:
5. Dosage:
6. Dosage:
7. Dosage:
8. Dosage
Other information of interest:
403
actuallPRN
actual/PRN
actual/PRN
actual/PRN
actual/PRN
actuallPRN
actual/PRN
actuallPRN
APPENDIX B
PRESCRIBING CHECKLIST
Medication Prescribing Checklist.
Over a time period of five days, please fill out all relevant details below for
every l!1i!!Lservice user for which any form of medication is prescribed.
I Demographic/Service User Informatioil!
Gender:
Age:
Male
Under 18 yrs. 18-30
Female
31-40 41-50 51-60 60+
Level of
Learning Disability: Mild Moderate Severe Profound
Living
Environment:
Home Community Residential/Institution
IInformation about Service Users Presenting Behaviour(!>/SymptomsJ
lMedical/Physica/~
Viral Infection
Respiratory Disorders
Sexual Disorders
Pain Disorders
Cardiovascular Disorders
Neurological Disorders
Skin Disorders
Allergic Disorders
Gastrointestinal Disorders
Nutritional Disorders
Anxiety
Withdrawn
Hysterical/Hyperactive
Sleep problems
Other (please specify) _
lBehavioura/~
Hitting/kicking staff or peers
Damage to property
Screaming & Shouting
Self-injurious behaviour
Depression
Other (please specify) _
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Anti-emetic
Anticonvulsant
Movement Disorder
CNS Stimulant
!Situational/Other Factors :1
Recent change of environment (institution/community move) -
Shortage/change of staff
Medication specifically requested
by staff member(s)
Expectation of client themselves
O~er(~easesped~)~~~~~~~~~~~~~~~~~~
!Resulting Medication<!) Prescribed:1
Please tick/outline medication(s) prescribed:
Hypnotic
Anxiolytic
Antipsychotic
Antidepressant
~er(~easesped~)~~~~~~~~~~~~~~~~~~
Dosage: Actual PRN
Information about Prescriber:1
Gender: Male Female
Length of
time prescribing:
0-5 yrs. 6-10yrs. 11-15yrs. 16-20yrs >20yrs
Do you prescribe mainly for:
Adults with
Learning Disability
Any Commentslviews:
Children with
Learning Disability
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Both Children & Adults
with Learning Disability
APPENDIX C
SEMI-STRUCTURED INTERVIEW
SCHEDULE
Dr. XXX,
Consultant Psychiatrist,
Address XXX,
Address XXX,
City XXX.
Date XXX.
Dear Dr. XXX,
Presently I am undertaking my Ph.D. (UCC), while working as
Psychology Assistant with the Brothers of Charity Services,
Bawnmore, Limerick. My Ph.D. to date has examined patterns of
prescribing for persons with learning disability in both residential
and community facilities throughout the Mid-West Region. For
the final stage of my study I am hoping to expand upon, and
further research some of the issues raised in relation to
prescribing for people with learning disability.
For the next phase of my research I am hoping to interview
Consultant Psychiatrists working in Learning Disability Services
throughout the Republic of Ireland.
I write this letter in the hope that you would be interested in
participating in the study. To participate in the study, the
following two phases would be involved:
Phase 1:
A brief Prescribing Checklist will be forwarded to all Consultant
Psychiatrists interested in participating in the study. This
Checklist is brief (1 page approx.) and will involve recording
details about service users for whom they prescribe any form of
medication over a one week period.
Phase 2:
The second phase of the study will involve a short semi-
structured interview with Consultant Psychiatrists. This recorded
interview will be approximately twenty minutes in duration and
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will examine some general issues in relation to prescribing for the
learning disabled population.
Note on Confidentiality:
As with any type of research, confidentiality is of the utmost
importance. The present study will involve completion of
Prescribing Checklists by Consultants. It will also involve
recording information by means of an interview.
Once each phase of the study has been completed, all data will be
transferred and original manuscripts will be destroyed
immediately. In relation to data gathered from interviews, such
data will be transcribed by the author and any recording devices
such as tapes or discs holding this information will be
subsequently destroyed.
Finally, by participating in this study, it is envisaged that it will
have a significant impact on both current academic knowledge
and clinical practice.
I thank you for taking the time to read this letter and I will be
following this letter up by means of a phonecall within the next
ten days.
Best Regards,
Barry J. Coughlan
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APPENDIX D
COpy OF LETTER SENT TO
CONSULTANTS
Prescribing Interview Schedule - Revised 2.
List ofquestions to be asked throughout interview.
1. Can you describe a recent case in which you prescribed medication?
- can you tell me something about the background to the case?
What were the presenting behaviours?
What kind of medication did you prescribe for this person?
- How did you feel about prescribing for this person?
2. From your experience in the field of learning disability, what are the
common presentations which give rise to prescribing?
- could you give me some relevant examples?
3. What factors do you feel influence the complexity of prescribing?
- what would you do in the case of a client who is non-verbal who
cannot describe how they are feeling?
in what instances would you rely on third-party information?
how would you describe the kinds of records kept that you would
have access to prior to prescribing?
in general, how do you feel about this sort of information?
how much do you think other peoples expectations may influence
prescribing?
4. What issues do you feel are important In relation to prescribing and
challenging behaviour?
- could you describe some of these issues?
- how do you feel they relate to prescribing?
- what do you feel is the role of medication in relation to behavioural
difficulties?
5. Can you describe a case In which you felt "uncomfortable" about
prescribing?
- can you tell me about the case?
- presentation of the problem?
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